<SEC-DOCUMENT>0001601485-26-000042.txt : 20260511
<SEC-HEADER>0001601485-26-000042.hdr.sgml : 20260511
<ACCEPTANCE-DATETIME>20260511161219
ACCESSION NUMBER:		0001601485-26-000042
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		84
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260511
DATE AS OF CHANGE:		20260511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39990
		FILM NUMBER:		26963337

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>eltx-20260331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054,d:f1548e21dc2e4a12ac1a19ae3433fb4d-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:eltx="http://www.eltx.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>eltx-20260331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-25">March 31, 2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-28">12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001601485</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">False</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-67" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-292">0.1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="eltx-20260331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>eltx:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>eltx:entity</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2024RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2026RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-28</xbrli:startDate><xbrli:endDate>2026-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eltx:AngionCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">eltx:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">eltx:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eltx:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:The2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:Inducement2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:March2024PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">eltx:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">eltx:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">eltx:GKCCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">eltx:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">eltx:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2026ATMProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-05-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:116%">UNITED STATES</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:116%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:116%">_____________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:116%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:116%">_____________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">For the quarterly period ended March&#160;31, 2026</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:116%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">For the transition period from &#160;&#160;&#160;to </span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-4">001-39990</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:116%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-5">Elicio Therapeutics, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-6">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">11-3430072</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">451 D Street, 5th Floor</ix:nonNumeric>,  <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">02210</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">857</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">209-0050</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">Registrant's telephone number, including area code</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-14">Common Stock, par value $0.01</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-15">ELTX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-16">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-17">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-18">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-19">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-20">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:116%">The number of shares of the registrant&#8217;s common stock outstanding as of May&#160;8, 2026 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">19,086,081</ix:nonFraction>.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span><br/></span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_19">PART I FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_22">Item 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_25">Condensed Consolidated Balance Sheets (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_31">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_34">Condensed Consolidated Statements of Stockholders&#8217; </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_34">Equity </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_34">(Deficit) </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_34">(unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_40">Condensed Consolidated Statements of Cash Flows (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_40">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_43">Notes to Unaudited Interim Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_43">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_100">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_100">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_124">Item 3. Quantitative and Qualitative Disclosures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_124">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_127">Item 4. Controls and Procedures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_127">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_130">PART II OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_133">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_133">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_136">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_136">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_139">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_139">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_142">Item 3. Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_142">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_145">Item 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_145">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_148">Item 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_148">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_151">Item 6. Exhibits </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_151">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_154">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_154">32</a></span></div></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">2</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q, including the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations, are forward-looking statements.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our financial condition, including our ability to obtain the funding necessary to advance the development of ELI-002 7P and any other current or future product candidates, our ability to continue as a going concern and our cash runway;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to utilize our platform to develop a pipeline of product candidates to address unmet needs in oncology and other disease areas;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, progress and results of clinical trials for ELI-002 7P, and other current or future product candidates we may develop, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the studies or trials will become available, and the timing, progress and results of our research and development programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, scope and likelihood of regulatory filings and approvals, including timing of Investigational New Drug applications and U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval of ELI-002 7P and any current or future product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, scope or likelihood of foreign regulatory filings and approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to develop and advance our current product candidates and programs into, and successfully complete, clinical studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our manufacturing, commercialization, marketing capabilities, strategy and associated timelines;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the need to hire additional personnel and our ability to attract and retain such personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the size of the market opportunity for our product candidates, including estimates of the number of patients who suffer from the diseases we are targeting;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">expectations regarding the approval and use of our product candidates in combination with other drugs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">expectations regarding potential for accelerated approval or other expedited regulatory designation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our competitive position and the success of competing therapies that are or may become available;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our anticipated research and development activities and projected expenditures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">existing regulations and regulatory developments in the United States, Europe and other jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the extent to which global economic and political developments, including the ongoing conflict between Ukraine and Russia, the conflicts in the Middle East, including the conflict between Israel and Palestine and the conflict between Israel and Iran, geopolitical tensions with China, and other geopolitical events, as well as the macroeconomic conditions, including tariffs, inflation, volatility in interest rates, potential for economic slowdown or recession and potential government shutdowns, will affect our business operations, clinical trials, or financial condition;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our expectations regarding other macroeconomic trends;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our intellectual property position, including the scope of protection we are able to establish and maintain for intellectual property rights covering ELI-002 7P, other current or future product candidates we may develop, including the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates, and for the manufacture of our product candidates for clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to have manufactured sufficient supplies of drug product for clinical testing and commercialization;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our projected financial performance;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our anticipated use of proceeds from potential financing activities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our planned operating expenses and capital expenditure requirements; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the potential impact of anticipated funding pressures and the expected effect from U.S. export controls and tariffs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the impact of laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in the sections titled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2025 (the &#8220;Form 10-K&#8221;) filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 12, 2026, as may be updated or supplemented in subsequent filings with the SEC, and elsewhere in this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and are based on assumptions as of the date they were made. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. In addition, statements such as &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into or review of all relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely on these statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q also contains estimates, projections and other information concerning our industry, our business and the markets for certain drugs, including data regarding the estimated size of those markets, their projected growth rates and the incidence of certain medical conditions. Information that is based on estimates, forecasts, projections or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, medical and general publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In this Quarterly Report on Form 10-Q, unless the context indicates otherwise, the terms &#8220;Company,&#8221; &#8220;Elicio,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Elicio Therapeutics, Inc. and our wholly-owned subsidiaries. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Trademarks</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this Quarterly Report on Form 10-Q are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">4</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Part I FINANCIAL INFORMATION</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_22"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Item 1. Financial Statements</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_25"></div><div style="text-align:center;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Condensed Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">14,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">18,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-34">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">16,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">19,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-37">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-38">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease, right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-39">4,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-40">4,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Restricted cash, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-41">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-42">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-43">995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-44">770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-45">22,689</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-46">25,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Liabilities and stockholders&#8217; (deficit) equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-47">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-48">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">5,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">7,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">8,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-55">3,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-56">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">3,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Long-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">9,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">9,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-61">24,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-62">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Commitments and contingencies - Note 9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-63"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-64"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Stockholders' (deficit) equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-65"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-66">0.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-67"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-68">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-69">18,654,350</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-70">17,814,762</ix:nonFraction> shares issued at March&#160;31, 2026 and December&#160;31, 2025, respectively; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-71">18,639,895</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-72">17,800,307</ix:nonFraction> outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-73">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-74">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-75"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-76">14,455</ix:nonFraction></ix:nonFraction> shares outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-77">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-78">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-79">244,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-80">235,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-81">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-82">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-83">245,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-84">233,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total stockholders' (deficit) equity</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-85">1,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-86">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total liabilities and stockholders'(deficit) equity </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-87">22,689</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-88">25,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:116%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">5</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-89">6,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-90">7,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-91">3,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-92">2,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-93">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-94">10,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-95">10,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-96">10,736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other (expense) income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-97">984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-98">507</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign exchange transaction gain</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-99">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-101">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-102">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-103">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-104">176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total other expense, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-105">1,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-106">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-107">11,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-108">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Other comprehensive income:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31.6pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-109">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-110">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-111">11,818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-112">11,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss per common share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-113"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-114">0.65</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-115"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-116">0.87</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average common shares and pre-funded warrants outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-117"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-118">18,211,745</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-120">12,950,574</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:116%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">6</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">For the Three Months Ended March 31, 2026</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:34.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.428%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Total <br/>Stockholders'<br/>Equity (Deficit)</span></td></tr><tr style="height:21pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-121">17,814,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-122">178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-123">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-124">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">235,407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-126">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-127">233,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-128">1,636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-129">0.2</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-130">819,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-131">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-132">7,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-133">7,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-134">20,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-135">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-136">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-137">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-138">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-139">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-140">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-141">11,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-142">11,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-143">18,654,350</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-144">186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-145">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-146">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-147">244,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-148">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-149">245,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-150">1,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">For the Three Months Ended March 31, 2025</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.229%"><tr><td style="width:1.0%"/><td style="width:34.743%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.277%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated <br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">(Deficit) Equity</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-151">11,043,837</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-152">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-153">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-154">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-155">183,004</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-156">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-157">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-158">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-159">0</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-160">106,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-161">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-162">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-163">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-164">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-165">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-166">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of senior note payable into common stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-167">0.3</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-168">3,500,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-169">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-170">20,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-171">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and warrants from the January 2025 Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-172">0.8</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="eltx:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-173">1,261,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="f-174">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-175">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-176">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon the exercise of common warrants</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-177">68,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-178">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-179">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-180">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-181">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-182">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-183">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-184">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-185">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-186">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-187">15,983,191</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-188">160</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-189">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-190">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-191">214,348</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-192">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-193">205,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-194">8,904</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"> </span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:116%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">7</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_40"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">11,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-197">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-198">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of right-of-use assets, operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-199">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-200">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:InterestExpenseNoncash" format="ixt:fixed-zero" scale="3" id="f-201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:InterestExpenseNoncash" scale="3" id="f-202">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-203">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-204">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-205">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="f-206">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-207">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-208">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-209">504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-210">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-211">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:fixed-zero" scale="3" id="f-212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-213">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-214">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="eltx:IncreaseDecreaseInAccruedExpenses" scale="3" id="f-215">602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="eltx:IncreaseDecreaseInAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-216">2,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="f-217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-218">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-219">240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-220">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-221">11,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-222">10,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-223">7,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" scale="3" id="f-224">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Payment of offering costs for the issuance of common stock from at-the-market offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" scale="3" id="f-225">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" format="ixt:fixed-zero" scale="3" id="f-226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from the exercise of common warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="f-228">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="f-229">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-230">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-231">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-232">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-233">8,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-234">10,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Effect of foreign currency on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-235">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-236">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-237">3,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-238">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-239">19,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-240">19,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash, cash equivalents, and restricted cash at the end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-241">15,654</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-242">19,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Components of cash and cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-243">14,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-244">18,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-245">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-246">1,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-247">15,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-248">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Supplemental disclosure of noncash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" scale="3" id="f-249">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" format="ixt:fixed-zero" scale="3" id="f-250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of common stock warrants upon settlement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:FairValueOfCommonStockWarrantsUponSettlement" format="ixt:fixed-zero" scale="3" id="f-251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:FairValueOfCommonStockWarrantsUponSettlement" scale="3" id="f-252">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Conversion of Convertible Note and interest into equity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="eltx:SettlementOfPromissoryNotesPayable" format="ixt:fixed-zero" scale="3" id="f-253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="eltx:SettlementOfPromissoryNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-254">20,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:116%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">8</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">ELICIO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_46"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-255" continuedAt="f-255-1" escape="true">Description of the Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="f-255-1" continuedAt="f-255-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mutant Kirsten rat sarcoma viral oncogene homolog (&#8220;mKRAS&#8221;)-positive pancreatic cancer, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these unaudited interim condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2026, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-256">245.5</ix:nonFraction> million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. The Company&#8217;s sources of liquidity are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="eltx:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-257">200</ix:nonFraction>&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC (&#8220;Jones&#8221;), as agent, to provide for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" name="eltx:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-258">40</ix:nonFraction>&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the year ended December&#160;31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-49" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-259">1,717,507</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-50" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-260">9.46</ix:nonFraction> per share under the 2024 ATM Program for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-261">16.2</ix:nonFraction>&#160;million after deducting sales commissions. During the three months ended March 31, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-262">699,678</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-263">9.52</ix:nonFraction> per share for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-264">6.7</ix:nonFraction>&#160;million after deducting sales commissions under the 2024 ATM Program. In March 2026, the Company terminated the 2024 ATM Program and was not subject to any penalties related to the termination.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In February 2026, the Company filed a registration statement on Form S-3 (the &#8220;2026 Registration Statement&#8221;) with the SEC, as subsequently amended in March 2026, that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="eltx:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-265">400</ix:nonFraction>&#160;million. In March 2026, the Company entered into the At Market Issuance Sales Agreement with B. Riley Securities, Inc. (&#8220;B. Riley Securities&#8221;), Jones, and Ladenburg Thalmann &amp; Co. Inc. (&#8220;Ladenburg Thalmann&#8221;), (each an &#8220;Agent&#8221; and collectively, the &#8220;Agents&#8221;), under which the Company may issue and sell, from time to time at its sole discretion,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">up to $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="eltx:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-266">100</ix:nonFraction>&#160;million of shares of common stock in &#8220;at-the-market&#8221; offerings through the Agents under the 2026 Registration Statement and related prospectus filed with the 2026 Registration Statement (the &#8220;2026 ATM Program&#8221; and, collectively with the 2024 ATM Program, the &#8220;ATM Programs&#8221;). During the three months ended March&#160;31, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-267">119,479</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-268">11.42</ix:nonFraction> per share for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-269">1.3</ix:nonFraction>&#160;million after deducting sales commissions under the 2026 ATM Program. The Company incurred offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-270">0.2</ix:nonFraction>&#160;million related to the initial setup of the 2026 ATM Program, of which $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" scale="6" id="f-271">0.2</ix:nonFraction>&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-272">1.1</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2026.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-273">819,157</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-59" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-274">9.80</ix:nonFraction> per share for aggregate net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="eltx:SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" scale="6" id="f-275">8.0</ix:nonFraction>&#160;million after deducting sales commissions and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-276">7.8</ix:nonFraction>&#160;million after deducting offering costs under the ATM Programs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-255-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">January 2025 Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-60" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-277">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-61" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-278">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-279">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-280">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-61" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-281">five years</ix:nonNumeric> from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-282">9.2</ix:nonFraction>&#160;million after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC, LLC (&#8220;GKCC&#8221;), an entity controlled by a member of Elicio&#8217;s board of directors, pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-283">10.0</ix:nonFraction>&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-284">103,225</ix:nonFraction> shares of common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-285">7.75</ix:nonFraction> per share, is immediately exercisable, and expires <ix:nonNumeric contextRef="c-64" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-286">five years</ix:nonNumeric> from the date of issuance. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-287">9.9</ix:nonFraction>&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 8 and 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-288">14.9</ix:nonFraction> million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all. If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Note 2&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-289" continuedAt="f-289-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-290" escape="true"><ix:continuation id="f-289-1" continuedAt="f-289-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December&#160;31, 2025 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s most recent Annual Report on Form 10-K.</span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-291" escape="true"><ix:continuation id="f-289-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis on January 1, 2026. The Company&#8217;s adoption of ASU 2024-04 did not have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div></ix:continuation></ix:nonNumeric><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-293" continuedAt="f-293-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-293-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-294" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-295">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-298">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-299">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-302">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-304">3,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="eltx:WarrantsFairValueDisclosure" scale="3" id="f-305">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-306">3,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-308">3,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-309">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-310">3,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-311">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-314">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-315">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-318">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-320">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="eltx:WarrantsFairValueDisclosure" scale="3" id="f-321">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-322">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-324">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-325">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-326">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">_________________</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at March&#160;31, 2026 and December&#160;31, 2025 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-327" continuedAt="f-327-1" escape="true">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-327-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-328">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-329">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-330">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-332">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-333">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-334" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-79" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-335">76.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-80" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-336">76.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-70" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-337">2.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-73" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-338">2.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-339"><ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-340">76.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-341">67.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-342"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-343">4.0</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-84" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-344">3.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;July 2024 Public Offering&#8221;), consisting of (i) <ix:nonFraction unitRef="shares" contextRef="c-87" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-347">500,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-348">1,800,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-349">2,300,000</ix:nonFraction> shares of common stock, (the &#8220;July 2024 Common Warrants&#8221;). The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-350">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable, and will expire <ix:nonNumeric contextRef="c-91" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-351">five years</ix:nonNumeric> from the issuance date. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, together with its affiliates, to exceed the <ix:nonFraction unitRef="number" contextRef="c-3" decimals="INF" name="eltx:SaleOfStockBeneficialOwnershipLimitationPercentage" scale="-2" id="f-352">19.99</ix:nonFraction>% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of the Stockholder Approval, the July 2024 Common Warrants held by GKCC are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. Refer to Note 8 for further discussion.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2026 and 2025, the Company recognized a change in fair value of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-353">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-354">0.5</ix:nonFraction> million, respectively, on the remeasurement of the liability-classified July 2024 Common Warrants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_61"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-355" continuedAt="f-355-1" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="f-355-1" continuedAt="f-355-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="f-356" continuedAt="f-356-1" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-355-2"><ix:continuation id="f-356-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:PrepaidResearchAndDevelopmentExpenses" scale="3" id="f-357">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:PrepaidResearchAndDevelopmentExpenses" scale="3" id="f-358">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:AdvancedProfessionalFees" scale="3" id="f-359">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:AdvancedProfessionalFees" scale="3" id="f-360">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-361">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-362">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-363">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-364">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-365">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-366">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-367" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-368">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-369">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-370">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-371">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-372">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-373">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-374">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-375">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-376">1,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-377">1,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-378">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-379">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the three months ended March 31, 2026 was an <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="0" id="f-380">immaterial</ix:nonFraction> amount. For the three months ended March 31, 2025, depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-381">0.1</ix:nonFraction> million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-382">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-383">0.8</ix:nonFraction> million for March&#160;31, 2026 and December&#160;31, 2025, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-384" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-385">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-386">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="f-387">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-388">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued clinical trial and research and development costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-389">3,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-390">2,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:AccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-391">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:AccruedInterest" scale="3" id="f-392">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="eltx:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-393">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="eltx:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-394">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-395">5,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-396">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Note 5 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-397" continuedAt="f-397-1" escape="true">Research Grants</ix:nonNumeric></span></div><ix:continuation id="f-397-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases, for $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="eltx:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-398">2.8</ix:nonFraction> million. The development efforts as defined in the first grant agreement were completed in the second quarter of 2023. In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="eltx:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-399">3.1</ix:nonFraction> million. The development efforts as defined in the second agreement were completed in the third quarter of 2024. In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="eltx:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-400">1.5</ix:nonFraction> million. The third grant agreement activities were completed in the second quarter of 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the <ix:nonFraction unitRef="agreement" contextRef="c-103" decimals="INF" name="eltx:NumberOfResearchGrantAgreements" format="ixt-sec:numwordsen" scale="0" id="f-401">three</ix:nonFraction> grant agreements was recorded as contra-expense to offset the research and development costs incurred. For the three months ended March&#160;31, 2025, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-402">0.5</ix:nonFraction> million in research and development expenses related to this project, of which $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="eltx:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" scale="6" id="f-403">0.5</ix:nonFraction> million was reimbursed from available grant funds. Following completion of the third grant agreement with GI Research Foundation during the second quarter of 2025, the remaining $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="eltx:GrantRevenueNonoperating" scale="6" id="f-404">0.4</ix:nonFraction> million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">12</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Note 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-405" continuedAt="f-405-1" escape="true">Common Stock and Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-405-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-406">300,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-407">0.01</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-408">10,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-409">0.01</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-106" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-410">106,823</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-411">7.82</ix:nonFraction> per share under the 2024 ATM Program for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-412">0.8</ix:nonFraction> million after deducting sales commissions. During the year ended December&#160;31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-49" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-413">1,717,507</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-50" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-414">9.46</ix:nonFraction> per share under the 2024 ATM Program for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-415">16.2</ix:nonFraction>&#160;million after deducting sales commissions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-416">699,678</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-52" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-417">9.52</ix:nonFraction> per share under the 2024 ATM Program for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-418">6.7</ix:nonFraction> million after deducting sales commissions. In March 2026, the 2024 ATM Program was terminated by the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-419">119,479</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-420">11.42</ix:nonFraction> per share under the 2026 ATM Program for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-421">1.3</ix:nonFraction> million after deducting sales commissions. The Company incurred offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-422">0.2</ix:nonFraction>&#160;million related to the initial setup of the 2026 ATM Program, of which $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" scale="6" id="f-423">0.2</ix:nonFraction>&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-424">1.1</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2026.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">January 2025 Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors, the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-425">1,261,830</ix:nonFraction> shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-426">1,261,830</ix:nonFraction> shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-427">7.925</ix:nonFraction> per January 2025 Share and accompanying January 2025 Common Warrants. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-62" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-428">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-110" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-429">five years</ix:nonNumeric> from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-430">9.2</ix:nonFraction>&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of Elicio&#8217;s board of directors, pursuant to which the Company issued a <ix:nonFraction unitRef="number" contextRef="c-112" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-431">3</ix:nonFraction>% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-432">20.0</ix:nonFraction>&#160;million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-112" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-433">3</ix:nonFraction>% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-434">19.7</ix:nonFraction>&#160;million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-435">3,500,573</ix:nonFraction> shares of common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-436">20.0</ix:nonFraction>&#160;million plus $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="eltx:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-437">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-438">10.0</ix:nonFraction>&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-439">103,225</ix:nonFraction> shares of common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-440">7.75</ix:nonFraction> per share, is immediately exercisable, and expires <ix:nonNumeric contextRef="c-64" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-441">five years</ix:nonNumeric> from the date of issuance. Refer to Note 11 for further detail.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">13</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 7&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-442" continuedAt="f-442-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-442-1" continuedAt="f-442-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, there was an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-443">1,280,971</ix:nonFraction> shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-444">645,103</ix:nonFraction> shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-445">178,953</ix:nonFraction> shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and <ix:nonFraction unitRef="shares" contextRef="c-118" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-446">456,915</ix:nonFraction> shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to Note 7 &#8211; &#8220;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-447" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes information and activity related to the Company&#8217;s stock options for the three months ended March 31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-448">2,621,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-449">13.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-119" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-450">6.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-451">5,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-452">524,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-453">8.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-454">20,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-455">4.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-456">2,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-457">4.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-458">3,123,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-459">12.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-460">7.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-461">11,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-462">1,574,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-463">18.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-464">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-465">6,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-466">524,793</ix:nonFraction> stock options were granted during the three months ended March 31, 2026. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2026 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-467">6.73</ix:nonFraction>. As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested stock option awards granted was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-468">8.1</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-469">3.2</ix:nonNumeric> years. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-470" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-471">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-472">4.4</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-473">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-474">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-120" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-475">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-121" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-476">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-477">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-478">106.9</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-442-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="f-479" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s restricted stock units (&#8220;RSUs&#8221;) for the three months ended March&#160;31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Restricted Stock Units</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-482">235,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-483">8.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs vested</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" format="ixt:fixed-zero" scale="0" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of March&#160;31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-487">235,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-488">8.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested restricted stock units was $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-489">1.8</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="c-123" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-490">3.8</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-491" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense, which includes expense related to stock options and RSUs, as recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-492">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-493">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-494">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-495">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-496">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-497">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period were determined by Angion&#8217;s board of directors. In February 2026, Elicio amended and restated the ESPP, and filed the amended and restated ESPP as an exhibit to the Annual Form 10-K on March 12, 2026. No offering periods or purchasing periods were active as of March&#160;31, 2026. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-498">453,312</ix:nonFraction> shares remained available for purchase under the ESPP and <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="f-499">no</ix:nonFraction> offerings have been authorized.</span></div></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 8&#8212;<ix:nonNumeric contextRef="c-1" name="eltx:WarrantsAndRightsOutstandingTextBlock" id="f-500" continuedAt="f-500-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-500-1" continuedAt="f-500-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;), certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 1 and 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-501">1,261,830</ix:nonFraction> shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-502">1,261,830</ix:nonFraction> shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrants were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-130" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-503">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-130" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-504">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-131" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-505">five years</ix:nonNumeric> from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-506">9.7</ix:nonFraction> million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 1 and 6, in June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-65" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-507">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-508">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-64" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-509">five years</ix:nonNumeric> from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-510">0.6</ix:nonFraction> million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-500-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March&#160;31, 2026, there was no warrant activity in the period. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-511" continuedAt="f-511-1" escape="true">The following tables summarize information regarding the warrants outstanding at March&#160;31, 2026:</ix:nonNumeric></span></div><ix:continuation id="f-511-1"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Underlying the Warrants Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-133" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-512">144,814</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-134" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-513">53.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-135" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-514">3.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-515">3,950</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-516">76.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-138" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-517">2.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-518">1,032,702</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-519">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-520">1,600,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-142" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-521">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-522">441,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-523">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-145" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-524">3.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-525">1,600,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-526">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-148" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-527">3.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-528">1,261,830</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-529">7.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-150" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-530">3.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">June 2025 Common Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-531">103,225</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-152" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-532">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-153" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-533">4.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at March&#160;31, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-534">6,188,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-535">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-536">3.5</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of March&#160;31, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div></ix:continuation></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 9&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-537" continuedAt="f-537-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-537-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from the Massachusetts Institute of Technology (&#8220;MIT&#8221;), which agreement has been amended from time to time to add additional intellectual property rights to the Company&#8217;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from <ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="eltx:RoyaltyRatePercent" scale="-2" id="f-538">0.25</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-156" decimals="4" name="eltx:RoyaltyRatePercent" scale="-2" id="f-539">2.00</ix:nonFraction>%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company would be required to pay a total of up to $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="eltx:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" scale="6" id="f-540">26.2</ix:nonFraction>&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur. <ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="0" id="f-541">No</ix:nonFraction> such expenses were recorded in the three months ended March 31, 2026 and 2025. <ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="0" id="f-542">No</ix:nonFraction> commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="eltx:CollaborativeArrangementFutureMinimumMaintenancePayments" scale="6" id="f-543">0.1</ix:nonFraction>&#160;million for the year ended December&#160;31, 2026 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">16</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 10&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-544" continuedAt="f-544-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-544-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;). The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-545">11.1</ix:nonFraction>&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#8220;ROU&#8221;) lease asset of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-546">8.0</ix:nonFraction>&#160;million with a corresponding lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-547">8.0</ix:nonFraction>&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:ProceedsFromSecuredLinesOfCredit" scale="6" id="f-548">0.7</ix:nonFraction>&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2026 and December&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for the three months ended March 31, 2026 and 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-549">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-550">0.3</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" id="f-551" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-552">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-553">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-554">3.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-46" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-555">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-556">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-46" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-557">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-558" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">As of March&#160;31, 2026, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2026 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-559">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-560">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-561">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-562">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-563">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-564">5,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-565">834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-566">4,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-567">1,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-568">3,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Note 11 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-569" continuedAt="f-569-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-569-1" continuedAt="f-569-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 6, in August 2024, the Company closed the Convertible Note Financing with GKCC pursuant to which the Company issued the Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-570">20.0</ix:nonFraction> million. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-112" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-571">3</ix:nonFraction>% per annum, and had an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-572">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-573">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-574">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="eltx:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-575">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-569-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Notes 1 and 8, in June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-576">10.0</ix:nonFraction>&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus <ix:nonFraction unitRef="number" contextRef="c-66" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-577">5.00</ix:nonFraction>%, provided that the maximum interest rate shall not exceed <ix:nonFraction unitRef="number" contextRef="c-164" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-578">12.5</ix:nonFraction>% per annum, with an initial interest payment date of July 1, 2026. As of March&#160;31, 2026, the interest rate was <ix:nonFraction unitRef="number" contextRef="c-165" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-579">12.5</ix:nonFraction>% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by <ix:nonFraction unitRef="number" contextRef="c-166" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-580">3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-167" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-581">2</ix:nonFraction>%, or <ix:nonFraction unitRef="number" contextRef="c-168" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-582">1</ix:nonFraction>%, respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of March&#160;31, 2026, the Company was in compliance with all covenants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-583">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-584">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-64" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-585">five years</ix:nonNumeric> from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of <ix:nonFraction unitRef="number" contextRef="c-169" decimals="4" name="eltx:ClassOfWarrantOrRightOwnershipPercentMaximum" scale="-2" id="f-586">49.99</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-587">0.6</ix:nonFraction> million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-588">9.9</ix:nonFraction> million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of March&#160;31, 2026, the net carrying value of the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-589">9.5</ix:nonFraction> million and the debt discount for the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="f-590">0.5</ix:nonFraction> million. For the three months ended March 31, 2026, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-591">0.1</ix:nonFraction> million in accretion of the debt discount and $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="f-592">0.3</ix:nonFraction> million in accrued interest recognized on the consolidated balance sheet.</span></div></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_88"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 12&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-593" continuedAt="f-593-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-593-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company did <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-594"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-595">no</ix:nonFraction></ix:nonFraction>t record a provision or benefit for income taxes during the three months ended March&#160;31, 2026 or 2025. As of March&#160;31, 2026 and December&#160;31, 2025, the Company continued to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December 31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.</span></div></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 13&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-596" continuedAt="f-596-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="f-596-1" continuedAt="f-596-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-597" continuedAt="f-597-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2026 and 2025 as follows (in thousands, except share and per share data):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-596-2"><ix:continuation id="f-597-1"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-598">11,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-599">11,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-600"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-601">18,211,745</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-602"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-603">12,950,574</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-604"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-605">0.65</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-606"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-607">0.87</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-608" continuedAt="f-608-1" escape="true">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</ix:nonNumeric></span></div><ix:continuation id="f-608-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-609">3,123,218</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-610">2,265,453</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-173" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-611">3,555,319</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-612">3,642,099</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested shares under restricted stock grants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-613">235,234</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-614">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-615">6,913,771</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-616">5,907,552</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 14 &#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-617" continuedAt="f-617-1" escape="true">Related Party Transactions</ix:nonNumeric></span><ix:continuation id="f-617-1" continuedAt="f-617-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></ix:continuation></div><ix:continuation id="f-617-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-618">1,032,702</ix:nonFraction> shares of common stock. As of March&#160;31, 2026, all <ix:nonFraction unitRef="shares" contextRef="c-139" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-619">1,032,702</ix:nonFraction> of the March 2024 Pre-Funded Warrants held by GKCC remained outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">July 2024 Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As part of the July 2024 Public Offering described in Note 3, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors, purchased <ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-620">1,600,000</ix:nonFraction> of the July 2024 Pre-Funded Warrants and <ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-621">1,600,000</ix:nonFraction> of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, all of the <ix:nonFraction unitRef="shares" contextRef="c-141" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-622">1,600,000</ix:nonFraction> July 2024 Pre-Funded Warrants and accompanying <ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-623">1,600,000</ix:nonFraction> July 2024 Common Warrants held by Yekaterina Chudnovsky remained outstanding. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Jay Venkatesan, a member of the Company&#8217;s board of directors, and certain independently managed family trusts  purchased <ix:nonFraction unitRef="shares" contextRef="c-177" decimals="0" name="eltx:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-624">200,000</ix:nonFraction> of the July 2024 Pre-Funded Warrants and <ix:nonFraction unitRef="shares" contextRef="c-177" decimals="0" name="eltx:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-625">200,000</ix:nonFraction> of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-178" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-626">200,000</ix:nonFraction> of the July Common Warrants held by Jay Venkatesan and the family trusts remained outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-627">20.0</ix:nonFraction> million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-628">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-629">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-630">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="eltx:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-631">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company closed the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-632">10.0</ix:nonFraction> million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-633">9.9</ix:nonFraction> million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-64" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-634">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. As of March&#160;31, 2026, the June 2025 Common Warrant held by GKCC remained outstanding.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">19</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 15 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-635" continuedAt="f-635-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-635-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has <ix:nonFraction unitRef="entity" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-636">one</ix:nonFraction> reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-637" continuedAt="f-637-1" escape="true">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-637-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-638">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-639">4,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-640">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-641">2,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-642">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-643">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-644">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-645">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:RecoveryOfDirectCosts" format="ixt:fixed-zero" scale="3" id="f-646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-647">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-648">1,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-649">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-650">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-651">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-652">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" scale="3" id="f-653">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-654">11,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-655">11,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-656">22,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-657">28,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other segment items include interest income, interest expense, and change in the fair value of liability-classified warrants.</span></div></ix:continuation></ix:continuation><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_480"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 16&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-658" continuedAt="f-658-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-658-1" continuedAt="f-658-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of March&#160;31, 2026 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of March&#160;31, 2026, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2026 ATM Program</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="f-658-2" continuedAt="f-658-3"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the period ended March 31, 2026 through </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">May&#160;8, 2026</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-658-3">, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-191" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-659">445,456</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-660">5.0</ix:nonFraction> million under the 2026 ATM Program.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">20</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">You should read the following discussion and analysis of our financial condition and results of operations together with our condensed</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q and in our audited financial statements and accompanying notes for the years ended December 31, 2025 and 2024 included in the Form 10-K. In addition to the historical financial information, this discussion contains forward-looking statements that involve risks, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions, forecasts and projections. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors, including those set forth under the sections titled &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q and the Form 10-K, which you should read carefully to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section titled </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Forward-Looking Statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">at the beginning of this report.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_103"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (&#8220;CRC&#8221;), lung cancer and other mKRAS-positive cancers. We intend to build on recent clinical successes in the personalized cancer immunotherapy space to develop effective, off-the-shelf immunotherapies. Our proprietary Amphiphile (&#8220;AMP&#8221;) technology aims to enhance the education, activation and amplification of cancer-specific T cells relative to conventional immunotherapy strategies, with the goal of promoting durable cancer immunosurveillance in patients. Recent advances have identified T cell responses as a key component of effective cancer immunotherapy, and we believe our AMP technology can generate robust T cell responses in patients that can potentially translate to meaningful clinical benefit. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the therapeutic utility of currently approved and development stage cancer immunotherapies is limited in many cases due to their inability to sufficiently localize to lymph nodes and adequately engage with the critical immune cells responsible for stimulating adaptive immunity. Our AMP technology is specifically intended to localize payloads to lymph nodes leading to the generation of a robust T cell response that we believe is critical to generate an anticancer immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our lead programs focus on our cancer immunotherapy product candidates, which target biologically validated driver tumor mutations using common and well-characterized neoantigens. This strategy results in an &#8220;off-the-shelf&#8221; therapeutic option allowing patients to receive treatment without delays due to manufacturing timelines and without the increased costs associated with personalized immunotherapy approaches. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical pipeline includes the lymph node targeted cancer immunotherapy ELI-002 7P, currently being evaluated in a Phase 2 study, designed to stimulate an immune response against mKRAS pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), the most common form of pancreatic cancer. The ELI-002 7P formulation is designed to provide broad immune responses targeting seven Kirsten rat sarcoma viral oncogene homolog mutations that are observed in approximately 88% of PDAC patients and 25% of all solid tumors, thereby increasing the potential patient population for ELI-002 7P beyond PDAC alone. In August 2025, we announced that following the Independent Data Monitoring Committee&#8217;s (&#8220;IDMC&#8221;) pre-specified interim review of unblinded safety and efficacy data in our Phase 2 AMPLIFY-7P study in mKRAS-driven PDAC, the IDMC recommended that the trial continue to the final analysis without modifications. In addition, the IDMC confirmed the favorable safety profile of ELI-002 7P as of such date. The final disease-free survival analysis is anticipated mid-year 2026. ELI-002 2P (2-peptide formulation) has been studied previously in the Phase 1 (AMPLIFY-201) trial in patients with high relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy. ELI-002 2P and ELI-002 7P also have been studied in patients with mKRAS-positive CRC in Phase 1 studies. The AMPLIFY-201 Phase 1 data for PDAC and CRC was presented at the ESMO Immuno-Oncology Congress 2024 and published in Nature Medicine (Wainberg et al, 2025) and included a 16.3-month median recurrence-free survival and 28.9-month median overall survival for the full study population. In the future, we plan to expand ELI-002 7P to other indications including mKRAS positive lung cancer and other mKRAS positive cancers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our preclinical pipeline includes the lymph node targeted immunotherapies ELI-007, currently being evaluated in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers, and ELI-008, currently being evaluated in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. We believe that each of our immunotherapy product candidates, if approved, has the potential to reduce the risk of recurrence of tumors carrying specific oncogenic driver mutations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operations to date have been financed primarily by aggregate net proceeds of $227.5 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant operating losses. Our net loss was $11.8 million and $11.2 million for the three months ended March&#160;31, 2026 and 2025, respectively. As of March&#160;31, 2026, we had an accumulated deficit of $245.5&#160;million and cash and cash equivalents of $14.9 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway. As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations into the fourth quarter of 2026 based on our current financial operating plan. This period could be shortened or lengthened if there are any significant increases or decreases in planned or actual spending on development programs or more rapid progress of development programs than anticipated. There is no assurance that financing will be available when needed to allow us to continue as a going concern. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. We plan to address this condition through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all. If we are unable to obtain additional capital when and as needed to continue as a going concern, we might have to further reduce or scale back our operations and/or liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses. We expect to continue to incur net losses for the foreseeable future, and we expect our research and development expenses, general and administrative expenses, and capital expenditures will continue to increase. In particular, we expect our expenses to increase as we continue our development of, and seek regulatory approvals for, our product candidates, as well as hire additional personnel, pay fees to outside consultants, attorneys and accountants, and incur other increased costs associated with being a public company. In addition, if and when we seek and obtain regulatory approval to commercialize any product candidate, we will also incur increased expenses in connection with commercialization and marketing of any such product. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">advance our lead product candidate, ELI-002 7P, to late-stage clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">advance our preclinical programs to clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expand our pipeline of product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">seek regulatory approval for our investigational medicines;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">maintain, expand, protect and defend our intellectual property portfolio;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">acquire or in-license technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expand our clinical, scientific, management and administrative teams; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">operate as a public company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations into the fourth quarter of 2026 based on our current plan. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have not had any products approved for sale. We do not expect to generate any product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. As a result, until such time, if ever, that we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed or on favorable terms, if at all. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">22</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_106"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Components of Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following discussion summarizes the key factors our management believes are necessary for an understanding of our financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operating expenses since inception have consisted primarily of research and development expenses and general and administrative costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses consist primarily of costs incurred for the development of our product candidates and our drug discovery efforts, which include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">personnel costs, which include salaries, benefits, and equity-based compensation expense;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expenses incurred under agreements with consultants and contract organizations that conduct research and development activities on our behalf;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to sponsored research service agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to production of preclinical and clinical materials, including fees paid to contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory and vendor expenses related to the execution of preclinical studies and planned clinical trials; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory supplies and equipment used for internal research and development activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expense all research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and service providers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses are not currently tracked on a program-by-program basis. We use our personnel and infrastructure resources across multiple research and development programs directed toward identifying and developing product candidates. Substantially all our research and development costs are incurred on the development of ELI-002 7P and our preclinical candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, including investments in conducting clinical trials, manufacturing and otherwise advancing our programs. The process of conducting the clinical research necessary to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. At this time, we cannot reasonably estimate the nature, timing and costs of the efforts that will be needed to complete the development of, or the period, if any, in which material net cash inflows may commence from ELI-002 7P or any of our preclinical candidates. This is due to the numerous risks and uncertainties associated with developing drugs, including the uncertainty of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the scope, rate of progress and expense of our research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">clinical trials and early-stage results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the terms and timing of regulatory approvals; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability to market, commercialize and achieve market acceptance for ELI-002 7P, or any of our preclinical candidates that we or our future collaboration partners may develop in the future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any of these variables with respect to the development of ELI-002 7P, or any other of our preclinical candidates that we may develop could result in a significant change in the costs and timing associated with the development of such candidates. For example, if the FDA or other regulatory authority were to require us to conduct preclinical and clinical studies beyond those which we currently anticipate will be required for the completion of clinical development or if we experience significant delays in enrollment in any clinical trials, we could be required to expend significant additional financial resources and time on the completion of our clinical development programs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our general and administrative expenses consist primarily of personnel costs, including equity-based compensation, and other expenses for outside professional services, including marketing, legal, audit and accounting, facility-related costs not otherwise included in research and development expenses, and recruiting. We expect our general and administrative expenses to increase over the next several years to support our continued research and development activities, manufacturing activities, increased costs of expanding our operations and operating as a public company. These increases will likely include increases related to the hiring of additional personnel and legal, regulatory and other fees and services associated with maintaining compliance with the Nasdaq Marketplace Rules or the Nasdaq Listing Rules and SEC requirements, accounting and audit fees, director and officer insurance costs and investor relations costs associated with being a public company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other (Expense) Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2026 and 2025, other income and expense consisted primarily of interest income, foreign exchange transaction gains, interest expense, and the change in fair value of our warrant liabilities. </span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_109"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Comparison of the Three Months Ended March 31, 2026 and 2025</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes our results of operations for the periods indicated (in thousands, except percentages):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">% Change</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Operating expenses:</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:20pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;text-indent:20pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,845&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,958&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:30pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">10,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">10,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(134)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Loss from operations</span></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(10,602)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(10,736)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total other expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Net loss</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(11,823)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(11,209)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(614)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses were $6.8&#160;million for the three months ended March 31, 2026, compared to $7.8&#160;million for the three months ended March 31, 2025. The decrease of $1.0&#160;million was primarily due to less clinical trial costs as the Phase 2 study of ELI-002 7P continues and the patients moved out of the active dosing phase and into the follow up phase of the trial.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses were $3.8 million for the three months ended March 31, 2026, compared to $3.0 million for the three months ended March 31, 2025. The increase of $0.9&#160;million was primarily due to increased Company headcount resulting in increased personnel costs and a slight increase in professional fees.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other expense for the three months ended March 31, 2026 was $1.2 million compared to $0.5 million for the three months ended March 31, 2025. The increase of $0.7&#160;million was primarily due to the change in fair value associated with the outstanding liability-classified common warrants and the interest related to the June 2025 Promissory Note.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">24</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sources and Uses of Liquidity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operations through March&#160;31, 2026 have been financed primarily by aggregate net proceeds of $227.5 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant operating losses. Our net loss was $11.8 million and $11.2 million for the three months ended March 31, 2026 and 2025, respectively. As of March&#160;31, 2026, we had an accumulated deficit of $245.5&#160;million and cash and cash equivalents of $14.9&#160;million. Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. The unaudited condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. We plan to address this condition through the sale of our common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. However, there is no assurance that we will be successful in raising additional capital or that such additional funds will be available on acceptable terms, if at all. Should we be unable to raise this amount of capital our operating plans will be limited to the amount of capital that we can access. We may also consider steps to reduce our operating expenses. There can be no assurances that we will be successful in any of the foregoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Summary Statement of Cash Flows</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth a summary of our net cash flow activity for the three months ended March 31, 2026 and 2025 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by (used in)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(11,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(10,119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">10,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net (decrease) increase in cash</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(3,613)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Operating Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2026, net cash used in operating activities was $11.6&#160;million, which consisted of a net loss of $11.8&#160;million and a decrease in our assets and liabilities of $2.0&#160;million, partially offset by non-cash charges of $2.2 million. The non-cash charges were related to $1.0&#160;million of change in the fair value of warrant liabilities, $0.9&#160;million of stock-based compensation, $0.2&#160;million amortization of the ROU asset, and $0.1 million depreciation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025, net cash used in operating activities was $10.1&#160;million, which consisted of a net loss of $11.2&#160;million and a decrease in our assets and liabilities of $0.3&#160;million, partially offset by non-cash charges of $1.4&#160;million. The non-cash charges were primarily related to $0.5 million of change in the fair value of warrant liabilities, $0.5 million of stock-based compensation, $0.2 million amortization of the ROU asset, $0.1 million of non-cash interest expense, and $0.1&#160;million of depreciation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Financing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2026, net cash provided by financing activities was $8.0&#160;million as a result of the issuance of $7.9&#160;million of our common stock under our ATM Programs, net of paid issuance costs, and $0.1&#160;million from the exercise of stock options. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2025, net cash provided by financing activities was $10.3&#160;million, primarily as a result of the issuance of $0.8&#160;million of our common stock under our 2024 ATM Program, $9.1&#160;million from the January 2025 Offering, and $0.4&#160;million from the exercise of common warrants and stock options.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Future Cash Needs and Funding Requirements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on our current operating plan, as of the filing date of this Quarterly Report on Form 10-Q, we believe our cash and cash equivalents will be sufficient to fund our planned operations into the fourth quarter of 2026. However, we have based our projections of operating capital requirements on assumptions that may prove to be incorrect and we may use all our available capital resources sooner than we expect. We are unable to estimate the exact amount of our operating capital requirements. The amount and timing of our future funding requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the scope, progress, results and costs of researching and developing product candidates, and conducting preclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the outcome of any future clinical trials, for any existing or future product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">whether we are able to take advantage of any FDA expedited development and approval programs for any of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the outcome, costs and timing of seeking, obtaining and maintaining FDA and any foreign regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the number and characteristics of product candidates we pursue, including product candidates in preclinical development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the ability of our product candidates to progress through clinical development successfully;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our need to expand our research and development activities, including to conduct additional clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">market acceptance of our product candidates, including physician adoption, market access, pricing and reimbursement;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs of acquiring, licensing or investing in businesses, products, product candidates and technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our ability to maintain, expand and defend the scope of our intellectual property portfolio, including the amount and timing of any payments potentially required to make, or that we may receive, in connection with the licensing, filing, prosecution, defense and enforcement of any patents or other intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our need and ability to hire additional personnel, including management, clinical development, medical and commercial personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the effect of competing technology, market developments and government policy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with being a public company, including our need to implement additional internal systems and infrastructure, including financial and reporting systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with securing and establishing commercialization and manufacturing capabilities, as well as those associated with packaging, warehousing and distribution;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the economic and other terms, timing of and success of our existing licensing arrangements and any collaboration, licensing or other arrangements into which we may enter in the future and the timing and amount of payments thereunder; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the timing, receipt and amount of sales and general commercial success of any future approved products, if any.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Until such time as we can generate significant revenue from sales of product candidates, if ever, we expect to finance our operations through the sale of our common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. To the extent we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through additional collaborations, or other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to and/or may reduce the value of our common stock. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_118"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our critical accounting policies are described under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Significant Judgments and Estimates&#8221; in the Form 10-K. There have been no material changes in our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the three months ended March 31, 2026 compared to those disclosed in the Form 10-K. </span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company and an emerging growth company, as defined under the Jumpstart Our Business Startup (&#8220;JOBS&#8221;) Act. Under the JOBS Act, emerging growth companies can delay the adoption of new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years of audited financial statements in a registration statement for an initial public offering, an exemption from the requirement to provide an auditor's report on internal controls over financial reporting pursuant to Sarbanes-Oxley Act of 2002, as amended (&#8220;Sarbanes-Oxley&#8221;), an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i) we are no longer an emerging growth company or (ii) we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting standards as of public company effective dates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We will remain an emerging growth company until the earliest of (i) December 31, 2026, (ii) the last day of our first fiscal year in which we have total annual gross revenue of $1.235 billion or more, (iii) the date on which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which means the market value of equity securities that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter and (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company&#8221; and/or &#8220;non-accelerated filer&#8221; which may allow us to take advantage of many of the same exemptions from disclosure requirements including not being required to comply for a period of time with the auditor attestation requirements of Section 404 of Sarbanes-Oxley, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_127"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Disclosure Controls</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluates these controls and procedures on an ongoing basis. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management, with the participation of our President and Chief Executive Officer, our principal executive officer, and our Chief Strategy and Financial Officer, our principal accounting and financial officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March&#160;31, 2026. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the evaluation of our disclosure controls and procedures, our President and Chief Executive Officer and our Chief Strategy and Financial Officer concluded that our disclosure controls and procedures were effective as of March&#160;31, 2026.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)) under the Exchange Act) that occurred during the quarter ended March&#160;31, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">28</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Part II OTHER INFORMATION</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_133"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 1. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be subject to various legal proceedings, claims and administrative proceedings that arise in the ordinary course of our business activities or otherwise. Although the results of the litigation and claims cannot be predicted with certainty, as of the date of this report, we do not believe we are party to any claim, proceeding or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to us, including any costs associated with the indemnification of directors and officers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">29</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors, described in the section titled &#8220;Risk Factors&#8221; in the Form 10-K as well as the other information in this Quarterly Report on Form 10-Q, before deciding whether to invest in shares of our common stock. There have been no material changes in our risk factors from those described in the Form 10-K.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_139"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None.</span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_142"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_145"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_148"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal quarter ended March&#160;31, 2026, none of our directors or executive officers <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-661"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-662">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-663"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-664">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">30</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">Item 6.    Exhibits </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.127%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Filed Herewith</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148526000032/eltxatm-salesagreement.htm">At Market Issuance Sales Agreement, dated as of March 16, 2026, by and between Elicio Therapeutics, Inc. and B. Riley Securities, Inc., JonesTrading Institutional Services LLC and Ladenburg Thalmann &amp; Co. Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3/16/2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit312.htm">Certification of Principal Financial Officer</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit312.htm"> and Princip</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit312.htm">al</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit312.htm"> Accounting Officer</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit312.htm"> Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#x5E;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit321.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#x5E;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm">Certification of Principal Financial Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm">and Princip</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm">al</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm"> Accounting </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm">Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-q1exhibit322.htm">Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Instance Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%">__________________________________</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">&#x5E;          The certification that accompanies this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, is not deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">31</span></div></div></div><div id="if1548e21dc2e4a12ac1a19ae3433fb4d_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if1548e21dc2e4a12ac1a19ae3433fb4d_13">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:116%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">/s/ ROBERT CONNELLY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">May&#160;11, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Robert Connelly</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">President and Chief Executive Officer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;padding-left:72pt;text-align:right;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">/s/ PREETAM SHAH, PH.D.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">May&#160;11, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Preetam Shah, Ph.D.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chief Strategy and Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>elicio-q1exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-q1exhibit311</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-q1exhibit311001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit311001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 31.1  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO   SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Robert Connelly, certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of the  circumstances under which such statements were made, not misleading with respect to the period  covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(0) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to me  by others within those entities, particularly during the period in which this report is being prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of financial  statements for external purposes in accordance with generally accepted accounting principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such evaluation;  and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of  directors (or persons performing the equivalent functions):  a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information: and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-q1exhibit311002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit311002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)  Date:  May 11, 2026    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>elicio-q1exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-q1exhibit312</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-q1exhibit312001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit312001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 31.2  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL  ACCOUNTING OFFICER PURSUANT TO SECTION   302 OF THE SARBANES-OXLEY ACT OF 2002  I, Preetam Shah, Ph.D., certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of the  circumstances under which such statements were made, not misleading with respect to the period  covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to me  by others within those entities, particularly during the period in which this report is being prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of financial  statements for external purposes in accordance with generally accepted accounting principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such evaluation;  and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of  directors (or persons performing the equivalent functions):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-q1exhibit312002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit312002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which arc reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah, Ph.D.   Preetam Shah, Ph.D.  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  May 11, 2026  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>elicio-q1exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-q1exhibit321</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-q1exhibit321001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit321001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 32.1  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer's knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended March  31, 2026 (the &quot;Quarterly Report&quot;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.  ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)    Date:  May 11, 2026  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>elicio-q1exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-q1exhibit322</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-q1exhibit322001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-q1exhibit322001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 32.2  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended March  31, 2026 (the &#8220;Quarterly Report&#8221;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.  ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah, Ph.D.   Preetam Shah, Ph.D.  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  May 11, 2026  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>eltx-20260331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:eltx="http://www.eltx.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.eltx.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eltx-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eltx-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eltx-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eltx-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.eltx.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.eltx.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialCondition" roleURI="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition">
        <link:definition>9952157 - Disclosure - Description of the Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.eltx.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.eltx.com/role/BalanceSheetComponents">
        <link:definition>9952160 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrants" roleURI="http://www.eltx.com/role/ResearchGrants">
        <link:definition>9952161 - Disclosure - Research Grants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquity" roleURI="http://www.eltx.com/role/CommonStockandStockholdersEquity">
        <link:definition>9952162 - Disclosure - Common Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.eltx.com/role/StockBasedCompensation">
        <link:definition>9952163 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.eltx.com/role/Warrants">
        <link:definition>9952164 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.eltx.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.eltx.com/role/Leases">
        <link:definition>9952166 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.eltx.com/role/Debt">
        <link:definition>9952167 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.eltx.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.eltx.com/role/NetLossPerShare">
        <link:definition>9952169 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.eltx.com/role/RelatedPartyTransactions">
        <link:definition>9952170 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.eltx.com/role/SegmentReporting">
        <link:definition>9952171 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.eltx.com/role/SubsequentEvents">
        <link:definition>9952172 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.eltx.com/role/FairValueMeasurementsTables">
        <link:definition>9955512 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.eltx.com/role/BalanceSheetComponentsTables">
        <link:definition>9955513 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.eltx.com/role/StockBasedCompensationTables">
        <link:definition>9955514 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.eltx.com/role/WarrantsTables">
        <link:definition>9955515 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.eltx.com/role/LeasesTables">
        <link:definition>9955516 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.eltx.com/role/NetLossPerShareTables">
        <link:definition>9955517 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.eltx.com/role/SegmentReportingTables">
        <link:definition>9955518 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialConditionDetails" roleURI="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails">
        <link:definition>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9955520 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails">
        <link:definition>9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955524 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofAccruedExpensesDetails" roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails">
        <link:definition>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrantsDetails" roleURI="http://www.eltx.com/role/ResearchGrantsDetails">
        <link:definition>9955529 - Disclosure - Research Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquityDetails" roleURI="http://www.eltx.com/role/CommonStockandStockholdersEquityDetails">
        <link:definition>9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.eltx.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofShareOptionActivityDetails" roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails">
        <link:definition>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails">
        <link:definition>9955533 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails" roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails">
        <link:definition>9955534 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails">
        <link:definition>9955535 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://www.eltx.com/role/WarrantsNarrativeDetails">
        <link:definition>9955536 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofOutstandingWarrantsDetails" roleURI="http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails">
        <link:definition>9955537 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.eltx.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955538 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.eltx.com/role/LeasesNarrativeDetails">
        <link:definition>9955539 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" roleURI="http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails">
        <link:definition>9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.eltx.com/role/DebtDetails">
        <link:definition>9955542 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.eltx.com/role/IncomeTaxesDetails">
        <link:definition>9955543 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" roleURI="http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails">
        <link:definition>9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" roleURI="http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails">
        <link:definition>9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.eltx.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955546 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9955547 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.eltx.com/role/SubsequentEventsDetails">
        <link:definition>9955548 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="eltx_WarrantLiability" abstract="false" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JanuaryOfferingMember" abstract="true" name="JanuaryOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ConversionOfConvertibleDebtMember" abstract="true" name="ConversionOfConvertibleDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" abstract="false" name="StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="eltx_InterestExpenseNoncash" abstract="false" name="InterestExpenseNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_IncreaseDecreaseInAccruedExpenses" abstract="false" name="IncreaseDecreaseInAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" abstract="false" name="PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" abstract="false" name="NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_FairValueOfCommonStockWarrantsUponSettlement" abstract="false" name="FairValueOfCommonStockWarrantsUponSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_SettlementOfPromissoryNotesPayable" abstract="false" name="SettlementOfPromissoryNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_WarrantsAndRightsOutstandingAbstract" abstract="true" name="WarrantsAndRightsOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="eltx_WarrantsAndRightsOutstandingTextBlock" abstract="false" name="WarrantsAndRightsOutstandingTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" abstract="false" name="ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="eltx_A2024RegistrationStatementMember" abstract="true" name="A2024RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_A2026RegistrationStatementMember" abstract="true" name="A2026RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JanuaryCommonWarrantsMember" abstract="true" name="JanuaryCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_SeniorSecuredConvertiblePromissoryNoteMember" abstract="true" name="SeniorSecuredConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_SaleOfStockAggregateInitialOfferingPrice" abstract="false" name="SaleOfStockAggregateInitialOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AngionCommonStockMember" abstract="true" name="AngionCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_WarrantsFairValueDisclosure" abstract="false" name="WarrantsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_MeasurementInputStrikePriceMember" abstract="true" name="MeasurementInputStrikePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JulyCommonWarrantsMember" abstract="true" name="JulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JulyPreFundedWarrantsMember" abstract="true" name="JulyPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JulyPublicOfferingMember" abstract="true" name="JulyPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JulySharesAndJulyCommonWarrantMember" abstract="true" name="JulySharesAndJulyCommonWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" abstract="false" name="SaleOfStockBeneficialOwnershipLimitationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="eltx_PrepaidResearchAndDevelopmentExpenses" abstract="false" name="PrepaidResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AdvancedProfessionalFees" abstract="false" name="AdvancedProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" abstract="false" name="OtherPrepaidExpensesAndOtherAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" abstract="false" name="AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_AccruedOtherOperatingLiabilitiesCurrent" abstract="false" name="AccruedOtherOperatingLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ResearchAndDevelopmentArrangementGrant" abstract="false" name="ResearchAndDevelopmentArrangementGrant" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_NumberOfResearchGrantAgreements" abstract="false" name="NumberOfResearchGrantAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" abstract="false" name="ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_GrantRevenueNonoperating" abstract="false" name="GrantRevenueNonoperating" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_JanuaryPublicOfferingMember" abstract="true" name="JanuaryPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_PreFundedWarrantMember" abstract="true" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_AccruedInterestPremiumForConvertiblePreferredStock" abstract="false" name="AccruedInterestPremiumForConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_The2021PlanMember" abstract="true" name="The2021PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_The2022PlanMember" abstract="true" name="The2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_Inducement2024PlanMember" abstract="true" name="Inducement2024PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_January2025CommonWarrantsMember" abstract="true" name="January2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ElicioWarrantsMember" abstract="true" name="ElicioWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_AngionWarrantsMember" abstract="true" name="AngionWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_March2024PreFundedWarrantsMember" abstract="true" name="March2024PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JulyCommonWarrantOneMember" abstract="true" name="JulyCommonWarrantOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_June2025CommonWarrantsMember" abstract="true" name="June2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" abstract="false" name="ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="eltx_CommitmentsAndContingenciesDisclosureTable" abstract="true" name="CommitmentsAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="eltx_UniversityMember" abstract="true" name="UniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_CommitmentsAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentsAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="eltx_RoyaltyRatePercent" abstract="false" name="RoyaltyRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" abstract="false" name="CollaborativeArrangementFutureMinimumMaintenancePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="eltx_BostonMassachusettsMember" abstract="true" name="BostonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_June2025WarrantsMember" abstract="true" name="June2025WarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_GKCCMember" abstract="true" name="GKCCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" abstract="false" name="ClassOfWarrantOrRightOwnershipPercentMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" abstract="true" name="JulyPreFundedWarrantsAndJulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" abstract="true" name="JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_PurchaseOfWarrantsMember" abstract="true" name="PurchaseOfWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_July2024PublicOfferingMember" abstract="true" name="July2024PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ClassOfWarrantOrRightIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="eltx_ClinicalTrailMember" abstract="true" name="ClinicalTrailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_EmployeeRelatedReasearchAndDevelopmentMember" abstract="true" name="EmployeeRelatedReasearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_TranslationalMedicineAndCMCMember" abstract="true" name="TranslationalMedicineAndCMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="eltx_A2026ATMProgramMember" abstract="true" name="A2026ATMProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>eltx-20260331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019ce305-88c7-7dc1-bf1e-f5b449eabfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7453-a9e9-fb0de0343979" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019ce305-88c7-7dc1-bf1e-f5b449eabfcb" xlink:to="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7453-a9e9-fb0de0343979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiability_019ce305-88c7-7aea-a057-df93edd39991" xlink:href="eltx-20260331.xsd#eltx_WarrantLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019ce305-88c7-7dc1-bf1e-f5b449eabfcb" xlink:to="loc_eltx_WarrantLiability_019ce305-88c7-7aea-a057-df93edd39991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-88c7-7b69-8b36-194986ea56a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019ce305-88c7-7dc1-bf1e-f5b449eabfcb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-88c7-7b69-8b36-194986ea56a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019ce305-88c7-7446-bf63-6ea90616978d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019ce305-88c7-7dc1-bf1e-f5b449eabfcb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019ce305-88c7-7446-bf63-6ea90616978d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7fd6-a9a1-9d47268e40ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019ce305-88c7-7c0e-88c9-0b914bf63c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7fd6-a9a1-9d47268e40ec" xlink:to="loc_us-gaap_AccountsPayableCurrent_019ce305-88c7-7c0e-88c9-0b914bf63c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-88c7-7f0f-b117-cf4d88969ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7fd6-a9a1-9d47268e40ec" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-88c7-7f0f-b117-cf4d88969ef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-88c7-71c5-bfef-640b67aa9914" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7fd6-a9a1-9d47268e40ec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-88c7-71c5-bfef-640b67aa9914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-88c7-7977-b10a-766e7070c7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-88c7-7977-b10a-766e7070c7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-88c7-7d8b-911c-1339d77047bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-88c7-7d8b-911c-1339d77047bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019ce305-88c7-732c-a973-d6739ace01fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:to="loc_us-gaap_AssetsCurrent_019ce305-88c7-732c-a973-d6739ace01fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019ce305-88c7-7e06-9056-c5cf28086d52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019ce305-88c7-7e06-9056-c5cf28086d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-88c7-77f6-8f05-51b864286210" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019ce305-88c7-7cb5-b857-2257634e91bb" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-88c7-77f6-8f05-51b864286210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_019ce305-88c7-7f58-ac04-fbb02ec87086" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:to="loc_us-gaap_TreasuryStockCommonValue_019ce305-88c7-7f58-ac04-fbb02ec87086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019ce305-88c7-7e8c-bbad-471b18d57e92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:to="loc_us-gaap_CommonStockValue_019ce305-88c7-7e8c-bbad-471b18d57e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019ce305-88c7-7426-a570-063409e3a61b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019ce305-88c7-7426-a570-063409e3a61b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019ce305-88c7-7944-8bdf-adb341aa2371" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019ce305-88c7-7944-8bdf-adb341aa2371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019ce305-88c7-7ee4-8e62-4de8720191fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019ce305-88c7-7947-9814-fed221e92021" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019ce305-88c7-7ee4-8e62-4de8720191fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019ce305-88c7-7379-82c3-67b56864c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-7e30-9cd2-2f2a8ba25464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019ce305-88c7-7379-82c3-67b56864c1dc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-7e30-9cd2-2f2a8ba25464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-88c7-70a5-bb39-8fff36a6c50b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019ce305-88c7-7379-82c3-67b56864c1dc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-88c7-70a5-bb39-8fff36a6c50b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7c45-a777-fcd1681cdb84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019ce305-88c7-774c-96ba-fbc7b4eeaa24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7c45-a777-fcd1681cdb84" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019ce305-88c7-774c-96ba-fbc7b4eeaa24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-798f-9086-3a42dfad88c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7c45-a777-fcd1681cdb84" xlink:to="loc_us-gaap_StockholdersEquity_019ce305-88c7-798f-9086-3a42dfad88c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019ce305-88c7-71e6-b723-227580d8b583" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7c45-a777-fcd1681cdb84" xlink:to="loc_us-gaap_Liabilities_019ce305-88c7-71e6-b723-227580d8b583" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-718c-8089-43a902770b72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019ce305-88c7-7a6b-8d2a-359a244ce4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-718c-8089-43a902770b72" xlink:to="loc_us-gaap_CostsAndExpenses_019ce305-88c7-7a6b-8d2a-359a244ce4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-88c7-77fd-aec3-0211273c09c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-7506-b587-8844b2381e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-88c7-77fd-aec3-0211273c09c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-7506-b587-8844b2381e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7a4a-bafc-4e86a6547cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-88c7-77fd-aec3-0211273c09c8" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7a4a-bafc-4e86a6547cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7bf4-b3dc-4a2dd21bcc71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-745e-987a-67b999048d69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7bf4-b3dc-4a2dd21bcc71" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-745e-987a-67b999048d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019ce305-88c7-7846-9928-4c6408a56528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7bf4-b3dc-4a2dd21bcc71" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019ce305-88c7-7846-9928-4c6408a56528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019ce305-88c7-77ea-b3d1-df92be955057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7bf4-b3dc-4a2dd21bcc71" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019ce305-88c7-77ea-b3d1-df92be955057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019ce305-88c7-7dbc-b71f-aaae9cdd0d97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7bf4-b3dc-4a2dd21bcc71" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019ce305-88c7-7dbc-b71f-aaae9cdd0d97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e32-8288-d0c2df6c7636" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7493-aaa4-00ca41207685" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e32-8288-d0c2df6c7636" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7493-aaa4-00ca41207685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-731e-8c08-55f6a8999eff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e32-8288-d0c2df6c7636" xlink:to="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-731e-8c08-55f6a8999eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019ce305-88c7-78e8-acde-ad7d0d1b69c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-88c7-760f-9205-b8464df9db5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019ce305-88c7-78e8-acde-ad7d0d1b69c7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-88c7-760f-9205-b8464df9db5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-88c7-7e52-8640-1173c28d157f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019ce305-88c7-78e8-acde-ad7d0d1b69c7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-88c7-7e52-8640-1173c28d157f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-8980-770a-af8c-0a994ef147f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-8980-7fd3-95d7-b29ccfb852cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-8980-770a-af8c-0a994ef147f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-8980-7fd3-95d7-b29ccfb852cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-8980-78b0-9860-c18147ffe39b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-8980-770a-af8c-0a994ef147f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-8980-78b0-9860-c18147ffe39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8980-7816-bd8c-a710b68d457b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-8980-770a-af8c-0a994ef147f4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8980-7816-bd8c-a710b68d457b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8980-7adb-b405-452a7febeb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-8980-72a6-ae53-cc294b33bcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8980-7adb-b405-452a7febeb0f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-8980-72a6-ae53-cc294b33bcbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019ce305-8980-7f94-8942-673e50584594" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8980-7adb-b405-452a7febeb0f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019ce305-8980-7f94-8942-673e50584594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7f17-aef3-603db5dede69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7f17-aef3-603db5dede69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019ce305-88c7-7096-8a43-94d9cec2d96e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019ce305-88c7-7096-8a43-94d9cec2d96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_InterestExpenseNoncash_019ce305-88c7-7ad7-8c48-249636e6fb3f" xlink:href="eltx-20260331.xsd#eltx_InterestExpenseNoncash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_eltx_InterestExpenseNoncash_019ce305-88c7-7ad7-8c48-249636e6fb3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-88c7-78f2-8f8f-94d69ebbb9db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-88c7-78f2-8f8f-94d69ebbb9db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-70ba-a859-454fff3a98a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-70ba-a859-454fff3a98a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019ce305-88c7-7401-89cd-bd9775bfd7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_ShareBasedCompensation_019ce305-88c7-7401-89cd-bd9775bfd7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019ce305-88c7-7687-8f3e-68736569f78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019ce305-88c7-7687-8f3e-68736569f78a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019ce305-88c7-7675-b94b-b587e87b7573" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019ce305-88c7-7675-b94b-b587e87b7573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019ce305-88c7-76cc-9ee5-3eae97f04c04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019ce305-88c7-76cc-9ee5-3eae97f04c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_IncreaseDecreaseInAccruedExpenses_019ce305-88c7-78b8-a05f-de3e5b39c464" xlink:href="eltx-20260331.xsd#eltx_IncreaseDecreaseInAccruedExpenses"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_eltx_IncreaseDecreaseInAccruedExpenses_019ce305-88c7-78b8-a05f-de3e5b39c464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019ce305-88c7-76b2-bcfa-ad9cc81d5634" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019ce305-88c7-76b2-bcfa-ad9cc81d5634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019ce305-88c7-79ef-83ef-ef9410f94c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019ce305-88c7-79ef-83ef-ef9410f94c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019dfd7d-9d72-7591-844f-198de0a54598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7751-984e-0563011895e4" xlink:to="loc_us-gaap_Depreciation_019dfd7d-9d72-7591-844f-198de0a54598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_019ce305-88c7-728f-9731-8bcbbd860148" xlink:href="eltx-20260331.xsd#eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:to="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_019ce305-88c7-728f-9731-8bcbbd860148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_019ce305-88c7-7c1b-a763-0fe3c144d312" xlink:href="eltx-20260331.xsd#eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:to="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_019ce305-88c7-7c1b-a763-0fe3c144d312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_019ce305-88c7-7741-a11b-19ab05d676fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_019ce305-88c7-7741-a11b-19ab05d676fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019ce305-88c7-7e14-aa00-ef3211826c26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019ce305-88c7-7e14-aa00-ef3211826c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019ce305-88c7-70e8-a7a8-e14e510927cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-7b88-8084-2a929db3d997" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019ce305-88c7-70e8-a7a8-e14e510927cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-758a-8533-8d6ba15ac850" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7998-8f8a-c872259587c6" xlink:href="eltx-20260331.xsd#eltx_WarrantsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-758a-8533-8d6ba15ac850" xlink:to="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7998-8f8a-c872259587c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-7a43-b40f-4e59d4b9771b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-70ed-ab87-0c2afffbbb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-7a43-b40f-4e59d4b9771b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-70ed-ab87-0c2afffbbb5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-74d8-b84f-d5510043f9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_019ce305-8980-75ab-bc4e-42177d98eb60" xlink:href="eltx-20260331.xsd#eltx_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-74d8-b84f-d5510043f9d4" xlink:to="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_019ce305-8980-75ab-bc4e-42177d98eb60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PrepaidResearchAndDevelopmentExpenses_019ce305-8980-7d22-ae9b-69aca280b04b" xlink:href="eltx-20260331.xsd#eltx_PrepaidResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-74d8-b84f-d5510043f9d4" xlink:to="loc_eltx_PrepaidResearchAndDevelopmentExpenses_019ce305-8980-7d22-ae9b-69aca280b04b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AdvancedProfessionalFees_019ce305-8980-7191-a21d-859c7f254b3e" xlink:href="eltx-20260331.xsd#eltx_AdvancedProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-74d8-b84f-d5510043f9d4" xlink:to="loc_eltx_AdvancedProfessionalFees_019ce305-8980-7191-a21d-859c7f254b3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019ce305-8980-78db-9e20-3c88809ad7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-74d8-b84f-d5510043f9d4" xlink:to="loc_us-gaap_PrepaidInsurance_019ce305-8980-78db-9e20-3c88809ad7e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-70c4-b621-c81f922bae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-7ba3-8d46-ae6de1210599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-70c4-b621-c81f922bae7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-7ba3-8d46-ae6de1210599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7e69-966c-2e4847f3a382" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-70c4-b621-c81f922bae7d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7e69-966c-2e4847f3a382" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019ce305-8980-7001-80b1-906ae53b5b29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019ce305-8980-7001-80b1-906ae53b5b29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019ce305-8980-7c7b-8067-8bec670263e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019ce305-8980-7c7b-8067-8bec670263e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_019ce305-8980-777a-b156-41ad766282c3" xlink:href="eltx-20260331.xsd#eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:to="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_019ce305-8980-777a-b156-41ad766282c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterest_019ce305-8980-7167-ac55-87342c59ddb8" xlink:href="eltx-20260331.xsd#eltx_AccruedInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:to="loc_eltx_AccruedInterest_019ce305-8980-7167-ac55-87342c59ddb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent_019d424a-dc72-7c19-83d3-126a99153710" xlink:href="eltx-20260331.xsd#eltx_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7286-8e6b-d2f4e9ed541f" xlink:to="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent_019d424a-dc72-7c19-83d3-126a99153710" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019ce305-8981-7d21-b10f-e13c1bf768b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019ce305-8981-7d21-b10f-e13c1bf768b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019ce305-8981-7849-8684-bb8bfc9b6855" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019ce305-8981-7849-8684-bb8bfc9b6855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019ce305-8981-735c-a418-d6df91c6efe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019ce305-8981-735c-a418-d6df91c6efe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019ce305-8981-72e0-b606-3d0a41244acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019ce305-8981-72e0-b606-3d0a41244acb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019ce305-8981-7332-a46a-cf3794525cda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-767d-9d16-497554bf9ff2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019ce305-8981-7332-a46a-cf3794525cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-7812-ac4c-ca7e6680bcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-8981-7dcb-8e4e-b4a49b28bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-7812-ac4c-ca7e6680bcfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-8981-7dcb-8e4e-b4a49b28bb13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7e46-96b4-3be005cabcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-7812-ac4c-ca7e6680bcfb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7e46-96b4-3be005cabcfc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-7be6-8850-cf75db533a72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019ce305-8981-7c63-9194-1cbeba441a73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-7be6-8850-cf75db533a72" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019ce305-8981-7c63-9194-1cbeba441a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-763c-a946-ec21d98c3345" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-7be6-8850-cf75db533a72" xlink:to="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-763c-a946-ec21d98c3345" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>eltx-20260331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:to="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7553-9df4-41cc7a253239_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:to="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7553-9df4-41cc7a253239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:to="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019ce305-88c7-7319-a85a-3cfeb30b38b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_CommonStockMember_019ce305-88c7-7319-a85a-3cfeb30b38b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_019ce305-88c7-78a7-8efa-8feefe46e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_019ce305-88c7-78a7-8efa-8feefe46e8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019ce305-88c7-71b2-bc4a-c07cc787e4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019ce305-88c7-71b2-bc4a-c07cc787e4a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019ce305-88c7-737c-9285-fb3ea50c85e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019ce305-88c7-737c-9285-fb3ea50c85e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019ce305-88c7-7906-896d-fffbbd62033e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_RetainedEarningsMember_019ce305-88c7-7906-896d-fffbbd62033e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-79ed-8821-9bfd83b54274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-79ed-8821-9bfd83b54274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-78d3-a935-73681c95defe" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:to="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-78d3-a935-73681c95defe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryOfferingMember_019dc35e-9e8b-7062-b692-78c3acca2095" xlink:href="eltx-20260331.xsd#eltx_JanuaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:to="loc_eltx_JanuaryOfferingMember_019dc35e-9e8b-7062-b692-78c3acca2095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-7d15-839f-f84ba1df206c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-7d15-839f-f84ba1df206c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ConversionOfConvertibleDebtMember_019ce305-88c7-7170-9a00-09554bd0e08b" xlink:href="eltx-20260331.xsd#eltx_ConversionOfConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:to="loc_eltx_ConversionOfConvertibleDebtMember_019ce305-88c7-7170-9a00-09554bd0e08b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7231-8d4a-befeca3a01a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7231-8d4a-befeca3a01a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-72fd-be10-c7ee8bc5050a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockholdersEquity_019ce305-88c7-72fd-be10-c7ee8bc5050a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7c59-98c4-b28985a2139f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7c59-98c4-b28985a2139f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019ce305-88c7-75cf-b80f-df49982b5a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019ce305-88c7-75cf-b80f-df49982b5a5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019ce305-88c7-75cb-b715-6fe069d9157f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019ce305-88c7-75cb-b715-6fe069d9157f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-88c7-7aa8-aae1-fc20b20a0c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-88c7-7aa8-aae1-fc20b20a0c5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019ce305-88c7-77c8-9bfc-fe81729a3e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019ce305-88c7-77c8-9bfc-fe81729a3e8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019ce305-88c7-776f-9a54-550a3b9c3266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019ce305-88c7-776f-9a54-550a3b9c3266" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019ce305-88c7-78d8-b9aa-f0fc77523174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019ce305-88c7-78d8-b9aa-f0fc77523174" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_019d420c-b617-7e88-8230-e69143e5937d" xlink:href="eltx-20260331.xsd#eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_019d420c-b617-7e88-8230-e69143e5937d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019ce305-88c7-7335-9bca-9a4dbc46be8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019ce305-88c7-7335-9bca-9a4dbc46be8e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d90-9a1c-8a7f09d1debb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d90-9a1c-8a7f09d1debb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d26-b9de-0785199554f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d26-b9de-0785199554f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019ce305-88c7-7c80-8158-d32e25fec614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019ce305-88c7-7c80-8158-d32e25fec614" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-74a7-8f17-e06d48c3de27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-74a7-8f17-e06d48c3de27" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e07-87a7-4cfe99333084" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e07-87a7-4cfe99333084" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-77d3-96cc-b2cd79a263c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-702d-b80a-cb39d6b6ab51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-72b6-8fa3-75b5d0df9280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:to="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-7fab-aad4-ce892db39edd" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:to="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-7fab-aad4-ce892db39edd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryOfferingMember_019dc3d3-6377-73bc-9578-10a2763efa30" xlink:href="eltx-20260331.xsd#eltx_JanuaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:to="loc_eltx_JanuaryOfferingMember_019dc3d3-6377-73bc-9578-10a2763efa30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019ce305-88c7-7d74-b0c2-f8243de5a805" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019ce305-88c7-7d74-b0c2-f8243de5a805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019ce305-88c7-74c3-9c6c-853364d6e777" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019ce305-88c7-74c3-9c6c-853364d6e777" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-750b-803f-92ded437021b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-750b-803f-92ded437021b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2024RegistrationStatementMember_019e0012-81f8-7514-ab01-2d1c93217725" xlink:href="eltx-20260331.xsd#eltx_A2024RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_A2024RegistrationStatementMember_019e0012-81f8-7514-ab01-2d1c93217725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019e0012-81f8-74a5-b4dc-757a97bcf1b3" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019e0012-81f8-74a5-b4dc-757a97bcf1b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026RegistrationStatementMember_019e0012-81f8-7050-bd3f-fd41cab6948c" xlink:href="eltx-20260331.xsd#eltx_A2026RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_A2026RegistrationStatementMember_019e0012-81f8-7050-bd3f-fd41cab6948c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019e0012-81f8-7f4e-ad8c-93d6b7ea160d" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019e0012-81f8-7f4e-ad8c-93d6b7ea160d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019e0012-81f8-72f4-8a0c-b7393b36f967" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketOfferingMember_019e0012-81f8-72f4-8a0c-b7393b36f967" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:to="loc_us-gaap_EquityComponentDomain_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:to="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e0012-81f8-742e-9d2b-353c2774a82f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:to="loc_us-gaap_CommonStockMember_019e0012-81f8-742e-9d2b-353c2774a82f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-7f17-8ff9-7239589eb9ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-7f17-8ff9-7239589eb9ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryCommonWarrantsMember_019e0012-81f8-76ae-bebd-50ca358a2804" xlink:href="eltx-20260331.xsd#eltx_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:to="loc_eltx_JanuaryCommonWarrantsMember_019e0012-81f8-76ae-bebd-50ca358a2804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-75e1-903f-26591f29097d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-75e1-903f-26591f29097d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019e0012-b820-70a9-a6e5-3627ba7e2b17" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019e0012-b820-70a9-a6e5-3627ba7e2b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e0012-81f8-7a03-a70d-8543c291b920" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e0012-81f8-7a03-a70d-8543c291b920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019e0012-81f8-7295-9f09-3b43a7dd1bfe" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019e0012-81f8-7295-9f09-3b43a7dd1bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e0012-81f8-7ea5-83cb-b520762ed0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e0012-81f8-7ea5-83cb-b520762ed0b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019e0012-81f8-7ff6-bec5-7f3b37e9d3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019e0012-81f8-7ff6-bec5-7f3b37e9d3ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e0012-81f8-7fa6-a984-e35e2a4cd403" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e0012-81f8-7fa6-a984-e35e2a4cd403" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019e0012-81f8-7b49-94bf-80b8a2f7847a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019e0012-81f8-7b49-94bf-80b8a2f7847a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019e0012-81f8-7f94-934e-b1340cab0315" xlink:href="eltx-20260331.xsd#eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019e0012-81f8-7f94-934e-b1340cab0315" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_019e0012-81f8-779e-88a7-2443140cf8c7" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_019e0012-81f8-779e-88a7-2443140cf8c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019e0012-81f8-7b74-bcec-52c09388c64e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019e0012-81f8-7b74-bcec-52c09388c64e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019e0012-81f8-7d61-b4db-2cea31203c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019e0012-81f8-7d61-b4db-2cea31203c6a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019e0012-81f8-784e-969c-4fdae275a2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019e0012-81f8-784e-969c-4fdae275a2f2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e0012-b820-7a93-b224-088b16ec9252" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e0012-b820-7a93-b224-088b16ec9252" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e0012-b820-79d3-85b3-ef29165b5ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e0012-b820-79d3-85b3-ef29165b5ee3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019e0012-b820-762c-b569-d628f836f5df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019e0012-b820-762c-b569-d628f836f5df" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019e0012-b820-7e1f-80a3-58edaa6b85d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019e0012-b820-7e1f-80a3-58edaa6b85d2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e0012-b820-7a41-9724-59e94aa4dfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e0012-b820-7a41-9724-59e94aa4dfe3" xlink:type="arc" order="15"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019ce305-8980-75f4-8ec9-61254f19383b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:to="loc_us-gaap_ClassOfStockDomain_019ce305-8980-75f4-8ec9-61254f19383b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:to="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionCommonStockMember_019ce305-8980-7dfc-9f96-8cf0085613a9" xlink:href="eltx-20260331.xsd#eltx_AngionCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:to="loc_eltx_AngionCommonStockMember_019ce305-8980-7dfc-9f96-8cf0085613a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_019ce305-8980-7100-8fbe-431faf97bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_019ce305-8980-7100-8fbe-431faf97bd0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7070-84e8-349491c9bfea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7070-84e8-349491c9bfea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019ce305-8980-7da8-979a-88fec7484c03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019ce305-8980-7da8-979a-88fec7484c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019ce305-8980-70a5-bd93-2193279920ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019ce305-8980-70a5-bd93-2193279920ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-7e06-9699-932ea6905e16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-7e06-9699-932ea6905e16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-71d3-a86f-5dabcaffc85e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-71d3-a86f-5dabcaffc85e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-73f4-bdb4-e79bff1d34c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-73f4-bdb4-e79bff1d34c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7262-ac0b-af912f3c88be" xlink:href="eltx-20260331.xsd#eltx_WarrantsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:to="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7262-ac0b-af912f3c88be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-7524-a384-f5b5301b6aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-7524-a384-f5b5301b6aae" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7548-93fd-57b9d8f46c56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7548-93fd-57b9d8f46c56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiabilityMember_019ce305-8980-7f77-a2dc-dd9b4160b323" xlink:href="eltx-20260331.xsd#eltx_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:to="loc_eltx_WarrantLiabilityMember_019ce305-8980-7f77-a2dc-dd9b4160b323" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-7604-8a8c-dc276c28adeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-7604-8a8c-dc276c28adeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019ce305-8980-736d-b619-e4b2e7581d74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019ce305-8980-736d-b619-e4b2e7581d74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-749c-aceb-19887517cc54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-72ce-ade2-52034c42ef8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-72ce-ade2-52034c42ef8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-71c4-9e4e-18f3a5b83395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-71c4-9e4e-18f3a5b83395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-790f-9221-3d1e032e9b5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-790f-9221-3d1e032e9b5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_MeasurementInputStrikePriceMember_019ce305-8980-7353-bc31-96488dc9c14f" xlink:href="eltx-20260331.xsd#eltx_MeasurementInputStrikePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_eltx_MeasurementInputStrikePriceMember_019ce305-8980-7353-bc31-96488dc9c14f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_019ce305-8980-7083-9e99-84156f590a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_019ce305-8980-7083-9e99-84156f590a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019ce305-8980-7454-967e-4ff4576717bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019ce305-8980-7454-967e-4ff4576717bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019ce305-8980-79aa-9bb7-7c63bdeb675b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019ce305-8980-79aa-9bb7-7c63bdeb675b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019ce305-8980-757b-973b-57d93d83a012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019ce305-8980-757b-973b-57d93d83a012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019ce305-8980-7ea4-86a4-89c8dfde13c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019ce305-8980-7ea4-86a4-89c8dfde13c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-78f7-a71a-73299f126f3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-78f7-a71a-73299f126f3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantsMember_019d7109-960a-77c7-8c9c-032a45ac6898" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:to="loc_eltx_JulyCommonWarrantsMember_019d7109-960a-77c7-8c9c-032a45ac6898" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsMember_019dc36b-5284-7095-bfec-ec240244caf2" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:to="loc_eltx_JulyPreFundedWarrantsMember_019dc36b-5284-7095-bfec-ec240244caf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-7699-9746-c37c42379315_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-7699-9746-c37c42379315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPublicOfferingMember_019d7109-960a-769a-8b2b-0079a70b670c" xlink:href="eltx-20260331.xsd#eltx_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:to="loc_eltx_JulyPublicOfferingMember_019d7109-960a-769a-8b2b-0079a70b670c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-7d83-8a41-254f2872eae5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:to="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-7d83-8a41-254f2872eae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:to="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulySharesAndJulyCommonWarrantMember_019dc36c-1a98-7173-8b08-5fff9968b4eb" xlink:href="eltx-20260331.xsd#eltx_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:to="loc_eltx_JulySharesAndJulyCommonWarrantMember_019dc36c-1a98-7173-8b08-5fff9968b4eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019dc36b-5284-7bf7-96e2-eff9532aafa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019dc36b-5284-7bf7-96e2-eff9532aafa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc36b-5284-7f22-9a46-bc8fb49d1d10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc36b-5284-7f22-9a46-bc8fb49d1d10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019dc36c-1a98-7fe0-abab-b861c998ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019dc36c-1a98-7fe0-abab-b861c998ddd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1a2-6272-7d02-9232-67f72cba5d05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1a2-6272-7d02-9232-67f72cba5d05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_019d7109-960a-7d8d-a5e2-27e31c2e5817" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_019d7109-960a-7d8d-a5e2-27e31c2e5817" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019d7109-960a-7c20-84d4-1a35a079143b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019d7109-960a-7c20-84d4-1a35a079143b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7058-aa17-48c564cd0c9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7058-aa17-48c564cd0c9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_019ce305-8980-7467-ad82-3a739028eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_EquipmentMember_019ce305-8980-7467-ad82-3a739028eb84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019ce305-8980-794d-9484-efd827d7b268" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019ce305-8980-794d-9484-efd827d7b268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019ce305-8980-7afa-a5d6-6f7e7470218c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019ce305-8980-7afa-a5d6-6f7e7470218c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-703a-8327-20be98e4b2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-703a-8327-20be98e4b2c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7bcf-9b6b-6781e17a73df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7bcf-9b6b-6781e17a73df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-7e62-8472-02889f448405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-7e62-8472-02889f448405" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/ResearchGrantsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#ResearchGrantsDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/ResearchGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb0-9519-e0104d9c23e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:to="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb0-9519-e0104d9c23e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:to="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_019dc382-bbeb-7754-89f3-fcaa217b5e98" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_019dc382-bbeb-7754-89f3-fcaa217b5e98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_019dc382-bbeb-775c-9cda-dd6ec53b09d2" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_019dc382-bbeb-775c-9cda-dd6ec53b09d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_019dc382-bbeb-7d3c-b685-eccbbd9ef17a" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_019dc382-bbeb-7d3c-b685-eccbbd9ef17a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementGrant_019dc382-bbeb-7681-a9de-505889c7a1ea" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_ResearchAndDevelopmentArrangementGrant_019dc382-bbeb-7681-a9de-505889c7a1ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NumberOfResearchGrantAgreements_019dc382-bbeb-7d42-9b16-e1d8511e36e3" xlink:href="eltx-20260331.xsd#eltx_NumberOfResearchGrantAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_NumberOfResearchGrantAgreements_019dc382-bbeb-7d42-9b16-e1d8511e36e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019dc387-9b99-78d0-8b87-628f30afb6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019dc387-9b99-78d0-8b87-628f30afb6c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_019dc387-5a97-7bf7-b1ef-b0111ee48292" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_019dc387-5a97-7bf7-b1ef-b0111ee48292" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GrantRevenueNonoperating_019dc382-bbeb-7e72-86b8-cb0d13fbd258" xlink:href="eltx-20260331.xsd#eltx_GrantRevenueNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_GrantRevenueNonoperating_019dc382-bbeb-7e72-86b8-cb0d13fbd258" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:to="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:to="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019dc3ac-eefd-7247-bdbb-b916ecf98e93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:to="loc_us-gaap_CommonStockMember_019dc3ac-eefd-7247-bdbb-b916ecf98e93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-781c-8997-aee27293c04e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-781c-8997-aee27293c04e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019dc3ac-eefd-7d25-b184-19cd1c89b8d2" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019dc3ac-eefd-7d25-b184-19cd1c89b8d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019dc3ac-eefd-766d-bbae-161114bfbd90" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019dc3ac-eefd-766d-bbae-161114bfbd90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019dc3ac-eefd-79a9-8551-791ec521f796" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketOfferingMember_019dc3ac-eefd-79a9-8551-791ec521f796" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryPublicOfferingMember_019dc3ac-eefd-7815-8fff-d28098486f85" xlink:href="eltx-20260331.xsd#eltx_JanuaryPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_JanuaryPublicOfferingMember_019dc3ac-eefd-7815-8fff-d28098486f85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-734e-9fe7-3d883812608e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-734e-9fe7-3d883812608e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryCommonWarrantsMember_019dc3ac-eefd-7d3a-b436-b8d8af4dddc2" xlink:href="eltx-20260331.xsd#eltx_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:to="loc_eltx_JanuaryCommonWarrantsMember_019dc3ac-eefd-7d3a-b436-b8d8af4dddc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019dc3ac-eefd-7325-a029-e685a07e8a41" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:to="loc_eltx_PreFundedWarrantMember_019dc3ac-eefd-7325-a029-e685a07e8a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019dc3ac-eefd-7645-8dfd-c4602bd92f03" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019dc3ac-eefd-7645-8dfd-c4602bd92f03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7ab6-ada1-861005a40ae7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7ab6-ada1-861005a40ae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019dc3ac-eefd-7f42-9e1e-36191de357fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:to="loc_us-gaap_ConvertibleDebtMember_019dc3ac-eefd-7f42-9e1e-36191de357fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019dc3ac-c6d1-79f6-9c16-d123d23beb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019dc3ac-c6d1-79f6-9c16-d123d23beb6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019dc3ac-c6d1-7a61-8983-6093a17248ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019dc3ac-c6d1-7a61-8983-6093a17248ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019dc3ac-c6d1-702a-8732-a2ae75a4393e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019dc3ac-c6d1-702a-8732-a2ae75a4393e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019dc3ac-c6d1-7e32-87db-d567f0bec6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019dc3ac-c6d1-7e32-87db-d567f0bec6cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019dc3ac-eefd-7f4c-ab3c-86d89e6f8912" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019dc3ac-eefd-7f4c-ab3c-86d89e6f8912" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019dc3ac-eefd-7abf-b390-72ddcbd22855" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019dc3ac-eefd-7abf-b390-72ddcbd22855" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019dc3ac-eefd-7a66-888c-fb53b39168fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019dc3ac-eefd-7a66-888c-fb53b39168fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019dc3ac-eefd-70d5-8d41-5abae0bfe79c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019dc3ac-eefd-70d5-8d41-5abae0bfe79c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019dc3ac-eefd-736e-9104-19dc30043b63" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019dc3ac-eefd-736e-9104-19dc30043b63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc3ac-eefd-7149-8baa-3ae01b79551c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc3ac-eefd-7149-8baa-3ae01b79551c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dc3ac-eefd-7d0c-bd0c-73370cf42328" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dc3ac-eefd-7d0c-bd0c-73370cf42328" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019dc3ac-eefd-7d23-b3fa-21cfcc1a64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019dc3ac-eefd-7d23-b3fa-21cfcc1a64b3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019dc3ac-eefd-7cac-a995-7170041e73f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019dc3ac-eefd-7cac-a995-7170041e73f5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dc3ac-eefd-780c-af26-e42a1da722c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dc3ac-eefd-780c-af26-e42a1da722c3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019dc3ac-eefd-75d2-ad05-f161655366eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019dc3ac-eefd-75d2-ad05-f161655366eb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019dc3ac-eefd-740b-8b12-add389035823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019dc3ac-eefd-740b-8b12-add389035823" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019dc3ac-eefd-70b7-8569-9aad1fad82b8" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019dc3ac-eefd-70b7-8569-9aad1fad82b8" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:to="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019ce305-8980-7863-8abb-317d50f4b04d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:to="loc_us-gaap_PlanNameDomain_019ce305-8980-7863-8abb-317d50f4b04d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:to="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2021PlanMember_019ce305-8980-7821-9453-9cc3b65685bd" xlink:href="eltx-20260331.xsd#eltx_The2021PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_The2021PlanMember_019ce305-8980-7821-9453-9cc3b65685bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2022PlanMember_019ce305-8980-707b-b0b7-409b016da6c3" xlink:href="eltx-20260331.xsd#eltx_The2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_The2022PlanMember_019ce305-8980-707b-b0b7-409b016da6c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_Inducement2024PlanMember_019ce305-8980-7328-8bb5-0d4e86b45cf4" xlink:href="eltx-20260331.xsd#eltx_Inducement2024PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_Inducement2024PlanMember_019ce305-8980-7328-8bb5-0d4e86b45cf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:to="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-7230-9c21-068e890f8ae1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-7230-9c21-068e890f8ae1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019ce305-8980-7069-9c26-a3961e7f8065" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:to="loc_us-gaap_EmployeeStockMember_019ce305-8980-7069-9c26-a3961e7f8065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3cb-a925-7328-8a92-5f5070a0c7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3cb-a925-7328-8a92-5f5070a0c7ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019ce305-8980-77e7-ab18-8ec2cbfc6b87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019ce305-8980-77e7-ab18-8ec2cbfc6b87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_019ce305-8980-76cf-891a-368b848f326e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_019ce305-8980-76cf-891a-368b848f326e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-772e-84d6-9726f4a68e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-772e-84d6-9726f4a68e7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dfd8b-5cee-7ac3-a0ba-22be6f4f5ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dfd8b-5cee-7ac3-a0ba-22be6f4f5ca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-7491-b075-dff5b642be83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-7491-b075-dff5b642be83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019ce305-8980-7867-a957-90375ee02e85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019ce305-8980-7867-a957-90375ee02e85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019ce305-8980-7b05-873f-beca8444e487" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019ce305-8980-7b05-873f-beca8444e487" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_019ce305-8980-7259-833c-b29cf137d70e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_019ce305-8980-7259-833c-b29cf137d70e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:to="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-77ba-a871-cb25d7e96f53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-77ba-a871-cb25d7e96f53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019df1bf-9000-7542-a06b-59683b7da746" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019df1bf-9000-7542-a06b-59683b7da746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019df1c0-aa28-7b30-9f5b-98ef8051741f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019df1c0-aa28-7b30-9f5b-98ef8051741f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019df1bf-9000-7d84-adee-c4fad880d765" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019df1bf-9000-7d84-adee-c4fad880d765" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019df1bf-9000-7391-a53e-bf1f3455eec9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019df1bf-9000-7391-a53e-bf1f3455eec9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019df1c1-497e-727c-85c4-c3106623dd84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019df1c1-497e-727c-85c4-c3106623dd84" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:to="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7ebd-a56b-ab86a52d195d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7ebd-a56b-ab86a52d195d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3c3-6103-7e45-8157-727977c20e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3c3-6103-7e45-8157-727977c20e5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c3-6103-7afa-9d45-bbf7583afada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c3-6103-7afa-9d45-bbf7583afada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019dc3c3-6103-72b1-b8a3-2dc7dd7f9782" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019dc3c3-6103-72b1-b8a3-2dc7dd7f9782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_019dc3c3-6103-790f-939b-e31b70f2ff21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_019dc3c3-6103-790f-939b-e31b70f2ff21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019dc3c3-6103-7389-90bf-7b465d39eda7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019dc3c3-6103-7389-90bf-7b465d39eda7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c6-8e2a-755c-b60e-86481b9dbf19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c3-6103-73d4-9012-4f82194e48d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c3-6103-73d4-9012-4f82194e48d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dc3c3-6103-7f61-877e-59a81718d6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dc3c3-6103-7f61-877e-59a81718d6a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019dc3c3-6103-75a2-abb6-d7ca2f158a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019dc3c3-6103-75a2-abb6-d7ca2f158a5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c9-038e-7536-afca-1bf47383ea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7796-8dee-29ce5362d6dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7796-8dee-29ce5362d6dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019ce305-8980-77c1-9f2e-1cee98fa775e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019ce305-8980-77c1-9f2e-1cee98fa775e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019ce305-8980-70eb-a77f-02c3bdf84414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019ce305-8980-70eb-a77f-02c3bdf84414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019ce305-8980-7445-9156-46eb50c0abc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019ce305-8980-7445-9156-46eb50c0abc4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_January2025CommonWarrantsMember_019df1cb-9ca8-7977-9edf-94f26a08e54b" xlink:href="eltx-20260331.xsd#eltx_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:to="loc_eltx_January2025CommonWarrantsMember_019df1cb-9ca8-7977-9edf-94f26a08e54b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019df1cb-9ca8-7247-89b1-a50c94ca8850" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:to="loc_eltx_PreFundedWarrantMember_019df1cb-9ca8-7247-89b1-a50c94ca8850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-71df-886b-1804d2d50254_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-71df-886b-1804d2d50254_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019df1cb-9ca8-72fe-b2f2-4f4f59aacb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:to="loc_us-gaap_CommonStockMember_019df1cb-9ca8-72fe-b2f2-4f4f59aacb2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-7ba4-85e9-546e9006b356_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-7ba4-85e9-546e9006b356_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPublicOfferingMember_019df1cb-9ca8-7833-8a37-e9fd8cf73090" xlink:href="eltx-20260331.xsd#eltx_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:to="loc_eltx_JulyPublicOfferingMember_019df1cb-9ca8-7833-8a37-e9fd8cf73090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7c5c-bda4-a4a60f616889_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7c5c-bda4-a4a60f616889_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cb-9ca8-79e6-bfaa-2b6ac4014e01" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cb-9ca8-79e6-bfaa-2b6ac4014e01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cb-9ca8-737f-977a-e0aec5baf498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cb-9ca8-737f-977a-e0aec5baf498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019df1cb-9ca8-7c90-b845-b94ca4e1d766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019df1cb-9ca8-7c90-b845-b94ca4e1d766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019df1cb-9ca8-709a-a4ee-af01277d1c17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019df1cb-9ca8-709a-a4ee-af01277d1c17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1cb-9ca8-7f49-96e9-3f5947e3876f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1cb-9ca8-7f49-96e9-3f5947e3876f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019df1cb-9ca8-722b-bd56-4d7ceb3a17e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019df1cb-9ca8-722b-bd56-4d7ceb3a17e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019df1cb-9ca8-76b0-baab-8cb8ea8a8af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019df1cb-9ca8-76b0-baab-8cb8ea8a8af7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cb-9ca8-7ce0-a0fa-b01a4ac87319" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cb-9ca8-7ce0-a0fa-b01a4ac87319" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cb-9ca8-7673-bdf0-8eae7d323329" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cb-9ca8-7673-bdf0-8eae7d323329" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7777-94c5-19b266a12a95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7777-94c5-19b266a12a95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ElicioWarrantsMember_019ce305-8981-7c4d-a578-ed7171b3bb3d" xlink:href="eltx-20260331.xsd#eltx_ElicioWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_ElicioWarrantsMember_019ce305-8981-7c4d-a578-ed7171b3bb3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionWarrantsMember_019ce305-8981-7125-ad55-43d8caa74664" xlink:href="eltx-20260331.xsd#eltx_AngionWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_AngionWarrantsMember_019ce305-8981-7125-ad55-43d8caa74664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_March2024PreFundedWarrantsMember_019ce305-8981-72e0-a51c-8b0f4fe389bc" xlink:href="eltx-20260331.xsd#eltx_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_March2024PreFundedWarrantsMember_019ce305-8981-72e0-a51c-8b0f4fe389bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019ce305-8981-7a47-9d6a-bfd952a5c9d3" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_PreFundedWarrantMember_019ce305-8981-7a47-9d6a-bfd952a5c9d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantsMember_019ce305-8981-7a39-a473-4f121106a5b9" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_JulyCommonWarrantsMember_019ce305-8981-7a39-a473-4f121106a5b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantOneMember_019d7110-e008-72cc-9687-4c47ca0d8a3a" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_JulyCommonWarrantOneMember_019d7110-e008-72cc-9687-4c47ca0d8a3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_January2025CommonWarrantsMember_019ce305-8981-71c4-aff1-2ba748693b9d" xlink:href="eltx-20260331.xsd#eltx_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_January2025CommonWarrantsMember_019ce305-8981-71c4-aff1-2ba748693b9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025CommonWarrantsMember_019ce305-8981-7051-86e5-087c6eaf9fbf" xlink:href="eltx-20260331.xsd#eltx_June2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_June2025CommonWarrantsMember_019ce305-8981-7051-86e5-087c6eaf9fbf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:to="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-7730-a2e1-0e2fd4fdea95_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:to="loc_srt_RangeMember_019ce305-8981-7730-a2e1-0e2fd4fdea95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:to="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_019ce305-8981-73a2-8c36-ead49a145611" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:to="loc_srt_WeightedAverageMember_019ce305-8981-73a2-8c36-ead49a145611" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8981-76ea-bc51-1aa7fabe6863" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8981-76ea-bc51-1aa7fabe6863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8981-77a9-8f36-d5142735583d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8981-77a9-8f36-d5142735583d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019ce305-8981-77cc-93d0-9507c2cc2b62" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019ce305-8981-77cc-93d0-9507c2cc2b62" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-7047-a8a5-bdb554fcb0e7_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:to="loc_srt_RangeMember_019ce305-8981-7047-a8a5-bdb554fcb0e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:to="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019ce305-8981-7bcb-9d05-2e76de67c95f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:to="loc_srt_MinimumMember_019ce305-8981-7bcb-9d05-2e76de67c95f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019ce305-8981-71a9-a322-faf2cf490702" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:to="loc_srt_MaximumMember_019ce305-8981-71a9-a322-faf2cf490702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-70d3-92d1-796cecae3869_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-70d3-92d1-796cecae3869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019ce305-8981-7b9d-8259-d12357e07979" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019ce305-8981-7b9d-8259-d12357e07979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-7547-993a-48899718d5da_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-7547-993a-48899718d5da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_UniversityMember_019ce305-8981-76b4-a0da-68ef75400f8e" xlink:href="eltx-20260331.xsd#eltx_UniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:to="loc_eltx_UniversityMember_019ce305-8981-76b4-a0da-68ef75400f8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-75cf-aaf6-5958552977af_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:to="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-75cf-aaf6-5958552977af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:to="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_019d9c44-6792-7e3d-bdc5-e4f58acade36" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:to="loc_srt_ScenarioForecastMember_019d9c44-6792-7e3d-bdc5-e4f58acade36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_RoyaltyRatePercent_019ce305-8981-7869-9376-45602c85cea8" xlink:href="eltx-20260331.xsd#eltx_RoyaltyRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_RoyaltyRatePercent_019ce305-8981-7869-9376-45602c85cea8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019ce305-8981-775a-a62c-59c8dcbefc75" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019ce305-8981-775a-a62c-59c8dcbefc75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-7b9c-bced-083a6e20511f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-7b9c-bced-083a6e20511f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019ce305-8981-7cfb-9a4d-a187121896e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_us-gaap_RoyaltyExpense_019ce305-8981-7cfb-9a4d-a187121896e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_019ce305-8981-76d0-a2ea-8b80c8867d31" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_019ce305-8981-76d0-a2ea-8b80c8867d31" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:to="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019ce305-8981-79af-8f31-cef76da28b32_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:to="loc_srt_SegmentGeographicalDomain_019ce305-8981-79af-8f31-cef76da28b32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:to="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_BostonMassachusettsMember_019ce305-8981-7f4f-bbd8-7282cec07126" xlink:href="eltx-20260331.xsd#eltx_BostonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:to="loc_eltx_BostonMassachusettsMember_019ce305-8981-7f4f-bbd8-7282cec07126" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_019ce305-8981-778b-92c3-29290cde68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseExpense_019ce305-8981-778b-92c3-29290cde68bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-8981-789d-b9fe-748b2060e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-8981-789d-b9fe-748b2060e75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7476-8a7d-0d2f7a7c3741" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7476-8a7d-0d2f7a7c3741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_019ce305-8981-703c-84d4-f258fbadd120" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_019ce305-8981-703c-84d4-f258fbadd120" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/DebtDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-7908-9923-925a3e6df640_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-7908-9923-925a3e6df640_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019d9c38-8e91-7e24-83ac-dfb87a8ab8ae" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019d9c38-8e91-7e24-83ac-dfb87a8ab8ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-740f-8f9a-6182f3e438ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-740f-8f9a-6182f3e438ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019d9c38-8e91-7441-8d27-da7aa13c689b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:to="loc_us-gaap_ConvertibleDebtMember_019d9c38-8e91-7441-8d27-da7aa13c689b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7174-9b35-6be684343a3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7174-9b35-6be684343a3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019d9c38-8e91-7d98-9dbb-5f78dce14a89" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:to="loc_eltx_PreFundedWarrantMember_019d9c38-8e91-7d98-9dbb-5f78dce14a89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025WarrantsMember_019d9c3b-e773-7e14-8947-985818d0cfb3" xlink:href="eltx-20260331.xsd#eltx_June2025WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:to="loc_eltx_June2025WarrantsMember_019d9c3b-e773-7e14-8947-985818d0cfb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-7983-85f3-a6972217d5ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:to="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-7983-85f3-a6972217d5ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:to="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d9c38-8e91-7a3d-b0ec-91b217012b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:to="loc_us-gaap_CommonStockMember_019d9c38-8e91-7a3d-b0ec-91b217012b98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d9c3a-921d-7243-8a66-88e4ddd746a1_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:to="loc_srt_RangeMember_019d9c3a-921d-7243-8a66-88e4ddd746a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:to="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d9c3a-921d-7173-990b-fdad1b9e4d8d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:to="loc_srt_MaximumMember_019d9c3a-921d-7173-990b-fdad1b9e4d8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7748-80b5-ffb1f497b097_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7748-80b5-ffb1f497b097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019d9c3a-921d-783b-8851-9262a0511b36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019d9c3a-921d-783b-8851-9262a0511b36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019d9c3a-921d-7667-8b06-a0f15b3767ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019d9c3a-921d-7667-8b06-a0f15b3767ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019d9c3a-921d-7ab5-861b-3c32d507ced2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019d9c3a-921d-7ab5-861b-3c32d507ced2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9c3b-e773-708a-90da-a9135a242aa7_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:to="loc_dei_EntityDomain_019d9c3b-e773-708a-90da-a9135a242aa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:to="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GKCCMember_019d9c3b-e773-7fb1-88ee-f2cae8f5d890" xlink:href="eltx-20260331.xsd#eltx_GKCCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:to="loc_eltx_GKCCMember_019d9c3b-e773-7fb1-88ee-f2cae8f5d890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d9c38-8e91-7c31-8761-72b2b621c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d9c38-8e91-7c31-8761-72b2b621c43b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019d9c38-8e91-7c70-8708-ef4133fed614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019d9c38-8e91-7c70-8708-ef4133fed614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019d9c38-8e91-7609-a6e1-a2ac4535c746" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019d9c38-8e91-7609-a6e1-a2ac4535c746" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019d9c38-8e91-7430-af3f-ce165c1e1901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019d9c38-8e91-7430-af3f-ce165c1e1901" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019d9c38-8e91-745e-94a4-917daa7b543d" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019d9c38-8e91-745e-94a4-917daa7b543d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019d9c3a-921d-7ab7-9b7a-2b9077f14d06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019d9c3a-921d-7ab7-9b7a-2b9077f14d06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019d9c3a-921d-79cc-92c6-3194fa6acc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019d9c3a-921d-79cc-92c6-3194fa6acc9e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019d9c3b-e773-73b3-96b2-8f07a8cebd80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019d9c3b-e773-73b3-96b2-8f07a8cebd80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019d9c3b-e773-784d-b96a-86d71b9eb499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019d9c3b-e773-784d-b96a-86d71b9eb499" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_019d9c3b-e773-7add-9302-691315178211" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_019d9c3b-e773-7add-9302-691315178211" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019d9c3b-e773-72de-9359-2f2483cb52a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019d9c3b-e773-72de-9359-2f2483cb52a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019d9c3c-6175-774b-8f83-50210d2f5ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019d9c3c-6175-774b-8f83-50210d2f5ebc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019d9c3c-6175-7eb5-9ba6-86e2e64baa73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019d9c3c-6175-7eb5-9ba6-86e2e64baa73" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019d9c3c-6175-7fe1-a354-3ca32611bcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019d9c3c-6175-7fe1-a354-3ca32611bcb7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d9c3c-6175-7fdc-8244-18d0100a6f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d9c3c-6175-7fdc-8244-18d0100a6f17" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d9c3c-6175-7539-ada4-724755a2f819" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d9c3c-6175-7539-ada4-724755a2f819" xlink:type="arc" order="15"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7713-bdd1-ad790456455f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7713-bdd1-ad790456455f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019ce305-8981-7c3b-925e-d41a95abdeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019ce305-8981-7c3b-925e-d41a95abdeb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019ce305-8981-7938-8d89-e71f2a82df83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_WarrantMember_019ce305-8981-7938-8d89-e71f2a82df83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019dc3ce-370b-79da-8184-22a0f481b2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_RestrictedStockMember_019dc3ce-370b-79da-8184-22a0f481b2b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019ce305-8981-728b-8666-3d64d0b48f05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019ce305-8981-728b-8666-3d64d0b48f05" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-7a5a-acbe-8df4de142779_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-7a5a-acbe-8df4de142779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_March2024PreFundedWarrantsMember_019df1cd-ea20-7782-93b9-b44258f6a105" xlink:href="eltx-20260331.xsd#eltx_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_March2024PreFundedWarrantsMember_019df1cd-ea20-7782-93b9-b44258f6a105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019df1cd-ea20-72e5-af5b-33432e28ecbc" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_PreFundedWarrantMember_019df1cd-ea20-72e5-af5b-33432e28ecbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantOneMember_019df1cd-ea20-7491-9405-12e6ea59e484" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_JulyCommonWarrantOneMember_019df1cd-ea20-7491-9405-12e6ea59e484" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025CommonWarrantsMember_019df1cd-ea20-75d7-a20f-f9f8c2bb6800" xlink:href="eltx-20260331.xsd#eltx_June2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_June2025CommonWarrantsMember_019df1cd-ea20-75d7-a20f-f9f8c2bb6800" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019dfd71-04b8-7e82-b158-2141fa65537c" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019dfd71-04b8-7e82-b158-2141fa65537c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-7294-a7fc-983586afa5de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-7294-a7fc-983586afa5de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cd-ea20-7008-849a-555c83c93009" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cd-ea20-7008-849a-555c83c93009" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-704d-a530-31d5604a68a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-704d-a530-31d5604a68a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019df1cd-ea20-7cd5-bb77-a11cdbe0cc67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:to="loc_us-gaap_ConvertibleDebtMember_019df1cd-ea20-7cd5-bb77-a11cdbe0cc67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-7a44-9159-474ed3ccfc30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-7a44-9159-474ed3ccfc30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019df1cd-ea20-78d2-8861-1bf256c3af6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:to="loc_us-gaap_CommonStockMember_019df1cd-ea20-78d2-8861-1bf256c3af6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7b18-956e-73dbfd18a76b_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7b18-956e-73dbfd18a76b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_019dfd71-04b8-7a03-908d-58343857b91f" xlink:href="eltx-20260331.xsd#eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:to="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_019dfd71-04b8-7a03-908d-58343857b91f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-7e0a-ab2e-a678e30a5977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-7e0a-ab2e-a678e30a5977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PurchaseOfWarrantsMember_019dfd71-04b8-79a9-99f5-7fc1ea7adc28" xlink:href="eltx-20260331.xsd#eltx_PurchaseOfWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:to="loc_eltx_PurchaseOfWarrantsMember_019dfd71-04b8-79a9-99f5-7fc1ea7adc28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-71b5-9f05-13b337057b06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-71b5-9f05-13b337057b06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_July2024PublicOfferingMember_019dfd71-04b8-7d1f-a08a-ba6f4dad3de0" xlink:href="eltx-20260331.xsd#eltx_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:to="loc_eltx_July2024PublicOfferingMember_019dfd71-04b8-7d1f-a08a-ba6f4dad3de0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cd-ea20-735c-92df-1a38d253fead" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cd-ea20-735c-92df-1a38d253fead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod_019dfd71-04b8-75a2-9b83-504b7c8823a9" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod_019dfd71-04b8-75a2-9b83-504b7c8823a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019df1cd-ea20-7324-b4b1-1190000bfe12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019df1cd-ea20-7324-b4b1-1190000bfe12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019df1cd-ea20-7ad7-a358-800281e5f65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019df1cd-ea20-7ad7-a358-800281e5f65b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cd-ea20-7525-8b79-76174eb754d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cd-ea20-7525-8b79-76174eb754d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019df1cd-ea20-7ec2-aaba-cfb96a72edca" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019df1cd-ea20-7ec2-aaba-cfb96a72edca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cd-ea20-7ec1-9382-c63602d0327f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cd-ea20-7ec1-9382-c63602d0327f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:to="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ce305-8981-73a7-8e79-f9f5c61a3d03_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:to="loc_srt_ProductsAndServicesDomain_019ce305-8981-73a7-8e79-f9f5c61a3d03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:to="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClinicalTrailMember_019ce305-8981-7e47-b5ec-e8fc4302a771" xlink:href="eltx-20260331.xsd#eltx_ClinicalTrailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_ClinicalTrailMember_019ce305-8981-7e47-b5ec-e8fc4302a771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember_019ce305-8981-7fb4-97b8-9517d2b4fb0c" xlink:href="eltx-20260331.xsd#eltx_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember_019ce305-8981-7fb4-97b8-9517d2b4fb0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_TranslationalMedicineAndCMCMember_019ce305-8981-7f53-ba44-0939fee82974" xlink:href="eltx-20260331.xsd#eltx_TranslationalMedicineAndCMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_TranslationalMedicineAndCMCMember_019ce305-8981-7f53-ba44-0939fee82974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherMember_019ce305-8981-72db-a2ff-90be5a3b2ddb" xlink:href="eltx-20260331.xsd#eltx_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_OtherMember_019ce305-8981-72db-a2ff-90be5a3b2ddb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019ce305-8981-7e39-b68c-ea35d140a49d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:to="loc_us-gaap_SegmentDomain_019ce305-8981-7e39-b68c-ea35d140a49d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:to="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ReportableSegmentMember_019ce305-8981-7bf8-814d-a9b46cda2ee2" xlink:href="eltx-20260331.xsd#eltx_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:to="loc_eltx_ReportableSegmentMember_019ce305-8981-7bf8-814d-a9b46cda2ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-71b8-9bb3-d0c245b2de8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-71b8-9bb3-d0c245b2de8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_019ce305-8981-7d6a-9ded-64750e233e49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_019ce305-8981-7d6a-9ded-64750e233e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-8981-7b41-914e-746f349fd538" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-8981-7b41-914e-746f349fd538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019ce305-8981-76c1-9397-aeed4ca397f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019ce305-8981-76c1-9397-aeed4ca397f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019ce305-8981-7b13-b9ec-831a260d90b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019ce305-8981-7b13-b9ec-831a260d90b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-8981-7881-b0a1-1e034442bd15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-8981-7881-b0a1-1e034442bd15" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019ce305-8981-72de-b2e7-3a2054383b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_Assets_019ce305-8981-72de-b2e7-3a2054383b43" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.eltx.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:to="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d42ae-5545-75cc-9719-a0606af22ff0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:to="loc_us-gaap_EquityComponentDomain_019d42ae-5545-75cc-9719-a0606af22ff0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:to="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d42ae-5545-755b-b766-f9136f77d01f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:to="loc_us-gaap_CommonStockMember_019d42ae-5545-755b-b766-f9136f77d01f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-77c2-b227-0a65d479ef84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-77c2-b227-0a65d479ef84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026ATMProgramMember_019d9c0e-5a55-7784-8735-fc92cbf4de90" xlink:href="eltx-20260331.xsd#eltx_A2026ATMProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:to="loc_eltx_A2026ATMProgramMember_019d9c0e-5a55-7784-8735-fc92cbf4de90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-75bc-9d25-969968cb2871_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-75bc-9d25-969968cb2871_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019d9c11-5b70-718d-bfbd-5e57d08a3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:to="loc_us-gaap_SubsequentEventMember_019d9c11-5b70-718d-bfbd-5e57d08a3b1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d42ae-5545-74a9-9a6e-801cf5c114af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d42ae-5545-74a9-9a6e-801cf5c114af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d42ae-5545-768b-ab17-6273e2bf4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d42ae-5545-768b-ab17-6273e2bf4cec" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>eltx-20260331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod_019ce305-8a4b-7921-b3be-b2fd32cf7717_terseLabel_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod_label_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod_documentation_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:to="lab_eltx_ClassOfWarrantOrRightIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_019ce305-8ac6-7c00-8cb1-4dc72743d399_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019ce305-8a4a-76b7-8ef7-128d900a27bf_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_019ce305-8a4a-7d20-a174-0d2c3e49f3f4_terseLabel_en-US" xlink:label="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:label id="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_label_en-US" xlink:label="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]</link:label>
    <link:label id="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_documentation_en-US" xlink:label="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:href="eltx-20260331.xsd#eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:to="lab_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_019ce305-8a4a-7deb-99dc-70c38b217f31_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019ce305-8a4a-77b6-8497-e28d9b135d06_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026 (remaining nine months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019ce305-8a4a-7a44-a7a0-60f6b5db8a68_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019ce305-8a4a-7e53-8e35-6121d0f61752_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_019ce305-8a4a-73dc-8c04-573ee334e2a0_terseLabel_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership maximum (as a percent)</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_label_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_documentation_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:to="lab_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019ce305-8a4a-7bc2-bd49-2731abb09e08_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019ce305-8a4a-7727-a880-f4ba8a12447b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JanuaryOfferingMember_019dc35e-9e8b-7818-a635-be374b851fd2_terseLabel_en-US" xlink:label="lab_eltx_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Offering</link:label>
    <link:label id="lab_eltx_JanuaryOfferingMember_label_en-US" xlink:label="lab_eltx_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Offering [Member]</link:label>
    <link:label id="lab_eltx_JanuaryOfferingMember_documentation_en-US" xlink:label="lab_eltx_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryOfferingMember" xlink:href="eltx-20260331.xsd#eltx_JanuaryOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JanuaryOfferingMember" xlink:to="lab_eltx_JanuaryOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ReportableSegmentMember_019ce305-8a4a-7c72-81e6-0d9948cd81de_terseLabel_en-US" xlink:label="lab_eltx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_eltx_ReportableSegmentMember_label_en-US" xlink:label="lab_eltx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_eltx_ReportableSegmentMember_documentation_en-US" xlink:label="lab_eltx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ReportableSegmentMember" xlink:href="eltx-20260331.xsd#eltx_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ReportableSegmentMember" xlink:to="lab_eltx_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8a4a-753f-ba8f-1bc5bbdff148_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-funded warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8a4a-74d8-9287-fee60407e902_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019ce305-8ac6-785a-b2f7-22f1957c0d8f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019ce305-8ac6-7ba5-ba73-4dfaa6ff0235_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019ce305-8a4a-7bbc-8aa0-783cf4c6f6e9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember_019ce305-8a4b-7f2f-8985-b1eaa048cf23_terseLabel_en-US" xlink:label="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related research and development expenses</link:label>
    <link:label id="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember_label_en-US" xlink:label="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development [Member]</link:label>
    <link:label id="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:href="eltx-20260331.xsd#eltx_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:to="lab_eltx_EmployeeRelatedReasearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8a4a-7065-94b2-c35282536fcc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8a4a-7cda-89fb-6581f84b567d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-703f-a28a-8a7b8f09e5fb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_019ce305-8a4a-7b0f-a81f-3b63c28567de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019ce305-8a4a-7588-b64e-756aeb45db37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019ce305-8a4a-78b2-8402-f641c402f9e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock and common warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019ce305-8a4a-7931-be01-64c5dd0b1e03_terseLabel_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:label id="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_label_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants [Member]</link:label>
    <link:label id="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:to="lab_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-79e0-a830-ec70553e93a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ElicioWarrantsMember_019ce305-8a4a-725d-99cc-783ef3604b64_terseLabel_en-US" xlink:label="lab_eltx_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:label id="lab_eltx_ElicioWarrantsMember_label_en-US" xlink:label="lab_eltx_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Elicio Warrants [Member]</link:label>
    <link:label id="lab_eltx_ElicioWarrantsMember_documentation_en-US" xlink:label="lab_eltx_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ElicioWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_ElicioWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ElicioWarrantsMember" xlink:to="lab_eltx_ElicioWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_019ce305-8a4a-7398-87ef-abf410ad59c8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AngionCommonStockMember_019ce305-8981-7569-baca-fb3b0c7d2061_terseLabel_en-US" xlink:label="lab_eltx_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:label id="lab_eltx_AngionCommonStockMember_label_en-US" xlink:label="lab_eltx_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Common Stock [Member]</link:label>
    <link:label id="lab_eltx_AngionCommonStockMember_documentation_en-US" xlink:label="lab_eltx_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionCommonStockMember" xlink:href="eltx-20260331.xsd#eltx_AngionCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AngionCommonStockMember" xlink:to="lab_eltx_AngionCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019ce305-8a4a-7b64-bd71-a4f8c755fe1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_MeasurementInputStrikePriceMember_019ce305-8a4a-7512-9951-01e6dd05187b_terseLabel_en-US" xlink:label="lab_eltx_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average strike price</link:label>
    <link:label id="lab_eltx_MeasurementInputStrikePriceMember_label_en-US" xlink:label="lab_eltx_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price [Member]</link:label>
    <link:label id="lab_eltx_MeasurementInputStrikePriceMember_documentation_en-US" xlink:label="lab_eltx_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_MeasurementInputStrikePriceMember" xlink:href="eltx-20260331.xsd#eltx_MeasurementInputStrikePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_MeasurementInputStrikePriceMember" xlink:to="lab_eltx_MeasurementInputStrikePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019ce305-8a4b-79cc-be78-2dc92f827ca8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019ce305-8a4b-7335-805d-d24982a8b7c4_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_019ce305-8a4a-7090-b4d4-e0852ddd0444_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8a4a-7ff3-85ef-d9a535cbe797_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_NumberOfResearchGrantAgreements_019ce305-8a4a-7100-bc16-1d410910a6a1_terseLabel_en-US" xlink:label="lab_eltx_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of research grant agreements</link:label>
    <link:label id="lab_eltx_NumberOfResearchGrantAgreements_label_en-US" xlink:label="lab_eltx_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:label id="lab_eltx_NumberOfResearchGrantAgreements_documentation_en-US" xlink:label="lab_eltx_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NumberOfResearchGrantAgreements" xlink:href="eltx-20260331.xsd#eltx_NumberOfResearchGrantAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_NumberOfResearchGrantAgreements" xlink:to="lab_eltx_NumberOfResearchGrantAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8a4a-7e5e-8d32-cfb7f23795b4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019ce305-8ac6-761d-861b-4179985f2faa_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' (deficit) equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019ce305-8ac6-7bcd-a24c-c5add3f61cb7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019ce305-8ac6-78ae-b185-743bac402b95_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019ce305-8a4a-7bf9-bf96-8d5dfd8b9886_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_019ce305-8a4a-774f-b734-6fbe51548a0f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019ce305-8a4a-7617-b91a-3edc491b157d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_019ce305-8a4a-7063-89e9-12479e8b1393_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grants</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019ce305-8a4a-71b2-ad9c-ed32fc21d128_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019ce305-8a4a-7823-b166-dd29462b428c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019ce305-8a4a-7216-a0bd-13c8caed43d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-8ac6-76f4-9970-cf302b1ab0f8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8a4a-7764-81ef-734d9a412bb0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8a4a-7bf0-8cd8-918c48b44ade_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-8a4a-7088-bc7d-6f18502f21d7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8ac6-7cc8-bb4a-68c2b2a213e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_019ce305-8a4b-7624-bce7-c7008358e26e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019ce305-8a4a-7e4d-a234-8e6b04321ef4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_019ce305-8a4a-73f5-b057-e863e3c4a6c8_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019ce305-8a4a-7185-8d25-8b754168e5cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulySharesAndJulyCommonWarrantMember_019ce305-8a4a-7ce7-a805-15f821d5c7ac_terseLabel_en-US" xlink:label="lab_eltx_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Share And July Common Warrant</link:label>
    <link:label id="lab_eltx_JulySharesAndJulyCommonWarrantMember_label_en-US" xlink:label="lab_eltx_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant [Member]</link:label>
    <link:label id="lab_eltx_JulySharesAndJulyCommonWarrantMember_documentation_en-US" xlink:label="lab_eltx_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulySharesAndJulyCommonWarrantMember" xlink:href="eltx-20260331.xsd#eltx_JulySharesAndJulyCommonWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulySharesAndJulyCommonWarrantMember" xlink:to="lab_eltx_JulySharesAndJulyCommonWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019ce305-8a4a-788d-aea7-3a29e0972b44_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_019ce305-8ac6-72da-807a-c32429cb41a3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested shares under restricted stock grants</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_019ce305-8981-7f31-882b-211be6c2e03a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8a4a-7dc8-8e43-02e9ec13ae80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_019ce305-8ac6-7589-996d-df28287e32af_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8a4b-7883-9cad-31dde1e007cc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_019ce305-8981-7372-998b-0f5afd1f2254_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-8a4a-735e-833c-c78fd5bc3cce_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-8a4a-700b-86cd-18aa07cb0ab6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019d9c3a-921d-7247-b1ca-9af8d3964258_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_WarrantLiabilityMember_019ce305-8a4a-7227-9bcf-7023a41d5dea_terseLabel_en-US" xlink:label="lab_eltx_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_eltx_WarrantLiabilityMember_label_en-US" xlink:label="lab_eltx_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_eltx_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_eltx_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiabilityMember" xlink:href="eltx-20260331.xsd#eltx_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_WarrantLiabilityMember" xlink:to="lab_eltx_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019ce305-8ac6-78a0-a77f-dc9a136167f5_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_WarrantLiability_019ce305-8a4a-7577-9bcf-63a491219d43_terseLabel_en-US" xlink:label="lab_eltx_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_eltx_WarrantLiability_label_en-US" xlink:label="lab_eltx_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_eltx_WarrantLiability_documentation_en-US" xlink:label="lab_eltx_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiability" xlink:href="eltx-20260331.xsd#eltx_WarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_WarrantLiability" xlink:to="lab_eltx_WarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_019ce305-8a4a-70c4-95ce-b24054aae07b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-74e9-8e61-0bfed11a06b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-8a4a-7931-a281-ea2f69a830fa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' (deficit) equity:</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_Inducement2024PlanMember_019ce305-8a4b-7cf0-b7df-00e2ae6250f2_terseLabel_en-US" xlink:label="lab_eltx_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:label id="lab_eltx_Inducement2024PlanMember_label_en-US" xlink:label="lab_eltx_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan [Member]</link:label>
    <link:label id="lab_eltx_Inducement2024PlanMember_documentation_en-US" xlink:label="lab_eltx_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_Inducement2024PlanMember" xlink:href="eltx-20260331.xsd#eltx_Inducement2024PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_Inducement2024PlanMember" xlink:to="lab_eltx_Inducement2024PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019ce305-8a4a-7738-83d0-1a5924c5c070_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-8a4a-7179-8156-c504275f64e2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_019ce305-8a4b-7e8b-90a8-aab33b9d9d8a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AccruedInterest_019d424a-50d6-7309-8591-2498167a57d5_terseLabel_en-US" xlink:label="lab_eltx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_eltx_AccruedInterest_label_en-US" xlink:label="lab_eltx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_eltx_AccruedInterest_documentation_en-US" xlink:label="lab_eltx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterest" xlink:href="eltx-20260331.xsd#eltx_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AccruedInterest" xlink:to="lab_eltx_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019ce305-8a4b-72b9-b223-12b80419465a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8a4a-75e9-a2c0-8e3a85c396b4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8a4a-79a2-8793-dc4d08424843_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019ce305-8a4a-7096-9433-ece071b4cdd2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019ce305-8a4a-7b83-a56d-e4da7c9e44b4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019ce305-8a4b-73de-a898-06b931afb574_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_019ce305-8a4a-7c05-aa28-6ad493be0e7f_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019ce305-8a4a-7433-8260-e9fbc5701699_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_019ce305-8ac6-7c22-be69-e1bb7347caba_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019ce305-8a4a-76c9-b6db-2d49da34cac1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_019ce305-8a4a-7f50-bbf1-a04b7ab47c89_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8a4b-7b1d-a66e-bb9cee0be8d0_terseLabel_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="lab_eltx_CommitmentsAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019ce305-8a4a-7591-ab89-c3aae6f128ad_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019ce305-8a4a-7ec0-9f6d-1b38842262a8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_019ce305-8ac6-73ce-a061-2b34d439e178_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019df190-7a0c-7753-afe7-85328dd064c7_terseLabel_en-US" xlink:label="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable</link:label>
    <link:label id="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_label_en-US" xlink:label="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid</link:label>
    <link:label id="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_documentation_en-US" xlink:label="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:href="eltx-20260331.xsd#eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:to="lab_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019ce305-8a4a-77c1-8bf9-bf504e1e4b73_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-8a4a-7b2c-bd0c-d65f6f0da3cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_019ce305-8a4a-76b8-af87-41bd14cd3f2a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items(1)</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8ac6-747d-bc09-2007d80e7d4e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of foreign currency on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_019ce305-8a4a-7092-91e0-664a5e5e40cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019dc3c3-6103-7e43-aa89-6d4023724b55_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_RoyaltyRatePercent_019ce305-8a4a-73ce-bc16-b8d92ad79cb5_terseLabel_en-US" xlink:label="lab_eltx_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty rates (as a percent)</link:label>
    <link:label id="lab_eltx_RoyaltyRatePercent_label_en-US" xlink:label="lab_eltx_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:label id="lab_eltx_RoyaltyRatePercent_documentation_en-US" xlink:label="lab_eltx_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_RoyaltyRatePercent" xlink:href="eltx-20260331.xsd#eltx_RoyaltyRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_RoyaltyRatePercent" xlink:to="lab_eltx_RoyaltyRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8a4a-7bc8-8e6b-6ae97efabd33_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019ce305-8981-77b2-9eaf-402137cfaf13_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_019ce305-8a4a-70e9-834e-509cdea3cb86_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019ce305-8a4a-756f-ae0a-873117898114_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8a4a-75b9-b1e2-f60e3f142c22_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8a4a-7e68-b081-b2c1d9cec4d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019ce305-8a4a-7348-b9ee-0dbcb5b57f37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_019ce305-8a4b-73d0-8c79-8970a7af92aa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019ce305-8a4a-799c-89e2-8d39584b70cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019ce305-8a4a-7441-a205-f6ddf90d30cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019ce305-8a4a-7af3-820c-e801bf49ef78_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_019ce305-8a4a-709b-87b0-6b750ee164af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_019ce305-8a4a-7dc9-99c3-905bbe1806c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulyCommonWarrantOneMember_019d7110-e008-7d48-9b7d-7d09f5c1bb5f_terseLabel_en-US" xlink:label="lab_eltx_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Common Warrants One</link:label>
    <link:label id="lab_eltx_JulyCommonWarrantOneMember_label_en-US" xlink:label="lab_eltx_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrant One [Member]</link:label>
    <link:label id="lab_eltx_JulyCommonWarrantOneMember_documentation_en-US" xlink:label="lab_eltx_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrant One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantOneMember" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulyCommonWarrantOneMember" xlink:to="lab_eltx_JulyCommonWarrantOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019ce305-8ac6-7ec1-bd7f-d87a8c025190_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_019ce305-8a4a-79ad-b65b-8e6d2422f9d5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-8a4a-7020-8875-730b814e8353_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019ce305-8a4a-7f40-930d-0e3b3db16be4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019df1c1-497e-7a69-bc85-79d7bcf9b675_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019ce305-8981-7835-83fd-e65ded40626e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8a4a-73a1-897a-8534eb3a9226_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8a4a-7b88-a53e-0118dbeed0e1_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019ce305-8981-743f-a25e-68d11d673e04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019ce305-8a4a-7792-a1fa-54b3c764b0c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019ce305-8a4a-771c-b792-843b9ed0e2c2_terseLabel_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life (years)</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:to="lab_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_019ce305-8a4a-7676-ad76-22df5b5315db_terseLabel_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement from grant funds</link:label>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_label_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_documentation_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:to="lab_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8a4a-7be5-8089-839bbf7a3eda_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8a4a-7de2-8150-95d81556b4ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-8a4a-7111-a50c-114514b19880_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019ce305-8a4a-701c-9978-b3b300c62a88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019ce305-8a4a-722e-a78c-c4980e1e310b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-8a4a-7817-afac-a3ff1fdf444f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_019ce305-8981-7f84-8f53-fe4e6f322711_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (per share)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019ce305-8a4a-7c6c-ab27-b26c56be9a93_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8a4a-7803-a133-af2ba93945ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8a4a-7073-b98d-d1ba10a80533_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8a4a-760f-a4b4-044ae9bcfb41_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-8a4a-7929-8023-fea44b26bef8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019ce305-8a4a-74b2-bbf2-a89db93f6298_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019ce305-8a4b-708b-a668-51df3bd1c0a1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019ce305-8a4a-738d-90b8-bec20aaf0f42_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_019d9c3a-921d-7062-b13e-4be0830c7e73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, prepayment fee prepaid (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019ce305-8a4a-7b27-9fd4-d6193611c78d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019ce305-8a4a-73f5-947b-baa9ed591961_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019ce305-8a4a-78c6-a51c-fe1f8c62002b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019ce305-8a4a-7664-9a57-a6859b33ae54_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8a4a-7ecd-8f77-ab843dffe6be_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_OtherMember_019ce305-8a4a-7c4b-8be0-ee70d15ab0cd_terseLabel_en-US" xlink:label="lab_eltx_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other research and development expenses</link:label>
    <link:label id="lab_eltx_OtherMember_label_en-US" xlink:label="lab_eltx_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_eltx_OtherMember_documentation_en-US" xlink:label="lab_eltx_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherMember" xlink:href="eltx-20260331.xsd#eltx_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_OtherMember" xlink:to="lab_eltx_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_019ce305-8a4a-7387-8e9c-a39eb653aee9_terseLabel_en-US" xlink:label="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued clinical trial and research and development costs</link:label>
    <link:label id="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_label_en-US" xlink:label="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Clinical Trial And Research And Development Costs, Current</link:label>
    <link:label id="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Clinical Trial And Research And Development Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:href="eltx-20260331.xsd#eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:to="lab_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019ce305-8a4b-73d6-aa63-9826d9716917_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019ce305-8a4b-7df5-b8f0-b5f678c6752c_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee related general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019ce305-8a4a-7454-acf9-bb2cae22d57a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-8ac6-78af-959f-85abc95e5cc2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_WarrantsAndRightsOutstandingAbstract_label_en-US" xlink:label="lab_eltx_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Abstract]</link:label>
    <link:label id="lab_eltx_WarrantsAndRightsOutstandingAbstract_documentation_en-US" xlink:label="lab_eltx_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingAbstract" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_WarrantsAndRightsOutstandingAbstract" xlink:to="lab_eltx_WarrantsAndRightsOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019d70f0-aa3e-75f4-8ee8-a6fa1f7d36cf_terseLabel_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2026</link:label>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_label_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2026 [Member]</link:label>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_documentation_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:to="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_019ce305-8a4a-7fcd-a1f9-9df7bf2e333d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_019ce305-8a4a-723c-a73f-51cd812d7861_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019df1b0-e078-7c0b-bdf2-d7bfaea92b84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_019ce305-8a4a-7db7-bcbf-d24a09553c7f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019ce305-8a4b-7ef0-a360-5d74a97e4c88_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019d9c3a-921d-7f70-923e-9de524c7e3e6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019ce305-8a4a-76ff-951e-0bd24963fcc7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019ce305-8a4a-78f5-b1d9-90d01cdebf52_terseLabel_en-US" xlink:label="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate sales milestone payments per product</link:label>
    <link:label id="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_label_en-US" xlink:label="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:label id="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_documentation_en-US" xlink:label="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:to="lab_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8a4a-7168-9578-dd7fe1abe7ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019ce305-8ac6-7303-b31c-683706b2899e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019ce305-8a4a-7ffa-9014-54728583f841_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8a4a-7b7a-91a9-05efdd300798_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_019ce305-8a4a-724d-bfa5-21b0adfbd12a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-8a4a-7b50-a4c8-653225b041fb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_019ce305-8a4a-7323-bbff-ba55a56c90cb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_019ce305-8a4a-7a60-a01a-60dc2ac498cb_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019ce305-8a4a-7139-b9d3-d160d270cad3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_GKCCMember_019ce305-8a4a-7bec-bdfc-71e724985ae1_terseLabel_en-US" xlink:label="lab_eltx_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:label id="lab_eltx_GKCCMember_label_en-US" xlink:label="lab_eltx_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GKCC [Member]</link:label>
    <link:label id="lab_eltx_GKCCMember_documentation_en-US" xlink:label="lab_eltx_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GKCCMember" xlink:href="eltx-20260331.xsd#eltx_GKCCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_GKCCMember" xlink:to="lab_eltx_GKCCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_019ce305-8a4a-7092-8f81-96aca87bad2b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-8a4b-713a-899e-988b08033a18_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8a4a-77c1-a76f-1150b0faceb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019ce305-8981-7e01-b120-b637c887c733_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ClinicalTrailMember_019ce305-8a4a-712f-9aec-466f043fc764_terseLabel_en-US" xlink:label="lab_eltx_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_eltx_ClinicalTrailMember_label_en-US" xlink:label="lab_eltx_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Trail [Member]</link:label>
    <link:label id="lab_eltx_ClinicalTrailMember_documentation_en-US" xlink:label="lab_eltx_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Trail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClinicalTrailMember" xlink:href="eltx-20260331.xsd#eltx_ClinicalTrailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ClinicalTrailMember" xlink:to="lab_eltx_ClinicalTrailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-727f-8832-2a57229339c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_BostonMassachusettsMember_019ce305-8a4a-7298-85d3-905b23b13f2f_terseLabel_en-US" xlink:label="lab_eltx_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:label id="lab_eltx_BostonMassachusettsMember_label_en-US" xlink:label="lab_eltx_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts [Member]</link:label>
    <link:label id="lab_eltx_BostonMassachusettsMember_documentation_en-US" xlink:label="lab_eltx_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_BostonMassachusettsMember" xlink:href="eltx-20260331.xsd#eltx_BostonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_BostonMassachusettsMember" xlink:to="lab_eltx_BostonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019ce305-8981-7081-86f0-1af39b085e42_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_June2025WarrantsMember_019ce305-8ac6-7eac-8d7f-1390246e674e_terseLabel_en-US" xlink:label="lab_eltx_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:label id="lab_eltx_June2025WarrantsMember_label_en-US" xlink:label="lab_eltx_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Warrants [Member]</link:label>
    <link:label id="lab_eltx_June2025WarrantsMember_documentation_en-US" xlink:label="lab_eltx_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025WarrantsMember" xlink:href="eltx-20260331.xsd#eltx_June2025WarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_June2025WarrantsMember" xlink:to="lab_eltx_June2025WarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019ce305-8a4b-76ab-aab1-c8a965ad0cd1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_019ce305-8a4a-7eb0-b331-b806575a5944_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019ce305-8a4a-7475-970a-bc85e527eb60_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019ce305-8a4a-7292-8825-7d666fd47686_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_019ce305-8a4a-739d-8879-3ac980c53066_terseLabel_en-US" xlink:label="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum annual maintenance payments</link:label>
    <link:label id="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_label_en-US" xlink:label="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:label id="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_documentation_en-US" xlink:label="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:to="lab_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_019ce305-8a4a-7e78-926a-96facdb5c331_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-8a4a-72f8-b6d5-1e5fe518615b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-8a4a-7361-af67-0ead1fbc09dc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019ce305-8ac6-7d84-9f4b-719f2fed1bb6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_A2026RegistrationStatementMember_019dfb6a-76e5-75a5-80e0-a14af47f2531_terseLabel_en-US" xlink:label="lab_eltx_A2026RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026 Registration Statement</link:label>
    <link:label id="lab_eltx_A2026RegistrationStatementMember_label_en-US" xlink:label="lab_eltx_A2026RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2026 Registration Statement [Member]</link:label>
    <link:label id="lab_eltx_A2026RegistrationStatementMember_documentation_en-US" xlink:label="lab_eltx_A2026RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2026 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026RegistrationStatementMember" xlink:href="eltx-20260331.xsd#eltx_A2026RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_A2026RegistrationStatementMember" xlink:to="lab_eltx_A2026RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019ce305-8a4a-7126-a417-f441083929fa_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_June2025CommonWarrantsMember_019ce305-8a4a-736c-a620-b53adffce18f_terseLabel_en-US" xlink:label="lab_eltx_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:label id="lab_eltx_June2025CommonWarrantsMember_label_en-US" xlink:label="lab_eltx_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_eltx_June2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_eltx_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025CommonWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_June2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_June2025CommonWarrantsMember" xlink:to="lab_eltx_June2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019ce305-8a4a-78a1-8987-303146f1400e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-8a4a-7d24-9afa-6e09ad9523ed_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-8a4a-7a0f-9c04-6d1f593a0124_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_019ce305-8981-76c5-a374-950f1f6f1229_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019ce305-8a4a-7cca-8e0c-8b1c71b8bbe2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019ce305-8a4a-7bfb-9981-62d439cb4b0b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_UniversityMember_019ce305-8a4a-745e-a23d-d484df4c854e_terseLabel_en-US" xlink:label="lab_eltx_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:label id="lab_eltx_UniversityMember_label_en-US" xlink:label="lab_eltx_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">University [Member]</link:label>
    <link:label id="lab_eltx_UniversityMember_documentation_en-US" xlink:label="lab_eltx_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_UniversityMember" xlink:href="eltx-20260331.xsd#eltx_UniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_UniversityMember" xlink:to="lab_eltx_UniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8a4a-71ee-83f8-b8b886e7f160_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_019ce305-8a4a-7873-acf3-b0772cfe4901_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-8a4a-757d-83d8-7a2724a32a6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_019ce305-8a4a-7b16-a90a-b32984212367_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_019ce305-8a4a-783c-ab20-556710d4396f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility (annual)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AngionWarrantsMember_019ce305-8a4b-7920-a232-754231eb8f49_terseLabel_en-US" xlink:label="lab_eltx_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:label id="lab_eltx_AngionWarrantsMember_label_en-US" xlink:label="lab_eltx_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Warrants [Member]</link:label>
    <link:label id="lab_eltx_AngionWarrantsMember_documentation_en-US" xlink:label="lab_eltx_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_AngionWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AngionWarrantsMember" xlink:to="lab_eltx_AngionWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019ce305-8a4a-7140-a316-836bc45e08ac_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_019ce305-8a4a-7351-a0af-a519b51437f8_terseLabel_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and grant reimbursements</link:label>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_label_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Direct Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecoveryOfDirectCosts" xlink:to="lab_us-gaap_RecoveryOfDirectCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019ce305-8a4b-7c10-9bc3-6341cd0a3540_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-8a4b-7310-bcb6-77bdc0450c9a_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8a4a-772b-9ba2-595aaa5ff556_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_019dfd79-3e5d-77b0-a0c8-90f03afa7545_negatedTerseLabel_en-US" xlink:label="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of offering costs for the issuance of common stock from at-the-market offering</link:label>
    <link:label id="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_label_en-US" xlink:label="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering</link:label>
    <link:label id="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_documentation_en-US" xlink:label="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:href="eltx-20260331.xsd#eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:to="lab_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8a4a-7ea2-8624-6526d7591713_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8a4a-714f-b910-b4965f8011dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8a4a-7990-9c88-b86b73b17bc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AdvancedProfessionalFees_019ce305-8a4a-71d3-ae05-83228559ec3f_terseLabel_en-US" xlink:label="lab_eltx_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advanced professional fees</link:label>
    <link:label id="lab_eltx_AdvancedProfessionalFees_label_en-US" xlink:label="lab_eltx_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:label id="lab_eltx_AdvancedProfessionalFees_documentation_en-US" xlink:label="lab_eltx_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AdvancedProfessionalFees" xlink:href="eltx-20260331.xsd#eltx_AdvancedProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AdvancedProfessionalFees" xlink:to="lab_eltx_AdvancedProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019ce305-8a4a-71da-b6cb-0048c27bcef6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8a4b-7f2b-8699-e127f4d6ee0b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8a4b-75ea-bfe1-cc6487025d20_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019ce305-8ac6-75da-851a-fd26dabfae04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8a4a-74e1-8775-aab5d98730a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019ce305-8a4a-72e7-aacb-a9ba64ce3e52_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_019ce305-8a4a-70d3-89bb-0bc8ffd2a991_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019ce305-8a4b-7165-92fd-bcaf704ca03e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8ac6-7816-ae90-a46f577a2f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_019ce305-8ac6-714c-8353-c1fa5c5707b1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019ce305-8981-7b6a-a73c-a090d3f69044_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_IncreaseDecreaseInAccruedExpenses_019ce305-8a4b-792f-857b-38a7980a6a86_terseLabel_en-US" xlink:label="lab_eltx_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_eltx_IncreaseDecreaseInAccruedExpenses_label_en-US" xlink:label="lab_eltx_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses</link:label>
    <link:label id="lab_eltx_IncreaseDecreaseInAccruedExpenses_documentation_en-US" xlink:label="lab_eltx_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_IncreaseDecreaseInAccruedExpenses" xlink:href="eltx-20260331.xsd#eltx_IncreaseDecreaseInAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_IncreaseDecreaseInAccruedExpenses" xlink:to="lab_eltx_IncreaseDecreaseInAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019ce305-8a4a-7c6c-a828-c2809a8651f3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_019ce305-8a4a-7db5-8015-71cc0909293e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8a4a-71f2-8979-939c49c53d46_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_019ce305-8a4a-764c-a97b-d55e72aef2cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019dc3c3-6103-7618-b6a5-4bea417db948_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019ce305-8a4a-7bd5-99ca-6ac6d16697c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019ce305-8a4a-7690-b5d4-3121b8134a98_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019ce305-8a4a-70dc-9e15-219406f1b921_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019ce305-8ac6-73e0-9351-20c853fb7544_terseLabel_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_label_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024 [Member]</link:label>
    <link:label id="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_documentation_en-US" xlink:label="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:to="lab_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019ce305-8a4a-7e5d-a922-bb54303fdc0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_019ce305-8a4a-727e-85fb-defcf1d22863_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-8a4a-733d-a5b2-a8228968c1ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019ce305-8a4a-7ff6-8e73-05b8a658f473_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_019ce305-8ac6-7a7a-acb8-f73bf0594458_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JanuaryCommonWarrantsMember_019ce305-8ac6-7a44-9037-36a897cc28ee_terseLabel_en-US" xlink:label="lab_eltx_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:label id="lab_eltx_JanuaryCommonWarrantsMember_label_en-US" xlink:label="lab_eltx_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Common Warrants [Member]</link:label>
    <link:label id="lab_eltx_JanuaryCommonWarrantsMember_documentation_en-US" xlink:label="lab_eltx_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryCommonWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_JanuaryCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JanuaryCommonWarrantsMember" xlink:to="lab_eltx_JanuaryCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019ce305-8981-7826-8c2d-0b6e05224f01_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019ce305-8a4b-7789-aa90-a2a5788009a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_019ce305-8a4a-7cf1-8256-8c303359f541_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019ce305-8a4a-7a65-b73b-3fb24c18f0d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_019ce305-8a4a-7510-b3ae-22216d90d551_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019dc3c3-6103-75d4-bfe2-4fcbdac53d27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">RSUs forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ConversionOfConvertibleDebtMember_019ce305-8a4a-7ddf-889c-ef84b6bfdbb0_terseLabel_en-US" xlink:label="lab_eltx_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Debt</link:label>
    <link:label id="lab_eltx_ConversionOfConvertibleDebtMember_label_en-US" xlink:label="lab_eltx_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt [Member]</link:label>
    <link:label id="lab_eltx_ConversionOfConvertibleDebtMember_documentation_en-US" xlink:label="lab_eltx_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ConversionOfConvertibleDebtMember" xlink:href="eltx-20260331.xsd#eltx_ConversionOfConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ConversionOfConvertibleDebtMember" xlink:to="lab_eltx_ConversionOfConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_019ce305-8a4a-7115-8900-4c2957521724_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019d9c3a-921d-729c-aa5f-89fe1090b48f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_019ce305-8a4a-7690-9fcd-010be2a1ee19_terseLabel_en-US" xlink:label="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quantitative Information Regarding Operating Leases</link:label>
    <link:label id="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases [Table Text Block]</link:label>
    <link:label id="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_documentation_en-US" xlink:label="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:href="eltx-20260331.xsd#eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:to="lab_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019ce305-8a4a-7990-8bb5-9e058f485fdf_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019ce305-8a4a-7edd-bbf6-d289f92e7816_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_019ce305-8a4a-7730-a96b-a4777f0fdd1a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019ce305-8a4b-7f0d-8e73-00ea78c9d917_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8a4a-7be5-ad0e-62d9cb6e6bfd_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_019ce305-8ac6-736a-b0ac-8ada3e44c0bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019ce305-8a4a-76c1-a15e-51be41ddf895_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_019ce305-8a4a-7cf6-afaa-89eb8f62d1c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019ce305-8981-7f91-97b3-1b14790b731e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_019ce305-8a4a-73c8-9eef-a612ab8c4aa3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from secured lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Secured Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulyPublicOfferingMember_019ce305-8a4a-7a19-bb79-fcc94572f38b_terseLabel_en-US" xlink:label="lab_eltx_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering</link:label>
    <link:label id="lab_eltx_JulyPublicOfferingMember_label_en-US" xlink:label="lab_eltx_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Public Offering [Member]</link:label>
    <link:label id="lab_eltx_JulyPublicOfferingMember_documentation_en-US" xlink:label="lab_eltx_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPublicOfferingMember" xlink:href="eltx-20260331.xsd#eltx_JulyPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulyPublicOfferingMember" xlink:to="lab_eltx_JulyPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dc3c3-6103-75a1-b0d0-92e5c662c162_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019ce305-8a4a-736c-b951-5d039d00a9fe_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019ce305-8a4b-7d42-9867-7aafd993ecfa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_019ce305-8a4a-708f-8295-cdc5d82c4bdc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_019ce305-8a4a-780c-863e-d4fe3f5c21ed_terseLabel_en-US" xlink:label="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, beneficial ownership limitation, percentage</link:label>
    <link:label id="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_label_en-US" xlink:label="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:label id="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_documentation_en-US" xlink:label="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:to="lab_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019ce305-8a4a-7b82-8b23-a8a2f99fca7a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8ac6-7224-aaa6-5c865054d738_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019ce305-8a4a-7672-8d0e-e387835f7043_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_019ce305-8a4b-7abb-abc8-bf8ad6d81d15_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019ce305-8a4a-73c3-9277-0aaecc664847_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_019ce305-8a4a-7a37-966e-d71a232ae8c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_019ce305-8a4a-7d3c-877b-8a970b0ae493_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019ce305-8a4a-7de0-a57d-04a2fbfb93ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_019ce305-8a4a-71e7-a60b-bf6ad36c24fb_terseLabel_en-US" xlink:label="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</link:label>
    <link:label id="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_label_en-US" xlink:label="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</link:label>
    <link:label id="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_documentation_en-US" xlink:label="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:href="eltx-20260331.xsd#eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:to="lab_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c3-6103-79ca-b1b7-2c5767d65377_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c9-038e-7378-943c-6d6db2d113ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_019ce305-8a4a-7359-9a72-fce28b520e46_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019ce305-8a4a-746f-9bc7-c9204785599e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_019ce305-8981-7011-8333-bae16332da86_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019ce305-8a4a-7e39-beda-9d3a465a92ce_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019ce305-8a4b-7e17-b7e5-71f8b839a1ed_terseLabel_en-US" xlink:label="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock_label_en-US" xlink:label="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:label id="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock_documentation_en-US" xlink:label="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:to="lab_eltx_AccruedInterestPremiumForConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019ce305-8981-7512-8136-46927cc3b45b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_PurchaseOfWarrantsMember_019ce305-8a4a-76bf-bafa-62161a3aefc1_terseLabel_en-US" xlink:label="lab_eltx_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Warrants</link:label>
    <link:label id="lab_eltx_PurchaseOfWarrantsMember_label_en-US" xlink:label="lab_eltx_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants [Member]</link:label>
    <link:label id="lab_eltx_PurchaseOfWarrantsMember_documentation_en-US" xlink:label="lab_eltx_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PurchaseOfWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_PurchaseOfWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_PurchaseOfWarrantsMember" xlink:to="lab_eltx_PurchaseOfWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019ce305-8a4b-7fe7-86fa-5b99ea88189e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_019ce305-8a4b-7560-8db8-0b0fa79e015a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019ce305-8a4a-74e7-80eb-f512c12245d4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_019ce305-8a4a-7e8d-979e-19b2baba1324_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8a4a-74b6-b451-15cb29eb01b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement_019ce305-8a4a-73a1-ab41-e279ce884eaf_terseLabel_en-US" xlink:label="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common stock warrants upon settlement</link:label>
    <link:label id="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement_label_en-US" xlink:label="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:label id="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement_documentation_en-US" xlink:label="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:href="eltx-20260331.xsd#eltx_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:to="lab_eltx_FairValueOfCommonStockWarrantsUponSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019ce305-8a4b-7d1a-a664-59f7b2db657e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019ce305-8a4a-7cd0-8de1-a703eecfb517_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of common stock to purchase (up to) (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8ac6-7cbc-a096-d60cf6f83df2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_July2024PublicOfferingMember_019d4235-877a-714e-a29d-1907e5fb678a_terseLabel_en-US" xlink:label="lab_eltx_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Public Offering</link:label>
    <link:label id="lab_eltx_July2024PublicOfferingMember_label_en-US" xlink:label="lab_eltx_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July 2024 Public Offering [Member]</link:label>
    <link:label id="lab_eltx_July2024PublicOfferingMember_documentation_en-US" xlink:label="lab_eltx_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_July2024PublicOfferingMember" xlink:href="eltx-20260331.xsd#eltx_July2024PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_July2024PublicOfferingMember" xlink:to="lab_eltx_July2024PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_019ce305-8a4a-72d7-aa98-3b6f0f09132d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019ce305-8a4a-7630-916d-d4bb15839866_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_019d429d-df01-7604-ab13-501c3563a901_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_019ce305-8981-7332-b934-e192fd1cc8b1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019ce305-8a4a-7ffc-ad11-97fa7b8d4df3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 18,654,350 shares and 17,814,762 shares issued at March&#160;31, 2026 and December&#160;31, 2025, respectively; 18,639,895 and 17,800,307 outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019ce305-8ac6-7d4e-9f09-ddc2f8b723b3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-8a4a-7619-87f9-8c10b455c328_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-8a4a-7fe8-8267-c662b9ca905c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019ce305-8a4b-7be0-90eb-75adc79623ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies - Note 9</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_019d420c-b617-769d-8b98-994a1a38416a_terseLabel_en-US" xlink:label="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock and warrants from the January Offering (in shares)</link:label>
    <link:label id="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_label_en-US" xlink:label="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants</link:label>
    <link:label id="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_documentation_en-US" xlink:label="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:href="eltx-20260331.xsd#eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:to="lab_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019ce305-8a4b-7cba-ab24-2cf91526c38f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019ce305-8a4a-7219-acaa-8492a16cc06f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_A2024RegistrationStatementMember_019ce305-8a4a-7439-84b4-9ecece4b1032_terseLabel_en-US" xlink:label="lab_eltx_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:label id="lab_eltx_A2024RegistrationStatementMember_label_en-US" xlink:label="lab_eltx_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Registration Statement [Member]</link:label>
    <link:label id="lab_eltx_A2024RegistrationStatementMember_documentation_en-US" xlink:label="lab_eltx_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2024RegistrationStatementMember" xlink:href="eltx-20260331.xsd#eltx_A2024RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_A2024RegistrationStatementMember" xlink:to="lab_eltx_A2024RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_PreFundedWarrantMember_019ce305-8a4a-735e-acc9-03b0807c81c8_terseLabel_en-US" xlink:label="lab_eltx_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:label id="lab_eltx_PreFundedWarrantMember_019ce305-8a4a-7147-aa1b-060a19f89049_verboseLabel_en-US" xlink:label="lab_eltx_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_eltx_PreFundedWarrantMember_label_en-US" xlink:label="lab_eltx_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant [Member]</link:label>
    <link:label id="lab_eltx_PreFundedWarrantMember_documentation_en-US" xlink:label="lab_eltx_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_PreFundedWarrantMember" xlink:to="lab_eltx_PreFundedWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019ce305-8a4a-70bc-b006-22af77e31882_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019ce305-8a4a-7477-9f0f-b469a0f7e54f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019ce305-8a4a-7bb4-9408-142fb7d636db_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019ce305-8a4a-7f78-82db-8d9d915a3c1d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019ce305-8a4b-72f2-b24f-ba0a29044c09_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019ce305-8a4a-7e1f-9440-8b14aa225d35_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulyCommonWarrantsMember_019ce305-8a4a-7022-835d-adf6905b769e_terseLabel_en-US" xlink:label="lab_eltx_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:label id="lab_eltx_JulyCommonWarrantsMember_019ce305-8a4a-7a06-91e6-7b404011f859_verboseLabel_en-US" xlink:label="lab_eltx_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Common Warrants</link:label>
    <link:label id="lab_eltx_JulyCommonWarrantsMember_label_en-US" xlink:label="lab_eltx_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrants [Member]</link:label>
    <link:label id="lab_eltx_JulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_eltx_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulyCommonWarrantsMember" xlink:to="lab_eltx_JulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JanuaryPublicOfferingMember_019ce305-8a4a-75ce-a8f7-05240c61fcd5_terseLabel_en-US" xlink:label="lab_eltx_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2025 Public Offering</link:label>
    <link:label id="lab_eltx_JanuaryPublicOfferingMember_label_en-US" xlink:label="lab_eltx_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Public Offering [Member]</link:label>
    <link:label id="lab_eltx_JanuaryPublicOfferingMember_documentation_en-US" xlink:label="lab_eltx_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryPublicOfferingMember" xlink:href="eltx-20260331.xsd#eltx_JanuaryPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JanuaryPublicOfferingMember" xlink:to="lab_eltx_JanuaryPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_GrantRevenueNonoperating_019ce305-8a4a-7a86-96fb-5c4c7ec2ab8b_terseLabel_en-US" xlink:label="lab_eltx_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant income</link:label>
    <link:label id="lab_eltx_GrantRevenueNonoperating_label_en-US" xlink:label="lab_eltx_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Revenue, Nonoperating</link:label>
    <link:label id="lab_eltx_GrantRevenueNonoperating_documentation_en-US" xlink:label="lab_eltx_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Revenue, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GrantRevenueNonoperating" xlink:href="eltx-20260331.xsd#eltx_GrantRevenueNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_GrantRevenueNonoperating" xlink:to="lab_eltx_GrantRevenueNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_019ce305-8a4a-7b65-a766-11f97596f7af_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_SettlementOfPromissoryNotesPayable_019ce305-8a4b-7529-a7cf-db872a5102e2_terseLabel_en-US" xlink:label="lab_eltx_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Note and interest into equity</link:label>
    <link:label id="lab_eltx_SettlementOfPromissoryNotesPayable_label_en-US" xlink:label="lab_eltx_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:label id="lab_eltx_SettlementOfPromissoryNotesPayable_documentation_en-US" xlink:label="lab_eltx_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SettlementOfPromissoryNotesPayable" xlink:href="eltx-20260331.xsd#eltx_SettlementOfPromissoryNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_SettlementOfPromissoryNotesPayable" xlink:to="lab_eltx_SettlementOfPromissoryNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019ce305-8a4b-757d-8b9b-b6aba0d7a1b4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019ce305-8a4b-77f1-b8e7-963fc6bca954_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-8a4a-76f2-bd89-2507ae9b6972_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-8a4a-7180-89dc-b40fd99f522f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense related to accretion of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019ce305-8a4a-7121-a9a4-6842f4eb6fac_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_019ce305-8a4a-7059-8356-fcbceb23430f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019ce305-8a4a-7445-b945-061027881f04_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019ce305-8a4a-75ed-8a41-8851101b9bc3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019ce305-8a4b-7851-9ca6-7ab4cd5c27ee_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_019ce305-8a4b-73d7-8755-493221374bf2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019ce305-8a4a-7731-9277-63b375bc11af_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_019ce305-8a4a-76ca-a38b-83c0396a4763_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019ce305-8a4a-7bf7-b54c-e9550a2c83f3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019ce305-8ac6-7b4a-bf71-815a8e070f6f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_January2025CommonWarrantsMember_019ce305-8a4b-7d62-8aa6-3d172e38f679_terseLabel_en-US" xlink:label="lab_eltx_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:label id="lab_eltx_January2025CommonWarrantsMember_label_en-US" xlink:label="lab_eltx_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_eltx_January2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_eltx_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_January2025CommonWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_January2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_January2025CommonWarrantsMember" xlink:to="lab_eltx_January2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_A2026ATMProgramMember_019d9c0e-5a55-7750-a057-83e1ec915612_terseLabel_en-US" xlink:label="lab_eltx_A2026ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026 ATM Program</link:label>
    <link:label id="lab_eltx_A2026ATMProgramMember_label_en-US" xlink:label="lab_eltx_A2026ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2026 ATM Program [Member]</link:label>
    <link:label id="lab_eltx_A2026ATMProgramMember_documentation_en-US" xlink:label="lab_eltx_A2026ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2026 ATM Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026ATMProgramMember" xlink:href="eltx-20260331.xsd#eltx_A2026ATMProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_A2026ATMProgramMember" xlink:to="lab_eltx_A2026ATMProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-8981-7082-9597-3f702e44942d_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of cash and cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8a4a-7b65-aa82-70057f373775_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementGrant_019ce305-8a4a-7a32-ac2f-3f380cdfa10c_terseLabel_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award</link:label>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementGrant_label_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:label id="lab_eltx_ResearchAndDevelopmentArrangementGrant_documentation_en-US" xlink:label="lab_eltx_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementGrant" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ResearchAndDevelopmentArrangementGrant" xlink:to="lab_eltx_ResearchAndDevelopmentArrangementGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AtTheMarketOfferingMember_019ce305-8a4a-7082-8109-247b2f581aaf_terseLabel_en-US" xlink:label="lab_eltx_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:label id="lab_eltx_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_eltx_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-the-Market Offering [Member]</link:label>
    <link:label id="lab_eltx_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_eltx_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AtTheMarketOfferingMember" xlink:to="lab_eltx_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_019ce305-8a4a-7fd1-8287-ba2d96a4ddc1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_019ce305-8a4a-7f41-8d1d-e7dc15d621ac_terseLabel_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2023</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_label_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023 [Member]</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_documentation_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:to="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019ce305-8a4a-79e3-adcb-fd78e26bf014_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8a4a-73a4-96ce-c39e13ec7dbd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option Activity, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_019ce305-8a4a-7c9b-842c-42dcdefb8327_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_019ce305-8a4a-7816-8a4a-01c5bb242a87_terseLabel_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Aug. 2024</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_label_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024 [Member]</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_documentation_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:to="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8a4a-7285-a62e-61826d4cb4dc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_PrepaidResearchAndDevelopmentExpenses_019ce305-8a4a-7329-befc-d4f2dd9a935a_terseLabel_en-US" xlink:label="lab_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid research and development contract services</link:label>
    <link:label id="lab_eltx_PrepaidResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:label id="lab_eltx_PrepaidResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:href="eltx-20260331.xsd#eltx_PrepaidResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:to="lab_eltx_PrepaidResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019ce305-8a4a-7ef4-b3a4-99b1ba2bb97d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8a4a-7c2f-9110-7bcd68d054e5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_WarrantsFairValueDisclosure_019ce305-8a4a-7352-9f2b-8e4fe1bcae17_terseLabel_en-US" xlink:label="lab_eltx_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_eltx_WarrantsFairValueDisclosure_label_en-US" xlink:label="lab_eltx_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:label id="lab_eltx_WarrantsFairValueDisclosure_documentation_en-US" xlink:label="lab_eltx_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsFairValueDisclosure" xlink:href="eltx-20260331.xsd#eltx_WarrantsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_WarrantsFairValueDisclosure" xlink:to="lab_eltx_WarrantsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019ce305-8a4b-7724-b7c3-7ee186244775_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange transaction gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_019ce305-8ac6-7658-88f9-9cbd460907cf_terseLabel_en-US" xlink:label="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other prepaid expenses and other current assets</link:label>
    <link:label id="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:label id="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_documentation_en-US" xlink:label="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:href="eltx-20260331.xsd#eltx_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:to="lab_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-72a3-b019-0bff804ce6c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019ce305-8a4a-7720-84b0-a65f98bc1a4d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019ce305-8a4a-7070-8e34-9af7157fb1b1_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_019ce305-8a4a-78a1-ae28-78962cf06ce0_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019ce305-8a4a-76e1-8f24-29a19a8f4b02_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_019ce305-8a4a-7df9-a842-4df3c37d3610_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_019ce305-8a4b-70a5-895e-94e55d6f0cfa_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8a4a-7037-9d52-56cfd8a66ec6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019ce305-8a4a-7ad5-99c5-435140643bff_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares sold in offering (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019ce305-8a4a-7af9-af33-5e69ca592cdf_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019ce305-8a4a-7055-a520-8b2ab46784dc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019ce305-8a4a-7c79-96a9-709c95ac3da7_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_019ce305-8a4a-71bb-a0d4-049cfb6e0c20_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019ce305-8a4a-760e-968a-0a66d99c5ac6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019ce305-8a4a-7111-8ce8-29cc6638e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019ce305-8a4a-7fa7-86a1-75dfd9036968_terseLabel_en-US" xlink:label="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:label id="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:to="lab_eltx_SeniorSecuredConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019ce305-8a4a-756c-949f-06745a1492b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019ce305-8a4a-799a-bc54-da15e4b030d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019ce305-8a4a-7644-ab0d-2665c21400e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8a4a-7cf4-8016-8506c937c772_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019ce305-8a4a-755a-bb56-79d3ad2787de_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8a4a-7648-9024-20966eacf5e7_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_019dc3c3-6103-7a66-826e-d62672a71490_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019ce305-8a4a-7941-a456-74285271667f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_SaleOfStockAggregateInitialOfferingPrice_019ce305-8ac6-7ab8-8d07-d934678c2066_terseLabel_en-US" xlink:label="lab_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate initial offering price</link:label>
    <link:label id="lab_eltx_SaleOfStockAggregateInitialOfferingPrice_label_en-US" xlink:label="lab_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:label id="lab_eltx_SaleOfStockAggregateInitialOfferingPrice_documentation_en-US" xlink:label="lab_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:to="lab_eltx_SaleOfStockAggregateInitialOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019ce305-8a4a-7607-a75b-4cf97d00b38d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019ce305-8a4a-76c0-b65e-a7448d47829c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019ce305-8a4a-70ff-9694-4703b6160bd5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_019ce305-8a4a-713d-ade9-5bd9a1bb5850_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_WarrantsAndRightsOutstandingTextBlock_019ce305-8a4a-733f-8847-bacaf402ce61_terseLabel_en-US" xlink:label="lab_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_eltx_WarrantsAndRightsOutstandingTextBlock_label_en-US" xlink:label="lab_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Text Block]</link:label>
    <link:label id="lab_eltx_WarrantsAndRightsOutstandingTextBlock_documentation_en-US" xlink:label="lab_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:to="lab_eltx_WarrantsAndRightsOutstandingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_March2024PreFundedWarrantsMember_019ce305-8a4a-7c94-9d79-e2f0db28d608_terseLabel_en-US" xlink:label="lab_eltx_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_eltx_March2024PreFundedWarrantsMember_label_en-US" xlink:label="lab_eltx_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_eltx_March2024PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_eltx_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_March2024PreFundedWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_March2024PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_March2024PreFundedWarrantsMember" xlink:to="lab_eltx_March2024PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8a4a-7461-bea9-5eca0693c06c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8a4a-7287-be17-b65a46e2b7a0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019ce305-8a4a-7a0a-8440-8b9435ba3304_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_019ce305-8a4a-7fb5-ae39-a46bc0787098_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_019ce305-8a4a-78ad-8a3b-4664a2e2cbe0_terseLabel_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2022</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_label_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022 [Member]</link:label>
    <link:label id="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_documentation_en-US" xlink:label="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:to="lab_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_019ce305-8a4b-7f0c-83f5-97fbd90b82d7_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share of shares issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_TranslationalMedicineAndCMCMember_019ce305-8a4a-7478-85c9-6d1cabfa2c87_terseLabel_en-US" xlink:label="lab_eltx_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chemistry, manufacturing and controls expenses</link:label>
    <link:label id="lab_eltx_TranslationalMedicineAndCMCMember_label_en-US" xlink:label="lab_eltx_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC [Member]</link:label>
    <link:label id="lab_eltx_TranslationalMedicineAndCMCMember_documentation_en-US" xlink:label="lab_eltx_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_TranslationalMedicineAndCMCMember" xlink:href="eltx-20260331.xsd#eltx_TranslationalMedicineAndCMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_TranslationalMedicineAndCMCMember" xlink:to="lab_eltx_TranslationalMedicineAndCMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019ce305-8ac6-7801-aa6b-775a935ce797_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_019ce305-8a4a-73f9-ac84-09610d4b910c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019ce305-8a4b-7c5b-9d3d-8a2429d1f0be_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019ce305-8a4a-77a0-98b3-8bf15fb8981b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_The2022PlanMember_019ce305-8981-7969-903f-7cff9275bdde_terseLabel_en-US" xlink:label="lab_eltx_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:label id="lab_eltx_The2022PlanMember_label_en-US" xlink:label="lab_eltx_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2022 Plan [Member]</link:label>
    <link:label id="lab_eltx_The2022PlanMember_documentation_en-US" xlink:label="lab_eltx_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2022PlanMember" xlink:href="eltx-20260331.xsd#eltx_The2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_The2022PlanMember" xlink:to="lab_eltx_The2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_JulyPreFundedWarrantsMember_019ce305-8a4a-766e-a184-4c524740b32d_terseLabel_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:label id="lab_eltx_JulyPreFundedWarrantsMember_label_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_eltx_JulyPreFundedWarrantsMember_documentation_en-US" xlink:label="lab_eltx_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsMember" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_JulyPreFundedWarrantsMember" xlink:to="lab_eltx_JulyPreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_019ce305-8a4b-707e-9584-3af2a5a8e543_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019ce305-8a4a-7082-a8be-88ce564869b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019ce305-8a4a-7cb8-b06e-78904f57cd71_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_019ce305-8a4a-7b06-8ffc-f7e98c4c76e4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019ce305-8ac6-7e62-bd96-617b4bcbf43f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent_019ce305-8a4b-7d37-850f-990e23e19fa7_terseLabel_en-US" xlink:label="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent_label_en-US" xlink:label="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:label id="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent_documentation_en-US" xlink:label="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:href="eltx-20260331.xsd#eltx_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:to="lab_eltx_AccruedOtherOperatingLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-70bb-a788-9f9c48da16a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019ce305-8a4a-7366-8fbb-b78002a99a09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019ce305-8ac6-7239-ad37-3d76c31dceb7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-8a4a-7cf5-9199-f383260a0c1a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-8a4a-778c-95ec-a191d09fc74c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dfd8b-5cee-7505-b14f-6dbf3c063b58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8a4b-7fd2-831d-549da42ceae1_terseLabel_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_eltx_CommitmentsAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:to="lab_eltx_CommitmentsAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_019ce305-8a4a-721d-aeda-561d62056873_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019ce305-8a4a-7aec-8731-c1890bc16d19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019ce305-8ac6-7032-9ee8-f6f326a59f47_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019ce305-8ac6-79eb-b3a9-196eb8fd4393_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8a4b-75cf-83df-d9a7d4caecf7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8a4a-787e-be00-3ec2b08f3dd5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019ce305-8a4a-7c28-9829-ae0c50c5df74_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_019ce305-8a4a-7029-b50e-78f7aee06b81_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_019ce305-8981-74e4-84b9-0342ac2b1b20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_019ce305-8a4b-7444-87be-f09e6ab27b6e_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 14,455 shares outstanding</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_019ce305-8981-7b37-b48c-ea19445dc15f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-8a4b-7b88-9392-fe095a561edb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019ce305-8a4a-7bb0-a473-1ff5be9ca5c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019ce305-8a4a-76df-a0c1-5263c874f00f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019ce305-8a4a-7cdc-9f61-05d1a4c9f4ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8ac6-7858-a530-8046760698ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019ce305-8a4a-7ff2-9de7-48cfa4fa6e01_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock and common warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-8a4a-7aca-9c6f-d645875f57dc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-8a4a-7d73-acd1-3494c6a9d6d5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8a4a-7a46-adb4-1dee4c6fffe4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_019ce305-8ac6-76d6-aed9-6d6e04643411_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019ce305-8981-7b73-8d5b-9f62b20915eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Loss Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_019ce305-8a4a-7a77-afb4-10a22eb70aa3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019ce305-8a4a-7124-8f06-97013c4104c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_019ce305-8981-7f0c-acea-33729dc19612_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_019ce305-8a4a-7ee9-9143-433cb711c46a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019df1c0-aa28-7b34-b0cf-4512a2624ead_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_019ce305-8a4a-703b-87bd-02f251534176_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019ce305-8ac6-71e0-9bd5-97af18090648_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_019ce305-8a4b-732e-977e-61acc980a2df_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019ce305-8a4a-7a18-a3a8-8dc272aa90a9_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock and warrants from the January Offering</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8981-74cd-905f-a0cad16c39ab_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8981-7884-bdb6-fa45c67da0ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8a4a-79ca-b34a-1e8ddd89a6cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019ce305-8a4a-7bd4-b77d-ad7302258208_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019ce305-8ac6-7936-a45e-6f39cbb343d5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019ce305-8a4a-7df9-a9a4-5642b6fc6b95_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term&#8212;operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8a4a-78b7-83b0-cdc7e3902684_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_019ce305-8a4a-7290-880e-dcade70e364c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019ce305-8a4a-7066-8461-a69fd831b93b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_019ce305-8a4a-7c28-944c-e7cce3c0067c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019ce305-8a4a-7136-8569-de514b2fa415_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019ce305-8a4b-7fce-a23b-fcde39c1ea45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-751f-ba52-9ba030d055bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019ce305-8a4a-75fb-814f-7bf7ad24edfa_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8a4b-78fe-931a-2fa972510f57_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_019ce305-8a4a-76ed-bd3d-f1d8fccc3e38_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019ce305-8a4a-79ca-95af-8efd846969d9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_019dfd75-c1bb-7e65-899d-6616b5d0b8d1_terseLabel_en-US" xlink:label="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration received net of sales commissions</link:label>
    <link:label id="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_label_en-US" xlink:label="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions</link:label>
    <link:label id="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_documentation_en-US" xlink:label="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:to="lab_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-8a4a-7e15-9bb4-87fbf588e289_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-8a4a-78c8-97ee-57faae6c49e9_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8a4a-767b-ac53-25ce6354048c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019ce305-8a4a-7fb0-b433-de200dc0b539_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_019dc3b5-5810-7958-8668-eb30810de528_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Unit, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_019ce305-8a4b-7470-b340-f266052ff93f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_The2021PlanMember_019ce305-8a4b-75a9-a53b-e30733bb48fe_terseLabel_en-US" xlink:label="lab_eltx_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:label id="lab_eltx_The2021PlanMember_label_en-US" xlink:label="lab_eltx_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2021 Plan [Member]</link:label>
    <link:label id="lab_eltx_The2021PlanMember_documentation_en-US" xlink:label="lab_eltx_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2021PlanMember" xlink:href="eltx-20260331.xsd#eltx_The2021PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_The2021PlanMember" xlink:to="lab_eltx_The2021PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_eltx_InterestExpenseNoncash_019ce305-8a4b-779c-89eb-4857d6f5b48a_terseLabel_en-US" xlink:label="lab_eltx_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_eltx_InterestExpenseNoncash_label_en-US" xlink:label="lab_eltx_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:label id="lab_eltx_InterestExpenseNoncash_documentation_en-US" xlink:label="lab_eltx_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_InterestExpenseNoncash" xlink:href="eltx-20260331.xsd#eltx_InterestExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_eltx_InterestExpenseNoncash" xlink:to="lab_eltx_InterestExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019ce305-8a4a-7666-9e6b-9b2e2657a70b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019ce305-8a4a-72b3-98fa-feedf25dee15_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_019d4235-2156-77b0-8627-331747dd3f77_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-8a4b-754b-8594-01bd1d867250_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_019ce305-8a4a-7d00-a9df-e5a193c98149_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>eltx-20260331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019ce305-8810-732a-a011-c1da7f22f708,g:2bcbb4c1-4194-4006-a367-3bfddc661054-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.eltx.com/role/Cover" xlink:type="simple" xlink:href="eltx-20260331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019ce305-88c7-768c-b5d5-4b0da1c7598a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentType_019ce305-88c7-768c-b5d5-4b0da1c7598a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019ce305-88c7-725c-b9cb-51d2b1077421" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentQuarterlyReport_019ce305-88c7-725c-b9cb-51d2b1077421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019ce305-88c7-7a88-a23e-4b3cc12c6e05" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentPeriodEndDate_019ce305-88c7-7a88-a23e-4b3cc12c6e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019ce305-88c7-7282-b88b-94a8a6dcc21b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentTransitionReport_019ce305-88c7-7282-b88b-94a8a6dcc21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019ce305-88c7-76da-b827-71918af58390" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityFileNumber_019ce305-88c7-76da-b827-71918af58390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019ce305-88c7-798b-a53f-79b0565ac475" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityRegistrantName_019ce305-88c7-798b-a53f-79b0565ac475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019ce305-88c7-7af4-8e5f-f3559551ad48" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019ce305-88c7-7af4-8e5f-f3559551ad48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019ce305-88c7-744e-b1ae-3480d5c6f4f5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityTaxIdentificationNumber_019ce305-88c7-744e-b1ae-3480d5c6f4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019ce305-88c7-7e81-b800-05f7e85cc2c1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityAddressAddressLine1_019ce305-88c7-7e81-b800-05f7e85cc2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019ce305-88c7-7418-9388-56659ac53f87" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityAddressCityOrTown_019ce305-88c7-7418-9388-56659ac53f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019ce305-88c7-7262-a4f1-e2362f6433dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityAddressStateOrProvince_019ce305-88c7-7262-a4f1-e2362f6433dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019ce305-88c7-7c3b-abdc-9abcab90ebb9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityAddressPostalZipCode_019ce305-88c7-7c3b-abdc-9abcab90ebb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019ce305-88c7-7b5d-a9ab-afc44287b9bc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_CityAreaCode_019ce305-88c7-7b5d-a9ab-afc44287b9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019ce305-88c7-76d7-93eb-76ce9a88e706" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_LocalPhoneNumber_019ce305-88c7-76d7-93eb-76ce9a88e706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019ce305-88c7-7786-ab04-1ed710ef4eb1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_Security12bTitle_019ce305-88c7-7786-ab04-1ed710ef4eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019ce305-88c7-7dd4-804a-dc18fcf2d3e1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_TradingSymbol_019ce305-88c7-7dd4-804a-dc18fcf2d3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019ce305-88c7-7b2e-b0f7-6a3e97ccf1fd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_SecurityExchangeName_019ce305-88c7-7b2e-b0f7-6a3e97ccf1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019ce305-88c7-7eb5-8374-59e83e66b84a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityCurrentReportingStatus_019ce305-88c7-7eb5-8374-59e83e66b84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019ce305-88c7-7632-9b92-3c85f6985aa4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityInteractiveDataCurrent_019ce305-88c7-7632-9b92-3c85f6985aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019ce305-88c7-71c7-a19f-394b4e5e0da1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityFilerCategory_019ce305-88c7-71c7-a19f-394b4e5e0da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019ce305-88c7-7b4c-8e3e-071b01c73d3a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntitySmallBusiness_019ce305-88c7-7b4c-8e3e-071b01c73d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019ce305-88c7-79a2-993a-56c85d2cc2cd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityEmergingGrowthCompany_019ce305-88c7-79a2-993a-56c85d2cc2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019ce305-88c7-76f5-be55-31924bbec36b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityExTransitionPeriod_019ce305-88c7-76f5-be55-31924bbec36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019ce305-88c7-7540-8628-af59f02b1adc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityShellCompany_019ce305-88c7-7540-8628-af59f02b1adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019ce305-88c7-7c02-8624-ef49a36bcd0f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019ce305-88c7-7c02-8624-ef49a36bcd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019ce305-88c7-7db2-8714-75c5b7dc2e5b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentFiscalYearFocus_019ce305-88c7-7db2-8714-75c5b7dc2e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019ce305-88c7-7809-b388-47ea265af176" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019ce305-88c7-7809-b388-47ea265af176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019ce305-88c7-732e-ad54-74e6f9f5f2b3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_CurrentFiscalYearEndDate_019ce305-88c7-732e-ad54-74e6f9f5f2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019ce305-88c7-787f-8604-b27b1d21799a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_EntityCentralIndexKey_019ce305-88c7-787f-8604-b27b1d21799a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019ce305-88c7-714b-9835-c2828f3e1c2d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019ce305-88c7-770a-bc67-b585fd5ef9cf" xlink:to="loc_dei_AmendmentFlag_019ce305-88c7-714b-9835-c2828f3e1c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-7097-9786-06941a409738" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-7097-9786-06941a409738" xlink:to="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019ce305-88c7-7176-b526-f0be4903003f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019ce305-88c7-7176-b526-f0be4903003f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-7901-8488-cb459eef3c66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019ce305-88c7-7176-b526-f0be4903003f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-7901-8488-cb459eef3c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-88c7-72a7-92a8-fb6e4c6df8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019ce305-88c7-7176-b526-f0be4903003f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-88c7-72a7-92a8-fb6e4c6df8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019ce305-88c7-7c85-a81e-948977d9a24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019ce305-88c7-7176-b526-f0be4903003f" xlink:to="loc_us-gaap_AssetsCurrent_019ce305-88c7-7c85-a81e-948977d9a24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-88c7-7e4c-96eb-325debfd03b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-88c7-7e4c-96eb-325debfd03b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-88c7-781e-8db7-e72909ebfa47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-88c7-781e-8db7-e72909ebfa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019ce305-88c7-74c4-93ba-64e086e6dfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019ce305-88c7-74c4-93ba-64e086e6dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-88c7-7158-8731-57a26e19ce52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-88c7-7158-8731-57a26e19ce52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019ce305-88c7-76d6-a0ad-7db42dc6bce0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019ce305-88c7-769f-af23-27bb03417123" xlink:to="loc_us-gaap_Assets_019ce305-88c7-76d6-a0ad-7db42dc6bce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-7097-9786-06941a409738" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019ce305-88c7-7d66-babc-f055ba81054b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:to="loc_us-gaap_AccountsPayableCurrent_019ce305-88c7-7d66-babc-f055ba81054b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-88c7-7b10-bb61-e563690465fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-88c7-7b10-bb61-e563690465fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-88c7-7a90-a299-760376410cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-88c7-7a90-a299-760376410cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7451-a249-b3d409358625" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019ce305-88c7-71e5-ac30-0fd9baf8e443" xlink:to="loc_us-gaap_LiabilitiesCurrent_019ce305-88c7-7451-a249-b3d409358625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiability_019ce305-88c7-71e5-ab89-d4e01ea982b6" xlink:href="eltx-20260331.xsd#eltx_WarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_eltx_WarrantLiability_019ce305-88c7-71e5-ab89-d4e01ea982b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-88c7-7572-8fe2-002ce333b871" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-88c7-7572-8fe2-002ce333b871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019ce305-88c7-7366-b41f-6d602d7716ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019ce305-88c7-7366-b41f-6d602d7716ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019ce305-88c7-74ab-a8a4-7c8b9d25a55c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_Liabilities_019ce305-88c7-74ab-a8a4-7c8b9d25a55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019ce305-88c7-7e56-97ac-65b4453eb6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019ce305-88c7-7e56-97ac-65b4453eb6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019ce305-88c7-77c6-acae-e4a3c1b3ee17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_CommonStockValue_019ce305-88c7-77c6-acae-e4a3c1b3ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_019ce305-88c7-79e9-af34-00bf29e90bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_TreasuryStockCommonValue_019ce305-88c7-79e9-af34-00bf29e90bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019ce305-88c7-774a-80f4-2039f16261f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019ce305-88c7-774a-80f4-2039f16261f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019ce305-88c7-7768-8c11-c1f0e78595c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019ce305-88c7-7768-8c11-c1f0e78595c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019ce305-88c7-7532-8bca-dbc8ff2a265c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019ce305-88c7-7532-8bca-dbc8ff2a265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-7402-a887-3fe967b75348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-7d61-8dc4-a12d061d09ba" xlink:to="loc_us-gaap_StockholdersEquity_019ce305-88c7-7402-a887-3fe967b75348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7efa-8057-c54b57624325" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019ce305-88c7-707c-9ea0-8ff004720b2b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019ce305-88c7-7efa-8057-c54b57624325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019ce305-88c7-7917-ab37-4007fb11b136" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019ce305-88c7-7917-ab37-4007fb11b136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019ce305-88c7-7560-9c10-6f5a2d732df0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019ce305-88c7-7560-9c10-6f5a2d732df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019ce305-88c7-787e-ad28-5d1fe026da0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:to="loc_us-gaap_CommonStockSharesIssued_019ce305-88c7-787e-ad28-5d1fe026da0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7c8b-a2df-a43426c4aac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7c8b-a2df-a43426c4aac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7949-90b3-700698f305bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019ce305-88c7-70ca-864c-abb9ad11f60b" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7949-90b3-700698f305bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-88c7-78ff-a8fb-4784cbfbee3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-88c7-78ff-a8fb-4784cbfbee3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-88c7-740e-b842-070d5513ceca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-88c7-78ff-a8fb-4784cbfbee3e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-88c7-740e-b842-070d5513ceca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-88c7-7aff-93c0-511613b388a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-88c7-78ff-a8fb-4784cbfbee3e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-88c7-7aff-93c0-511613b388a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019ce305-88c7-70a2-bf04-0c6bcb7d32fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_019ce305-88c7-78ff-a8fb-4784cbfbee3e" xlink:to="loc_us-gaap_CostsAndExpenses_019ce305-88c7-70a2-bf04-0c6bcb7d32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-7cfe-9528-4c37348e0e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_OperatingIncomeLoss_019ce305-88c7-7cfe-9528-4c37348e0e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-7906-a836-39553e692bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-7906-a836-39553e692bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019ce305-88c7-7612-b0ce-eccec5184022" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_019ce305-88c7-7612-b0ce-eccec5184022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019ce305-88c7-747d-80bb-3fff9e7434e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019ce305-88c7-747d-80bb-3fff9e7434e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019ce305-88c7-7d2d-9d5d-aee52302a050" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019ce305-88c7-7d2d-9d5d-aee52302a050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7981-a641-dab3f8da5e97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019ce305-88c7-7c65-80b4-84c7fc8d75f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019ce305-88c7-7981-a641-dab3f8da5e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7016-aa79-4d4904ad4076" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7016-aa79-4d4904ad4076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_019ce305-88c7-77cc-95cf-aafd0be7a537" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_019ce305-88c7-77cc-95cf-aafd0be7a537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-7991-859f-9e2891c8848a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_019ce305-88c7-77cc-95cf-aafd0be7a537" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-7991-859f-9e2891c8848a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-88c7-71d5-873f-c05c2fb47527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019ce305-88c7-71d5-873f-c05c2fb47527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019ce305-88c7-7ef3-8d11-ba03133b8853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_EarningsPerShareBasic_019ce305-88c7-7ef3-8d11-ba03133b8853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019ce305-88c7-7f62-9f81-a7640a49dde9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019ce305-88c7-7f62-9f81-a7640a49dde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-88c7-7df8-8b1f-0223cbd0132c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-88c7-7df8-8b1f-0223cbd0132c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-88c7-7294-8d72-f6efe32fb18f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019ce305-88c7-7a62-ae32-f8fade8c5a82" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-88c7-7294-8d72-f6efe32fb18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-711b-979e-b1bd74ee4d74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-711b-979e-b1bd74ee4d74" xlink:to="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019ce305-88c7-7553-9df4-41cc7a253239" xlink:to="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019ce305-88c7-7319-a85a-3cfeb30b38b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_CommonStockMember_019ce305-88c7-7319-a85a-3cfeb30b38b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_019ce305-88c7-78a7-8efa-8feefe46e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_019ce305-88c7-78a7-8efa-8feefe46e8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019ce305-88c7-71b2-bc4a-c07cc787e4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019ce305-88c7-71b2-bc4a-c07cc787e4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019ce305-88c7-737c-9285-fb3ea50c85e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019ce305-88c7-737c-9285-fb3ea50c85e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019ce305-88c7-7906-896d-fffbbd62033e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019ce305-88c7-7f9e-a69f-4ec0ea9673d3" xlink:to="loc_us-gaap_RetainedEarningsMember_019ce305-88c7-7906-896d-fffbbd62033e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-79ed-8821-9bfd83b54274" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-78d3-a935-73681c95defe" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:to="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-78d3-a935-73681c95defe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryOfferingMember_019dc35e-9e8b-7062-b692-78c3acca2095" xlink:href="eltx-20260331.xsd#eltx_JanuaryOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7584-822c-47d2bb42c348" xlink:to="loc_eltx_JanuaryOfferingMember_019dc35e-9e8b-7062-b692-78c3acca2095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019ce305-88c7-7d15-839f-f84ba1df206c" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ConversionOfConvertibleDebtMember_019ce305-88c7-7170-9a00-09554bd0e08b" xlink:href="eltx-20260331.xsd#eltx_ConversionOfConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_019ce305-88c7-739b-9cee-0c3b0af3d3ad" xlink:to="loc_eltx_ConversionOfConvertibleDebtMember_019ce305-88c7-7170-9a00-09554bd0e08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7b5c-9bf3-26425283fb72" xlink:to="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-76bb-9d26-3e470b1f4715" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7231-8d4a-befeca3a01a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-7231-8d4a-befeca3a01a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-72fd-be10-c7ee8bc5050a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockholdersEquity_019ce305-88c7-72fd-be10-c7ee8bc5050a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7c59-98c4-b28985a2139f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-7c59-98c4-b28985a2139f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019ce305-88c7-75cf-b80f-df49982b5a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019ce305-88c7-75cf-b80f-df49982b5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019ce305-88c7-75cb-b715-6fe069d9157f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019ce305-88c7-75cb-b715-6fe069d9157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-88c7-7aa8-aae1-fc20b20a0c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-88c7-7aa8-aae1-fc20b20a0c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019ce305-88c7-77c8-9bfc-fe81729a3e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019ce305-88c7-77c8-9bfc-fe81729a3e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019ce305-88c7-776f-9a54-550a3b9c3266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019ce305-88c7-776f-9a54-550a3b9c3266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019ce305-88c7-78d8-b9aa-f0fc77523174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019ce305-88c7-78d8-b9aa-f0fc77523174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_019d420c-b617-7e88-8230-e69143e5937d" xlink:href="eltx-20260331.xsd#eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_019d420c-b617-7e88-8230-e69143e5937d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019ce305-88c7-7335-9bca-9a4dbc46be8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019ce305-88c7-7335-9bca-9a4dbc46be8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d90-9a1c-8a7f09d1debb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d90-9a1c-8a7f09d1debb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d26-b9de-0785199554f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019ce305-88c7-7d26-b9de-0785199554f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019ce305-88c7-7c80-8158-d32e25fec614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019ce305-88c7-7c80-8158-d32e25fec614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-74a7-8f17-e06d48c3de27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019ce305-88c7-74a7-8f17-e06d48c3de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e07-87a7-4cfe99333084" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-7e07-87a7-4cfe99333084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-77d3-96cc-b2cd79a263c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019ce305-88c7-77d3-96cc-b2cd79a263c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019ce305-88c7-702d-b80a-cb39d6b6ab51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_StockholdersEquity_019ce305-88c7-702d-b80a-cb39d6b6ab51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-72b6-8fa3-75b5d0df9280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019ce305-88c7-7ba2-bfc8-5596254519bf" xlink:to="loc_us-gaap_TreasuryStockCommonShares_019ce305-88c7-72b6-8fa3-75b5d0df9280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-75a1-88da-38ee831f2211" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019ce305-88c7-75a1-88da-38ee831f2211" xlink:to="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019ce305-88c7-7bf2-a1ec-9ee2b2d25e62" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-7fab-aad4-ce892db39edd" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:to="loc_eltx_AtTheMarketOfferingMember_019ce305-88c7-7fab-aad4-ce892db39edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryOfferingMember_019dc3d3-6377-73bc-9578-10a2763efa30" xlink:href="eltx-20260331.xsd#eltx_JanuaryOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019ce305-88c7-7466-ac37-5f35d410e203" xlink:to="loc_eltx_JanuaryOfferingMember_019dc3d3-6377-73bc-9578-10a2763efa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ce305-88c7-7497-aec7-4be242d0d6b8" xlink:to="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019ce305-88c7-7d74-b0c2-f8243de5a805" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019ce305-88c7-7d74-b0c2-f8243de5a805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019ce305-88c7-74c3-9c6c-853364d6e777" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ce305-88c7-7a65-9b08-3f1a253747b9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019ce305-88c7-74c3-9c6c-853364d6e777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="eltx-20260331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-713c-9eb2-354f98abb90c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-713c-9eb2-354f98abb90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-88c7-756f-8ab7-86a359fcfd13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-713c-9eb2-354f98abb90c" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-88c7-756f-8ab7-86a359fcfd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-713c-9eb2-354f98abb90c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019ce305-88c7-7032-b92b-ae5e0ef3f1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_Depreciation_019ce305-88c7-7032-b92b-ae5e0ef3f1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019ce305-88c7-7970-895f-56aae14a70b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019ce305-88c7-7970-895f-56aae14a70b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_InterestExpenseNoncash_019ce305-88c7-7b88-af1e-ca5a73cc921f" xlink:href="eltx-20260331.xsd#eltx_InterestExpenseNoncash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_eltx_InterestExpenseNoncash_019ce305-88c7-7b88-af1e-ca5a73cc921f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-88c7-759d-adf6-b3f30737ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019ce305-88c7-759d-adf6-b3f30737ec74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-74dc-acc2-e7ad373ae527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019ce305-88c7-74dc-acc2-e7ad373ae527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019ce305-88c7-765e-86fd-2ae02f04f10a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_ShareBasedCompensation_019ce305-88c7-765e-86fd-2ae02f04f10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-7e01-b965-d59a91e9b7c0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019ce305-88c7-719f-9f68-cf7d3630707b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019ce305-88c7-719f-9f68-cf7d3630707b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019ce305-88c7-7595-8680-412e03330e00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019ce305-88c7-7595-8680-412e03330e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019ce305-88c7-7f25-bc21-a4cc62410b50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019ce305-88c7-7f25-bc21-a4cc62410b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_IncreaseDecreaseInAccruedExpenses_019ce305-88c7-7848-8bc6-da525cf0e394" xlink:href="eltx-20260331.xsd#eltx_IncreaseDecreaseInAccruedExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_eltx_IncreaseDecreaseInAccruedExpenses_019ce305-88c7-7848-8bc6-da525cf0e394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019ce305-88c7-70aa-8dfb-663c9c5da12f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019ce305-88c7-70aa-8dfb-663c9c5da12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019ce305-88c7-7174-90eb-4f3b95943499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019ce305-88c7-75c2-a7d4-a02d451cb56c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019ce305-88c7-7174-90eb-4f3b95943499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7487-bb5e-db2644a8f916" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019ce305-88c7-713c-9eb2-354f98abb90c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019ce305-88c7-7487-bb5e-db2644a8f916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_019ce305-88c7-7e3e-a37a-db00543bf950" xlink:href="eltx-20260331.xsd#eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_019ce305-88c7-7e3e-a37a-db00543bf950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_019dc363-de82-7653-980f-2a26da9bebba" xlink:href="eltx-20260331.xsd#eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering_019dc363-de82-7653-980f-2a26da9bebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_019ce305-88c7-731c-9e22-9525392a171b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_019ce305-88c7-731c-9e22-9525392a171b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019ce305-88c7-701b-ab54-03bbe6b13360" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019ce305-88c7-701b-ab54-03bbe6b13360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019ce305-88c7-7ab2-9097-1aab73d74bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019ce305-88c7-7ab2-9097-1aab73d74bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-77dd-9f8c-928d6dc795ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019ce305-88c7-726c-8b1a-7e5b9c5f568d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019ce305-88c7-77dd-9f8c-928d6dc795ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-709c-91b8-05aea8444cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-709c-91b8-05aea8444cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-88c7-7e84-9fa2-685bb5d547ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ce305-88c7-7e84-9fa2-685bb5d547ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-7802-918a-60021fd72aea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-7802-918a-60021fd72aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-76ba-a35b-3c3101545f57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-76ba-a35b-3c3101545f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-88c7-70d2-923a-9f71a121c45c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-88c7-70d2-923a-9f71a121c45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-72e6-9d14-a6f9b86ee469" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-88c7-70d2-923a-9f71a121c45c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019ce305-88c7-72e6-9d14-a6f9b86ee469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019ce305-88c7-7dd3-b818-61f11360eed0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-88c7-70d2-923a-9f71a121c45c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019ce305-88c7-7dd3-b818-61f11360eed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-71f8-9624-57e76e7a8990" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_019ce305-88c7-70d2-923a-9f71a121c45c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019ce305-88c7-71f8-9624-57e76e7a8990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-88c7-7906-bc99-6a6ed546c975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019ce305-88c7-791a-9b5a-b1cf07e78b82" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-88c7-7906-bc99-6a6ed546c975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019df190-7a0c-767b-aade-c6a101e102f9" xlink:href="eltx-20260331.xsd#eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-88c7-7906-bc99-6a6ed546c975" xlink:to="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019df190-7a0c-767b-aade-c6a101e102f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_FairValueOfCommonStockWarrantsUponSettlement_019ce305-88c7-7226-bde6-b4b10cadcf18" xlink:href="eltx-20260331.xsd#eltx_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-88c7-7906-bc99-6a6ed546c975" xlink:to="loc_eltx_FairValueOfCommonStockWarrantsUponSettlement_019ce305-88c7-7226-bde6-b4b10cadcf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SettlementOfPromissoryNotesPayable_019ce305-88c7-7d8b-a262-810a333590df" xlink:href="eltx-20260331.xsd#eltx_SettlementOfPromissoryNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019ce305-88c7-7906-bc99-6a6ed546c975" xlink:to="loc_eltx_SettlementOfPromissoryNotesPayable_019ce305-88c7-7d8b-a262-810a333590df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="simple" xlink:href="eltx-20260331.xsd#DescriptionoftheBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-773e-887e-2db6700740f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019ce305-8980-700f-afc5-fc90129e87c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-773e-887e-2db6700740f1" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019ce305-8980-700f-afc5-fc90129e87c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="eltx-20260331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-7140-8e99-6a81bf1daf23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019ce305-8980-7c18-83a1-d2709ada0cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-7140-8e99-6a81bf1daf23" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019ce305-8980-7c18-83a1-d2709ada0cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7775-bd42-55dd89039609" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019ce305-8980-7fad-9eb7-8c7e2fd48cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7775-bd42-55dd89039609" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019ce305-8980-7fad-9eb7-8c7e2fd48cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7def-84d2-46518a9aa459" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019ce305-8980-7e76-9af5-f743b05ba020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7def-84d2-46518a9aa459" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019ce305-8980-7e76-9af5-f743b05ba020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/ResearchGrants" xlink:type="simple" xlink:href="eltx-20260331.xsd#ResearchGrants"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/ResearchGrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_019ce305-8980-78da-bc5f-062985274458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_019ce305-8980-7a7e-9f59-ad316a561965" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_019ce305-8980-78da-bc5f-062985274458" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_019ce305-8980-7a7e-9f59-ad316a561965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommonStockandStockholdersEquity" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommonStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CommonStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019ce305-8980-73e5-93b5-b74fcecd1870" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019ce305-8980-73ff-abd5-a0bd327f21d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019ce305-8980-73e5-93b5-b74fcecd1870" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019ce305-8980-73ff-abd5-a0bd327f21d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-73cc-80ce-08d8cc121546" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019ce305-8980-7750-9e80-85f29fe462c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-73cc-80ce-08d8cc121546" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019ce305-8980-7750-9e80-85f29fe462c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/Warrants" xlink:type="simple" xlink:href="eltx-20260331.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-782e-a87f-8961e28622c7" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingTextBlock_019ce305-8980-7b4d-a658-ac3322424961" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-782e-a87f-8961e28622c7" xlink:to="loc_eltx_WarrantsAndRightsOutstandingTextBlock_019ce305-8980-7b4d-a658-ac3322424961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019ce305-8981-7fe8-9384-15c356976813" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019ce305-8981-7952-95dc-830edd290810" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019ce305-8981-7fe8-9384-15c356976813" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019ce305-8981-7952-95dc-830edd290810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/Leases" xlink:type="simple" xlink:href="eltx-20260331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019ce305-8981-7399-bcff-43d6c85f7aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_019ce305-8981-7087-93d1-444dce62c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7399-bcff-43d6c85f7aaa" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_019ce305-8981-7087-93d1-444dce62c07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/Debt" xlink:type="simple" xlink:href="eltx-20260331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019ce305-8981-7114-99c4-5e9dc31c1352" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_019ce305-8981-7d09-b5fd-7fff5fc502f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019ce305-8981-7114-99c4-5e9dc31c1352" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_019ce305-8981-7d09-b5fd-7fff5fc502f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="eltx-20260331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019ce305-8981-76e8-a1a9-87dee50c1517" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019ce305-8981-7a3e-9daf-6937f6aae4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019ce305-8981-76e8-a1a9-87dee50c1517" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019ce305-8981-7a3e-9daf-6937f6aae4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/NetLossPerShare" xlink:type="simple" xlink:href="eltx-20260331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-71c0-876c-dc07f8eb8aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019ce305-8981-70b9-90f9-6d54d7d43cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-71c0-876c-dc07f8eb8aae" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019ce305-8981-70b9-90f9-6d54d7d43cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="eltx-20260331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_019ce305-8981-7fbc-ae91-c9b3fc4988b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019ce305-8981-7acb-988e-a28373dce5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_019ce305-8981-7fbc-ae91-c9b3fc4988b7" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_019ce305-8981-7acb-988e-a28373dce5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SegmentReporting" xlink:type="simple" xlink:href="eltx-20260331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-75e0-9b4a-81a0598aabe4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019ce305-8981-70b5-a484-cd209ec725e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-75e0-9b4a-81a0598aabe4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019ce305-8981-70b5-a484-cd209ec725e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SubsequentEvents" xlink:type="simple" xlink:href="eltx-20260331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_019d42ac-9fe1-7db7-9bcc-f7568c1ad67c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_019d42ad-1aee-707b-9c3c-562d9f85bc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_019d42ac-9fe1-7db7-9bcc-f7568c1ad67c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_019d42ad-1aee-707b-9c3c-562d9f85bc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="eltx-20260331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-7034-b051-969125882828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019ce305-8980-78cf-9cd3-defb1ed7eec0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-7034-b051-969125882828" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019ce305-8980-78cf-9cd3-defb1ed7eec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019ce305-8980-7ab6-be73-dbe016eeacc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-7034-b051-969125882828" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019ce305-8980-7ab6-be73-dbe016eeacc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7dae-9353-d1947d814b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019ce305-8980-7806-87b8-8744f42c5d14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7dae-9353-d1947d814b2f" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019ce305-8980-7806-87b8-8744f42c5d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019ce305-8980-7f89-be7a-eb234c1f0447" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7dae-9353-d1947d814b2f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_019ce305-8980-7f89-be7a-eb234c1f0447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019ce305-8980-71c5-a770-962026085fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7dae-9353-d1947d814b2f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_019ce305-8980-71c5-a770-962026085fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-76c4-af8b-1af52655a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_019ce305-8980-7854-a489-1de8b479e269" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-76c4-af8b-1af52655a5ca" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_019ce305-8980-7854-a489-1de8b479e269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019ce305-8980-74bc-b903-7364b885d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-76c4-af8b-1af52655a5ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019ce305-8980-74bc-b903-7364b885d4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019ce305-8980-709e-a2db-7a5785841680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-76c4-af8b-1af52655a5ca" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019ce305-8980-709e-a2db-7a5785841680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7a6a-9da8-3f447d3ed071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019ce305-8980-7073-8fae-4ac219da62f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7a6a-9da8-3f447d3ed071" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019ce305-8980-7073-8fae-4ac219da62f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019dfb79-d3bc-7c14-b68b-a43e1be8ddcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7a6a-9da8-3f447d3ed071" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019dfb79-d3bc-7c14-b68b-a43e1be8ddcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019ce305-8980-7755-8812-9b53b651e8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7a6a-9da8-3f447d3ed071" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019ce305-8980-7755-8812-9b53b651e8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_019dc3b5-5810-7fc9-88af-3dfba5bc6a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7a6a-9da8-3f447d3ed071" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_019dc3b5-5810-7fc9-88af-3dfba5bc6a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/WarrantsTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-71c2-8925-bea1423a47ff" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019ce305-8980-7288-9f6c-61b13d451859" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-71c2-8925-bea1423a47ff" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_019ce305-8980-7288-9f6c-61b13d451859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019ce305-8981-7197-97df-e13c46d13faf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_019ce305-8981-7e3c-86d9-bf29c948dc30" xlink:href="eltx-20260331.xsd#eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7197-97df-e13c46d13faf" xlink:to="loc_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_019ce305-8981-7e3c-86d9-bf29c948dc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019ce305-8981-7ca2-b6aa-71b2e6beedf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7197-97df-e13c46d13faf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019ce305-8981-7ca2-b6aa-71b2e6beedf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7d30-bb3b-fff7f8e4ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019ce305-8981-716e-a5f4-a105d199d207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7d30-bb3b-fff7f8e4ca23" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019ce305-8981-716e-a5f4-a105d199d207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019ce305-8981-7daa-88f4-9e8ce95b6276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7d30-bb3b-fff7f8e4ca23" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019ce305-8981-7daa-88f4-9e8ce95b6276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="eltx-20260331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-7bfb-966b-174755a855d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019ce305-8981-76bf-9d1a-443617c31b93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-7bfb-966b-174755a855d2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019ce305-8981-76bf-9d1a-443617c31b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7c07-89ab-86f2904f553c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7c07-89ab-86f2904f553c" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e0012-81f8-750b-803f-92ded437021b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2024RegistrationStatementMember_019e0012-81f8-7514-ab01-2d1c93217725" xlink:href="eltx-20260331.xsd#eltx_A2024RegistrationStatementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_A2024RegistrationStatementMember_019e0012-81f8-7514-ab01-2d1c93217725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019e0012-81f8-74a5-b4dc-757a97bcf1b3" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019e0012-81f8-74a5-b4dc-757a97bcf1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026RegistrationStatementMember_019e0012-81f8-7050-bd3f-fd41cab6948c" xlink:href="eltx-20260331.xsd#eltx_A2026RegistrationStatementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_A2026RegistrationStatementMember_019e0012-81f8-7050-bd3f-fd41cab6948c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019e0012-81f8-7f4e-ad8c-93d6b7ea160d" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019e0012-81f8-7f4e-ad8c-93d6b7ea160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019e0012-81f8-72f4-8a0c-b7393b36f967" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e0012-81f8-74f4-89f7-95a4d008ad05" xlink:to="loc_eltx_AtTheMarketOfferingMember_019e0012-81f8-72f4-8a0c-b7393b36f967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e0012-81f8-73a5-b8ac-7e6cb37a4e9a" xlink:to="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e0012-81f8-742e-9d2b-353c2774a82f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e0012-81f8-79bf-bea7-65b829da4db3" xlink:to="loc_us-gaap_CommonStockMember_019e0012-81f8-742e-9d2b-353c2774a82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019e0012-81f8-7f17-8ff9-7239589eb9ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryCommonWarrantsMember_019e0012-81f8-76ae-bebd-50ca358a2804" xlink:href="eltx-20260331.xsd#eltx_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019e0012-81f8-72fd-bd67-bb44af860b43" xlink:to="loc_eltx_JanuaryCommonWarrantsMember_019e0012-81f8-76ae-bebd-50ca358a2804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e0012-b820-75e1-903f-26591f29097d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019e0012-b820-70a9-a6e5-3627ba7e2b17" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e0012-b820-7894-9f75-40376c8283bb" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019e0012-b820-70a9-a6e5-3627ba7e2b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4235-2155-74d8-9a78-4bdd88821282" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e0012-81f8-7a03-a70d-8543c291b920" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e0012-81f8-7a03-a70d-8543c291b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019e0012-81f8-7295-9f09-3b43a7dd1bfe" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019e0012-81f8-7295-9f09-3b43a7dd1bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e0012-81f8-7ea5-83cb-b520762ed0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e0012-81f8-7ea5-83cb-b520762ed0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019e0012-81f8-7ff6-bec5-7f3b37e9d3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019e0012-81f8-7ff6-bec5-7f3b37e9d3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e0012-81f8-7fa6-a984-e35e2a4cd403" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e0012-81f8-7fa6-a984-e35e2a4cd403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019e0012-81f8-7b49-94bf-80b8a2f7847a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019e0012-81f8-7b49-94bf-80b8a2f7847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019e0012-81f8-7f94-934e-b1340cab0315" xlink:href="eltx-20260331.xsd#eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid_019e0012-81f8-7f94-934e-b1340cab0315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_019e0012-81f8-779e-88a7-2443140cf8c7" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions_019e0012-81f8-779e-88a7-2443140cf8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019e0012-81f8-7b74-bcec-52c09388c64e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019e0012-81f8-7b74-bcec-52c09388c64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019e0012-81f8-7d61-b4db-2cea31203c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019e0012-81f8-7d61-b4db-2cea31203c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019e0012-81f8-784e-969c-4fdae275a2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019e0012-81f8-784e-969c-4fdae275a2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e0012-b820-7a93-b224-088b16ec9252" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e0012-b820-7a93-b224-088b16ec9252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e0012-b820-79d3-85b3-ef29165b5ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e0012-b820-79d3-85b3-ef29165b5ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019e0012-b820-762c-b569-d628f836f5df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019e0012-b820-762c-b569-d628f836f5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019e0012-b820-7e1f-80a3-58edaa6b85d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019e0012-b820-7e1f-80a3-58edaa6b85d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e0012-b820-7a41-9724-59e94aa4dfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e0012-81f8-723e-9643-2d3e7a8eb71c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e0012-b820-7a41-9724-59e94aa4dfe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-720f-913f-b63af55d2a39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019ce305-8980-720f-913f-b63af55d2a39" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019ce305-8980-75f4-8ec9-61254f19383b" xlink:to="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionCommonStockMember_019ce305-8980-7dfc-9f96-8cf0085613a9" xlink:href="eltx-20260331.xsd#eltx_AngionCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019ce305-8980-709a-b23b-488d2c3305da" xlink:to="loc_eltx_AngionCommonStockMember_019ce305-8980-7dfc-9f96-8cf0085613a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7d17-83d7-e496911439d4" xlink:to="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_019ce305-8980-7100-8fbe-431faf97bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019ce305-8980-796d-93e4-45ebefe51d37" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_019ce305-8980-7100-8fbe-431faf97bd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-76d4-aeac-43a35b5ad049" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-76d4-aeac-43a35b5ad049" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-7070-84e8-349491c9bfea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019ce305-8980-7da8-979a-88fec7484c03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019ce305-8980-7da8-979a-88fec7484c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019ce305-8980-70a5-bd93-2193279920ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019ce305-8980-70a5-bd93-2193279920ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-7e06-9699-932ea6905e16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7d32-9a6a-de358d21d83d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-7e06-9699-932ea6905e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019ce305-8980-7bac-8a51-ebee9df1f540" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-71d3-a86f-5dabcaffc85e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019ce305-8980-71d3-a86f-5dabcaffc85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-73f4-bdb4-e79bff1d34c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_019ce305-8980-73f3-8204-b58b565168bf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019ce305-8980-73f4-bdb4-e79bff1d34c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019ce305-8980-7930-a5d3-be506779f083" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7262-ac0b-af912f3c88be" xlink:href="eltx-20260331.xsd#eltx_WarrantsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:to="loc_eltx_WarrantsFairValueDisclosure_019ce305-8980-7262-ac0b-af912f3c88be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-7524-a384-f5b5301b6aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_019ce305-8980-7a7c-9a5e-abb0b2228367" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019ce305-8980-7524-a384-f5b5301b6aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-74e5-b217-f65456011815" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-74e5-b217-f65456011815" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_019ce305-8980-7548-93fd-57b9d8f46c56" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantLiabilityMember_019ce305-8980-7f77-a2dc-dd9b4160b323" xlink:href="eltx-20260331.xsd#eltx_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_019ce305-8980-7103-8056-d5b3bb1c3db9" xlink:to="loc_eltx_WarrantLiabilityMember_019ce305-8980-7f77-a2dc-dd9b4160b323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_019ce305-8980-7941-91e2-ca7cd4e20854" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_019ce305-8980-7327-add5-f3dedd8e4612" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-7604-8a8c-dc276c28adeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-7604-8a8c-dc276c28adeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019ce305-8980-736d-b619-e4b2e7581d74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_019ce305-8980-736d-b619-e4b2e7581d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-749c-aceb-19887517cc54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_019ce305-8980-7c5a-b8d6-7d66f2a15bb5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_019ce305-8980-749c-aceb-19887517cc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7f55-a1e9-db9e84ee91c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-7f55-a1e9-db9e84ee91c7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ce305-8980-72ce-ade2-52034c42ef8d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-71c4-9e4e-18f3a5b83395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ce305-8980-7ed3-861a-693cb39402a6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ce305-8980-71c4-9e4e-18f3a5b83395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019ce305-8980-790f-9221-3d1e032e9b5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_MeasurementInputStrikePriceMember_019ce305-8980-7353-bc31-96488dc9c14f" xlink:href="eltx-20260331.xsd#eltx_MeasurementInputStrikePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_eltx_MeasurementInputStrikePriceMember_019ce305-8980-7353-bc31-96488dc9c14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_019ce305-8980-7083-9e99-84156f590a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_019ce305-8980-7083-9e99-84156f590a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019ce305-8980-7454-967e-4ff4576717bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_019ce305-8980-7454-967e-4ff4576717bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019ce305-8980-79aa-9bb7-7c63bdeb675b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019ce305-8980-7082-a6cc-c913936f8854" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_019ce305-8980-79aa-9bb7-7c63bdeb675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_019ce305-8980-7c58-acb6-715a3fd1031e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019ce305-8980-757b-973b-57d93d83a012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_019ce305-8980-757b-973b-57d93d83a012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019ce305-8980-7ea4-86a4-89c8dfde13c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_019ce305-8980-75c8-aadd-4682f0c82334" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019ce305-8980-7ea4-86a4-89c8dfde13c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-74f5-9e6d-25f39398b2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019ce305-8980-74f5-9e6d-25f39398b2e7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d7109-960a-78f7-a71a-73299f126f3c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantsMember_019d7109-960a-77c7-8c9c-032a45ac6898" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:to="loc_eltx_JulyCommonWarrantsMember_019d7109-960a-77c7-8c9c-032a45ac6898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsMember_019dc36b-5284-7095-bfec-ec240244caf2" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d7109-960a-7ec4-a8a2-45014b80bb1e" xlink:to="loc_eltx_JulyPreFundedWarrantsMember_019dc36b-5284-7095-bfec-ec240244caf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7109-960a-7699-9746-c37c42379315" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPublicOfferingMember_019d7109-960a-769a-8b2b-0079a70b670c" xlink:href="eltx-20260331.xsd#eltx_JulyPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7109-960a-73d0-ae52-d15c30405a37" xlink:to="loc_eltx_JulyPublicOfferingMember_019d7109-960a-769a-8b2b-0079a70b670c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019dc36c-1a98-7d83-8a41-254f2872eae5" xlink:to="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulySharesAndJulyCommonWarrantMember_019dc36c-1a98-7173-8b08-5fff9968b4eb" xlink:href="eltx-20260331.xsd#eltx_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019dc36c-1a98-745b-b204-8d90ff558213" xlink:to="loc_eltx_JulySharesAndJulyCommonWarrantMember_019dc36c-1a98-7173-8b08-5fff9968b4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7c01-9f1b-4ea6ef526315" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019dc36b-5284-7bf7-96e2-eff9532aafa1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019dc36b-5284-7bf7-96e2-eff9532aafa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc36b-5284-7f22-9a46-bc8fb49d1d10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc36b-5284-7f22-9a46-bc8fb49d1d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019dc36c-1a98-7fe0-abab-b861c998ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019dc36c-1a98-7fe0-abab-b861c998ddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1a2-6272-7d02-9232-67f72cba5d05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1a2-6272-7d02-9232-67f72cba5d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_019d7109-960a-7d8d-a5e2-27e31c2e5817" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage_019d7109-960a-7d8d-a5e2-27e31c2e5817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019d7109-960a-7c20-84d4-1a35a079143b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019d7109-960a-7e4f-b74e-3ec4cae322f6" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019d7109-960a-7c20-84d4-1a35a079143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PrepaidResearchAndDevelopmentExpenses_019ce305-8980-7008-af90-e2997c7e1deb" xlink:href="eltx-20260331.xsd#eltx_PrepaidResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:to="loc_eltx_PrepaidResearchAndDevelopmentExpenses_019ce305-8980-7008-af90-e2997c7e1deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AdvancedProfessionalFees_019ce305-8980-70b7-be3d-b1be0d47837d" xlink:href="eltx-20260331.xsd#eltx_AdvancedProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:to="loc_eltx_AdvancedProfessionalFees_019ce305-8980-70b7-be3d-b1be0d47837d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019ce305-8980-7721-9606-d6bbd93a6fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:to="loc_us-gaap_PrepaidInsurance_019ce305-8980-7721-9606-d6bbd93a6fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_019ce305-8980-794d-84b9-07e761e99705" xlink:href="eltx-20260331.xsd#eltx_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:to="loc_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent_019ce305-8980-794d-84b9-07e761e99705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-7a5f-8796-9f4655a8b93c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-752e-8512-ebde379d7787" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019ce305-8980-7a5f-8796-9f4655a8b93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-720a-9732-8b2d28d11020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-720a-9732-8b2d28d11020" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019ce305-8980-7058-aa17-48c564cd0c9d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_019ce305-8980-7467-ad82-3a739028eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_EquipmentMember_019ce305-8980-7467-ad82-3a739028eb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019ce305-8980-794d-9484-efd827d7b268" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019ce305-8980-794d-9484-efd827d7b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019ce305-8980-7afa-a5d6-6f7e7470218c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019ce305-8980-7e35-9df1-8b746905b2c4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019ce305-8980-7afa-a5d6-6f7e7470218c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019ce305-8980-7eac-9698-497f3da80bb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-703a-8327-20be98e4b2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019ce305-8980-703a-8327-20be98e4b2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7bcf-9b6b-6781e17a73df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019ce305-8980-7bcf-9b6b-6781e17a73df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-7e62-8472-02889f448405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019ce305-8980-7087-add0-7d2d59cb8e32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019ce305-8980-7e62-8472-02889f448405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7d8c-b159-9551b59da52a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019ce305-8980-7c23-b892-5f19b7b1e4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7d8c-b159-9551b59da52a" xlink:to="loc_us-gaap_Depreciation_019ce305-8980-7c23-b892-5f19b7b1e4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-8980-7820-b03c-00cc2f4b3f52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-7d8c-b159-9551b59da52a" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_019ce305-8980-7820-b03c-00cc2f4b3f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019ce305-8980-79e6-9e2f-cd6bb35eba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019ce305-8980-79e6-9e2f-cd6bb35eba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019ce305-8980-7d2e-a812-e3ec03a71c70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019ce305-8980-7d2e-a812-e3ec03a71c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_019ce305-8980-7486-8476-3903851add20" xlink:href="eltx-20260331.xsd#eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent_019ce305-8980-7486-8476-3903851add20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterest_019d424a-50d6-771f-8334-a1a56b9a409f" xlink:href="eltx-20260331.xsd#eltx_AccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_eltx_AccruedInterest_019d424a-50d6-771f-8334-a1a56b9a409f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent_019ce305-8980-749b-ac1b-4e001b866b3a" xlink:href="eltx-20260331.xsd#eltx_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_eltx_AccruedOtherOperatingLiabilitiesCurrent_019ce305-8980-749b-ac1b-4e001b866b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7989-bef9-a24c6825938d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019ce305-8980-779c-afd8-f206b79f4876" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019ce305-8980-7989-bef9-a24c6825938d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/ResearchGrantsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#ResearchGrantsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/ResearchGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_019ce305-8980-7332-8005-e1835b6e5660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_019ce305-8980-7332-8005-e1835b6e5660" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_019dc382-bbeb-7eb0-9519-e0104d9c23e1" xlink:to="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_019dc382-bbeb-7754-89f3-fcaa217b5e98" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_019dc382-bbeb-7754-89f3-fcaa217b5e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_019dc382-bbeb-775c-9cda-dd6ec53b09d2" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_019dc382-bbeb-775c-9cda-dd6ec53b09d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_019dc382-bbeb-7d3c-b685-eccbbd9ef17a" xlink:href="eltx-20260331.xsd#eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_019dc382-bbeb-7eb3-906a-7c3bb98b6f71" xlink:to="loc_eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_019dc382-bbeb-7d3c-b685-eccbbd9ef17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_019ce305-8980-7bfb-97a8-c00eda822561" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementGrant_019dc382-bbeb-7681-a9de-505889c7a1ea" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_ResearchAndDevelopmentArrangementGrant_019dc382-bbeb-7681-a9de-505889c7a1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_NumberOfResearchGrantAgreements_019dc382-bbeb-7d42-9b16-e1d8511e36e3" xlink:href="eltx-20260331.xsd#eltx_NumberOfResearchGrantAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_NumberOfResearchGrantAgreements_019dc382-bbeb-7d42-9b16-e1d8511e36e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019dc387-9b99-78d0-8b87-628f30afb6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019dc387-9b99-78d0-8b87-628f30afb6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_019dc387-5a97-7bf7-b1ef-b0111ee48292" xlink:href="eltx-20260331.xsd#eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_019dc387-5a97-7bf7-b1ef-b0111ee48292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GrantRevenueNonoperating_019dc382-bbeb-7e72-86b8-cb0d13fbd258" xlink:href="eltx-20260331.xsd#eltx_GrantRevenueNonoperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_019dc382-bbeb-7fe4-9339-6cca92e517a5" xlink:to="loc_eltx_GrantRevenueNonoperating_019dc382-bbeb-7e72-86b8-cb0d13fbd258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019ce305-8980-770e-b3e5-81bc8f8d1d28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019ce305-8980-770e-b3e5-81bc8f8d1d28" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019dc3ac-eefd-7d1e-8ed8-ab606e9bb409" xlink:to="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019dc3ac-eefd-7247-bdbb-b916ecf98e93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019dc3ac-eefd-7116-9e10-db7164cf150e" xlink:to="loc_us-gaap_CommonStockMember_019dc3ac-eefd-7247-bdbb-b916ecf98e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dc3ac-eefd-781c-8997-aee27293c04e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019dc3ac-eefd-7d25-b184-19cd1c89b8d2" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2024Member_019dc3ac-eefd-7d25-b184-19cd1c89b8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019dc3ac-eefd-766d-bbae-161114bfbd90" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketEquityOfferingSalesAgreement2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketEquityOfferingSalesAgreement2026Member_019dc3ac-eefd-766d-bbae-161114bfbd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AtTheMarketOfferingMember_019dc3ac-eefd-79a9-8551-791ec521f796" xlink:href="eltx-20260331.xsd#eltx_AtTheMarketOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_AtTheMarketOfferingMember_019dc3ac-eefd-79a9-8551-791ec521f796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryPublicOfferingMember_019dc3ac-eefd-7815-8fff-d28098486f85" xlink:href="eltx-20260331.xsd#eltx_JanuaryPublicOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dc3ac-eefd-7672-b24a-ce51532de563" xlink:to="loc_eltx_JanuaryPublicOfferingMember_019dc3ac-eefd-7815-8fff-d28098486f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dc3ac-eefd-734e-9fe7-3d883812608e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JanuaryCommonWarrantsMember_019dc3ac-eefd-7d3a-b436-b8d8af4dddc2" xlink:href="eltx-20260331.xsd#eltx_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:to="loc_eltx_JanuaryCommonWarrantsMember_019dc3ac-eefd-7d3a-b436-b8d8af4dddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019dc3ac-eefd-7325-a029-e685a07e8a41" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dc3ac-eefd-75ee-a34f-ce7d5381533d" xlink:to="loc_eltx_PreFundedWarrantMember_019dc3ac-eefd-7325-a029-e685a07e8a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dc3ac-eefd-7be3-a9c0-60088b3c9ec0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019dc3ac-eefd-7645-8dfd-c4602bd92f03" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dc3ac-eefd-775e-ac0c-43adcfdedd0f" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019dc3ac-eefd-7645-8dfd-c4602bd92f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dc3ac-eefd-7ab6-ada1-861005a40ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019dc3ac-eefd-7f42-9e1e-36191de357fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dc3ac-eefd-7af6-a4de-57b98beb425d" xlink:to="loc_us-gaap_ConvertibleDebtMember_019dc3ac-eefd-7f42-9e1e-36191de357fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019ce305-8980-7a1e-b94a-1a0e713175af" xlink:to="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019dc3ac-c6d1-79f6-9c16-d123d23beb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019dc3ac-c6d1-79f6-9c16-d123d23beb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019dc3ac-c6d1-7a61-8983-6093a17248ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019dc3ac-c6d1-7a61-8983-6093a17248ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019dc3ac-c6d1-702a-8732-a2ae75a4393e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019dc3ac-c6d1-702a-8732-a2ae75a4393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019dc3ac-c6d1-7e32-87db-d567f0bec6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019dc3ac-c6d1-7e32-87db-d567f0bec6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019dc3ac-eefd-7f4c-ab3c-86d89e6f8912" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019dc3ac-eefd-7f4c-ab3c-86d89e6f8912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019dc3ac-eefd-7abf-b390-72ddcbd22855" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019dc3ac-eefd-7abf-b390-72ddcbd22855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019dc3ac-eefd-7a66-888c-fb53b39168fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019dc3ac-eefd-7a66-888c-fb53b39168fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019dc3ac-eefd-70d5-8d41-5abae0bfe79c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019dc3ac-eefd-70d5-8d41-5abae0bfe79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019dc3ac-eefd-736e-9104-19dc30043b63" xlink:href="eltx-20260331.xsd#eltx_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_eltx_SaleOfStockAggregateInitialOfferingPrice_019dc3ac-eefd-736e-9104-19dc30043b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc3ac-eefd-7149-8baa-3ae01b79551c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dc3ac-eefd-7149-8baa-3ae01b79551c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dc3ac-eefd-7d0c-bd0c-73370cf42328" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dc3ac-eefd-7d0c-bd0c-73370cf42328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019dc3ac-eefd-7d23-b3fa-21cfcc1a64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019dc3ac-eefd-7d23-b3fa-21cfcc1a64b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019dc3ac-eefd-7cac-a995-7170041e73f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019dc3ac-eefd-7cac-a995-7170041e73f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dc3ac-eefd-780c-af26-e42a1da722c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dc3ac-eefd-780c-af26-e42a1da722c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019dc3ac-eefd-75d2-ad05-f161655366eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019dc3ac-eefd-75d2-ad05-f161655366eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019dc3ac-eefd-740b-8b12-add389035823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019dc3ac-eefd-740b-8b12-add389035823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019dc3ac-eefd-70b7-8569-9aad1fad82b8" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019dc3ac-c6d1-7e0a-83af-00b574c2b353" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019dc3ac-eefd-70b7-8569-9aad1fad82b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7ce3-a2d3-8a84575f66d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7ce3-a2d3-8a84575f66d1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:to="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019ce305-8980-7863-8abb-317d50f4b04d" xlink:to="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2021PlanMember_019ce305-8980-7821-9453-9cc3b65685bd" xlink:href="eltx-20260331.xsd#eltx_The2021PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_The2021PlanMember_019ce305-8980-7821-9453-9cc3b65685bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_The2022PlanMember_019ce305-8980-707b-b0b7-409b016da6c3" xlink:href="eltx-20260331.xsd#eltx_The2022PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_The2022PlanMember_019ce305-8980-707b-b0b7-409b016da6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_Inducement2024PlanMember_019ce305-8980-7328-8bb5-0d4e86b45cf4" xlink:href="eltx-20260331.xsd#eltx_Inducement2024PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019ce305-8980-71c1-9801-fe5e49c82b05" xlink:to="loc_eltx_Inducement2024PlanMember_019ce305-8980-7328-8bb5-0d4e86b45cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:to="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019ce305-8980-7230-9c21-068e890f8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019ce305-8980-7069-9c26-a3961e7f8065" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:to="loc_us-gaap_EmployeeStockMember_019ce305-8980-7069-9c26-a3961e7f8065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3cb-a925-7328-8a92-5f5070a0c7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019ce305-8980-738c-8e0d-4f0b2b4e5377" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3cb-a925-7328-8a92-5f5070a0c7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019ce305-8980-7935-90a4-16fdef5a1121" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019ce305-8980-77e7-ab18-8ec2cbfc6b87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019ce305-8980-77e7-ab18-8ec2cbfc6b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_019ce305-8980-76cf-891a-368b848f326e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_019ce305-8980-76cf-891a-368b848f326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-772e-84d6-9726f4a68e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-772e-84d6-9726f4a68e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dfd8b-5cee-7ac3-a0ba-22be6f4f5ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dfd8b-5cee-7ac3-a0ba-22be6f4f5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-7491-b075-dff5b642be83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-7491-b075-dff5b642be83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019ce305-8980-7867-a957-90375ee02e85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019ce305-8980-7867-a957-90375ee02e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019ce305-8980-7b05-873f-beca8444e487" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019ce305-8980-7b05-873f-beca8444e487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_019ce305-8980-7259-833c-b29cf137d70e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019ce305-8980-772b-b587-51a09b12abde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_019ce305-8980-7259-833c-b29cf137d70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofShareOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8980-736b-b35a-86ad2268617f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8980-736b-b35a-86ad2268617f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-7f3f-8fdd-527f5119d923" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019ce305-8980-7f3f-8fdd-527f5119d923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-8980-75fd-b126-b35236bf017c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019ce305-8980-75fd-b126-b35236bf017c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019ce305-8980-77a2-8d17-f4b002b52cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019ce305-8980-77a2-8d17-f4b002b52cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8980-7d62-a8d6-95aa49ca7994" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019ce305-8980-7c69-b3a6-670bcf36e333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019ce305-8980-7d62-a8d6-95aa49ca7994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019ce305-8980-764a-a0f0-883966f303ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019ce305-8980-764a-a0f0-883966f303ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8980-73e1-a3bb-01bc9178e564" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8980-73e1-a3bb-01bc9178e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-713f-b845-051dabfa430d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019ce305-8980-713f-b845-051dabfa430d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019ce305-8980-7d41-b56b-013c4e4164ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019ce305-8980-7d41-b56b-013c4e4164ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019ce305-8980-71cf-9c21-d4a8f6b81c05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019ce305-8980-71cf-9c21-d4a8f6b81c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8980-7fa1-b542-ed8757860c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019ce305-8980-78d1-a1e5-db72bc6cc623" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019ce305-8980-7fa1-b542-ed8757860c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019ce305-8980-7037-a6f2-03aeb5a58cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_019ce305-8980-7037-a6f2-03aeb5a58cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-71f5-8c75-496bb552a3df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019ce305-8980-7a75-b4e8-d56edc2327a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019ce305-8980-7a75-b4e8-d56edc2327a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019ce305-8980-71ae-95eb-b93c725a2963" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_019ce305-8980-71ae-95eb-b93c725a2963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019ce305-8980-7134-8a3a-96341e163a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019ce305-8980-7134-8a3a-96341e163a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019ce305-8980-7627-8dc5-b6bf115a6ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_019ce305-8980-7afd-9757-b782d385eeb1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019ce305-8980-7627-8dc5-b6bf115a6ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019df1bc-2679-7af0-8f16-679c939b0e96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019df1bc-2679-7af0-8f16-679c939b0e96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:to="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019df1bf-9000-77ba-a871-cb25d7e96f53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019df1bf-9000-7542-a06b-59683b7da746" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019df1bf-9000-7874-a837-a1caa7882518" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019df1bf-9000-7542-a06b-59683b7da746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019df1bf-9000-74a1-8439-1dcf5cda7057" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019df1c0-aa28-7b30-9f5b-98ef8051741f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019df1c0-aa28-7b30-9f5b-98ef8051741f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019df1bf-9000-7d84-adee-c4fad880d765" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019df1bf-9000-7d84-adee-c4fad880d765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019df1bf-9000-7391-a53e-bf1f3455eec9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019df1bf-9000-7391-a53e-bf1f3455eec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019df1c1-497e-727c-85c4-c3106623dd84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019df1bf-9000-7e0c-80bc-6f1703fe4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019df1c1-497e-727c-85c4-c3106623dd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019dc3c2-5573-7c7c-979a-01f6e35a16b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019dc3c2-5573-7c7c-979a-01f6e35a16b2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:to="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019dc3c3-6103-7ebd-a56b-ab86a52d195d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3c3-6103-7e45-8157-727977c20e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dc3c3-6103-7d9a-ab62-4214c215a14f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dc3c3-6103-7e45-8157-727977c20e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dc3c3-6103-71d4-ae6f-551a2183a340" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c3-6103-7afa-9d45-bbf7583afada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c3-6103-7afa-9d45-bbf7583afada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019dc3c3-6103-72b1-b8a3-2dc7dd7f9782" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019dc3c3-6103-72b1-b8a3-2dc7dd7f9782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_019dc3c3-6103-790f-939b-e31b70f2ff21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_019dc3c3-6103-790f-939b-e31b70f2ff21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019dc3c3-6103-7389-90bf-7b465d39eda7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019dc3c3-6103-7389-90bf-7b465d39eda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c6-8e2a-755c-b60e-86481b9dbf19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019dc3c3-ce12-711d-acb3-910a6f0aecd9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019dc3c6-8e2a-755c-b60e-86481b9dbf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dc3c3-6103-7483-b00c-0959b2b8a0de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c3-6103-73d4-9012-4f82194e48d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c3-6103-73d4-9012-4f82194e48d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dc3c3-6103-7f61-877e-59a81718d6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019dc3c3-6103-7f61-877e-59a81718d6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019dc3c3-6103-75a2-abb6-d7ca2f158a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019dc3c3-6103-75a2-abb6-d7ca2f158a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c9-038e-7536-afca-1bf47383ea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019dc3c5-2c54-7574-b80e-558aa665c908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019dc3c9-038e-7536-afca-1bf47383ea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7cfe-827c-4671059d17c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019ce305-8980-7cfe-827c-4671059d17c1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019ce305-8980-7796-8dee-29ce5362d6dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019ce305-8980-77c1-9f2e-1cee98fa775e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019ce305-8980-77c1-9f2e-1cee98fa775e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019ce305-8980-70eb-a77f-02c3bdf84414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019ce305-8980-7ac6-9718-2edc554b079e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019ce305-8980-70eb-a77f-02c3bdf84414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019ce305-8980-7fde-9cf4-0860b03e4272" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019ce305-8980-7445-9156-46eb50c0abc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019ce305-8980-7aa3-8045-80bde5f58ef8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019ce305-8980-7445-9156-46eb50c0abc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-7e13-ba3f-fc93695176bd" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8980-7e13-ba3f-fc93695176bd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cb-9ca8-7712-bb6f-477bd9a2f6eb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_January2025CommonWarrantsMember_019df1cb-9ca8-7977-9edf-94f26a08e54b" xlink:href="eltx-20260331.xsd#eltx_January2025CommonWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:to="loc_eltx_January2025CommonWarrantsMember_019df1cb-9ca8-7977-9edf-94f26a08e54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019df1cb-9ca8-7247-89b1-a50c94ca8850" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cb-9ca8-7721-bdad-47d06455a374" xlink:to="loc_eltx_PreFundedWarrantMember_019df1cb-9ca8-7247-89b1-a50c94ca8850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cb-9ca8-71df-886b-1804d2d50254" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019df1cb-9ca8-72fe-b2f2-4f4f59aacb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019df1cb-9ca8-719d-86ce-9613847dbfdc" xlink:to="loc_us-gaap_CommonStockMember_019df1cb-9ca8-72fe-b2f2-4f4f59aacb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019df1cb-9ca8-7ba4-85e9-546e9006b356" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPublicOfferingMember_019df1cb-9ca8-7833-8a37-e9fd8cf73090" xlink:href="eltx-20260331.xsd#eltx_JulyPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019df1cb-9ca8-72db-ac03-78d3cb033b43" xlink:to="loc_eltx_JulyPublicOfferingMember_019df1cb-9ca8-7833-8a37-e9fd8cf73090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cb-9ca8-7c5c-bda4-a4a60f616889" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cb-9ca8-79e6-bfaa-2b6ac4014e01" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019df1cb-9ca8-7455-a887-906d435394e5" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cb-9ca8-79e6-bfaa-2b6ac4014e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8980-7d54-bfc3-430aa4ab963b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cb-9ca8-737f-977a-e0aec5baf498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cb-9ca8-737f-977a-e0aec5baf498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019df1cb-9ca8-7c90-b845-b94ca4e1d766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019df1cb-9ca8-7c90-b845-b94ca4e1d766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019df1cb-9ca8-709a-a4ee-af01277d1c17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019df1cb-9ca8-709a-a4ee-af01277d1c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1cb-9ca8-7f49-96e9-3f5947e3876f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019df1cb-9ca8-7f49-96e9-3f5947e3876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019df1cb-9ca8-722b-bd56-4d7ceb3a17e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019df1cb-9ca8-722b-bd56-4d7ceb3a17e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019df1cb-9ca8-76b0-baab-8cb8ea8a8af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019df1cb-9ca8-76b0-baab-8cb8ea8a8af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cb-9ca8-7ce0-a0fa-b01a4ac87319" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cb-9ca8-7ce0-a0fa-b01a4ac87319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cb-9ca8-7673-bdf0-8eae7d323329" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019df1cb-9ca8-79e7-ac78-367ab1fe1fe0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cb-9ca8-7673-bdf0-8eae7d323329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8981-714f-ad95-cf14f6ec0b88" xlink:href="eltx-20260331.xsd#eltx_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_WarrantsAndRightsOutstandingAbstract_019ce305-8981-714f-ad95-cf14f6ec0b88" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019ce305-8981-7777-94c5-19b266a12a95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ElicioWarrantsMember_019ce305-8981-7c4d-a578-ed7171b3bb3d" xlink:href="eltx-20260331.xsd#eltx_ElicioWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_ElicioWarrantsMember_019ce305-8981-7c4d-a578-ed7171b3bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AngionWarrantsMember_019ce305-8981-7125-ad55-43d8caa74664" xlink:href="eltx-20260331.xsd#eltx_AngionWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_AngionWarrantsMember_019ce305-8981-7125-ad55-43d8caa74664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_March2024PreFundedWarrantsMember_019ce305-8981-72e0-a51c-8b0f4fe389bc" xlink:href="eltx-20260331.xsd#eltx_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_March2024PreFundedWarrantsMember_019ce305-8981-72e0-a51c-8b0f4fe389bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019ce305-8981-7a47-9d6a-bfd952a5c9d3" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_PreFundedWarrantMember_019ce305-8981-7a47-9d6a-bfd952a5c9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantsMember_019ce305-8981-7a39-a473-4f121106a5b9" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_JulyCommonWarrantsMember_019ce305-8981-7a39-a473-4f121106a5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantOneMember_019d7110-e008-72cc-9687-4c47ca0d8a3a" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantOneMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_JulyCommonWarrantOneMember_019d7110-e008-72cc-9687-4c47ca0d8a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_January2025CommonWarrantsMember_019ce305-8981-71c4-aff1-2ba748693b9d" xlink:href="eltx-20260331.xsd#eltx_January2025CommonWarrantsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_January2025CommonWarrantsMember_019ce305-8981-71c4-aff1-2ba748693b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025CommonWarrantsMember_019ce305-8981-7051-86e5-087c6eaf9fbf" xlink:href="eltx-20260331.xsd#eltx_June2025CommonWarrantsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019ce305-8981-7279-8af6-25c0e9d0387c" xlink:to="loc_eltx_June2025CommonWarrantsMember_019ce305-8981-7051-86e5-087c6eaf9fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:to="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019ce305-8981-7730-a2e1-0e2fd4fdea95" xlink:to="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_019ce305-8981-73a2-8c36-ead49a145611" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019ce305-8981-7693-aac0-9ce3dcb150fa" xlink:to="loc_srt_WeightedAverageMember_019ce305-8981-73a2-8c36-ead49a145611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019ce305-8981-7185-a0b3-103197fca08e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8981-76ea-bc51-1aa7fabe6863" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019ce305-8981-76ea-bc51-1aa7fabe6863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8981-77a9-8f36-d5142735583d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019ce305-8981-77a9-8f36-d5142735583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019ce305-8981-77cc-93d0-9507c2cc2b62" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019ce305-8981-71e4-93aa-76099d8ddad4" xlink:to="loc_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019ce305-8981-77cc-93d0-9507c2cc2b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019ce305-8981-7085-a2e0-78242261de97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019ce305-8981-7085-a2e0-78242261de97" xlink:to="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019ce305-8981-7047-a8a5-bdb554fcb0e7" xlink:to="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019ce305-8981-7bcb-9d05-2e76de67c95f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:to="loc_srt_MinimumMember_019ce305-8981-7bcb-9d05-2e76de67c95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019ce305-8981-71a9-a322-faf2cf490702" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019ce305-8981-77f8-95f5-5d1080d407c7" xlink:to="loc_srt_MaximumMember_019ce305-8981-71a9-a322-faf2cf490702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019ce305-8981-70d3-92d1-796cecae3869" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019ce305-8981-7b9d-8259-d12357e07979" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019ce305-8981-7639-811c-78a8b0e10021" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019ce305-8981-7b9d-8259-d12357e07979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019ce305-8981-7547-993a-48899718d5da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_UniversityMember_019ce305-8981-76b4-a0da-68ef75400f8e" xlink:href="eltx-20260331.xsd#eltx_UniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019ce305-8981-75c3-ac84-6052944aebe8" xlink:to="loc_eltx_UniversityMember_019ce305-8981-76b4-a0da-68ef75400f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_019d9c44-4eb2-75cf-aaf6-5958552977af" xlink:to="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_019d9c44-6792-7e3d-bdc5-e4f58acade36" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_019d9c44-4eb2-7f56-9c7c-b84639f0ac25" xlink:to="loc_srt_ScenarioForecastMember_019d9c44-6792-7e3d-bdc5-e4f58acade36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:href="eltx-20260331.xsd#eltx_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureTable_019ce305-8981-7b12-b30f-aefdfb73b2b9" xlink:to="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_RoyaltyRatePercent_019ce305-8981-7869-9376-45602c85cea8" xlink:href="eltx-20260331.xsd#eltx_RoyaltyRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_RoyaltyRatePercent_019ce305-8981-7869-9376-45602c85cea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019ce305-8981-775a-a62c-59c8dcbefc75" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019ce305-8981-775a-a62c-59c8dcbefc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-7b9c-bced-083a6e20511f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-7b9c-bced-083a6e20511f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019ce305-8981-7cfb-9a4d-a187121896e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_us-gaap_RoyaltyExpense_019ce305-8981-7cfb-9a4d-a187121896e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_019ce305-8981-76d0-a2ea-8b80c8867d31" xlink:href="eltx-20260331.xsd#eltx_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_eltx_CommitmentsAndContingenciesDisclosureLineItems_019ce305-8981-779b-ae99-05445d5ea92d" xlink:to="loc_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments_019ce305-8981-76d0-a2ea-8b80c8867d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019ce305-8981-7633-b916-063b22835a03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7633-b916-063b22835a03" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:to="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019ce305-8981-79af-8f31-cef76da28b32" xlink:to="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_BostonMassachusettsMember_019ce305-8981-7f4f-bbd8-7282cec07126" xlink:href="eltx-20260331.xsd#eltx_BostonMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019ce305-8981-7244-94bf-cc84205a00aa" xlink:to="loc_eltx_BostonMassachusettsMember_019ce305-8981-7f4f-bbd8-7282cec07126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019ce305-8981-7972-a69a-9cfca10895ce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_019ce305-8981-778b-92c3-29290cde68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseExpense_019ce305-8981-778b-92c3-29290cde68bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-8981-789d-b9fe-748b2060e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019ce305-8981-789d-b9fe-748b2060e75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7476-8a7d-0d2f7a7c3741" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7476-8a7d-0d2f7a7c3741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_019ce305-8981-703c-84d4-f258fbadd120" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019ce305-8981-749e-8042-51d0a478fa3c" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_019ce305-8981-703c-84d4-f258fbadd120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019ce305-8981-7f32-a5f7-7e2a25792b14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019ce305-8981-752c-8967-2515dbc8233f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7f32-a5f7-7e2a25792b14" xlink:to="loc_us-gaap_OperatingLeasePayments_019ce305-8981-752c-8967-2515dbc8233f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019ce305-8981-77b2-9424-cec9fe2a4161" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7f32-a5f7-7e2a25792b14" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_019ce305-8981-77b2-9424-cec9fe2a4161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019ce305-8981-7c06-acd4-ac2a2bf982e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7f32-a5f7-7e2a25792b14" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_019ce305-8981-7c06-acd4-ac2a2bf982e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019ce305-8981-74ab-9674-2e7b65eee241" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019ce305-8981-74ab-9674-2e7b65eee241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019ce305-8981-7abf-acf8-c19481e8f3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019ce305-8981-7abf-acf8-c19481e8f3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019ce305-8981-7359-95a1-e08fda4b9109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019ce305-8981-7359-95a1-e08fda4b9109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019ce305-8981-7e10-a8cb-b41dcb3926b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019ce305-8981-7e10-a8cb-b41dcb3926b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019ce305-8981-73f1-a3b0-fec9b5aaba8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019ce305-8981-73f1-a3b0-fec9b5aaba8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-7544-96cd-879a5b8237b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019ce305-8981-7544-96cd-879a5b8237b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019ce305-8981-7114-bd8c-628840c6f45f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019ce305-8981-7114-bd8c-628840c6f45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-7937-ab38-322c3095bfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_OperatingLeaseLiability_019ce305-8981-7937-ab38-322c3095bfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7435-9615-304df9b1dced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019ce305-8981-7435-9615-304df9b1dced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-8981-790a-9a95-5fe76ea1d662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019ce305-8981-7fcc-af63-4387789e65e6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019ce305-8981-790a-9a95-5fe76ea1d662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/DebtDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019ce305-8981-7d31-b39d-e231d4581b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019ce305-8981-7d31-b39d-e231d4581b5e" xlink:to="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d9c38-8e91-7908-9923-925a3e6df640" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019d9c38-8e91-7e24-83ac-dfb87a8ab8ae" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d9c38-8e91-72cf-b3f0-88fa2e34d5cd" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019d9c38-8e91-7e24-83ac-dfb87a8ab8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d9c38-8e91-740f-8f9a-6182f3e438ca" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019d9c38-8e91-7441-8d27-da7aa13c689b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d9c38-8e91-7edf-ab75-f9a3ad945dcd" xlink:to="loc_us-gaap_ConvertibleDebtMember_019d9c38-8e91-7441-8d27-da7aa13c689b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d9c38-8e91-7174-9b35-6be684343a3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019d9c38-8e91-7d98-9dbb-5f78dce14a89" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:to="loc_eltx_PreFundedWarrantMember_019d9c38-8e91-7d98-9dbb-5f78dce14a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025WarrantsMember_019d9c3b-e773-7e14-8947-985818d0cfb3" xlink:href="eltx-20260331.xsd#eltx_June2025WarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d9c38-8e91-7a47-ab68-ce2d7102754d" xlink:to="loc_eltx_June2025WarrantsMember_019d9c3b-e773-7e14-8947-985818d0cfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d9c38-8e91-7983-85f3-a6972217d5ec" xlink:to="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d9c38-8e91-7a3d-b0ec-91b217012b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d9c38-8e91-75f8-946b-666936ac3207" xlink:to="loc_us-gaap_CommonStockMember_019d9c38-8e91-7a3d-b0ec-91b217012b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d9c3a-921d-7243-8a66-88e4ddd746a1" xlink:to="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d9c3a-921d-7173-990b-fdad1b9e4d8d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d9c3a-921d-71bb-8ac4-8699d5dc1ed6" xlink:to="loc_srt_MaximumMember_019d9c3a-921d-7173-990b-fdad1b9e4d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019d9c3a-921d-7748-80b5-ffb1f497b097" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019d9c3a-921d-783b-8851-9262a0511b36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019d9c3a-921d-783b-8851-9262a0511b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019d9c3a-921d-7667-8b06-a0f15b3767ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019d9c3a-921d-7667-8b06-a0f15b3767ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019d9c3a-921d-7ab5-861b-3c32d507ced2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019d9c3a-921d-7d59-a0c0-f37a75bb8d55" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019d9c3a-921d-7ab5-861b-3c32d507ced2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019d9c3b-e773-708a-90da-a9135a242aa7" xlink:to="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_GKCCMember_019d9c3b-e773-7fb1-88ee-f2cae8f5d890" xlink:href="eltx-20260331.xsd#eltx_GKCCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019d9c3b-e773-70ab-9462-233daf8f7f7c" xlink:to="loc_eltx_GKCCMember_019d9c3b-e773-7fb1-88ee-f2cae8f5d890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019ce305-8981-7d9c-81c2-943b8ffa7501" xlink:to="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d9c38-8e91-7c31-8761-72b2b621c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d9c38-8e91-7c31-8761-72b2b621c43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019d9c38-8e91-7c70-8708-ef4133fed614" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019d9c38-8e91-7c70-8708-ef4133fed614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019d9c38-8e91-7609-a6e1-a2ac4535c746" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019d9c38-8e91-7609-a6e1-a2ac4535c746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019d9c38-8e91-7430-af3f-ce165c1e1901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019d9c38-8e91-7430-af3f-ce165c1e1901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019d9c38-8e91-745e-94a4-917daa7b543d" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019d9c38-8e91-745e-94a4-917daa7b543d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019d9c3a-921d-7ab7-9b7a-2b9077f14d06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019d9c3a-921d-7ab7-9b7a-2b9077f14d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019d9c3a-921d-79cc-92c6-3194fa6acc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019d9c3a-921d-79cc-92c6-3194fa6acc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019d9c3b-e773-73b3-96b2-8f07a8cebd80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019d9c3b-e773-73b3-96b2-8f07a8cebd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019d9c3b-e773-784d-b96a-86d71b9eb499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019d9c3b-e773-784d-b96a-86d71b9eb499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_019d9c3b-e773-7add-9302-691315178211" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum_019d9c3b-e773-7add-9302-691315178211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019d9c3b-e773-72de-9359-2f2483cb52a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019d9c3b-e773-72de-9359-2f2483cb52a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019d9c3c-6175-774b-8f83-50210d2f5ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019d9c3c-6175-774b-8f83-50210d2f5ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019d9c3c-6175-7eb5-9ba6-86e2e64baa73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019d9c3c-6175-7eb5-9ba6-86e2e64baa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019d9c3c-6175-7fe1-a354-3ca32611bcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019d9c3c-6175-7fe1-a354-3ca32611bcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d9c3c-6175-7fdc-8244-18d0100a6f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d9c3c-6175-7fdc-8244-18d0100a6f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d9c3c-6175-7539-ada4-724755a2f819" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019d9c38-8e91-7544-934c-028761551ecf" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d9c3c-6175-7539-ada4-724755a2f819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019ce305-8981-7d47-b442-8629d5737840" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019ce305-8981-7ef0-a1e2-0e752ccdf9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019ce305-8981-7d47-b442-8629d5737840" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019ce305-8981-7ef0-a1e2-0e752ccdf9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7225-9238-f9b475787518" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019ce305-8981-7b3d-8d4c-764ad9e097d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7225-9238-f9b475787518" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019ce305-8981-7b3d-8d4c-764ad9e097d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-8981-7436-866c-021326ddadde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019ce305-8981-7b3d-8d4c-764ad9e097d7" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-8981-7436-866c-021326ddadde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019ce305-8981-72d7-8149-f8e815a272fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7225-9238-f9b475787518" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019ce305-8981-72d7-8149-f8e815a272fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-8981-7dec-9548-a5b07243a32d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019ce305-8981-72d7-8149-f8e815a272fc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019ce305-8981-7dec-9548-a5b07243a32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-8981-7774-859f-48f3125a8eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019ce305-8981-72d7-8149-f8e815a272fc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019ce305-8981-7774-859f-48f3125a8eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019ce305-8981-7e57-9d8e-c80ae16858a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7225-9238-f9b475787518" xlink:to="loc_us-gaap_EarningsPerShareBasic_019ce305-8981-7e57-9d8e-c80ae16858a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019ce305-8981-782c-b63a-77875479256e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-7225-9238-f9b475787518" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019ce305-8981-782c-b63a-77875479256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-721f-981f-09deb4a1d180" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019ce305-8981-721f-981f-09deb4a1d180" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019ce305-8981-7713-bdd1-ad790456455f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019ce305-8981-7c3b-925e-d41a95abdeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019ce305-8981-7c3b-925e-d41a95abdeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019ce305-8981-7938-8d89-e71f2a82df83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_WarrantMember_019ce305-8981-7938-8d89-e71f2a82df83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019dc3ce-370b-79da-8184-22a0f481b2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019ce305-8981-7050-864e-210979f0fca9" xlink:to="loc_us-gaap_RestrictedStockMember_019dc3ce-370b-79da-8184-22a0f481b2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019ce305-8981-7313-80fe-ae16f0a9abe1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019ce305-8981-728b-8666-3d64d0b48f05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019ce305-8981-7ad3-a60b-d1fb78464589" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019ce305-8981-728b-8666-3d64d0b48f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_019ce305-8981-7353-b300-a2ba5f096507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_019ce305-8981-7353-b300-a2ba5f096507" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019df1cd-ea20-7a5a-acbe-8df4de142779" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_March2024PreFundedWarrantsMember_019df1cd-ea20-7782-93b9-b44258f6a105" xlink:href="eltx-20260331.xsd#eltx_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_March2024PreFundedWarrantsMember_019df1cd-ea20-7782-93b9-b44258f6a105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PreFundedWarrantMember_019df1cd-ea20-72e5-af5b-33432e28ecbc" xlink:href="eltx-20260331.xsd#eltx_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_PreFundedWarrantMember_019df1cd-ea20-72e5-af5b-33432e28ecbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyCommonWarrantOneMember_019df1cd-ea20-7491-9405-12e6ea59e484" xlink:href="eltx-20260331.xsd#eltx_JulyCommonWarrantOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_JulyCommonWarrantOneMember_019df1cd-ea20-7491-9405-12e6ea59e484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_June2025CommonWarrantsMember_019df1cd-ea20-75d7-a20f-f9f8c2bb6800" xlink:href="eltx-20260331.xsd#eltx_June2025CommonWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_June2025CommonWarrantsMember_019df1cd-ea20-75d7-a20f-f9f8c2bb6800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019dfd71-04b8-7e82-b158-2141fa65537c" xlink:href="eltx-20260331.xsd#eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019df1cd-ea20-70c7-beae-a2db30d1ae74" xlink:to="loc_eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019dfd71-04b8-7e82-b158-2141fa65537c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019df1cd-ea20-7294-a7fc-983586afa5de" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cd-ea20-7008-849a-555c83c93009" xlink:href="eltx-20260331.xsd#eltx_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019df1cd-ea20-73c5-9b10-fdc6524470e1" xlink:to="loc_eltx_SeniorSecuredConvertiblePromissoryNoteMember_019df1cd-ea20-7008-849a-555c83c93009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019df1cd-ea20-704d-a530-31d5604a68a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019df1cd-ea20-7cd5-bb77-a11cdbe0cc67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019df1cd-ea20-7f5a-b821-fb1743e7fb2f" xlink:to="loc_us-gaap_ConvertibleDebtMember_019df1cd-ea20-7cd5-bb77-a11cdbe0cc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019df1cd-ea20-7a44-9159-474ed3ccfc30" xlink:to="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019df1cd-ea20-78d2-8861-1bf256c3af6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019df1cd-ea20-719e-b934-fad8bb34ad77" xlink:to="loc_us-gaap_CommonStockMember_019df1cd-ea20-78d2-8861-1bf256c3af6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019dfd71-04b8-7b18-956e-73dbfd18a76b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_019dfd71-04b8-7a03-908d-58343857b91f" xlink:href="eltx-20260331.xsd#eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dfd71-04b8-7940-9694-230b6200a38a" xlink:to="loc_eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_019dfd71-04b8-7a03-908d-58343857b91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019dfd71-04b8-7e0a-ab2e-a678e30a5977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_PurchaseOfWarrantsMember_019dfd71-04b8-79a9-99f5-7fc1ea7adc28" xlink:href="eltx-20260331.xsd#eltx_PurchaseOfWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019dfd71-04b8-726a-aaa1-91f6087a5b69" xlink:to="loc_eltx_PurchaseOfWarrantsMember_019dfd71-04b8-79a9-99f5-7fc1ea7adc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dfd71-04b8-71b5-9f05-13b337057b06" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_July2024PublicOfferingMember_019dfd71-04b8-7d1f-a08a-ba6f4dad3de0" xlink:href="eltx-20260331.xsd#eltx_July2024PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dfd71-04b8-7235-abb4-968bea40268f" xlink:to="loc_eltx_July2024PublicOfferingMember_019dfd71-04b8-7d1f-a08a-ba6f4dad3de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_019ce305-8981-7fd5-88c4-86bd45851dfd" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cd-ea20-735c-92df-1a38d253fead" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019df1cd-ea20-735c-92df-1a38d253fead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod_019dfd71-04b8-75a2-9b83-504b7c8823a9" xlink:href="eltx-20260331.xsd#eltx_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_eltx_ClassOfWarrantOrRightIssuedInPeriod_019dfd71-04b8-75a2-9b83-504b7c8823a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019df1cd-ea20-7324-b4b1-1190000bfe12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019df1cd-ea20-7324-b4b1-1190000bfe12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019df1cd-ea20-7ad7-a358-800281e5f65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019df1cd-ea20-7ad7-a358-800281e5f65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cd-ea20-7525-8b79-76174eb754d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019df1cd-ea20-7525-8b79-76174eb754d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019df1cd-ea20-7ec2-aaba-cfb96a72edca" xlink:href="eltx-20260331.xsd#eltx_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_eltx_AccruedInterestPremiumForConvertiblePreferredStock_019df1cd-ea20-7ec2-aaba-cfb96a72edca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cd-ea20-7ec1-9382-c63602d0327f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_019df1cd-ea20-72a5-a682-82b824b844ab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019df1cd-ea20-7ec1-9382-c63602d0327f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-7d54-9808-5cca79c1f605" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019ce305-8981-77d4-a6d2-5c74b28a7819" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-7d54-9808-5cca79c1f605" xlink:to="loc_us-gaap_NumberOfReportableSegments_019ce305-8981-77d4-a6d2-5c74b28a7819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019ce305-8981-7d54-9808-5cca79c1f605" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:to="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019ce305-8981-73a7-8e79-f9f5c61a3d03" xlink:to="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ClinicalTrailMember_019ce305-8981-7e47-b5ec-e8fc4302a771" xlink:href="eltx-20260331.xsd#eltx_ClinicalTrailMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_ClinicalTrailMember_019ce305-8981-7e47-b5ec-e8fc4302a771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember_019ce305-8981-7fb4-97b8-9517d2b4fb0c" xlink:href="eltx-20260331.xsd#eltx_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_EmployeeRelatedReasearchAndDevelopmentMember_019ce305-8981-7fb4-97b8-9517d2b4fb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_TranslationalMedicineAndCMCMember_019ce305-8981-7f53-ba44-0939fee82974" xlink:href="eltx-20260331.xsd#eltx_TranslationalMedicineAndCMCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_TranslationalMedicineAndCMCMember_019ce305-8981-7f53-ba44-0939fee82974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_OtherMember_019ce305-8981-72db-a2ff-90be5a3b2ddb" xlink:href="eltx-20260331.xsd#eltx_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ce305-8981-735a-a438-699e87d25750" xlink:to="loc_eltx_OtherMember_019ce305-8981-72db-a2ff-90be5a3b2ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019ce305-8981-7e39-b68c-ea35d140a49d" xlink:to="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_ReportableSegmentMember_019ce305-8981-7bf8-814d-a9b46cda2ee2" xlink:href="eltx-20260331.xsd#eltx_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019ce305-8981-7f27-9594-7b30f888e281" xlink:to="loc_eltx_ReportableSegmentMember_019ce305-8981-7bf8-814d-a9b46cda2ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019ce305-8981-7090-b5c5-f819aa71b401" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-71b8-9bb3-d0c245b2de8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019ce305-8981-71b8-9bb3-d0c245b2de8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_019ce305-8981-7d6a-9ded-64750e233e49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_019ce305-8981-7d6a-9ded-64750e233e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-8981-7b41-914e-746f349fd538" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019ce305-8981-7b41-914e-746f349fd538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019ce305-8981-76c1-9397-aeed4ca397f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019ce305-8981-76c1-9397-aeed4ca397f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019ce305-8981-7b13-b9ec-831a260d90b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019ce305-8981-7b13-b9ec-831a260d90b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019ce305-8981-7881-b0a1-1e034442bd15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_NetIncomeLoss_019ce305-8981-7881-b0a1-1e034442bd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019ce305-8981-72de-b2e7-3a2054383b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019ce305-8981-7951-b4cd-cd9df4c0eb28" xlink:to="loc_us-gaap_Assets_019ce305-8981-72de-b2e7-3a2054383b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.eltx.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="eltx-20260331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.eltx.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_019d42ac-9fe1-7d43-acab-d9bc83868965" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_019d42ac-9fe1-7d43-acab-d9bc83868965" xlink:to="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d42ae-5545-75cc-9719-a0606af22ff0" xlink:to="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d42ae-5545-755b-b766-f9136f77d01f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d42ae-5545-79b2-841f-ff54e46d75da" xlink:to="loc_us-gaap_CommonStockMember_019d42ae-5545-755b-b766-f9136f77d01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d42ae-5545-77c2-b227-0a65d479ef84" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_eltx_A2026ATMProgramMember_019d9c0e-5a55-7784-8735-fc92cbf4de90" xlink:href="eltx-20260331.xsd#eltx_A2026ATMProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d42ae-5545-738b-a456-39abe9e03270" xlink:to="loc_eltx_A2026ATMProgramMember_019d9c0e-5a55-7784-8735-fc92cbf4de90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d9c11-5b70-75bc-9d25-969968cb2871" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019d9c11-5b70-718d-bfbd-5e57d08a3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019d9c11-5b70-7c81-a3cf-8a969dea47f9" xlink:to="loc_us-gaap_SubsequentEventMember_019d9c11-5b70-718d-bfbd-5e57d08a3b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d42ae-5545-7ce8-95b3-f5a8d81e2c02" xlink:to="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d42ae-5545-74a9-9a6e-801cf5c114af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d42ae-5545-74a9-9a6e-801cf5c114af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d42ae-5545-768b-ab17-6273e2bf4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d42ae-5545-7000-bc6c-bbe476459fc7" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d42ae-5545-768b-ab17-6273e2bf4cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>elicio-q1exhibit311001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit311001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGBWDKE2G02XX^7GGMFL:XAU/3?V=9K/7Y7_M-M-D39,V9"23L3U+!2HQUXH
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M+2= <9!Q@L.^.O!YR:S_ -H.*6]\$65E:127%U_:"2^3"A=M@CD!; [9(&:
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MFO?&+6/'DMM-;:6J^18&9"C3D(L>\*>=N 3D]=P]#0!ZY1110 4444 %%%%
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MK/S7<F]?-*[3*JL0&(]2!^/7O0!V5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!RGBJ\M3J=IH^KZ1)?:+>V\IN)!;-,D+JR;"^ =H.Y
MN>Q /J1Q?@KPC;^&OB=J%]X;EN5\+-8?OS)N,?G%N$0G[^ ,YYQDC/->OT4
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M##UR:Y7POX!_X2N+QS87]G<V-W=78N-,N;BW>/)#2G@D#*G*Y'N#U KZ.HH
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MWNU*/*Z-YAZXZX SW).:]?HH \5TS0[OQ%XM^'TR6T\<&@Z5&;]I8F3RIE4
M1\@?-N7IZ<UAS^%-3TKP/XN\%QV5Q+J%[J\4E@JQDK/"70APV,  (=QSQWKZ
M&HH \G\::O+X<\/:1X,@T;6-2MEM(H+^73[=CF%4"^6KXP"^,$]0N>Y!':>"
M-8DUKP\+@Z)-HUO')Y%M:3IL=8U50"1@8YR![ 5TE% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M61J_B?2M#O+*TU"::.:]D$5N$MI9!(_]T%5(S6O7 _$/_D8_ O\ V&E_] :@
M#O0=R@C.",\C%9>O>(],\,V0O-6FDAMBX3S$@DD 8G !V*<9/%:M<#\9"1\.
M;@@9/VNUP/7]\E '2VGBK1[S55TM+B6&_=#(EO=6TEN[J.I42*N['MFMFO,S
MYWB[XK6<>H1+I<GAE6N([8OOENQ*  ZL !Y8P!QDYX.*Z"/5KW7O%FN:+97S
MV$6D1P*TD4:.\DLJE^=X(V@ < 9))Y&* -?5_$%CHESIUO>><)-0N5M8-D3,
MID;H"W0=#U/:M6O(-2\0:AXCT+PVTZP0ZM9>+4L)V"DQ&6,2#>%SG!R#C/J,
MUK7'BS7/!^M:Q8:[=1:M!%I$FJVDZ0"%_D;:8F XQDC!_G0!Z317%6MSXQ_M
MG2Y$@FGTZY1A?&Y%NJ0,5RKQ;'W%<\%6+''?-9F@WOBW7]*O[^;Q!#;16EU>
MVS1P62;I A948,Q.T@@<8/N3G@ ]'5E894@CID&L_4]<T_2'@BNYF\^X)6"W
MBC:264CKM1020.YQ@=\5@_# 7#?#O19[B\EN&FM4?]X%^7/7D#)^IR:R/#4C
M7WQJ\927G,MC;6EO:*W\$3*7;'U;!_&@#KX/$FGS:E!IS?:(+V<,T<%Q;O&S
M!1DD$C! ]B>HK7JGJ"6D<:ZA<IDV(>=7 Y7Y"&Q^!/%<%<^*M=B^'4/CN*Y5
MEVK=2Z88U\HV[/C:&QO#A2#NSC(/RXZ 'I-%<&FJ>(=8\:ZMH]GJ\-G9I86]
MU;R"S#/'YA;C#'!/ R3QZ =1EP^,O$5[X0\%:G#<6D5SJNHI978:#<&YD!8<
M\#]WG ]>"* /4*0G:I)S@<\#->=MXNU7PY<>,8=5N4U)='M(;RVD\I8B?,#?
M(VWC 91SUP3UK5LYO%T7B33@]O<7&DSQN+YKD6R?9W RK1>6Y8J3D$-N(XYH
M NKXWT9M U+6@;K[%ITTD%P?LS[U:/[WRXR /4@>];UK<)=VD-S%GRYHUD7(
MP<$9%>4Q_P#),/B7_P!A+5:W;[5M2T&+PA>_;-FA3B&UOD\M28V= (WW$9"E
ML!OJ,8H [ZBL;1[JZOM2U6=K@M81S_9[9-J@90 2-D#)^?<O/]T^M;#,%4L>
M@&30 M%</I&I>(_$N@Z7XCTJ]MT6ZN!(]C,B^4+7>01N"E_,V@'.<9R,57N]
M=\3:U!K,_AR*X\ZPO9+6VB"VYAF:(@,)2[!^3G[NW QUH ] I-REBN1N !(S
MR!_D&O/[O4O%NH>-?["M=0MM+\W1%OL-;+,UO*9 I7.[#],9Z8SQT-+X8BU1
M_B#XQCEUF:9K8VB*)(D*?-"6 V@ @ L2 "/<GK0!UMIKUG=:"VLR":SLT1WD
M-Y$8FC5"02RGD#@GZ5%IOB2TU+59=-6WO+>Z2%;A5N(2HDB)P&4\CKV.".XK
MSK6-5U/Q%^SS>:K?7F+MX9_.,4:JL@69D"XQP, =.>.M=)KU_K'AC^P;^359
M)=&:Y2WU$O#&&C5^$?(484,0&]B.E '<TA95*@D L< $]3UK'TNZNK[6M5E^
MT%M/@D6VACVK@R*,R,#C) )VXSU5O;'.^(EOG^*GA>"+5+B""6UNW\I%0JK*
M$&>5.20Q'/3MC)R =-I'B"QUNYU&WL_.WZ?/Y$XEB:/#X!X#8/0CG%:M>3K)
MK-M=?$>_TG4H[)[*Z-SS;B4RLELC;3NX"G&.!GGJ,<]+)KFHW\.@W'VU;"UU
M#3OM#+:H);EYF5"%1"K90!F)./3)% '9,RJ,L0!D#)/<\"EKR*[US5_$7@7P
M1J<U_):W%WKD$%RMNBA9"LS ,00>AC#8Z9['BO2DM-536H9CJ:/IJ6GEO;M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5+&>%K2'1I$U&9'!C(+@Q*QZ9^\1["N;T%--'[-TUPJVOFC1[J-I,+N#'?\
M+GKDD#CZ4 >E1^*_#\EX;--:L3<"'SS'YZY$>,ECSTQS].:LZ5K6F:Y;O<:5
M?V]Y$CF-W@D#!6'8XZ&O.;]M,-Q\+06M-F_*C*XP;8_^S8_''>MKPI/;M\3_
M !W%%+&26LFVJPZ^20QQ]<9H W_&5_?Z3X/U;4M-DACNK.UDN%,T1=3L4MC
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M3^#=%>&1)%^PP#*MD9\M:X;49=$G^.TRZG=6JQ)X>5?WLX0"3SR<9R.<'.*
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M*@T/%')C?&K8Z9&<4^B@!@AB5]XC0-ZA1FD2WACDD=(8U>3[[!0"WU]:DHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M MT4R&:.X@CGB;='(H=&'<$9!JM9ZK8ZA<7EO:7*2RV4ODW"KG,;X!P?P(H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M I7.UBIX(!Z@U9N+B&TMY+B>18XHU+.[= *X*R\>W\GP[T?7)[:V6_U*_6Q
M4-Y,):=HPY&<D +GJ,GTS6E::YK,OC34_#UTME);6MHES]HCC9&97W *1N(!
M!4_44 =)I>J6>LZ;!J.GSB>TG7=%* 0&&<9P<'M5NO(/!VNZWH'@'P3.%L'T
MJ[N(;"2(JYF_>.P$@?(48/\ #M/'?TZ?P_<ZQ<?$[Q7!<7\$EI:+9JL7V<@A
M&21@%._@@L<D@Y]N* .XHK \0:_)INI:-I%HL9O]6G>.)I02D:1H7=R 03@
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M06R3SSVXXJ!?#>H:3XLU/6M&FMFBU5(_M=K<EE"RH-JR(R@]1U7'..HKJJ*
M.$F\!7,&FZ!::?=6Y;3=4_M2XEF4@W$IWE@ ,[03(<=<8 YKN^HY_&BB@#A+
M3P/J.G^'-1\*6M[;_P!A7;2K%(P;S[:&4DO&!]UOO-AB1C/(.*T8/"]S9>-+
M?6+0VRV-OI(TR*V)8,%#A@V<8[ 8_'/:NJHH \^D\":K+X&U[PZUW9B35;N:
MX$X#8C$C[R-N.<=!R,Y]N=B?P_J5QXOT36WEM%CT^VE@DB!8ES)MR0<<8VC
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MGB+[EPW08Z=3ZCK6_;Z-KT^D7T>KZM:W%_<V[6\9@MS'!"",$[=Q+,>I)(Z
M #G.6O@C44TCPG8IJ5KGP_+')O-NW[_8A0#&[Y>"?7F@"S9ZKKTVL)X;N+NQ
M&I6]G]KO+R&!BA#2,L:HA;@X4EB2?0=<BO<>(?$VF)X635;>PBNM0U'[%>1Q
M@LN,.0Z'=\N0@.#G&:M:_P"%-3N/$UMXD\/ZI#8ZDEO]DG2YA,L,\6[< 0""
M""200:76O">H:CI>EF+54;5]/OEOUN9X<QRN RE2@(VKAL  Y&!R3DT 4[KQ
M3K,.H>-K6,V1_L2SANK1GA;YM\<CE7P_/W  1CKWJE_PE/BF&#PA?N^F2P:\
M(H6M_)=3%(\)</OW'(R#E=HXXS_%5[_A"M7>\\374NL6KR:[91VKC[(0(RJ,
MNY?GZ?.>#D].:DE\&ZA)IOA.T&H6H.@212;C W[_ ,N,Q@8W?+D$GOS0!7@\
M4:_93>+]/NHK?4[[1K:*ZM3:P-'YPD1B$*;F.04['D>]);^)[G6_#6L:AHNO
MV5U##8-)'*EOMFMY@&+*\9;C@#&1QSG=5]O"VJIX@\0:M:ZK!!+JD$,46(&)
M@,6=K'YOFSN.1Q1'X,$^M:EJUV;:"YO].:PE%FA59-QR9&SU;H!Z#N>P!FZ%
MJ&M6?@'PI*;NS$%Q;0?:;V8;3;Q&$$##/^\=FPN1Z_=JC=>/-;C^'OB/6(!:
M&]T;49+,-+;NJS(&0!BA8%6Q(.#W'3FM"'P/KEO8>&%CURS:ZT F.(/9L89(
M_+\L;EWYW@<[@1U/ J&Y^'6IW'AWQ+HYUR QZU?&[\QK0YC+%"V0&Y^X .F,
MG.>P!IC7M9TSQS!I6K2V,MC>V,UU']GB96MS$5RI8L=XPW7"\CH*33=9\2ZU
MI6C:]IT=F]G?3JTMDXVM%:L3\XDSRX&"1C')';)N7GAN]OO%VEZW-=6WEV=K
M+;26XB8^8)-NX@[N/NCC!K-\.^#-;\/JFD1^($D\.0R%X(3;_P"DA-V[RC)N
MQMSWQDCCB@""]\6:]?6>HWOAZU,[6=Y);PVAM'87/EOL?,N0%)(;'I@9SGA=
M6\:74&NSZ0;FWT>\>UCETZ/4(28[N1ERRF3< "&PN <YYYZ5-#X-U[2=;U!]
M"\0QVND:C<-<SVTMKYDD,C<N8FS@9//(('H:M:_X2O-=L-2TF>>SGTR\15A%
MS$SR69"!2ZG/S'(W#I@D\G- '62!VC81L%<CY6*Y /T[UYS'XYUI_AEIGB7;
M9"\FO5MYH_);8RFY,/RC=D' SU/->AVT"VMK#;JS,L2*@9SDD 8R3ZUYXWPZ
MUG_A%V\-QZY:1Z=#>BYM&^R$R >?YNV0[\-@DCC&>.>U &G-K'B6\\<:MX>L
M;G3;>*WLXKF&XDMGD9=[,,%=XW'Y>N1CT-5-)\=WNKZ#X45(K>+5]=>6,DJ3
M%$(=WFN!G)^[P,]6&3QSM6OA[4;;QE?Z^;VU?[59QVOD^2R[2A8AL[CU+'C]
M:P+?X;WUEX>T&"UUB%-7T*XEFL[O[.?+=9&)='3=G!#8R#VH IQZK/X9\;>.
MM5U.1+O['I=I*IC3RS(!YFU2,D YXR..^*W[?5_$X\06%N;7[3874;BXF-D\
M(LY N5(W-\Z$\8Z]\U#_ ,(+>:CJ>NW.MZC;30:S8)9SP6UNR;-H;#*Q<XQN
M[@Y]NE6_#N@>)].$,&K^(H;^ULUVVX2V,<DI PIF;<<X'8#DX))H J>"]9\4
M^(HXM1O)=+CL8[FZMYX8H7#OL=E5E)8@<CD'/0G/.!H>,-;U+P^^D7D#6PTR
M6^CMK\R1%FC20[0X(8 #=@'(/7-3^#O#UUX9TB:PN;N&ZW7,MPKQQ&/'F.7(
M()/0GK5[Q#HT/B'P]?Z1<'$=W T6['W21PWU!P?PH YFV\8W</BKQ/I.H3VQ
MBTVU6ZM##;L&D3'S9RQ#%6PN!C)(Z'BJ&J+K3?$#P>LDMFNJMIEYYLGE-Y2,
M?*R0F[+ =,;AGU%;#^ K>6?PW</=R-/I+,T\AZW>[YVW?64*_P"8[U>U#P]=
MWGC72M>CNX$BL()H?(:(EG$FW)W9XQM':@#F)O&FOV_P^\3:BQL'U70KV:U:
M0PL(I@FW#!=V5)#CN1D5T<NN7=[XDBT"QDBMYET];ZXN'CWX#-M557(Y)#$D
M]  ,<Y&1/X"U"?PUXHTAM3MA_;MY)=&46[?N=^T%<;OF^Z.>.M6=6\(:O)K.
MG:_HNK6]GK%O:?8KCS8#)!<Q9S@KN!!!Y'- &/XKEUV32/!K:O;6D6K+XD@4
MK$Y\IL+*%;N0",''.*Z'PYK.K2^*M=T#5Y;6X>Q2">&XMX3$&24-\I4LW(*]
M<\YIFK>$]2U.WT0/JT3W%AJ2:C--) <3.H8;54-\BX; Z]!U.2;FG^'KNS\:
MZKKTEW"\5_!##Y"QD,GE[L'=GG.X]J *_C#Q0/#<^EBXF^Q:?=.Z3Z@T)D2!
M@!L5L?=W$GYCQ\OOD5+GQ)J]E+X5#7&G74>JWSVTTD"$JZ8=D>,ASC*JO!SU
MK?U>QU"ZNK=[66U:U6.6.YL[J,LDX;;CD="-IZ@Y#$5S!^'DUEX?TBTTF^@@
MO-+U%]0A,D),&7+[HPH;(0!R!SGCWH =>>.;K1KWQI]OCAFMM#BMI+81*4:0
MS*2%8DD?>VC( ^E;EM_PD\&N6J71LKK39H&-Q)&AC:"48P%!8[E/(YY&,Y[5
MB-\/Y]0N?$YUC5(KB#7[>&*5(K?88VC4@,IW' !.0"#T&3UK1\/Z+XFLDB36
MM>M[];1"EMY5L8C(<;0\QW'<<'H,#OR<8 .$\-ZUK?AWX;Z;JUM)9'3HM3DA
MFMGB9I)4DNV0L'W *06X&T],YYQ7K]U+)#:32Q1&:1(V98P<%R!D#\:X,?#[
M41\/T\+_ -JVN5N_M/VG[,W_ #W\[&W=Z\9STKN;J&:XTZ:%)?)GDB9!*F?D
M8C&1]#S0!QWA3Q3=>*5!M-7LC+]D?[7:M;%)[*YRH *%LE1\XY[@<UF^#=6\
M0#X6Z7J?VJTGEN9MT]Q<@1BWC:9_-E8EP'(SD ;?QKH;7PI/)XHT_7]2DL_M
MUG;20--:1%&NMP S)D\ 8.%YY/7M6+!\/-6M?"FF:-#KMN6TF_2[LF:T.QU5
MG8+*-_S??ZC&-H[\T 07GBO5[OP]X\MX+Q$GT6W\RVO5MF1G1H#)RK'AN" P
MX(P0*T+/7;[3]-\-Z.)5DN[VQ^T>=%:,_EQ(D8QL#'+$N.<XX/%2#P-?S7'B
MMKS6(I(_$-HL,HCM=IC<1&/(^8_* <@=>F3ZQ7?@?69M.T.XM]=AM]>T93'!
M<I:GR9(BJJT;H6)((4'.>N< <8 *>I>+?%NE^$K^^N;&WBN;34([>*6>!D6[
M@>145PN[*-\W.<CCI6A)J_BF'QO_ ,(\UUI;+>6#7D$_V9Q]F*N%*E=_[S[P
MYROK[&76?"6LZ[X6DTZ^UF![Z>>*:6<6Q$2"-U=41-W RO))).3[ 7YO#U]+
MXWL_$7VNW"06+V9M_*;+;F5BV[/'*CC% &%8^.=07P_)]NC@DU5-;?15DAB;
MRW=6/[S9DG[H)V@\D8R,\2S>(?%-E#XA9[1'MK.P:\LKZXM&B5F4$M$Z;LD\
M<,,<>M,?X=7-QHFJ64VKK%=7&KMK%G=V\)!M9R<C@L=P'3MD$UI#P]XCOM U
M&TUG6[6>\NK22TC:"U,<42N,,Y7=EF/'< 8P ,G(!EV?BCQ%'<^#[F_?3Y++
M7D6-X(865X7,/F!@Y;!R0<C:,9QSUJKHVK:_9KX\U$S+J4MC>R+%;+;D,Q6&
M,J%PWW0/X<$GGG)K8?P=J#6WA*(:A;#^P&1B?(;]_MC,?][Y>#GOS4D'A35K
M"_\ $$VGZU#!%JEP+N(&V+/%-M53D[@&3Y>F 3GKZ@%CPEXA7Q$9KFTUBSU+
M3Q$FTQ1>7+%+EMRR*3D<;<9 []>M)XKUO4M!U'0YHVMO[)NKU+2]+Q$O'OR$
M8-N  W84Y!QD4_2O"YM/%=UXBG%K%=W%JMM)':(520AMQD?/5N@'H!U/:_XF
MT.+Q)X:O](E?8+F(JDF/]6XY1OP8 _A0!S-IXROEUSQ7IEY-:N^EQ+-9>3;L
MIG5@1W8[B)!L(&.?R%NXU_53JAT)946_MK&.XN[B"R>9?,D+!55-W &PDY)S
MD8[U))X%M7U7P_?_ &F3S-+1TF)ZW>2'R_OYJB3ZYINO^%-5G\30^(_#NKQ6
M&H?9Q:W,=Q 98;B,$LN0""&!)Y'TH R9O%GBZ.Q\,"XT^SL;_4KYK*ZAGC8@
M$*Y$BX;A2%!VGGMD=:OC7=<COUT"YN(6U."T^TW5U9V+RH=\CK&%3=QPA)R?
MIZBQJ7A/4[^309FU:*2XTV\^VS22P$^>Y5E*@!@$7#8 YQ@=><GB'PKJESXC
MMO$7A[5HM/U)+?[+.EQ#YL-Q%N+ , 00022"* -/PIJ&KZEH,4^N:?\ 8=0#
M,DL8&%;!X=022 1@X/2L#^VO%&H>(_%6D6=SIEN-+2W>WF>V=R1(C/M9=XYX
M W9XQ]WGCK=+M+BSLECO+PW=TQ+S3%=@9C_=7^%1P /0<DG).)9^&]0L_$?B
M+5EO;9O[72%$B,+?N?+0J"3N^;.<GI0!SEOXU\0RZ#X6\22#3ULM4NK>UGLD
MB<N/-.TR"0MQAN=NWIW-6_&'BW6O#UOK=XK6<2V CDM+4H9GNH\#>[[3F,9)
M4$@ %>^:>O@'4(_!F@>'UU2VW:1=PW(G-NW[WRFW*-N[C/<Y-,U3X?ZK?P>*
M+./6X([+76\UM]J7EC?:J[=^[&SY1QC('3'6@#9DUZZU'Q5_8.FR1VY@LEO+
MJ=X_,(WG"(HR!G@DDYXP.^1R'A77;G0M"U19!'+J-[XKNK,&.)F02%BS,$!R
M0 K$+GT&>]=%)X0U>V\0VGB#3-6M4U'[&MG?I/;,8;A <A@H;*L.W)X_'-'_
M (5O>2Z%J%G-KBI>RZP^L65W!;;3;3EB1D%CN&"1CCJ>M &WX?U/7I]=O['4
MK-WT](UEM+\VY@+$\-&RDGD=01@$5T]<K%I_B>WT6^GU'Q!:'5/(,=M+#:%8
M83_>*$DNQ('\@.N=G07U"30;)]5V_;S$/.*ILRWKM[$]2.QXH X>?Q/XMDLO
M&$]O/I,7]@3R;-UL[>>B1"3;C>-I.?O9/7H*VH/%=QK&KZ3I%AY=M/=Z2NJS
MRR+O\N-BJJJC(R2Q/)Z!>G/$2>#=06R\6VYU"V/_  D#2,&\AOW&^,1_WOFX
M&>W-$7@N]L;K0=4L;Z!=4TRP&G3%XCY5W  , C.5((W \\^M ',^+/%6LS^"
MO%^FR3Q6NJ:--#!/-!&=MQ!,5VLH)^0E6.>3C!QUX]4MDN$ME6YFCEG&=SQQ
ME%/I\N3C\ZY'4O 7]J>'_$5K->JFI:Y(DLURD7RH8]OEJ%SRH" =<G)/&<#K
M+%+N.SC6^GBFNL?O'BC,:$^RDD@?4F@#SN7Q5XLD\/\ BS4H9]*C;0+VXC"F
MV=A/'$BMM^_\I()YR>3VQSIIXEUR#Q!X9-TUBVFZ\KJ+>.)A);$1>8I\PMA\
MXP?E6G)X*U!= \5:8VHVQ.O7$\WF"!OW'FH$(QN^; '!XJQ/X3U":?PK+]OM
M@="Y8>2W[\^68^/F^7@Y[\T 54\6:U&?&RFUANYM$9!:16\3 R!H@_(W$L>>
MV,XXJSH7B!?$6G:C<VFL6>I:?]E&UHH_+EBD(;<LBYR.-N,@=^O6G6_A;5K3
M4/$M];ZK!%/J\L4T3+ W^CM&JJ,_-\X(7D<=Z=;^$I4US4M<)LK>_O;$6C+;
MQD1N<DF5^06;H!Z =3G@ YWPEK\FF^ O!.EVRG[3J%HQ#B$R[$C7+$*,9.64
M#L,D\XP=:#7O%BZ3JOVC3X$FM;J-(+ZY7R(I+=B-TK(S<%!NR,C/&*K_ /"O
M+^'PQX?M++6DMM9T D6=\L&4=2,,KH3T88!Y[5<U3PEKFLZ%''>Z["VK1WD%
MVKK;$6W[IMRQF/=DJ2222<DX[   %.V\?-8MXN;4'6ZM-#@AN89HX3$TRR*Q
M"D'C[RX##@@BJ?B4:S)J?@.YU&YM76;5HW>&*$KY3F)R K;CD8R#GDD \=*T
MI/ %SJ%_XAEU;58I[;7+.*WN(H;;RRCH&"E"6. -V<')R!SC@QGP;XENH/#\
M-]KUA)_8MXD\<JV3;IE1&4;_ -YC)#=OK0!9C\2:T^K^-++-EG1H89;1O);#
M;XVD(<;LGH!P1ZUFV7BWQ(MEX,U:]?3WLM=DAMIK:*%@Z/)$SAPY;'5?N[>
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MOE:6]W1#Y$C&)1CL1(53\>^*;\6)[RV^&FLS65VULZQ .RJ"61F"LN>V0>M
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M6W08C!^I+O\ ]M*Y_P")JWLFJ>$HM-N8;;4'OY1;2RKN57\AP"1WY(_^OTH
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M2)<6K1*J[&="21AA@'@].<UZ/H5O#::!I]O;_:/(BMXTC^T_ZS:% &[WQC-
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MN]*N"SVUJ88C/<C8=RATP"%(W95<\$'I5;XK2)%X-B,CJH_M*SY8X_Y;H?Y
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M$@ DG %>0V.JZ9!\._']Q=6RZE:KK=\9+9)2/,5I5 )*\A>021V!KUT@,""
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M #=\8[FN-LWL(?@7X?F1K='&L0OO! .X79YSZA?TKVZ.TMHA(([>)/-.9-J
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M6Q 'V>+ Z?(.* /%?%6M:;<^%_$Z6T\&GF#74,MB#NFD=;B(//(6R54XR-H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*2;3(U^:VQ<G=).QR06Y;JJ_-CG% 'K%WXP\.6+7:W.M64;695;A?-!,9;.
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M5R?Q'H]M?)93ZA!'.\@A4,V 9#T3=TW?[.<UP4UW81Z_\+O*GME40S@;'4
MVV/U;CZUD:+=>'[[0)O"GBB:_.N07D@ETSS9%:XE\TNCQXZAB0=V<#DGCF@#
MV&\O;73[22ZO;F*WMXQEY9G"*H]R>*R[7QAX=OM3ATVVUJREO9HQ+' LHW,I
M7<,#_=.<=<<T[Q< ?!>N@]/[.N/_ $6U><O;V&L>!?AY:Z0;=]3AN+&:/R,;
MX@J@SLV.0!@[L]3CN10!Z7?>(M'TVX$%[J$$#[E0[VP$9ONAFZ*3VR1FH=0\
M7^'=*FGAO]:LH)8 &E1YAE 3@9';/I7G%O?>'S)XC\+^,+F]AO)M2GD%IND
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M.M+10 Q(HXT")&JJ/X0,"G;5_NC\J6B@!" 1R,T;5QC:/RI:* &/%'( '16
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M*\EH;:XLDL_(#-O4*V[=G&">O'ZT =76=KUWJ%CHES<:79I=WJ >5"[A%))
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MO"9C("#!7DD_>Z<<UK[P'<?\(U8:5874+31:FFIW-Q."/.E$GF-A1G&6..O
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M]VTY\V!"A42LSG@D\@MP?:IO#NA>*+$0P:UXA@OK6T7; 8;8QRR\$ RMN.<
M] .3@DG%;>C:[I^OV\]QITK21P3O;R%HV0B1/O## '@UHT <=:^$+N;7-$U?
M5IK-[_2HW0WEM&5DN]R%,/GH.2<9//3'0VO'FB7&M>'XVLD\R^T^[AU"VCSC
M>\3;MOU(W >Y%=/10!R>JZ3=^(-5T#Q%HNI01?8A*/*NH&D1A( I.T,I5UP1
M^)!QS5;1_">NZ';7<=MK-K*9M5EO]LEL0'23=OC?#=RPP0,#'0]*[14522J@
M;CDX'4TM '/>%_#$7AV759XUAA.HW(N&MK9<0PD*%PH]3C).!DGIQ5.^\+ZE
M!XS?Q)H5_;027<"V]];W43.D@7[CKM((8=/0CTKK:I:KJMKHNES:C>&3[/#C
M>8HVD;DA>%4$GDT <0OPWU#_ (1Q[,ZXD6I0ZK)JEC>0VQ'DR,S$A@6.Y2&(
M(XZ]ZZ*QTSQ"=-NSJVJ6ESJ$T1BC$$#1P1#UV[B68]2<CH ,<D]%U%% '!3>
M!=1F^%T7@W^T+4/&D48N_*;!5'#CY,]?E ZUKOX?U&3QS;>(S<6H6+3VLC;[
M6R=SJY;=]5 QCI7344 >>M\.KV70+NS;5D@O_P"V'UBRO((C^XF9B<%2?F')
M'N#6A=>$-4\1^&=0TOQ5JT,\EW"(D-C 8HX<$,'P22S;E4\X'& !DYZNTO(+
MZ(RVS^9$&*AP#M;'=3W'N.*GH X;_A%?$][J'AZ\U/6M.>71Y7??':/F<,A0
MELOP2#VX!]>@Z3Q+I<VM^&M2TJ"6.%[VW>W\QU+! ZE2<#KUK5HH XX^$]2.
MH>$KHWEK_P 2&)XW7RV_?[HO+)'/R\<]^:O>'_#]YI.NZ]J%Q<P2IJMPDX2-
M"#$50)C)// 'I6CIVO:?JNH:A8V<KO<:>ZI<JT3)L9AD#Y@,\<Y'%:5 '*>*
M?#.HZYK6AW]G>6MN-)N#<*LT3/YC%=N#@C QFKZVGB"6_@EN;ZQ6WA#MY,$+
MJ9'*D+N8L?E&2< =0/2HM5\:Z'HSL+RXF$:3?9WFCMY)(TEQD(64$;CD<>IQ
MUK9L+V'4M/M[ZV+F"XC66/>A4[6&1D'D?C0!R%[X)U"=M*U.VU"V@\16ETT\
M]_Y3%9U88:,KG.P@* ,_*%&/6G77A/7;3Q5=:[X>U>TM#J4<:ZA;W5LTT9=!
MM$B892#CC!X/>NUHH Y6X\+WLGB?P_JJ7\;QZ3#/&XF4F2<RA0S$C@'Y<X Q
MSVK'N? &J7%AK,2ZK;1S7VKIJL7[EF0,I3]VZY^=3L'I]*[#6M>T_P /VT5Q
MJ,KQ1RRK"A6)GR[$!0=H.,D]3BM*@#BD\(:T-:UK4Y-6LWDU6P2UDC6U951U
M#@$?,3M ?.#DD]P*B/@G4O\ A'_"FEK?VF= N89_,,3?O_*1D QGY<ACSS76
MZ=JMKJOVO[*9#]EN'MI?,B9/G7&<9 R.>HX-7: /([F5]7\2Z[?6FM^%PJ7/
MV=[;6;8^9&(@!@X=?DW!F&1WS]-Z?0]=\0)H_BBPO[73/$%M'+;N1$TEM=0%
MSC@D-M;:KKW&?QKJ]2M-'AW:I?V%N[P+N,YM?,=0._ +<51C\;Z!-8"_BN;A
M[,H7%PME.8]HZG=LQCWH T='M+VTLS_:5Z+N\D;?+(B;(P< ;47)PH '<DG)
M[U6M=,OU\4W>J74]O) \"P6T:HP:%0Q9N2<$L2,\#[J^E:Z.LD:NARK $'U!
MIU ')WWA?4'^(5KXHL+VV@5+0VEQ \3$W$>=PR01@@]#@U2L/!FN:+J-_;:3
MKT,&@WUP]R\#VY:>W9SEUB?<  3T)!QZ9Y/6ZKJEIHNF7&HW\C1VMNA>5UC9
M]JCDG"@FIK2ZBOK*"[@):&>-98R1C*L,CCZ&@#!7PW>0>.I=>M;Z%+:YM([:
MXMWA+.?+9BI5MV!G=@Y!Z?E)XUT"Y\4>%;W1+:XBMOM:A'FD0MM&0> ",]/6
MN@HH Y'6?"%UJEEI%S!>Q66OZ25-O>QQED(P Z,N02C#J,\>M.U#P[K4_B33
M?$%E?6$-]#:265RLL#O&\;,K94!@005Z$_C7644 >>R?#W4I/!6O>'CJ]NYU
M6^ENA.UN<Q!Y-Y!PV&/ Z!0,GK6AK/A76Y=?M?$6A:K;6.JK;"TNXIX3);W$
M8)89 ((().#[X^O944 <Z^CZR(K4-?VU_P#)*M_#=1$1W)?;C:!D(%VD 8;@
MG.22:F\)^'8_"VA+IL3AE\Z6;:@PD>]RVQ!V49P/I6FVHVBZFFFFX07KPM.L
M.?F,8(4M],L!5F@#G/%'A^]UV\T6:VN;>%-,ODO2)$+&0JK+MX(P,,>>:O:G
M'KS7=K)I=QIZ6X!%Q%<Q.Q8\8*LK#&.>"*U: <C(Z4 <?JW@A]1\+ZQI\>H"
M+4=4N%NI[H1?(SJ4PNS/W-L:KC)XSG.33K+POJR^,AX@O]2LI1+IPLKBVBM"
MJD!RPVDL<#GG.<^V>-.[\6Z+9:L=*GN91?B/S?(6UE9BF<;AA3E<\9'%7M+U
MC3M;M/M6F7D-U &*%HFSM8=5(['V/- $\%G;6I8V]M#$6ZF- N?RK!\.>'[W
M1M7UR\N;FWE35+H7.R-&4Q$*J[<D\C"]>*Z2LV/7M/E\0RZ$DK_VC%;_ &EX
MS$P CW;00Q&#SQP3T- &6^C:]J4-YIVLZE8S:7<.RD06S),\)/\ JR2Q X^4
MD#)&>AYJOJ.G?V5\0K#Q(!BSGL6TRZ(Z1'>'B<^V=RY[96NNI&4,I5@"",$'
MO0!Q=WX3UZR\4WNK^&M;MK2'4]AO;6[MC,H=5"^8F&&&P!QT/\G>,-';6=%T
M_P )I+)<&YGA>\E<Y801N'=V[ L5"@>K<# ..R    & .@%9UEK6DWVJWNGV
M5Y!->VH5KE(CDINR%W$<9X/'6@"76-/.JZ)?Z<MP]NUU;R0":/[T>Y2-P]QG
M-<A9>"M=AOO"]W/J]ANT.&2W$<-FRJ\;(J?W^&^4<]!Z>N]J_C3P[H-ZEGJ>
MIQV\S%0=R,50MTWL 53/^T16\#D9'2@#@7\!ZE+X0\1Z$VH6F[6;R:Z\X1-B
M(2L&*XSSC'!R.M6Y?">KVOB:'Q#I.H6D-W+:):7\$\+/%,%^ZZX((8?EBNSJ
MM?ZA9Z7927E]<Q6UM$-SRRL%4#ZF@#%\'>';SPW9ZA!=WT-V;J_FO%,<)CV>
M8Q8@Y8Y_3'O2^,?#]WXDTRVL[6Y@M_*NX;EGE0MGRW#!0 1U(ZUMV-[;ZE86
M]]:2"6VN8EEBD (W(PR#@\]#6+9^./#6H:^VAVFK13:DKNA@16)#)G=SC'&#
MWH N:O#KLMO:MI%W96]PD@:=+F%I$D7'*@@@CGG/M5*?PK%J=AJT6KRK/<ZK
M;"UGDA38$C ;:J DD8+LV23DD]L ;;7D"WJ6>_-PR[]B@DJOJ?09&!GJ>E8^
MI^--#T>;9>W3QQK.+:2X$+M%%*0"%=P,*>1UZ9YQ0!SI\%>)KC3=!L+S7=/D
M31;Z&XAF%F^^98U8*'&_&<$#CZY]>Y6QM%F\\6L FSDR",!L]SGK4Z.LB*Z,
M&5AD,#D$4M '-W7A^^G\=V7B%+FW6"VM9+7R"C;F#LK%MV< C:.,5:O;?Q(=
M8,EAJ&G)ISQA3%<6S-)&_.6!5QD'C@XZ5M44 <3XD\*&+P[IC::DD]UH^I)J
M@7C?<L'+3=/XF#N<#O@58\1:!<^(;C2?$7AS5H[/4K-7$,KQ^9%/$^-R.N0<
M< ^H/OTW-3U[3]'N;"WO97CEOYUM[<")F#R'H,@8'0]2.AK15%3.U0N3DX&,
MF@#G96U+1?#=W/?W8U#5YU(C2"/8C2E<)'&A)P,]R3W)('3!NO#DVD?"BV\%
M6;K)J%U;"R!'3+G]](?15#.<_0=2*Z^VUK2;[6+C3;:\@GO[1 TT:'<8@QQR
M>@)QTZU7U_Q1H/A80SZU?PV9N,I&S@DOCDC@$X&?UH OP:?':Z1%IL#O'%%
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MB&>680,(HQ&ZNJ(F[.,KR2<G)]@.THH ;'O\M?,V[\?-MZ9]J=0"",@Y!HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KDOB<+@_#?7C!.(L64OF93=N7:05'(QGUKK:QO%6BS>(O
M#-_H\-TEJ;R(PM*\1DVJ>N!N'/XT <[J.JZQH&C^$S'<VDPO=0M+*8M;$,(I
M .%.[ /R]P>O;%/;5?$^H>,]?T&ROM/M8K.V@F@F:U9V7?OX(WX)^4<Y'3[O
M/%W5_"E_JNF:#:G4[>.32KR"[,GV5B)3$.!C?\H/?DU/:^'+ZT\6ZOKJ:A;M
M_:%O%"(3;-^[\O=M.=_/WCG@4 8^E^+-5UGPAX:U<M:6,5^#]ON"03&0& $2
M'[S,X  YP.QK,N/'6NI\/-8UB VIO=,U1K$M+;,OG()50-M)!1L."<@\CI5[
M3_AYJ6E6'AB*SUV#[3H)G5'ELBT<R2\'*>8"&'8ANYI)_AQ?R^'-=T;^WT,>
MJ:B;_P Q[/+1DR+(0<. 3E!TP,9X] "\OB#5])\;OIFL7%I<6,VF2WZ&" HT
M!C8!ER6.\8;KQR.@I^EZEXFU?3="UVS-F]KJ#I+<V3KM\FV<$AE?J9%&W(Z'
MG %6[KPQ<WOB^TUR>]MVBAL9+*2V^SG]XKD%CNW\?=Z8-9_ASP7K&@+%I?\
MPD9G\/VTF^WMC; 3A0VY8VESRH/MDCC@<4 /LO$.NSZIXTL5CL[FXTCRA8H
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MC>6+S(I8W&&1U!!QQP0>* .1L=8N?#&N?$34+MDN[F*XL(XRJ; [/&J1Y'_
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M 0 <@9?).[@<BMF3PO>O\0H_%(U& (EB;'[+]F.2A??G?O\ O9]L4ND^%)]
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M*** "BBB@!&4,I5@"",$'O45O:6UHK+;6\4*L<D1H%!/X5-10 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR>!)F"M+@R A1_$<D# R<UQFDS:=<?#KX9)+);/MUM$D5F!Q_KLJ?Q*\>XH
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M HHHH **** "BBB@ HHHH **** "BBHKFY@L[:2YN9HX8(UW/)(P55'J2>E
M$M%</:>)GNOBF^GPZJ)-+31GN9(&15\F42H,DD!A\ISSQSFMK1=3LXM">\E\
M0QZI;FXD"WGR $ER!&NSAL$A1CDT ;U%4(-:TRXL[B[COH/L]LQ2>1FVB)@
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M$3QN&W!HC_'Q_#_M=*P_'&LW=GI&C7^CZB$BN-3M(F:((ZS122 '!(/!'<4
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M>H037"()#$K?,4/&\#NON.*6UU[2[ZZ6VMKZ*29T,B*I^^@P"R_WEY'(R.:
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M8#$>F>M6"0 23@"N$USQ8'\6>%;72-81K>\O&CN($52)HQ&Q#*Q&2,@#*G%
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MTC7KA5 %/K&\(7EQJ/@O0[Z[D,MS<:?!++(0 6=HU)/'J36S0 4444 %%%%
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MTZ9! +U>'6]VW_"HX(+8F=]*ULSZK:1@LZ0+>.[!E'3C:V#V!/:O<:0*JYP
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M'U!KHZ0*%&%  ]J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L7Q7=VMGX=N7N]<_L5&PHO5*[D.
M0?E# @DXQC'>MJN'^+\D:?"[6E=E#.D:H">6/F*<#U/% '17OB;1-,O#97NJ
MVT5TL7G-$SC>$R!D@>I(QZYXK/U?QGIMMX'O?$FFW,5W#'!*T#*"5>158A3C
MD<C!SC%8M]>V$OQCT*07-NX&D7&Q]ZD99T*X/J1NQ[9KG8;ZS'PR^)"K<PX?
M4=2$8#CYMX^3'KN[>M '8:%>-'#:Z]<^))Y;.XMDBFM)X1AKDA2&CX# \D;%
M!!SQTK=C\2Z+)875]_:4"6]HQ6Y:5O+,+#LX;!4^Q%<+J-\MM=?#S76F5]#M
M4>*[F5LI!)) J1NY[ '<"3TW>]1:PL4^N>-M<LYXCI,GA[[++,KCRY[G#X /
M1BJ[5X_O 4 =C_PGWA,+(3KUD/+2.1LR8.'^Y@=R?0<U./&7APW-U;_VQ:^=
M:IYDJ[N0N=N1_>Y('&>3CK7G_B*6P_X9ZL?+:WR]E81_+C)97B++]1\Q([<U
MN:E=:>WQA\-LL]L<:9<A2&4X)*;0/J-V/QH ZNW\3:+=:*=8AU*!]/#;3/NP
M V=NT@\[LX&.N2*C?Q5HZ:?J-[]J8IIPS=1^4XEBXR 8R PR.G'->8Q:W86&
MA^*9GBM;J(^+MWF2 O';*S1XN&"G)52">HR>,U=TZZBN?%'CZ""[GOI;S2;=
MH)#%@S@12@E=J@%<D $<'(Y- '4_\)3IVM^&-&U ZVVC->RV[J!C<[MM;R0&
M'S [@"170ZAK>G:6^R[N-LFPR%$1I&"#JY"@D+_M'BO++W5M/N/A#X,$=U&3
M!=:9')GC:T93>.?[N#GT[UT>GZE%HGQ0\2MK5S%;V^I6]K+IUS,X6.2.-"'0
M,>,AB6QGOF@#JY_$VAVMO97$VK6:PWS*MJ_F@B8GIM]1[]*=I/B'2-=:Y72[
M^&Z:V8+,J'E">1D'L>QZ&O)&M%TSPMX?CO"D5I<>,A=6<$WR[+0R/M.T]%Q\
MWT8>M=GI-U;-\9M>2.>(L^EVPPK#YF5GR/<@$?G0!TVI^)M$T:X6WU'5+:VG
M:-I!'(_S;5&2<>E1R>*]#CT^&_.H(]M-#]H1XU9_W7]\A02J^YP*YOQ7<6:_
M%3P.L\L(9!?9#L/E+1J%^F2"!ZFLK4]3TKP[\0M9@\3375CI^HV]O_9]Q')(
MD+*B%7B.SC()) /]X^HR ;_B36+E-<\'2Z9J9-AJ-[Y<B1;&CG0Q,X.[&>PZ
M'%;MWXGT:QN7@N;^.-XY$BD8@E(G;&U7<#:I.1@$CJ/6N#U2/2=';X>VEC&U
MC8Q:F[PPW$C;TB*288[SN )8<'IN XZ5A>--8M+SPYXZLHR+"X@O@7L(8LR7
M&UH_](D)!.T@<$;0,#))- 'ITGC#3X_&:^&B7^T?9O/=RC;02ZJJ@XP<Y;)Z
M#%16&OZ-96>L:E/XGBN[**\8/+*Z!+4[5_<J0.<=>YYK%.IVD?QDM+IY2L-]
MH BM7*-^^?[03A>.>"#].>E<Q<7MFW@;XI*MQ"3)J-R4 <?/NCC QZY(('N*
M /4+/Q1H>H:J=,M-3MYKT1^9Y*MR5'7'8X[@=.]%WXHT2P>1;O4885BD$4LK
MY$4;D9"M)]U6P1P2#R/6N+O+RP'C'X;&&XMP@M[I1L<8 ,"A1QTR1@>XKFKO
M4=!_L_Q+X/O?$-C96]UK,DK2W9=+B(>:KN I7:?F4[6W#@@XXP0#V8ZC9_V:
M=16X26S\OS1+%^\#+URNW.?PK'\/^,M,UWPV-<\T6UJ<LQFRNU=Q"Y)XR0!P
M,\G%;J2QW-HLL$BRQ2)NC=&W!@1P0>X->*:9>./A5X-F@$DL&AZG!)J\2(Q:
M%%=P=PQ_ 2&(ZC@T >PV&M:=J<\\%K<AKB#'FP.C1R(#T)1@& /8XP:SO$'B
MVP\/:CI5C<[S-J$QC7:C$(H4DL2![8QUY]C6)B'6?BKI6K:-<17%K;:9-'>W
M$#AT8,RF*,L."<[FQV SW%+X_N(K#7O!M_=.(K2'5&$LS?=3="X7)[9/% $=
MMXL32O''BB/6M9(TNW@LY+99E \O>)"P4*H)Z9YR<#GI78/K.G)I]O??:T>V
MN0# \>7\[(R-@7)8D<X / KB-*OM.;XG^,II)X%!T^S&9"%( 63>.>F,KD=N
M,UQ^B:G#I/A?P!J^HR7(T2"UN;.[GMG<?9969=C/LY ^4K[9]Z /:=,U:PUF
MT-UIUU'<0AS&Q3JK#JK \@CT/-9M]XT\-:;<3V]WK5G%-;NB3(9,E&<D*#CH
M>#].]5O!L6@M%J%_X?CF:UO9_-DNI))&%S)CEEWG..@R."<^E8^D2V,WQC\3
MQL]N\K6%HBJ2"25+E@/I\N1]* .JO/$NCZ?="WN[^.)S(L19@=BNW1&?&U6.
M1@$@\BI;_7--TR1H[NY".L1F=55G*1C@NP4':ON<#@UY587?AU[75O"/B]=0
M;5#?SM]A$LX%\KS-)&T84X.<CTQC)Q6CK.MZ=X5\?ZJ9]0M+9K_2K>.2/47D
M559=X4HX5MXQG<#CG')R< '7:EX@T74+73I+3Q5;VZ2W\4<<EI-')]H?(_<]
M_O;AG'(R*T[[Q!I>G2R1W5T$,04RD(S+'G[NY@"%SVR1FO-=4.CZ;\._!%G8
M:S;W]K;:S8J+I9!A]DF7;KP!SQV'6I_%=R^G:SKVJ:!K$#W2^4NHZ#> ,E^/
M*3:8L?,&*$*,9R1B@#L_^$STS_A+;G0&<I);6ZS2RNI"@DD 9QC@ DGI^M2V
MOC;PS>S10VVMV4CRQR2IB3@I&2';/3 P>?8GI7/0ZA!8?&&^:^;[,UYHUOY*
MO_$5DDW 'I\N>?0<]*Q?"MY86_P5U:Y&GPZF86OFEM%ZR!I7X;'(!7!SZ"@#
MT2S\2:1?SM!!>IYJP?:-LBM&3%_ST&X#*?[0R/>JB^.?"[M;!-<LV^U2>5"5
M?(9MQ7&>@R00">#CBN&TK6;"7XD>';U=56[@FT:>-)8H=D"MNC.Q,#HH!SDD
MKCDBL22YL1\"=65)H!*VKLP 8;B?MH8''7[HS]!Z4 >I_P#"7Z>?&;>&AO\
MM$=N)G<HV-S-A5!QSWR>G;UQT-<"+^VM_C2SR2@)?:%"EJP!83,)W)"D=< @
MGT'/2NIT'Q'I/B>SEN](NQ<PQ3- [;&4JZ]1A@#W'YT 5H]1L%\4:AGQ"K&W
MM%,^GETV6X#']X3C()SCD]J2#QOX9N9K**'6K21[UMMOM;B1LD  ],D@XSU[
M9K MKZSB^-&L%[F% NBPJQ9P,%9'+ ^X!!/M7%6=S91?!#PP/.@21-7@=AN
M92+HDDCV7GZ4 >P:EXATK2&<7UXL1C02285F\I.FY\ [%X/+8'!K!UG5+R+X
M@>$8+34'.FZA'=M+"@4I)LB#(P(&3][/7'2L&V\0Z5H?BWQ7I7BDA(]6F2>T
M>2)I$O(&B5/+7 .[&"-O?=Q5K5IK.V\>_#R%8X[%(X;M5MF(4PJ85"*1VZ8
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M2[J\BM8;H-+,6$7R,%EV_>V,1A@,<D$U<O+VVT^W,]W,L40(7+=R3@ #N2>
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M[MSLB\LDM"78\/R#R><#KQ0!T'PXU>ZUK0]1N;J_:_":I<PPW#!1NB5L)]T
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M;3Q-;7K*X<'!98]OT)P<#KP:Y:\>6XT3QB^F_P"E);>*8[ZXMX#N:6W7RBY
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M-@\EDCN(Q"S!U+*"XSC[I(Z>U=/_ ,)5HO\ 9E[J/VW_ $2QE:&ZD\I_W+J
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M= (284%TQ)8=1P0?H1777=[;W/Q=T&:-\(VDW"@LI7!9T*@@]"0"0#S7?44
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MY!P[.%.47.W QC!R><#UNB@#RVWOK2Y\6_#F4,-L>F7"DR(5V,T<07.1QG#
M>O;-;)FB7XWH-Z@#P^8O;?YX;;]<<XZXKN:9*KO"ZQOY;E2%?&=I[''>@#SE
M-*O;#QO>>&(82="U:9=7+CI"%8>=%]'D\KCIAVK>^)EEJ&H_#G6K72XWDNWA
M&(T^\ZA@74>N5##'?-7_  ]HE]IHDN=7U9M5U*5%C:Y,"PJ$4DA51>!RQ)/?
M\ !N4 >7:GXHTC7O$G@2\TUWECCNY?-1('+09@9=C #Y3D@8_'I65?7\%AX9
M^)FB3B4:E<7EW<Q6XB8L\3Q)M<<8V\'G_P"M7LU% 'F<%U:S?$'P7(2!MT:9
M/WB%2CL(PH((R"0&QGK6B;BWB^-DCM*B(OAX1EB<*&$Y;;GIG;SCTYKNZ* /
M#Q+ /@1Y(*BX_M7?Y8'S_P#']OSCK]SGZ5OZYK^F^'/B#JMRU_%"-2TR .;J
M*4Q$@N$:-D5@P SE3C.1@]<>HUR\OA[7;?7+Z_TGQ!#%#?.KRV][8^?L(4+\
MC!T(&!T.1G)[F@"3P%'I5OX*TRTT;4EU&SMHO)%RI^\P^]D?P\GIVXKAENH[
M?P?\3-,F$B7CWFHRK&T;#<LB 1D'&#NSP.IKU#3-.&G0R@RF:>>0RSS%0ID?
M &<#@#"J /0#J>:NT >7S7%L-3^%[))&%B20.5(P@-MLY]/FXY[\5E:5/H9T
M^^\'^*[+4Y]8%Y,19>9<^7?!IFD1TVG8 2023C!&37LM% '&_%,8^%>OC'2T
M]<]Q6;J<=GXA\1>"GT5XI9=.F:>:2''^CP>404;'W2S;5"GG@\<&NH\8:#-X
MG\+7VBPW:6GVM/+:9XC)M7.3@;ASQZUK6D<L-I%'.Z/*JA69%*@D=P"3C\Z
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MI7CIC!Y!!!&/:KM06=I#8VD=M;J5C3.,G)))R23W))))[DU/0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=WX@U&Z\2:]I-E+#9'2K&*YC>:/?Y[N'.3R/W:[0#CG)ZC% '845@>"]6O\
M7O"6GZOJ*0QS7D0F$<,;($4C@?,Q)^O&01Q6_0 45S!UJ]U?Q9JN@Z;<1V@T
MN"%YYWB\QFDE#%5 R!M"KD]SN &,<\S+X_UR7P]:W$$%C'J4&OKHM_$Z,49]
MX4M&<_*""#R&QGVY /3:*S]'BU:&S=-9NK6YN?-8K);0F)=F?E!4D\_C5'7]
M;FL-2T;2+3RUO-5G>-))!N6-$0N[8R,G   ]3GM@@&]17)W%WXMT[2]9,D>G
M3/!*GV&ZD<1JT1QO>49 !0;CU&[':L^Q\5:C/JGB338[J*X6PL8[RTNWMBF[
M<'R",@,N4X9<<'O0!WE%< /&&K-X;\$:K_HH?6KJVM[N/RC@"1&8E/FXQM[Y
MZU(/&%Q/XLNM$:_M]/U"&]C2&QNX=OVJVRNYXW)&YB-Y&.F,8[T =W2,P1"S
M= ,G S7"7_B?7;]-9D\/0%Y=.N7MH8#:F1;AX\;PS[AMR20,=,9).<"_;>(-
M1US7Y-'M0NG2VEC#<WID02/'+*"5B SC@*23SG@#'6@#=T;6]/U^R:\TV8S0
M+*\)8QLGSJ<,,, >#6A7#?"D3#PO?"X*&<:O>^88P0I;S3G /09KH/%>K7.A
M^&KO4;2W>XEAV$JD9<JA<!WVCEMJDMCOB@#9HKSV^\8W:^!];\1:+K.GZG;V
MD*RVTHAYR,[TE4,"&Z'^'@CCUU[S7]0MO&'AC3E,!M-6@N'F!C.]6CC5AM;/
M0ENX[4 =76;I^O:=JFI:AI]I,SW.GLBW*&-EV%@2O4#.0,\5SFGZWXC\0:)9
M^(-$%F]O/=86RE7&ZV$A0L9,\/@;NF!TP>IQE;64\<?$*71[JTMI84LY2]Q"
M9=Q6W)"@!AC/<Y./3T /3J*R?"^KOK_A72M7DC6.2\M8YG1>BLR@D#VS6M0
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M-&T<!22X,8_=^9EB!C@G'WB!TY!;'X/U!!XK_P")E;'^W\D?Z,W[C,8C_O\
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M^)]0&H6Q_MN.-%0V[?N=D90'._YN#GMS6YK>MV7A[2)]4U%Y$M(%W2-'$TA
M^B@_GTJ[%(LT*2I]UU##/H: ,KPKHTOA[PQI^CS7"7+6<*PB5(RFX 8!QD\_
MC6Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX#NKCX;P^#SK$02)(HA="S.2L;!A\OF=?E'.?PK3/AR\/C6+Q(=1@W)IYL3
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M&"<=3[FH8_!UY&_BEO[5A)U[K_HA_<?N_+X_>?-\H]N?RH KCQ9>7TG@NWC
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M0T2S%]:W;P9$\+*3AE! #@@C(X/7%:S>!Y4M?#<MMJ:1ZMH,0@@NOLY*31;
MC(\>[." .C<'D4^^\%/J&G^(!-?QC4=;@%M/<K;G9%$%*A43=G^)CDMR3Z8
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MGZFEJMI=N]H)8KI%^Z2FX889.#GVH WO"]WK-[X=M)O$%@MCJA!$\*,&7()
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MPBJSD>8(T5=P*CG<22#T [USMUK6IZCX:\=:'?716^T2&0&ZAC4?:(7A9TW
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MFRZ/H=EIDEPMQ]DA2!)!'L+*JA1D9//%9VF>&[K3?$NM:S_:,4K:KY6^(VQ
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M<>?F/./3I3?#GA+5-%:"&_\ $]UJEA:#%I;R0(A7 PN]QS)@=,X&>>PQUE%
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ML/A\^EWL\5CX@OX=!GF::32 B%,L<LJR$;E0GJHQU/-:^E^')--\2:SK(O\
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MU15MC [1$!A+O._YCN^[C (QZG"\/R7$$-NGA[QRFI72(B_86TB/?)C'RRL
MKJ/5F.1U.376R^!)X?$%[J.C^([_ $JWU&3S;ZSA1'61\8+(6!,;'N1S0!4:
M_P#$M]X^&AG4QIT,NAI>ND4$<C0RF38P5F!!QCJ<CKQT(HZ3XSU>?PWH=O<.
MT^J7VIW&GO<PI&K,L)D)=58A Q" <\<DX/2NIC\+&W\6#7;>\"%-/&G1VQAR
MBQAMP.=V2<_I^=9!^&MO)X:_LB35;A98;YM0M+V% DMO,S%B1S@C+'CT/XT
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M6S#;W5I]FC5,O 7#A@-P;*\\XYX JWX2@OW\4>-C_;-V[17RQIYRQLO,*$'
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MR-PUP+5464$F4]$X[\C\Q4[^)-'CU".Q?4(EN)9##&#D*\@ZH&^Z6_V<Y]J
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MFU)H[73KW2EAL9WPD2R)(6>//0,<[O?'M7)ZY;_9/AG\0+H.$T[4-3:6P4G
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MN70KALDD;6[ 8&>KO#VLS>*(9-;;7+K3C9:A,TD9C(MVM8W*[&W +D@9+9W
MD]N!/X)U"S/BGQLWVJ':VHK(K%P R"% 6![@%2,^U<O8F>\^#^IKIB/=7%OJ
M\EW):PL1)+$MWYA QSRHR,=>U 'J=CXATO4;Z:QM[DB[A02O!-$\3[#P'"N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/"SQ0RKJ3-#+/]G$HMY=B/NVX=MN$RW W8S70WEY;Z?9RW=U*(H(EW.YYQ^
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M3^9/)/N>M34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[6X\Z*,EHI!RH(4 #CKC/)YI_P!H\0ZIXZ\1Z)#KS6=K;6MO- T5K&SQE]_
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M&_<"H[X]O7;N-9\2Z_#K<OA\W45Q8WTEI:HHMS S1$!A+O._YCGIC (QSDD
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M/(Y'2@#T-'21=R,K+R,J<BG5Y#I^HZYH_P )O"5[I^KR>==W-G"XN(D<;9'
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MYAJLPAMYH0&CR5+ DYZ8!/&:VJ .2UCP+%J":7/8ZK>:?JNF%S!J"[9';?\
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MYZ9/ J[JFGW5[)9S6E^UI+;2F3_5ATD!4J589&1SG@@Y YJZ\R(VPL#(5+A
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M$>WYQM/RG(/'TP?>NNK+\1Z(GB/0;O2);F6WANXS'*\0!;:>H&00/RH Y?\
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M\.JZ3=Z;=;C!=P/!+M."592IQZ'!KE[7X?BWN-"N)?$&ISS:,KQV[-Y8!C9
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M$C6.WBS)&8U8HQ*]/FX(YZYSQC<L?!R00Z9;7NIW-_::5(LEG%,J@AE!"%V
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M9)BPVA>  "><-P36-=7-]KFK_#&^EU&YMY+^WEFE6#:$$AM"Q8*5(S\Q'.<
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M2@".VU+4_$>O:QI'VUM-DTRTMMPM2K$SS(7+98'*K@ #OSG/&,G5+36#XR\
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M&RWGC^9UR!G!3YAD]B!70>&DO/[$AGOY9GN+DM.4F(S"KG*Q_P# 5(4^I!-
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M6L7FR0PE2^.3T) ['J>U7*\TT*TD77OB&[WUW+Y4P4+))D-FV!YX[9XQ@ 4
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M.-HX&!DG(/&,JZG\7VTG@O3]3UL07]W<S6U\UFJ,D@6-V5QE.'P!_LYYP>E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=)&,X/<54LO UG9V-MIC7UY<:1:3+-;V,Q0HA5MR*6V[F56P0">PSD"NIHH
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M29_-L@TR#REP1LX09&&QD_,.Q%;-IX8BL_$]_KR:C>-<7L:12Q-Y?EA4SM
M3(QD]^];M% '.:=X-LK%-:BENKJ]M]8E>6[AN=FUF=0K8VJ"!@ =>U5_#O@6
M#P])$!K.K7UK; BTM;R</';C&.  "< D#).!TKJZ* .0T?X>V.B79^R:GJ8T
MM9C/%I33#[/&^=W QNV@\A<XSZU:E\)007^N:C:ZCJ=N^J1_O8K>10%D$>P2
M)\N0^.F3C/..!CI:* ,KPU97NF^'[2TU"ZGNKB(,#+<.'D*[B5#L.&8*5!/<
M@FJ)\'6RZMK%_!J-_ =54"XAC9/+#A-F\ J3G;V)([XSC'1T4 <G_P (%9C1
MM#TL:IJ(@T6>.XM3F+<60$+N.SD $^E,N?A]:2>(+K5K+5]6TW[:0U[;6<X2
M.X8#&XC!*DCJ5(/T/-=?10!$(%CM1!!^Y14V)L ^0 8& >.*PM(\&Z=I7A6;
MPV\MQ?:;*)%9+HJ3B0EF&55>[$^HKHJ* .3T/P:GAE!(FJZOJL=I&WV*TNYU
M98N" %X&3C*@L> >U<3HJ2FQ2.Q\2>+K'5FW2-I;V!D6*5B6*;I(L%=Q/S,^
M#UR*]BHH YZ'PQO\0Q^(;N^N/[0;3Q8RQ1[/)VYW' V[OO9.<TEEX2AM[G2I
MKK4+N_;259;,W 3<NY=A+%5!8[>/QR<GFNBHH XR7X;Z?+X?U'0_[4U1-.OI
MVF,2O'^ZW/YC*F4Z%N><GT/7.GK/A6/69-*N7U.^MK_3)&>"\@,8?YEVL&!4
MJ01_LUT%% '%S_#739]+UK3FU351;:O<"XN%\Y&(?Y<X+*>I1<YSTXQS6O-X
M8CG\2:?KDNHWC75C"\*)^[".KXW;ALSD[1T(Z5NT4 8GA_PS;^'#=I:7EW);
MW$\DZP3.I2$NVY@N #@D_P 1..W?-K4]*;4)K2>*_N;.:U<NC0[2'R,%6# Y
M7\N0.:T:* ,W1=$MM$AN5@9WDN[E[JXE? ,DK8R<  #@ 8 [>O-53X9B/BR3
MQ$M_>+=O9_8O+'E^6L>XL, IG.XYSFMRB@#CA\.[$>$4\-#5-2^PI<?: V8O
M,W>9YN,^7C&_GI6G_P (M;CQ.VO+>WBSRVZ6]Q"K*([@(25+#;G(W'H0#W&*
MWJ* ..T;X=V.AW8^R:KJO]EI+YT6E/.#;QOG<,#&[ /(7.,]<UJZ-X9CT2ZU
M6X@U"\E?4YS<2B7RR$D( RN$'8#@Y'%;E% ''?\ "N['_A$?^$:_M34OL/VC
M[1NS%YF[S/-QGR\8W\]/TJ2]\ 6=[>:Q.VJ:G''K$ AOH(I$5)2$V!_NY!QV
M! /<$<5UM% '+CP3;!O#[_VIJ)?0P?LY+1G>2NP[\IS\O'&*VM8TBRU[1[K2
MM1A\VTN4*2)G''J#V(."#ZBKU% '-Z%X/BT>/9=:MJ6KJL1AB74)%<11G@@
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MN9][ '9@ MSTKL** .4U7P-!J.LP:S;ZOJ>G:FD(MYKFS=%-Q&#G#J5*D^A
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MH&V[MF[G;GVS@XK1B\-0P^+IO$8OKLW$ULMJT!V>5Y:DL!C;NR"2<Y[UMT4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M25+,%(3.,\XXYZ<UTU>4V.IC1!XZT368[A+^\N[J[M&\AW%U#)& FP@'.T*
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M*U102RQN)23$'[D+CCJ1S56VFA&N_$R1B D\<7E,1Q+BV"';_>^;Y>.YQWH
M[BX\1:7;K9$W)E-]&9;9+>-I6E0 $LJH"<8(YZ<CUKEO'>OBZ^&S:[X?U69$
M,\ CFMSL+ SI&RG(W#JP(X((K"T;51:6/@:RN+>6UC_L?RVU"*T,LZRA4!ME
M.TE"<9/&3M &.M96YE^!U]IYM[M+J/52/)DA?>?]-#\9'S849.,XH ]OJG?Z
MK9Z:8EN)&\R8D111QM)(^!DX502<#J<<5:CD26-9(V#HPRK*<@BN"\4:B_AC
MXBZ7X@OX)WT633Y;&2>*)I!;2&17#,%!(#!0,@=J .HM_%&BW6D#58;Y6M#)
MY.[:V_S,[?+V8W;\\;<9]J(/$^D7 O<71C>Q4-<Q31/')$I&02C -@]CC!KB
M_$3;X_#_ (BTS2I8M'L]8-U<QQVQ1Y(W0J;DQX#<%B>1G'-6;E8M2\?S^(K&
M97TVVT*2VGNDY25V?<J ]&( ).,XR!U- &_:>//#5]<:?#;ZEO.H<6S^3($D
M;&0N\KM#8&=I(/M4-EXXL;K7M;T^2*Y@BTK8KS26T@!)4LQ)VX QMQG&[MG(
MK@X&6/X9_#N%E99;;5K-YH]IW1!&;>6'50,\D^OO71:==1Z?X[\<QW231B[6
MWFA<Q-L=!;A2V[&,;ACKUXH Z'3_ !WX:U-V6TU2-@MH;UG9'1!"#@L68 #&
M1D9R,U<M/$FEWNHII\<\D=W)&98HKB"2$RH.K)O4;L=\9Q7G$.FW^H_L[VEC
MID#O?001-):!2KN8Y0[QD=<D \=_QK=U6:#QAX@\'W6C.SM97;7=S(%(-O%Y
M9#1O_=9B57:>>#Q@4 7_  /=WMQJ?BR"[O9[I;75VBA,S9V)Y:':,8 &2>@K
ML20 23@#J37#^ I%.N>,>2/,U=I8\C&]/+1=R^HR",BNA\4V-WJ?A+6+"P?;
M=W-G+%"<X^=D('/;GO0 R'Q9HL]U:P)=L#>,5M9'A=8IR.R2$!6/<8//;-3V
M/B'3-1U*^T^UGD>[L,?:8C!(ICSRO50#D#(QU%>>7KCQ1\//#VAV44D6MP3V
M:R6[(5DLFA9?,=AU50%;![Y&,YK8\46.IZ9XVL=5T:)S_;,#:5=L@_U3 %HI
MR.^T;\^V!0!U(\1Z8]C!=I+*\=PS+"JV\ADD(Z[4V[B!CKC%4V\<>&TTN+4G
MU-$M9+C[*&9'#++G!1E(RI!(SN Q7,^+Q%X9\2^']2N+:^/AZWLI=/D>R:4&
MT),91F$9#%2$Q^'TK,\2QZ.?!HN-'TZXBMKW6[6Y+2K*9+K$B&24H_S8P.IZ
MXST() /2='UW3M?MIKC39S-'#,T$A,;(0ZXR,, >XYK1I$=9$5T8,K#(8'((
M]:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBN?\;:[)X<\'ZIJ<".UQ#;R&$K$SA7VDJ6P#A0>
MYP* .@HKSA$TR.?0=3N_$7B2T-Y-;PK:L\XCN;G((W!U.%;)! (4CZ5TMYXX
MT*ROKZQ>:YDO+%5>>"&TED<!LX("KR."21P.,GF@#HJ*QO\ A*M':QTV[ANC
M/'J?_'DL*,SS_*6.% SP 2<XQWQ5:7QQX?@T%]:EO'2RCF-O(Q@?='*&VE&7
M&5.[CG'44 =%16+IWBK2=4UB;2K::7[9'%YX26!XQ)'G&]"P =<\9&13/^$P
MT47=I ;EPMY.;:VG,+B&:49^19,;2>#CG!QQF@#=HKF=/UC18M3\2W:ZM=M]
MD,;7T=TSB*TPG\ 8# *C<<9SUJ[8>)M,U2__ +.ADGCNGMA=1QS0/&7A)QO7
M<.1DCW&1D4 ;-%<;\.KFZN-/UQ;J[N+IH-;NX(WGD+L$1@%&3V K0U;QQH.B
M7\]A>W,RW4-O]I>*.VD<^7G&1A3NYSTSC!SC% '145A:AXPT;3(9)[B:;[/#
MM\^:.WD=(-P!&\@?+P02#T!!. :BO_'/A_3KZ2RFNY'ND@%P(8;>21G0G *;
M5.[//3/ )[4 =%16):>+M#O]!AUJUOUEL9G$4;*C%FD)P$"8W;L\;<9IUOXH
MTJ=KZ/S98I[%!)<V\L#K*B'HVW&6!]1D4 ;-%<1??%+0(M$NM0L#=7WE637D
M:QVL@5U!Q]\K@8)&>>/TJU>:YIE[#X<DO;[4K&>YNXS!'%%+")Y=I_=OE>4.
M2<' ..O% '6T5S=WX[T"SNM1M7GN9+G3PIN88;25W0,"<X"Y*X&2PX&1SR*O
MMXCTH:?87R70EAU J+/RU+-.6&X!5'/0$GT .<8H U:*R-*\2Z7K5W<VEE-*
MUS:L5N(G@=#$P(R"2 ,\COR#D<5K,0JDG. ,\#- "T5ROA[QO9ZU;ZQ=3136
M5MI]S+$TES"T:JD8 8LQ&T'.X[<Y QD5I6OB?3+K4H=.WSP75Q&9;>.Y@>+S
ME'4IN SC/(ZCTH V**Y_QGXF7PGX<FU,VTL[AECC5(RP#,P4%L=!DCZ]!R:Y
M_6==^Q_$7P].;R_CL+FQNV>T*2#>R; N(<;BW)P,$^E 'H%%8MAXJT?4=&?5
M8+EA;1RF"021,LB2AMOEE"-V_) VXR21CK4NF^(M.U6_NK"!Y8[VU"M-;SQ-
M&ZJW1L,!E3ZC- &K16'K'B[1M"OX;&_N)4N9HWDBC2"1RX49.W:#D].!SR.*
M:_C#2%T^.]1KF:)K9;LB&UD=HXFR0SJ!E>AX/)P<#@T ;U%9)\2:4;;3YX;H
M7 U$9LU@!=IP%W$J!V ZDX [UEW?BWP]J?A[5W_M*\M[:VCDBNYX8)8Y;8X(
M;!VY#K[=.M '545C0ZU86ECIL,<MU=-/:B6$"-I9GB 7+M@9_B7)/4GUK+U#
MQY9VNH^';>WM[N>'6"[K*EK(<1K&S< #);(7C&0,DXXH ZF>(S0O&)7BW#&^
M,@,/IFDMK:&SM8K:WC$<,*!(T'15 P!7/R>/?#T6I2Z>;J<W44\=O)&MK*2C
MR?=S\O Y'S=.1S4\?C+1);FWB6YD*7-RUI!<>2_DR3+D%%?&"<JP]"00": -
MZBN:N_'OA^SN-1MWN+EY].V_:HHK.5VC!!.[ 7.T 9+=!D<\BH=5\<V5C>>'
M8K6*>[@UEBT<\,#R+Y7EL^1M&2QP. .!DG% '5T5SYT_4SXVBU*'4;S^S6M"
MDUI)CR0V?E*C[P?J2?08[U9B\2Z;/=V]O&T[?:)G@AE$#^5(Z!BP#XQQL;GH
M<<9H UZ*I:IJMEH]H+J^F\N-I%B3"EF=V.%55')))Q@5GCQ?H_V34[AY9XQI
M?_']&]N_F0#;NR5 SC;SD9&* -VBLAO$VE+/I,)N'W:LNZR/DOME^7?UQ@';
MS@XK"\=>)+:W\*>(8[2[O$NK.UD#7%G&Y$$NS**SJ, Y*Y] 1G - ':45QMC
MJ-@[^"X;W5+^/4I[3S((49_+NCY&7\TXPV!R,G.?K5O0_&5OK.KZW:&WN+>+
M39_*\R:!T4@(&9F8C"]> 2#@9[T =/16);^+=(N+NSMQ-+&;X$V<DT#QI<8&
M?D8@ G'('<<C(JJOCWP])J1T^.ZF>Y6[6S=5M9?DE89 8[?E!SU/'OP: .EK
M!.@7L_B1M0O=:FN-.1UEMM-\A%2*0+C<7'S/U) /0X/85/:>)=.OKBUA@:=A
M=AC;2F!Q',%&25?&,8Y'J.1D59U/5[+1X8I;R4IYTJP0HJEFDD;HJ@<D\'\B
M>@H O45@-XST./2=0U*6YEB@TZ0Q78>!]\+@ X9<9Z$'/3GK2V/C'1=0U>'3
M(+B7[3/$9H"]NZ),HQNV.0%?&1G!- &]17G_ ,2/$\$/@C7O[/O;Z*YM5,?V
MJS1PL<W'R&0# /.#SP>"0:[6&?RM)CGD$C[80[!%+LWR]@.2: +=%>5>(/&4
MOB#X3RZ_8RWVFRI=1X*AXOW9NA& 6Z-\G7:2 37>:;XITG5=7GTNVFE%Y#$)
MMDL#Q[X\XWH6 #KGC(R* -FBL(>+]&^VV=LT\B"]D,5K.\+B&=_[JR$;23@X
MYY[9K2U/5+/1M/DOK^<0VT> S$$\D@  #DDD@ #DDT 6Z*Q(O%>ER#407N(Y
M=-19+J%[=Q)&C D-MQE@0#R,]#2_\)9HWV?2+C[2_D:NR)92>0^V5G&5&<?*
M2 3\V* -JBN7\5^(;.VT?6;:*YNUN;:U9I9;.-V-L2I*EF4':>A]0.3@<UDZ
M+JEG+X;\!_VKJVHQZA<PP20B-WQ=R&'E96P0PY)P2.10!WU%<UI/BZ+5?%NL
M:(MI=1_V>8D\Q[=P&9E9B2<848VXSC/.,\5LZAJEKIBP_:';?._EPQ1H7>1L
M$X51R> 2?0#)H N45BVWBS1;K3+K4$O-L-I,;>X61&5XY00/+*$;MV2  !SD
M8SFGVWB;3+F]N++?-%>6\7GO;30.DACZ;U4C+#/'&>>.M &O17*1_$?PQ+:V
M5VM]+]CO)/*CNC;2"%7W%0'<KA"2.C$<8/0U?L?%VD:CJ-U802W"W5O#]H:.
M6UDC+Q9QO0,HWKGC*YH W**Y1/B/X8DM+2\6]E^QW4IA2Y-K*(D?>4 =]N$R
M1QNQQ@]#6AI_BS2-2U6?3+>687<4/G[);:2/S(LXWH64;USQD9H VZ*X&X\8
MZ9X?\%:MK>FW&I:JB7TL8-PLC>7,S@;.0"L:L0,?@,FM.^\;V]KXDT?25LK\
M_;TEE:1K*4%50= NW=G)&>, ?44 =716'J?B[1](\UKR>58()%BGN%@=HH&.
M,!W PO49],C.*EU/Q)IVE"4SM/)Y,0FF^SP/-Y49S\S;0<#@^YP?2@#7HJ"S
MO+;4+*"\LYDFMIT$D4B'(92,@BLFZ\8:+9[WGN9%MHY_L\EWY+F!),[=K28V
MCG@G. >"0: -VBN(\6^(OL_BSP_H9^W+:WC3O=&VAFW.J19559!D_,P)VG(P
M,\$UJ23+X'\'7=W<7.I:I#9)).#-F6;9RP4MC. .-S= .30!T=%>:ZSXEEG?
MP-J_VN[LX;J["W<.V2)),P,Y&T@%QG&.H/;-=AIGBO1]5MK^>&X>)=/8K=K=
M0O \/&[+*X! QSF@#:HK'M/$^F7FKC2@\\-Z\7GQ17-N\1EC'!9=P&<=QU'I
M3]:\2:5X>-K_ &G<F#[5,(83Y;,&<] 2 0.AZ^AH U:*PK;Q=I5Y8PW-L;J4
MS&01P"UD$Q\LX<^65W  X&2 .0.I%.A\6Z)<:+%JT5Z&M99A;IA&WF4MM\O9
MC=OSQMQF@#;HK#M_%FD75[=V"RW"WEHN;B!K:0/&,9&?EQR.1@G/;-5/#^LZ
M/;>%-+FL]1OM1MKEFCM)KC?+<7#9<GJ 3@*W4# 6@#IZ*Y+7/'EGIEA8W-O;
M7<YNM2CL,&UD'EL9 K[AC.0-V!C).,9%3ZAX^\/Z7<R6UW<7*7,=L+IH?L<I
M?RR<9V[<GOGTP<XQ0!TU%<]=>-M"L_/:6YD\FWDCBN)U@<QP.^-JNP& ?F7/
MID9Q4E_XPT;3M7?29YYSJ"P?:/L\5M)([ID#Y0JG<<GH,]#Z&@#=HKCM5^(6
MFVWAS3M8TY)[R&_O([6,I _R$R!&WC&01S\O4D8 J]J-IJ.H:[H>HZ=J%];V
MT98W-LR;(I(R/XU8!MW0 =NO&.0#HZ*R)_$NFV]R\+-.VRX2U>2.!W1)7*A4
M+ 8!^9?89Y(JIX]DG@\!:[<6MS/;3P6,LT<L#[&5E0D<CW% '145Q_AWQQHE
MU_9.CO?2_P!HSVJ&-IH9%2=@@+;)&&UR.^":U+[Q=H^G?:6N)Y?)M9!'<W$<
M#O% QQP[@$#&1GTSSB@#<HK)OO$FFV%Q';-))/</ ;E8K:)I6\H$ OA0>,D
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M ZYKTFB@#RZ6XNK;4_B9=6ND-J#RI;M;V\UNS1W06 (P (PX!SD#KT[TFDW
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MRRX&#@X)S@XQ7(6UK<7>H?$>TMK34W.IZ;%]DDNH9 9C]G=<[F P2Q "\'T
M X]9HH \DAU-;_\ X5P;>QU)EL)!'=DV4H\EQ;%"""N3@]2,@=S4,5W/I7@O
MQMX9U.SO?[6D-_+"R6LDBW:2ABKJR@CO@Y/&*]AHH \Q+NVK?#)S;7:"V@E%
MQOMG7R2;;8-^1\N6XYJ"XTW4+Y/B1H-O;W4=]J,IEMG,++'(A@0#]YC;R05Q
MG//L<>JT4 >9ZB[>+_#OA;3[.VN(-1MK^TGN8Y(61K+RO]86R..A4?WLC'%:
M?@ML>*/&C-#*HGU!98F>)E$J")5RI(P1D$<5W-% 'EOA2&YTS7-%BT"ZNY]"
MNP[W&DW\1+Z4=A(*NP!4;CLVGKDXSU'2^.]0FT^'1W6S:2W;4$$]W':_:)+-
M=K?O$7!PV?EW8.-QXYKK:* /&)TE70_B9:)8ZH6O,/;>?;REI@T"J,$C)).>
M.H[@8KHKR3S/%GP[F2*8QP0W F<0MB+= %4.<?+EACG'->BT4 >)?:;FR^$6
MO^$+^QO_ .W8!<KM6UD<7(>5G$JL 00=W7/4?2O8M+D$VE6D@21,PK\LL91A
MQT*D @_6K=% 'B8%P/@1_8C6%^-0MKI$D@-I)G(O-YV\?-A1G(R,5U>KI)??
M%"$VWFJDWAZXMEN1&VQ9'=2H+8P#@$XKT&B@#RCPE-IUYIVCZ!JGAO4SKVF-
M"CPW"2F")XL#SU<G8!@$C'/.!UKL/'UY<6/A9YK?3Q>XN(1(#;^?Y*>8,RB/
M!W%/O#W /:NGHH \NTR.2X\:^)UMX-4ECU'1H5M[F[@D42L!("26 "\D #"^
MPQ65!?F?PC\/;*/3]3:?2]2M$O5^PRYA9(G5@1MR?7Y<X'7&1GV:B@#RNQOI
M="3QQHFJVE[]KOKNZO+.1+:21+F*2,!0&4$97 !!QC\#4,)E'A[X7QM:7B26
M<T/VE7MI 80L#(2V1P-Q R>*]:HH XC06DLOBAXMBGM;I1?&TEMY?(8QNJP[
M6._&T888QG.:C\;7%UHGBSPYXD-G<W6EVBW%M>"WC,CP>:%VR;1R1E<''0?6
MN[HH \V\5&?6-"L=;T32+@6UEK5MJ,L0MC'->QIG>XC(#$\@C(R=G3IF_<"/
M7?B%H6NZ>S_8=,LKDW5R8V56\P*$CY')&&8CM@9P2*[JB@#Q:.*9?@3IMB;2
MZ%XE^C-;_9W\Q0+S>25QG&WG/I77W$ZCXPV=YME^RC0I8VG$3; QE1PI;&,[
M03BNZHH \6$4W_"A$L/LEU]M^W[OL_V9_,Q]N\S.W&<;.<^E=A>3*WQ>TFZ5
M)3;C2)XVF$3; S.C*I;& 2 3BNYHH \9GM+NZ^%'C.""RNGG?6YKE(?(8.\1
MN4<,JD9(*@GCTKI];O?,\=>#M;CL[][$P7L6];20L&<1[ RXRN[:<;@/?%=_
M10!Y)926>G7VM^'/$NA:K>37.H3SVODQRR0WL4KEU'!V C.#NP!CDU--)#X:
M\9:M#K^E:BVFZG';M9RV"S2QJ5B6-H2(^>J\9'(->JT4 9NA6D-GH-K;6U@-
M.A5#Y=J.L2DD@'WYY'.#GK7FFG17$'PCU/P5?6=PVO1QW%HD/E,?M#.[&.56
MQ@K\P);/&#G%>NT4 >=:A#)IWC+X?V\QFF_L^UN8KJX6)F128$52S8P-Q!ZU
MU7C&VFO?!&OVMM$TL\VG7$<<:#)9C&P  ]2:VZ* /+)[P7EI\.7CM;T+:7,?
MG^9:R+Y86W*$L".!N.,GBJ^LZ=J&JZE\2;?38)C<7,5B]KN1D6X,2Y=5;@'I
MMX/>O6Z* .#\,ZAHGB+5;&]M-!U./4+17\V74(Y5-GN7#(&?@L3@87MDG&!4
MOQ&)+^%ML,LOE:];3R>7$S[(U#9<X!P!D<UV]% 'G7B^=M%\=6&N7UE?W.AS
MZ>;.26R$C-;2"3>&94.=K X^H%4_$,&F6WA/3]2T_2KW3HUUV*^MBML\CL^,
M-++%]_##>,?>/RGC/'J-8GB#P_+K,MC<VFJ7&G7MC(TD,L2JZDLNTAD88;@G
MT(R<&@#FO">LZ#=^)]9U,:C(^J7L,9>![*:W"11# VB09<Y8DD>HX'?G]!TZ
MTN/A9X6T_5?[3TVZAGD,=Y CQRV,P,A#-QPI!QSQ\P]<UZ3IND74%PEUJ>IR
M:C=(I6-C"L21@XSA5[G Y)/MC)SKT >27[:]-X0T^XU:-[TZ=XFMY#>6]J0U
MS:QN/WYC49[D<#D#(R.:WX)Q/\9$O!;W*P2: (5DDMW4!S/NV$D8#;><'FN\
MHH \8\:3W>J:#XVT]M,OX;R.Y!@M+2S=8YXP8\7#NJXD9@#P3P% QD9KJH[I
M9_B_!?B&Y2U;P^T?FR6[H YG#A22.&VC.#S[5WM% 'BZPW \ NXLKL_9?%8O
M9(Q;OO$'VG=O"XR1M.>!7L=O.MS;QSHLBJXW*)$*-CMD'D?0\U+10!Y9J\-S
M9:[>ZIX8N;N'47U!%N]$N(B\%]\RKYJ9'RG;ABZ\#;SC%=KXVM9[[P+K]I:Q
M/-<3:?/''&@RSL4(  ]2:WJ* /-IXE\3Z?X*LM/BE,^G7EM=W4CPLGV98D.Y
M6W 88G"[>IY/056T=I=(\)^*/#.K6MP^HO/>&!1"S?;DFW%60@8;);!_NXYQ
M7J5% 'EU@EYH5]H7A_4K6Z58="CB^V65LSR7$P.#!YR@E$7&>J^N0.N+I7FI
MX$^'=M+8WJ2V.L1M<(]I(#&J^:"Q&/N@LO/3\C7M=% ' :U=3:!\5;/6[V"X
M?1KK2C8K<0PM(()O-W_,%!(## SCJ/:IOAW(S7OBTM:W4*SZW+<1&>W>,.C)
M& 06 [J>.H[UW-% '!Q22^'?BCK=YJ:R#3M7M+;[+=!"R1O"&5HB0/E)W%AG
MK]:YS4M'O++X2>,5^RW&_6-0N;JRM%A8R"-Y%VC8!D$A2V,<9YQ7K]% %>QG
MCN;*&6(DHR#&00>G<'D58HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJ6I6FDV3WE[+Y<*D+G
M!8LQ.%50.222  .235NN+^)%KJ#:?HVI6%I->+I6JP7MQ:P#=))$NX':O\1&
MX''M0!3M-7DG^,;PYU*&%=!>:2TGW[0WG( ZID@DCCY?0CKFKNG>*_#>C>$F
MU9+[4)=,:\D3S[E)9'$AD((.1E5W' W8%4+741J/Q7MM6M['4O[/;0G@^T26
M,L:A_.#;3N4$< ]N>U<S+;7A^#VH6(TO4C=OK+2K;_89=[)]K$F[;MSC9SF@
M#TJV\7:;=Q2-$EYY@N3;)"]JZ22N%W?(K 97;SNZ8ZXI;7QAHUUIUW>?:'B6
MSG^SW,4L;++'+D (4QDDDC&,YSQFN>\>+<0ZIX<\0II=UJ>F6GGQWEO;QL95
M254VR!."=I3D=<&LO6[)KO0(]=\,^&IX?LNJ6VH/;O 8KB^6+=N^0\\!AMSR
M=IP.F0#J[OQSIUK;:N3;WAO=+M_M,UD8L2F,@D,.Q7@\YX[XJ32_%EO<>&=+
MU.]CEAGODB5(1"VZ65D#8C7J1U.>F 23@$UG76IGQ;X:UQM-T:]A,VF30+)>
M6Q@DED*$+&H;D@9.3TR1C/..=C%^MC\/M>CT[4#:Z+&;6_MVM765-\"QF01D
M;F",#D@="2,CF@#N4\7Z2;;4Y9'GADTL;KVW>!S+",9#%5!)4CD$9'7GBJMG
MX^T._B$L!NS&T4,D3M:NJS>:0J*A(PS;C@@'@Y]#CG=4L9=0U_Q-XBM;>Y^Q
MOX?.G1@6[[KF8EVRJ8W$ %5SCN?0U8CM+2[^$N@Z=JVG:D8Q;VL$Z0PR)<6T
MB*O[P*!N!1@#D#IGJ* .ST[58=2:Y1(IX9;:01RQS1[2K%0W'8C!'()%9&H:
MJ][XRM?#-O(T:K:-?WKH<-Y>[8D8(Z;FR2>N%QWJIX%768'U:SU"]FU&P@EC
M%AJ%S#Y<TRE<L&X&[:<#=WY].*]O;R6?QKO)90?*U#14,+'H6BDPZCW =3^-
M &_?^);#3YKJ'9<W#V<8DNA;0F3R%(R"V.^!G:,G'.*KWGC?0;*/2Y6NWECU
M3_CS>"!Y%EX)P"!C/'W>I/&*PM$DG\+^+/%,.JVUV]OJ-T+ZSN8K=Y5E4H%,
M?R@X9=H 4]1TKG;#0[[P_IO@"SN;*[9[;4IKJX2&W>5;9)!(5#%00,%U!]\]
MJ /4=,U>WU;1XM3MX[A()%9@DL#)(,$@@H1G.0>,<US9^*7A9;:&Z-Q=_8Y9
MC"UT;.410L&*XD8KA"2.AYQ@D &NSKQK1V75?@[JN@6]I//?W=S>00Q^0VUF
M:=\/NQM"J>2<\;?6@#T_4_$-GIC2JT=S<R0Q">9+6(R&.,YPQQZX.!U.#@'%
M9]QX^\/0#32+F:<:G$TUF8+:1Q,JKN(7"\MVV]<D<5R$L'_"*>+[Q=:T74-4
MTV_M;9;>[L[=Y]DD48C9'5>1NQN'U^N+MQ:"T\6> _LNASV5G:_;6>&"U9DM
M5DCP@<H"JDD\C/!SVYH Z8>--+:P:\CBO9(H[9;J<+;-N@C8$@NIYS\IX )X
MSTP:OWNNVEG=+:*D]S=F+S_L]O'O<1YQN/8#/ R<G!QG!KB/&5@TFLZCJ6CS
M:IIGB"WMU$3PV[RV^I*%RL3KM*L<DKZC(/TL:>VHZ%\0+S5-9M)A:ZQIUJ/-
M@B:5+>>($-$=H) .XD$\'US0!OS>._#T&C6>K->LUE=SK;QR+"Y"R%MNU^/D
M(/7=CH:EL/%^DW]W?VH>XMIK&(3S+=V[P'RCG$@# 97@\^U>>7NB7UEX<FF^
MPWI_M'Q:FJ1V\=L[O%!YJG<RJ"5X7=@],XZ\5O:D6;XE:K>-I=Y=V3>&3 0+
M:0),XD=S$&VXR5(X]Z .NL-?MM0O(K9(+J)YH#<Q&:$JLD8*C(/_  ->#@\\
MBFZYXFTKPXUH-3FDA^URB&%A"[*6()P2!@< \'DXXKD?"%E>Z1XEM[/2KS4+
MSPT]H[&'48&633W!7;&KN Q!Y&PYQM^F;7Q*G6VD\(3.KLB>(8"1&A=L>7+T
M Y/X4 ;6C^-=%UJ74(8IIK:?3UWW,-[ UN\:8R'*N =N._YT^+Q=I;ZG;V$@
MNK>>ZB::T\ZW91<JHRVSC)('.TX;':N.\2>'+SQ;KGB#4-*C>..3P\VF1RR(
M8Q<3-(7P,XRH  +=/FQV-7/#>H:=K-S8R2>#[ZSU2R!>XDN[1E6U;;AO+<_>
M)/ "\D')Z4 ;6G_$#1-5EB2P74+CS3*%9+*7:&C)#*3CAN,X//3U&>;\+ZE!
MK6@6WBW5]0U2QGM;F>:617=8)(_-=%AVG*L,!1@#=N'J3G6^&ADLO"%PEW:W
M=M)'?74C)-:R(Q5I692 5R<@CI7)V6E:O=?!BQMK73[Q=1TW4?MKV,T#Q/,J
MW3R;0& R2I!'T ZT >E6_B:PFU,Z;*MS;7WDFX2"XA*M+&.K)C.['<#D=Q69
M;?$;P_>$&W:_DC)F#2I83%4,6=P;"\' )P>>G'(S1OE'B;QEX7U:QANDMM*6
MYN+F66W>(J'C"B/# $L3R0,X"\]1FOX*$MMX"UJ*>RO89?M=[((I+217=7=B
MA52N6R".E &O'\1?#SIILQENDM=1P+>Z>U<0EB"0A?&-Q /'MCK5[3O%NF:I
M<7]M$M[%<V*+)-!/:21R;&SM94(W,#@]!GVK@!!=I\.?A]:G3M0^T66I6+W,
M0LY2\*QD[RPVY 'K71P.\?Q;U.]:UO!:'1HHA/\ 99-C.LCL5#;<$X(X% $V
ME>*_#>B^#]'NH]0OY=-O)OL]K<W2R2.[-(1\[D?*,Y^]C@>U;.E>*M,U>_O;
M&'[3!<V:K)+%=V[P-Y;9PX#@94X//YUYG96M[%\*O!MF^F:B+JUUJ"6>#[%+
MOC1+AG9B-N0-I!S74M%]H^*>JRRV5XUC-H*6YE^SNJ.PD=F0.0!G:P[T ;#^
M.]$BCLII&NQ;7[%;*=+621;@CL@0%NF2,@9 R,BM;6M431=%O-3D@FG2UB:4
MQPKEF &>/\:\ET'5=+_LCPO:ZW)JUM9:/*ES;B;2)D"D*1'YDPRI50_W@ #@
M'@5ZMXCMY;SPQJUM A>::RFCC0=68H0!^9H X/7/$<U_X?\  NNM+=V)N=4L
MQ=(K/''(KQ,[#;_&N0,'GI79Z9XLTK5&U)$>:VDTW#74=Y"T#1H06#D,!\I
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M'>F7-Q97LPU._=XX[:$R-&DTK%'8=DVX)/;- 'HU%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5._TV&_,#N6CGMW\R"9/O1MC!Q[$$@@\$&KE% !1110 UPY
MC81L%?'READ _3C-8OA7P[_PB^D'3EO&NH_.DF5GC"L"[%V'!P>2<5N44 %%
M%% !1110 4444 %87B+PX^OW&E2_;3;C3;Q+V-1%NWR*" &Y^[ACP.?>MVB@
M '3GK1110 4444 %%%% !1110 54U33H-7TJ[TZY,@@NH6AD,;;6VL,'!['F
MK=% ',V?A:^CA%IJ'B6_U"P"[/L\L,*>8G3:[J@9ACKC&>^>:Z:BB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7 7P=-X:76K@VLEW]I#O$I9/WOFA1T_BZDYS[5VZ!Q&HD96?'S%1@$^PR<4
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MD@L^,#C ]>E>[O/%=SXHT+1Y=6&FRWVDS27:V\4<@BG38"R%@<\L>#D8]^:
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M&.]MX P HP% &=V>U9ESJ'C**Y\%Z?J&HQ65_J$EQ;WXMXXY%8I&[*ZDCAL
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDU.YT_4HM>O;/6[*(P#48$0--&>2LB$;6&>>@&>U=%IU_)?-=B2QN;3[/<-
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M>7.E+*D1,42!PX52&PO/ Y/4^U:MQX9L+GQ;9^(W#?;;6V>W7!X8,<@GW&7
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M-T9PH]/Q.3574?A_;W=Y8:A::SJFGZI:VPM6O;:1 ]Q&.<2 KM8YR>@Y/TP
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MH K27FI:3\0+;P^-0N9M/U6QEEA>3:\MK-&1DAB#E2".&S@^W%<MIVM^(O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>elicio-q1exhibit311002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit311002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#:.",@<X-4M+OH[CQQX-OXS?W$3V%Q"S_8GCBB<B/$:*% 55P1GG&.6.*
M.X\)^+(/%=M=3PVUS"L5S+$HE@=,JC;<DD8W9!^7.1WK8U*X@M=,N9[JX:W@
M2-B\R]4&.HZ\BN0^&DI@T_5=-FAGBNH-4NWD62%E #2DKAB,'(.1C/%=3KKK
M'X?U%G.%^S2#ZY4@"@#'LO%'A_2-!T03:W+/#>QHMI=7>YI+CY<AF.T8) SD
MXJS;>,]"NK'4;R*[E\K33B\5K659(1C.2A7=C'.<8QGTKSZ%U7P?\,(G5A):
MWMNUPI4YA"Q.K%Q_" Q R?6NFT+RI?BCXR5U#17%O9(I9?EEVI(' /0XW 'T
MS0!TR^(=,?3++44FD>TOB@MW6"0F3?\ =XVY /J1BHK_ ,5Z-IK7 NKIU2V8
M+<2I!(\<!." [JI5>""<D8!!. :Y?P/I>H65_/H-Y#)_9_AZXD%C,_(F249B
MP>Y1&=3_ +P]*H:+<#1]%\6^']<CD^WRW=W+#&4+&^CFR5,?]\G.T@9(QS0!
MN^(KZZB\>>"UM=0F%G>2W*RPQN/+E @9E)QUYYZXZ5O:=XCTO5I+Z.RFEDDL
M'\NY0V\BF-L9VX91DX[#->?P:?<Z'=?"^PU!B;BQ29;EOO"+-N5 8] ,G:#W
MQ6IKNEZA8^/=VFPR&S\36PM+UTX\B2/GS<]B8BZCW5: .K_X233#8VMW')/*
MEW&98$BMI&DD08RPC"[L<CG&.1ZBFP>*=&N].M;^UO/M$%TYC@$,;N[L,[EV
M ;@1M.01QCFN/\5SQ>'/'ECJFI6]^- FTW[%Y]BTH%M*LA8;A$<[6! [\@5%
M>Z7X?FTK3_L?]H>'5FO)KNPU)2ZLDI4 O().BOEAA\9 '0M0!Z%IVI6NJV@N
MK-W:+>\?SQLC!E8JP*L 0001R.U0ZUKNF>'K(7FJW0MX"X0,5+98G & #W(K
M*\"W>JW?A]SK A:XCNI8DN88_+6[0-Q,%[;N3Z'J.#6?\5_G\!7$*JTDCW-M
MMC12S-MG1C@#G@ G\* -0>.?#IO;BS^W.+F",2^4;:7=(A. T8V_O1G^YNJ>
M#Q=H5SHBZQ%? V;3>0"8W#^;NV^7L(W;]W&W&:Y^]G@?XP:/<*ZM"-(G0RCE
M S.A4;NF2 2!7+V^IG3M&UN460FCD\8/(9WMC+]EA9@1<JF.<$?*W(R<\XP0
M#TA?%NB&SU&Z>\,4>FG%XLL+H\/&X;D(W8(Y!Q@BH[+QKX?U'4;.PM;\O/>1
M>;;9AD5)0%W$*Y7:6 ZKG([BO/EF5+GXF*%U"1;W38FMY;F!P9_]&=>,J!DL
M0 N![#%79)8Q;?"_'6W9/.PI_<C[,4.[^[\W'..: .WE\7Z'#=?9WO&'^E"R
M,HA<Q"<_\LS)MVAL\=>O'6K-_P"(--TV>2"XF<S10_:)(X87E:./IN8(#@<'
MKUP<=#7DVO:BVH:'?A[*[M+FUU^.233[:R=8XT%PI,SL%_>,X^;.3G/ XS6W
MK6NV7A_Q_J5X;B:U_M'2X!+]IL9Y$W9<(R[%)&!G<K8R3U&#0!W5OXHT:[TV
M/4+:]$]M+)Y<311LQD;&<(H&6..> > 3V-5)/'/AR'2;G4IM1\JWM9O(N!)"
MZR12?W60KN!Y';O7 S'3M(\/>#-0T>>]U;P[H[36U[+9F1)D+J!YA5<,,-G(
M[!J?XK71KWX<^)+[0=/NR-1:V'VB99C+>NLBYPLGSD*O?'//]V@#O#XX\/"_
MFL3?L+F*/S0AMY 95SC,7R_O>>/DW5:L/%&C:EH\NJVUX#9PNT4K.C(T;@X*
M,K ,&R0,8R<CUKF]5G@E^*_AB>-U>);&Z4RJ,JI?9L!;H"<''K7)S17DNC>*
MI["VN+EK;Q4NI&V@++)<6Z^5DQD8)^Z2".Z\4 >EIXNT1VOD>[>"2QC$UQ%<
M021.D9Z/M902ON :ALO'/AS4+NPMK;4"[Z@F^U8P2*DOR[MH<KMW8YVYS[5S
M5O>^&]9L]4UG2+._DF72Y;>6^O!.&0'D0#S?O$G)PN0#]163O1/!?PQCP1):
MWUHUPNTYA"PNKEQ_" Q )/K0!W.B>+K?6O$6KZ5%;74?]GR+%ODMI%#-MW$D
MD84<C&<$]1D$5TE<-X7E-I\0_&%I-#.LEU=03PL86V-'Y"C=NQMQD$=>M=;J
MUO/=Z-?6UK)Y5Q-;R1Q29QM8J0#^!H H#Q=HGGP1F\(6XF\B&=H7$,DF2-JR
MXV$Y! YY((%5]0\>>&M,O;JSN]2"7%J8Q-&L,CE-YPOW5/&1U[<9QD5P4JMK
M7P9M?"$=O)#XAB2WLC9LA$D,D<BYE/HF%+;^F.^3BNFT5T'Q=\1$Y.^PM8TD
M*\.R;]X!Z$C(R!_2@#NJR=0\2Z5I<DZ7,\A:V027'DV\DHA4\@N44[>!GGMS
MTK6KSW0+Q/#GB/Q=8Z_NC^VWS7UI*Z$K<PLBKL3^\R[=NWKSP* -O5O&MCIN
MJZ!9Q1S72:LSLD]O \J>6L;/E2@.XDA>!G@DG K"L_%46B>-O&*:QJ=W)96P
MLW@B,;RF)6C9G*HBDA1QDXXXR:P=+TN]\+:=\-6U2"Y5+.XN_/"1-(8/.CD\
MM"%!.?F"_45N:?<0KXS^(,TGR1S6UJ(V=<!]L+!@I[D$@$#/)Q0!VKZ]IJ65
MI=K<&:*\4/;>1&TK3*1NRJJ"2,<]..]9[>.?#::7'J3ZFB6LEQ]E#-&X99<X
M*,I&5()&=P&*\TTVX?1-'\#ZQJ-OJ+Z3#I4FGWC6AE62SD)1@SJA#8.S!_#V
MK3\2QZ0?!HN-'TZXBMKW6[6Y+2I*9+K$B&24H_SXP.I'.,]",@'I&CZ[IVOV
MTUQIL[2QPS-!(6C9"'7&1A@#W'/2M&D1UD171@RL,A@<@CUI: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***KWM];:=;&XNI-D>X*,*6+,3@* .223@ <T 6**Y__A--$6#4Y)IY
MH&TQ0]Y%+;R"2)2,ABN,E2!G(R*A7Q_X=-S:0-=31_;(O-MI'MI%CFPNXJC[
M<,V/X02<\=>* .FHKG8/&^A3:=J5Z9YX8],.+Q)[65)(>-P+1E=V".<XZ5'9
M^/\ PY?ZM::;#>N+B\3=;-) Z1S<9*JY&UB.X!Z\=: .FHKBO#-[-%XQ\;Q7
ME_,]I9SV[1FXE)6%3 ';&>%&236U;^+-)N;VTM1+-$]ZI:T:>!XUN !D[&8
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M!-NXG=QTZUR]IXECT3QYXQ&HWFH3VD,5E+#;K').8@4D9RJ*"57IDX '&>U
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M:R-*(P2-S)C*\@@9ZX.,T ;U%8T?BG1I].T^^MKP7$.HMMLQ"I9IC@D@+UX
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M8RK*SN"J#(^; !8XZ' ZUW%% '%?"A)(?A[8V\\,T$\4MQOBFC9&7=/(PX8
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MD55)"YVJ H "C<V![G)- %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN\O/A7I#WC,S)YD4;-U,:NP7\@,?04 :M_\ $7PSID-U/>7ES%;VEPUM-/\
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M/(X]Z\B\(ZHG@SXUW.FMK$6I6'B&-7-U'*K@W)R<G!P#OWKCT=:U?CR66_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8-IXFSI 9_+!L@+F)6))59-^WJ3R4/6NYHH KPVJ6=A%:602&.&,10@J65%
MP!C(R !ZUR/@?X?-X*U'5KJ/5?M:ZG()9D>WV%6!8_*0QP/G/4&NVHH XCQ)
M\/I/$7C+2?$;:L+>72V4P0BVW*V&W?,=W/X8JSXH\!6GB+4]/UJ&\ET[7;#'
MD7T" Y']UD/#+R>,]SS7744 8EMI>LR30MJNM1S1PL'$5E:FW$A'3>2[DC/.
M 0#WR.*J6/AW5])>_P#L&NH8;RZFN?*N[3S1 TCEB(]KJ0.>ASSD\9Q7344
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\B@#'_X33PK_ -#-HW_@?%_\51_PFGA7_H9M&_\  ^+_ .*K8^SP_P#/&/\
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MX'Q?_%4?\)IX5_Z&;1O_  /B_P#BJV/L\/\ SQC_ .^11]GA_P">,?\ WR*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'4=-N!<6<V?+E4$!L$@]0#U!K$76]0UC7M7TW1Y+2%-*"1RRW$32>9,Z[MH
M9<*!C)Y))[8YH?"+/_"K=#R,'9)D#_KJ] '4ZAJ^GZ4(OMMU'"TIVQ(3EY#Z
M*HY8_057C\2Z-*TB#485EBB::2)R5D1%(!9D.& ^8=1WKC_ \S:Q\1?&NIWG
MSW%E<IIUL&_Y8PJ"2%]-Q^8^M=M=Z;:R7JZF8Q]KAMY(%D'4H^TE3[94&@"3
M2]3L]9TV#4=/G$]I.NZ*4 @,,XS@\]J;'JUC+K$^DI.#?01+-)%M/RHQ(4YQ
MCJ#WKRWP=KNMZ#X!\$SA;!]*NYX;"2(JYF'F.P$@?.T8/\.T\=_3L3XKN;3Q
M;X@L;^.W73],TU+]7B!\PJ=^=V3CHG84 ==63J_B72-"#G4;LQ"-5>0K$\@B
M5C@,^T'8I((RV!P?2N<M/%.OSWFB3QZ>;JQU!E%S%'831M9JXRK^:WRNHS@\
M#/456\-0ZC/\2_&D5U=6<T ^QI/&;5OG0PL0JYD(7J<Y#9YZ4 =EJ.N:7I%B
MM]J%]#;VC8Q.[83GI\W3G(QZU GBC1))X8%U*'S9G$<:DD;V/0#/>N8^- "_
M"36@  !]GP!_UWCK>?4+Z[U*PLKG0)H;660N\\TD;!60;T ",3G<H.3QQ[T
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M&B7$T,4>H1YG.V!F!5)CV".0%<_[I-:%Y>6]A;F>ZE$<8(7)Y)8G   Y))(
M Y)-8_C:PM]0\#:U;3J/+^Q2NI_N,JEE8>A! (^E>=S:GK6L^"/AQ?2WD*RW
M&IVJN98&=GD D =B'&0=H)&!D\YH ]'@\7Z'<V\DL-XSF.9K=X1!)YPD49*^
M5MWY !/W>G-.T+Q9H7B5YTT?4$NV@5'E"*PVALXSD#GY3QU&.<5R>MV^JI\5
M/"ZQWFGI)):7C[A9-@L$B#%AYOS$]N>!Q\U:$?BV32]8\8P7UM:QZ?H5M#=Q
M_9D(>02+([;LG&25'0#DGUH [:BN9L[[Q0UWI%Q-;V$VFWD3/=B(%'LSMW)A
MBQ\P9^4X4>O'2L2/QKK=]8Z=K&E:>UY9W4Z[K-;"82+;L2/,$Q.PL!AB,8YQ
MGC) /0:*X>TU[Q7J?BW6])M(]'C@TJ[ME=Y1(2\,B!V P?OX/!Z9'3G([B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH 1E5QAE!&0<$=QTI:** "BBB@ HHHH *JQZ98
M0W;7<5C;)<MG=,L2ASGKEL9JU10 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>elicio-q1exhibit312001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit312001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!Y</%>J>-?B;?>%M(OY--TC258WMS J^=/("%**Q!V
M#<2,@9^4\\BNM.C:Q9ZSIC6FLW<^E[W6\M[@J[ &-]K*^ WWMN1D]B,8->=Z
M7IMS\-_B_K.I:A;SMX?UL.Z7T<;.D,C/OVR8!VC.X9/J#ZX]2L_$5CJ5RL>G
ME[J$*6END7$,8 _OG@D^@SCJ<4 >5:#XGU2?QWXULM7\17\>DZ*)'A"&-64!
M\ 9*\G' SU-=MJMOK>A>!/$\TVM75Q<6L<]U87;;!($6$,JL H4X8,.G->7:
M-H^E:K\2?'0UZU*V-Z9?L=W+;,RA_,X>-L=>XP>:](\0>)8=>\%>,$M89Q;1
MV,MK;O)"Z-<3-$V0BD9(Y4#CDY[4 <9:>)?$9^!@\9MXFNH]5B=CB1(FBEQ-
ML"E2GIZ=Z[S0)-;\7Z/H.MW%_<Z7#-8[Y[:U"KYLK$8;YE)"X!('^T.>*\;L
M_ UW?_"/2M8TR"1=>T6>2:>QEC),R>86&8VZD#D<<C(YXKW;PGXJ@\0>%X-4
MGA:PE1 +JWG4H87'7K_">Q[CWH \V^&^H^*O''AWQ$\GB>^BU"UF,5G(JQ!0
M=I(W#9R,XS6EXJU[6K+XW^'O#]KJUU%I=_ LL\"[>3NDS@D9 ^0=#5/X 12V
M=EK\%W#+;S2W@DC2:,H77!Y (YIGC+<_[0OA>^1)&L[6V6.>X5"8XFW2\,W0
M?>'TS0!>\9:YK=C\9/#GA^SUF[M]-U&)6GB383G<XX+*2/NBNJM;6\EGO;RS
M\1WUWI@MYX2LC1DQ7$;@!D95&>C@@YZ5P7Q!MH=1^.7A>66U%UIL,"QW3M%Y
MD*9>3AS@J.HZ^M>G6FDZ=X6\+W=I9[(+$>=+&@X5-Y+;1^)X'T% 'G_PL\;W
M]Q\.=;\4^)M2GO#8SR+@A5&Q8T8   #)+8R?6M;P!/KOCS1SXGU?5[NTM[F5
MULK"Q81I&BL5RS8W.<@]3CCISQR'PJ\.3:S\'_$GAFZ62SO;NXD:-)T*$?NX
M]K8(R5W+@XKH_A9KJ>%?"J>%_$\<FE:AI\LBH+A"$F1G+AD?&UN6(X/:@#O-
M"M-8L[G4H]4U!KZ$RJ;.5T16$>T9#!0!D-GG SQ7'S?$66W^,UOX<F4II-S;
MF"&5AQ)<ACD@^F5,>/[PKIM4\5):>'+K4HK:X1MWE68FA8&9B %;9C<$R>20
M.%)Z8SYK\4O!U['X+TO4[+4X[N\TB1'M#!;XEEW,-S ACN;.'/'8F@#O_%-I
MJ\%IKVL1:W=VT-MI[O:6T&S:)$1F+ME23DX&,]CZUR_PVN/$GBSP3I^MS^(K
MPWJWX\U&$?ERPK(-Z$;,C*YY!ZXKH+GQ"GB#X27^H21O!=7&F31R6[H5=9S&
M04"GDDGIZ@BLKX%(]M\.8K.XC>&YCN92\,JE7 )R#@\X/K0!1TS7=:E^/VI^
M&I-7NGTBVMQ/';DK][RXVP6QN(RY[U9T7Q9J/CSXCZOI5G>2V.@Z,"C_ &?
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MAJ6%U:QN7CN4Q@@,24X[<97_ (!6CJ\R7WB'3O#MC<1VBVB_:WS 6C++@11
M9 R,E\ Y&Q>*\YAAO/A_\<WN07N],UJ/_3I+:W8)#(Q/+ 9VD, W)Z.: -KQ
M)KNM6GQUT+P[;ZM=1:5?6XFF@7;R?WN0"1D#Y!WKUH#  KQ/Q=*!^T-X<U0)
M*]A:V@CGN(XF=(V_?<$@$?Q+^=>DQ^++>_\ $MEI.FK+.K1R37,_DN(T51@+
MN( W%B.G8'UH X_XX^(=9\+>'-/U'1-2FLYY+L0/L"LK*49NC \Y YKI%LKN
M75X(K#Q+?RS69AEOK65HV1XI-PP2%!5OE)Z]![UQG[0T,U]X4TRSLX9;BY%\
M)3%"A=@FQQN('09(%>@^'-!T72I;K5-(AM[>&_AA\U(%")N3?\V!P#\V#_NT
M <-X*UW6M3^+OBC0[W5[J;3M.#FWA)4;?G4#) !. 3U-9-[XW\3^ _' N-<N
MY[_PC=W4MLCNBEK<JY')50<C&<=USW'$W@$F#XW^,+R9'BM;H.()Y$*QRXD7
M[K'@\ GBNVMM-T?QGX9UG1[U?.@EO;C<,%67,C%9%R/H0W0^] &GIDC7'BJ]
MEBU.:XL&L;:X@C#JT8,C3 LI R00BXYKE_B3\0YO!VN:!%%&QLC=*=2EVY"Q
ML&55SZG#OC_IF/6J7POTC5/ [^)=/U^>1[73U@6TG*DJ]OF5AM'7JS?+R03B
MDUWPY/XR^'.J74NH6\?]H9OQ#);X>&4*/+C+%N"%"H>.YXYH [_Q,\O_  BF
MI7-G=R6\L5I)-#/ 1D%4+ \@@BO-_ OCK6K'Q3=^!_'5P?[2=LV5[@()@>B@
M@ <]5/KD'G J3P3XEGOO@S?6.KQ7%OJ-A92VH2:)E>9=A$94$9;C"\<Y'O6U
M\0? ]I\0_#$%YILBIJUJGFV-RIVDGKY;'J 3^*G\00"'7?&DO@7X=7&KW-Q+
MJ-^][/:VPN2/F82R*N=H' 5,G'7'O6KX;T/6[S0+74=7\2ZE_:MU"LS>042*
M L,A5CVE2!G'S9S7$:YX-UOQC\#-,@:.1M>M)GNI(9?E>63?()%/HQW$_4>]
M=IX6\<Z9-X<L8M0:>SU6&!(KBPEMY!,)% !"IC+9(R, ]: .8^).K^*O"?PR
ML[\ZO+'K27QAFGB5=LJ%I"#M((&0%([CI7I6A.__  CEA/<W#RN]LDLLLK#)
M)4$D]A7FWQS:?5?AQ:0PV5P+R6\CE%H%WRJH5^2%SCMGW.*Z&\U."X\):'H<
M5R(I=3@C@EE*%EAC$>9-_3;G;LP2#EO:@"CX!^(<WB3QIXCT6^C: Q.MQI\;
MKM8V^U1T]QM?_@9]*H?&#Q!K7A[5?#"Z1JMQ:)J%RT-PJ!6! ,8&-P.#\QZ5
MB?$33M5\)_$+P_XRLV.H7(;RKN"TMBK&(<9*@MU4LN?]E:F^-4PU6^\&7&GI
M-=1PW+3RF&)G,:$QD%@!D=#P>>#0![7&GE1J@9FP,98Y)^IKBOBEXZ;P'X5^
MVV\22W]S)Y%LK_=#8)+'U  Z>I%:%]XRLA=Z?9:;YMU=7EU'%\D#E(X]P+LS
M8P/E!QSU(KGOC1X,OO&'@^,:6GFWUC-YZ0@\RK@AE'OT(^F.] %N_P!-\0V'
M@"75$\0WK:_;VANW=@AA=PNYH_+V[0O51CGH<US]Y\0KWQ!\#;SQ7IT[Z?JM
MF5CE\G!59 Z!N&!R"K \],UMZKXUM+SX<W"P1S/K=S8FW72UB;[0L[)MVF/&
MX $]<8P*XZ;PA=^$?V=M2T>Z0MJU^ZW#6T8WMO,D?R@#J0JC./>@#H]!EU;7
MO ^CS1^*M0B\07]DUU$N8BCE",Y4IPN2HR/6J>O:WK<7QWTGPS!K5Y!I-[:F
M:6)-F0VR4\,5) R@K4^%OAK2XO#F@:S%:1VVJP63VUUB/9(VX@X<<'(*C!/K
M7+^*[.VU']HC1IKNT6ZTE+3R;F26'? &VR_*Q(V]67KT- ';M'?KI>L:K8^(
M[Z[T[[%/Y#2&,F&>)F4LI51N4E3UST]ZYOX?>.KR+X2ZEXO\1WT]]+;2R+AM
MJYQM"*   ,LP&?>NUN]*LO#/P]U'3+7"6J6]T((QVWEV5%'4_>P.YQ7F/@'P
MQ<>(O@1J_AF0-:ZA+</)''.I0A@49"0>=I*XS]: .Q\!KKOC'0(_$NMZU>6Y
MO69K6RL6$44$88@9X)<G&?F)XQQ2^*)/$GA_X?\ B>]GUF:2\M93+87:HBL8
MML8 90-N<[P>.3R,9JI\,_$D&A>$+7P[XC672M5TXM"T5S&R^:NXE60XPPP<
M<$]/<5I?$6^.I_"S7/+M;F-KB+R[:*2,B2;YEY"?>&>>" <#) H Q/#5UK7B
M7P'ILD?BK4(O$=]8SW46/)*$QR;?F4IP"64?G3OBUK^M:!KWA2+2M4N+2+4K
MHPW*)M(90T8XW X.&/2L[X>2>'O#'A'2=<NK66#6;>QGMKF"&R<SS;I0RA@!
MR?D&"?[W7%5?B\9]7N_ 4CV<DDB2^=?111LX@#>22&P.!PW7TH W-8\2ZWX7
M^+>@Z!;ZG-J>GZH@\ZUN$1I(,L1O#*H.,#/.>A_#U6O#5L+CX8?%1=5M;.74
M/#6N#!GBB,SVO/9@"=H)_%3W*UZYKVNPZ+X?GU0 SXCS D8+&5R/E QD\^O8
M9- '%ZK\19=.^,.F>'Y%*:/<1-;&8CY7N201@]\?*GU<^E=%X^CU=O"\C:%J
M,ECJ?G0QP2+C:6DE1,,"#Q\U>>?$WP9>3_#RUO(=5AO+O39/M%LT-OMDF=VS
M(0P8Y))+\#JM=7!XLCUGX?Z1?WRR6]\]W9BY@>)@ZNEQ&9#MQG;@%L],4 8O
M@+Q_?>(-(U3PUX@FEL?%.FQR9< (\H4'Y@,8W ]1C!&#ZXK_ !5\0:[X6^'N
M@ZGI>LW<5[-+'%-*VUO,#1,Q)!7 .1VQ5KXL> 9]7BC\7^&&,>NV2;SY'6YB
M [>K =/4<<\5D_&V":]^&WAVRM();BZ6:&5H8D+L$$+#) Z#) H V/'7B37_
M (<IH^N1ZC-J>D7,JP7EG=HFY25+!HW500<!N#D9 ]:]0@GBOK**XA<M#/&'
M1AQE6&0?R->2?$RWO/B%I6B>&?#UM//FX2XNKQH62&W4(5^9F !/S$[1D_+7
MJ]C:Q:7I=M:(V(;6%8@S'^%5 R?P% 'C&E^(?$5_KGQ#MI?$]Y;Q:$)7LGVQ
M$)M9\!LH=P^4"EO/'OB6_P#@/_PE7VF2QU:&Y$(FA0!9UWA2VT@CN1QW!QZ4
MWP%HNGZI\4?&QUC3([BUNKII+0W<&8YAYCG*[AAN,']:ZCXU6Z_\*NN=-L;?
M,CR0K!;6\>3M5P3M51T % '/^+/%7B'PKX \*>)[/79[B\OEM_M%E<I&Z3[X
MM[$ *&'(QP?XJT/C1XFUSP[X<T?4]'O[C3[BYG$<L8"L,%"V"&!Y!%<EJ7AR
M]\/Z=X.\>Z!9-?/96EM#J.GE"Y1_+4,0I!*G.0<#(.#ZUK?&^^7Q/X+T"72H
M+F=Y+H3M L+&6)=A!WJ!E2"<<T =5\28O%=II-@_A+5+M+]=Y>([7\]54L>&
M4_-QQC&>GI5?0/'H\=^!X[JVO9=/UBVN;:"]C@(!4O*B$@,#\K G'H<CM74Z
MAJUB==\/;;A6#M*P9<E0#&0-QZ+D\<XYXK@?&/P^NM(\?Z5XJ\.!X[6\U"WC
MU6VB'&#,AWX_ND@$^A /K@ U_%OC#5)?'NE> /#MS]ENKA1)>W[*)'AC"EL*
M#QN*J3DCN*Z2]T#6;.WMFT?7M0>1+B$W$=VR2B:+>OF<E<J=N>A [8].&\7Z
M'J'AKXQZ;X]@L[B\TJ11%??9XS(\'R&/<5'.W&TY'H?;/HUMXKTS4)(8M+D?
M4'D8 _9T)6)<\L['A<#G!.3T - ' W>NZTGQ_L_#*ZO=+I$UL9WMP5^]Y;MC
M=C=C*CO1JVL:V?CO9>%X=;O;?2KJS:=HX]F5;9(?E+*3C*CBL^])_P"&F+'4
M=C_88[0Q/<[#Y2OY3C!?IG) Z]>*9K]G;:C^T7ITUW;>?I2V1AFE>,F$/LDP
MK-TZD#ZF@#H?A3XOUKQ!J'B32]4G6_BTJZ\FWU 1JGG+N<8.T!2<*#P.].\*
M?$676?B?KGAZZ4QVIC2;2]PQYB*HW,#W#@AQ[ UN^(3I^@:%%HFEQ0Z9_:$@
MMD-M!M2!6X>0A0 N%S@G'.*\Y^*.AZIX=UOPWXNTV1+R^L9$@^S6EJ48PKDC
M@%LKC<I/^T* -WXW^(M:\+Z1I5[HFISV<L]T89 @5E9=I/1@>>*]1MXO)MTC
M\QY-H^_(<L?J:\5^.=R/$/A+P_)I<,]RSW/GF*.)F=$V$?,H&5.3CGOFO1=3
M\:V,,-I#IIEN[R[N(H(D2W<A-[@%W.,*%!)Y]* .JHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***I:MJ"Z5I5Q>F,RM&O[N)>LCDX1![LQ 'N: +M%>??"+QI<^
M+_#-PNIM_P 3>PN&BN5(P<$DJ<=NZ_\  #6;>^*=4\6_%67P7I%]+IVFZ=$9
M=0N;? FE(V@HK$':,LHR.>M 'J=%<U)H.I66HZ9+IFL7QLDG_P!,M;F;SO,3
M:V"'?+@AMO .".U<;X=\1ZE\3/&NLQ6^HW.G^&](81JEF_ER73DL S2#Y@OR
ML<+CJ* /5Z*Y::TO?#NI-JCZM=S:!;6,\D]M<.)&C==K!@Y^=AM#\$G'XUS'
MPWU75/B+9ZEXAU:^NK>T-RUO96-I,T*Q*H!+%EPSM\P')QP>/0 ]0HKS#PAX
MNU ?$+7/ .MW+W;6P,EE>'Y)6CPK;'*XRP5@=PP>#[53^#^M:MKGB#Q9'JFJ
M7=W'IUTL-LDLAPBEI0<@=>%'6@#UNBN0BM9G_P"$M4ZEJ \B;R[<BY;, ^SQ
M2?+_ ,"<GG/ITK@O!'CK7= \5'PEX[NWF%^JRZ?J#G ;>.!N&.#T'<-D=^ #
MVRBN-L=(U#4M.C6/7-1B5-6N3/()R9&AC>5$C4D' R$R>IP><UQ?A>]U?6/B
MUXI\.76O:H-/L8F-N$N,,AW(,YQS]X]<T >S45XM\5-2\1>$M!\+I;:[>+>R
MS&VNITD_UX &&(/ /T'>M[XG6GBB"ULG\(:G>PWD44LKP"4OYZ)M. &SEN3]
M>GI0!Z717F&@^.(O'W@NUO(;J>QU6VO;2"]AMY2A&^9$;CNK*3CN.><BF^(_
M%NI:G\3[#X?Z)=R6,2H)=1O4PTH79OV(6S@E=OS=<L/3D ]1HKE-6\-ZG#9Q
MOX?UK48;A)(S+%<7)G6>/<-XS)DH=N<%2*Z2\NXK"QN+R=ML,$;2R'T51D_H
M* )Z*\N^'&L:G\2(M4\0:G>W5MIZW)MK*PM)FA$8"ABS,N&9OF'4XX/'H[PK
MXNU"#XE:UX UJZ>\$2F2QNV^64H55]C%<9(5OO<'Y3[8 /3Z*\/\'^(KNZ\0
M^.DU_P 1:BNG:+.P@Q<["JB208S_ !'"@#/>M;XDOKW@[X<W=W;Z_?O=Q:@H
MM[II?G,+X^5@!@X.1G':@#UJBO/-*AFU33="%IXEU(:PUI;:A<1&Y#HZ$IO5
MU(X#9;&,=/:L2PU?57_:#O\ PZ^JWK:1!;">.V,QP&\M&Z]2,L3C- 'KU%>5
M67B;4_B!\2M4T*QU"?3M T8%9WM3MFNI0VW&_JJY#?=YPOOQV/\ 86I6FM6#
MVFKWLFD_O%NK6>;><E"%<2'Y^O;<>H(QB@#I**\.\,>)+N?Q?XXMM<\0:BNG
M:1.Z6J+<[& $KJJ@_P 1. !GO7;:_:ZMX?\ ASXCD?6;V>YM5FN+*[:3$JJ%
M!4-C .#D<CGK0!W=%>%'Q!K=M\"+3QD/$M]'K(<X\R172<^>4V[&!'W1GCTK
MU[PKJ5WK'A32M2OX/(N[FU266/!&&(R< ]!WQ[T :]%>1^)-3U6/X[Z)X=@U
M>_@TN_LS--#',1\^)N03R/N+QTJ/P9XIUS5Y/'&D7>H37MGI!E%EJ:X23Y2X
M4%D #'"@_GU!H ]@HKS'X):KJ7B3P5=:CK&H75Y=-=R0;Y)2-J!4(  P <D\
M]:?KUQ?Z=\*=?U.#5;\7]K<W0AG:X8LHCN7C48Z8VJ!TYZ]: /2Z*\+U'Q#K
M>E_!72/%\/B.]36)&3<DSK)'<9<@KL8'L,\8Z&N@\;>.M1TCPYX/U"_ANK&R
MU-HVU9[4$20@H&\M3U7))Z?-A2 <T >J45R'AN:WU:^34-$\0RZEH$MK(C0M
M.9&AF+)@[C^\!*[N&.1VQFN2^%NLZMJ_COQC9ZCJEY=6VEW1BM8Y)3A%\R1>
M?[W"CKF@#URBN?T:*1?$FNA[NZECBDB6**28LD8,:L< ^I/?/MBN1\=?$2?P
MOX\\/6@4KHYF:+49\?*'=1M4GL5#*Y]010!Z=17/^-8KJ3PE?O8WL]E>1Q[H
M9X7P5;MGU'J*X'X=^-M4;5[WP'XVFDCUN%F%O<[]AG7K@,,<XY4CJ/IR >O4
M5QFD:/J&J:/X>N9-=U%81:-+=;)\/<2N(RN3CA1A^!CJ/>N&^'%SKWC&3QA:
M7?B35(Y;&X$-E*DV/*R9 ,C&&^ZO6@#VRBLG4K#4;WPZ+*"_>TO76)7NHC\R
MX9=Y7(ZX#8X[UYAJ5[JUI\==&\*1Z[JG]E7-H994-P=S,(Y3G=C(Y1: /9:*
M\F\>>*M9^'VCVVCV5^]]JNK7KI97-WAVAA^3KQ@D,V!GZGTK8\96.K>%_ UQ
MK.E:[J#ZIIT:S227,IDCN0"-X:,_*H(R1M Q0!Z#17/^"?$T?C#PAI^MI&(F
MN$(DC!SL=258#VR#CVQ7!S^.[)?B;K>A^*M3O-)AA,::88YF@BP5R7=EQDDD
M$;LK@8^H!ZY17F_C*;6M#^$FJ7_]M3RZC:N9+>_B<*7C:8;"0ORGY& Z8]*H
M^''O?$?@[2E@\3:DGB*YT]KTE;D%?E=1AU(X#%L=NA]* /5J*\S\=>,M3;QQ
MH_@3P_<"TO+_ !)=7H0,T,7)(0'C=M5CD^U=#J'AC4K;3!_8FO:HMVK*7^U7
M'G"=01N4[\["1G!7;@T =717E?Q+&M^&/ VL:[!X@U!;XW@:%4EQ'#$TN%0+
MC^Z1USS6[X4TW4;_ $7PWK,FMZA*MSIZ/?02SDK(SQ [EQRI#>A'!]J .WHK
MQSX6>)=1O+_QI<ZYJMY=6NC2_NA)(2$C!EW<#J<(.OI6E\.-7U3XCP:IX@U2
M]NK:Q%R;:RL;29H5C4*"69EPSM\P')QP>/0 ]1HKR_PKXMU"/XC:W\/]:NI+
MOR5,EC>'Y)2A56V,5QDA6'S<'@^U<SI_CCQ'X$\:1Q>*KZ>^\,ZI)(EM=RX8
MP;9"N20.W\0]""/2@#W:BL#0HV.LZW)]MN;B%9XU@228NB*8HW.WZEB<\^W%
M;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5RFLSOJWBFRT>">>U6T!O'G^S%HWD'")N(VG +,>>"%KJZ* /#K:RU#
MP%\<9+F"&\OM)UB/_3IH+1BD4C$G)VC PP!^CFKK:-?> OC/>>*#9W-SX?UB
M)DFGMXFE-L[%6)=5!.-R]<=&]J]DHH R+/Q%:ZG=10Z=%<7,;9,MP(F2.(8.
M/F8#<2<#"Y/.3BO+O!&FW7PK\::]8ZI:W)T/4W66SU"*%I(UVEL*Y4':</CG
MNOH:]HHH P9;JV\56-_I<,-R;"YM9(9+MHC&F7&W:FX MP2<C@8QG-<)\+!/
MX TO4O#/B2*2U>&[:>VNO+8PW$; #Y& QG*YV]>1QUKUFB@#R?P3X:O]4^*F
MN^/;VTFL[.;,-A%.A225=JIYA4\J-J<9_O>U9WP]#^ O''C"SU^WN;9-0N5G
ML[@6[O%,H:0\,H(SAQQ]17M-% '+02-'H_B+5)X)XHKZ9Y8(VB;S2@@CB&4Q
MN!8QD@8S@C(!XK'\3^";'XB?#^R@P8-0@MU:TGDC*-%(%&58$9 .,$?0]J]!
MHH X_P"&,.IV?P^L8M;$JZC')<"X\[EBWG/DD]\]<]^M<3X&AN(?CKXKOYK.
M[BL[R-EM[B2W=8Y#O3HQ&.Q_*O9J* /&_CU:W>HP^'H;&RN[N2"[:65;>!Y-
MBX')V@XKT&]U.V/BG1=OG,KPSC>L+E5SLQN;&%S@]?2NCHH \@\3?#NYTGXD
M:1XH\/!TLKS4(%U6VBZ#]ZK;\?W2P!/H1GN<2>(/#E_X:^,MKX[@M)[S2;I/
M)OQ;QF22W/E^7NV#DKPI) /0^V?6Z* /)/'VKZSJ?B/PW'X-O=3EAFF(U(68
M?8D>Y,%N,)P7]*]1O;"*^TFXTZ4MY,\#0,2Q+;64J>3U.#5JB@#R3X617'P\
ML]5\,^(XI+?9=M<6MYY;&&X1E5?E8 C/R@[3S\U'A/P]>ZM\6=;^(%[:S6>G
M!3#8K<1E))0$5/,VGD+M4GD<[O:O6Z* / _ WA2UUOQ=X]M]<TB58-1N)&L9
M[JS8=9)#OC9@,'!4\$5V/QS@N+[X>26-G;7%U=27,3+%!"TC$ DDX4'BO2Z*
M .-\">'M,L]*TG5K2R2TO6TN*VNU6#RF=PJ'YQ@'<"&&2,\^U<5IT5P/VD]1
MU4VEV-.EM1"ET;=Q$S^5&,;L8Z@C\*]GHH \9T+2KSX:?%+6[N]M+F3P]K6Z
M2.]@A:58'+E@L@4$J!N89^A]<>H6>OVVHW&+*&XEME0O)=-$R1KCH 6 W$_[
M.0,<D< ZU% 'S[X8T6RNO'7CM]?TJ[2TOKF22QNI-.E;!\UV#H=O!Y4^]>@>
M)M>?Q%X!\6+;:??)#Y+VEHLEI(DMRY3)94(W;<L ..QKT*B@#YMA\!7TWPLT
M+7](L9H?$NB/))/:26Y#3+YS,,HP^9@,$>HR.>!7N_A/7V\2>'[:_FLKBQNF
M4">VN(F1HW[@;@,CT/I6W10!XKXNT]=1_:!T&ZN=,FNM(AL_(N97M&DA#8FP
M&.TCJR_G7K+Z/:0Z)<Z;I]M;V<,L3HJ0QA$4L",X K1HH \;^#U\/!OAZ_\
M#WB"UO;/4HKYY%B^R2/YJE5 *%5(;E3T]JW/%]I=Q_!S5[5[2<WUZ9YDM8T,
MD@,L[2A,+GD!\'MP:](HH ^<7\#ZA#\/O#/BO0;"5/$&C#-W926[!I0)"<E"
M,EA^JGV%>H3>*K?7K'1X]3\/7DFEZE;S#4+>>Q=S:R*8]N\;<[<EL-CT/8X[
MZB@#R#P?X,M]"^+#WOA-[@>'7LF^UABQB\TGY8T8_>QPW?;R,\XJMX,23P+\
M4/&"Z[;W-O;:K/\ :+.Z$#O%(/,=L;E! .'''L:]HHH YBSO_L5OKOB">UNE
MMYI0\$0@;SI$2)5!\O&X%F#8!&<8)QFN)\7>#[KQ'\+KJ:;4))+E]VI+!]E^
M;[0024'&_N4&>P [5Z[10!Y=X>\1WE_\(/+U>RU"'5+:(6LD4EI)YDN" K ;
M<ME<9([@U;^)W@)?&FD0:QHS&'7[$>;9SK\C2 '.PGL<\@]C]37HU% &!X/:
M6W\!:&UZ'CF33X/.#J0RML&<CL<]J\Y^"-M=6.M^+A>V5W:_:[M9;<W%N\8D
M4-(206 ]1^=>RT4 %>,:U%<-^TCHNJK:7;:=;VIAENEMW,:.8YA@MC'5E'XU
M[/10!Y?\9/!VI:_::3K6BP&YO]'F,OV9?O2H2I.WU(*#COD]^*L^.?$:>(/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG7L 0#4^"^L:[J_A&Z.N7+W9MKV2W@NG.6E10,G/\0!SS_A4'Q*\9:E9>)]
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M92RI,H)VLC(K!N,#@]17>V5Y)<V1NI[26U&25CDY?:.A(&<$]<<G\>* /'_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQN;N8VIMY#TN <&,'N>,@=<&MZ/6-.EO+NS6\B^T6BA[B,M@Q*<X8YZ#@\T
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MI^Q(;^*ZF-_%8ND)+>6[L 2Q X 7)]\8ZT =;13(94GA2:)MT;J&4^H-9O\
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M<A6W(< J!DC'(/'<51EOM9N/BM/X>36[F#3QI OU$<,)97,NS;EHS\N/Q]Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.F_VB'TW19="2UTV2\<A865]S1,S'Y7*[>I_A [5J_#"ZMIU\5"W<$'Q!=R
M 8^5MN#]#@UWC(KC#*&&<\C-  '0 =^* .$O+VWT_P"-EN]W*(5N=!\F L#^
M\D%QDJ/4@'/TYKBKNXL9/A)\0RDUNSRZS>,N&&7S,"A'KG&17N.!1@>E 'GU
M_?V<OQ7\),EU"Y?3;K!#@YW>7M_/!QZX-9.C74VE:UHZZ-J<&L:%?7[J-.G
M-UILC!R[*PY*KE@=W0'CKFO5\#TIH1 Y<*H8C!..: ./^*/AZ]\2>!KFUTU/
M,OH)([J"//\ K&0YV_4C./?%:$?C;0WT4:B]XB-LRUH3_I"R8_U7E_>WYXVX
MSFNBKG=<\&:9K>IVFKCS+/6+,Y@O[8@2*/[K9!#J<D8(Z$],T >;)HEUX4\
M^&[O6%^S.?$\.J7P;[MJCEA\Q[8!7/H36E=Z]ITGB_QG>10_VI;/X?B98$SM
MND'F[@IQRI!ZC/MFO4X(YOL^R[>*9^C%(RBG\"3_ #J4*!T % 'D6F:S83>/
M/!MXFJ17$$FF7$2^1%M@B;$>(TXSP.H9B1CG%:_PZ%G=^%M?^S""6?\ M2_8
M;,%OF=MI_%<8/<5Z,% Q@ 8Z<4M 'B5IJ\,'PT\#Z@'N)=/TB=%U7[+NWV^8
MY$W''/R,P)'49'J*O^))?"]WX'\8ZQH<\MRUY8K%/?23.R3..$1=W!8#TZ9
MKUW QC Q0J*BA54!1T '% 'F_P 0IM/3X0&2W>W6.460C:,@!PLT? QUP ?H
M :T/'0?2Y-*\;:=&UQ)IK>7=)!R;BSE(# >I4[7'T-=SBN?O=%U74->#W&JQ
M?V$ICD%@MN [2(=PW29^[N .,<XQTSD N>'[&:PT>);H#[9,6N+H@Y_>N=S
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MAT/5%L&MKVRDNK<VRN'A9&4%&+'#C#?> 7Z5T]VTR6DK6XC,P0E/,SMS[XH
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M+B5(H(E+R2.V%51R23V%<[_;E_JWB35]&T>6UMSI4<7G37,+2[Y9%+*H 9<
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M6 LI4N(&D>$ DYBPP SGD'N >>E;FD:YIVO0W$NFSF9+>X:VE)1EVR+C<N&
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M]OV# D9')X( (],UL54TVUFL[&.&XNGNI^6EF9=N]B<G [#L!V&*MT %%%%
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M;<LB\8'3''8\FE\6ZQJ.@ZAH=U%-&NDSWJ6E\&CRR!\A'#9X&[ /UH ZFBN
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MNRD2O;,1OD90V R#/&0#QQVH [FLS4M?T_2;[3[.\DD2>_F\BW B9@SX)P6
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M8)$8;))ZDENPQCOF#P+?)I/A6Q36+<?\(_*DBN;,GSMB% "/,X^4GUYKMZ*
M.3\0>$KZ]\1VOB+0M7&F:I% ;68R6_G13PYW!67(Y!Y!!HUCPC=ZCI>F+%JY
M&JZ??+?I>3P;UDD 8$,@(PI#$  \ #FNLHH XG_A"-2:[\274NN1/+KMG':R
MYL_EC*HR[E ?I\[8&?3)-22^"[V33O"UH-6MQ_8$D4BN;0GSRD9C&1YGR\$^
MO-=E10!R;^$]1&O:_JMOK,<$NJP0Q)MM23;F+.UL[_F^\<C S2IX-%QK&H:M
M?36XN[W3CI\ALX3&&4G)=LL<MT ] ,<UU=9=GX@L+_7;_1H#-]LL$1YP\3(
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MV6ARF87UZDDD(\IMA5!EOFQCC(X!SR*MZC?1Z9IMS?3)+)';QF1DAC+N0!G
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M\R*K1C!P1@G&>/3I6W?_  ]AU+2-0CGU"2/5KR]34/[0A3:89T $9123\JJ
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MQS1I(AZJZ@@_@: /.?!F@W&O_#CPM;W][!)ID45O<&**$AY"F&1&;<1@,!G
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M$@QEFYX P #TXKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQG;:IX6T(:SK%HVMW\3/Y+.B22'>P&$&.P].U ';T5GZAKVDZ2X34-1M;5B
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M[:&9IHK>&.5AAG5 &(]S2_9H/M/VGR(_/QM\W8-V/3/7% 'FFEZS96>J>/\
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M$4*$Y*QH%!/KQ0;6W,:QF"(QH=RKL& ?4"@#P^XN[=_ACX]A2Z,[Q>(3,Y(
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MD>M87BB:T'Q7\$)-)#O6.^.UV&03&FW\R#CZ5AVEQIOV?XJ,)K7YY)<G<OS
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MQKKJ\SL-1L['Q%\1;2ZN(X;B1UF6-S@F/[,HW_[N>,],X'4B@#:\%>,+'4-
MT"UU#5[>37+RRCE:)G >1BNX\#C..<>E;^H>(M'TJ;RK[4((&!4,7; 0M]W<
M>BY[9QFO*H;JPA^'WPN*SVZ,FJ69;#J"O[MP^?Q//N>:LQZAH":AXH\-^,+N
M\MY[K4)I8[?=(%O+>0CR]@4?,< +@<\"@#U^N+U_Q/$/&5CX:746LHY;:::X
MGBQY@8; B@D$#[Q/3L/>NKTZ%;?3+2!(GB6.%$$<C;F0!0,$]R/6N+U*^M(_
MC5HT;W,*N-(N$*EP"&,B$#ZD _E0!?\ #EZNFQZJ=7\:6^K-:>6+EV6*%+3
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M=Y-+!0\;E/G-_$, X].:RK?QKI'B#P[JUQ!K":7'"TL"W<F%,6WY1)A^.N2
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M/4(I+6:7R8V3+,\F<; H&XOD'Y<9X/%/M_$.DW6GW%]%>H;>WD,4Q8%6CD!
M*,I&X-DCY2,\CUH T?+3S/,V+OQC=CG'IFN:T3P[=V'BC7M5NVM98]3EBE1$
MR6A,<80<D<Y SGC%5/&?B'=X&\07.C:A/:W^GVQD8B'9)&<9 *R+D9'MGT-:
MFC>*-(U">#2X]2BEU,6ZR/%DY; &X@]#@]<'CO0!NNBNI5U#*>"",@T@10H4
M* HZ #@5F^(]93P_X>O]4==QMX))$7:3N95) ..@..M>;ZEJ.M?\(]X?\1V'
MB:^7[5/90W]H\(V2/(Z;BA8 H/F(PO!&/?(!ZWM4KMP,>F*J2Z=%/J4%[*2S
M6X/DI@85B""WJ3@D>F"?6H]0UO3],D$=U.1)L,ACCC:1P@ZN54$A?<\5#+XF
MT6&+3YFU"(Q:BP2TD3+K.QZ!2 03[4 :U)M4?PCGVK/M]=TV[U*[TZ"X\R\L
MP#<0B-MT8/3/'?MZ]LU$/$NDM;P3I<M)'.C21^7"[LR*<%MH4D*"1\V,<]:
M-0(HQA0,# XZ"EV+_='Y5%:74%]9P7EK(LMO/&LL4B]&5AD$?4&L^\\3:-83
M/'=7R1^6ZQRR%6,<3G&%=P-J$Y'#$=1ZT :I53U X]JP/[&U:Z\1-<ZAJ<,N
MDPRB:TLH[?:RN%P-[Y^8 DD#'7![8K/\8>)UTO5M"TA)I(1J%T5N)8XV++$(
MV;"D \D@#CD#/3K6KIRR>']#N9]1U:YU"WC9YXY98<RI">0A"C+D<\XR<]*
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MO;%_NC\J1HT9U=D4LOW6(Y'TK#T/4+"8ZS<PZ_\ VA!%=,92[KY=IA%)C#
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M,X-/HHH ;)&DJ[9$5UZX89%*0",$ BEHH   !@#%%%% !1110 4444 %%%%
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M@#R#QCJEK-_PGNEJG]GW*6(Q#!!F6_ AXD8X/[M1\ORXQ@Y/.*OG4[6+Q3X
MU*1W%I)I=Q DIC;YI"L6% QG)P<>O:O4** /(M0AN=6NOBM8Z/('O;B.W$*Q
MMS(!;A7"^O0K]3BK^JWEIXMTGP;%HDB'4(-2M;AXD/[RS2-3YOF#J@ RN#C)
M('>O3J,#TZT >2QW%D=.^*I\V M*\P7YAEQ]F"C'K\V1]:,Q3:9X<N]+\31Z
M-KMOH<.Q[DJUM<QX^:-P>X9>HY&3P<<>M4$ ]10!C>$KRXU#PEI5W=6 L)Y+
M9"ULH($?&, 'D#'('85Y-J.N6=[HME*N; VGB>)[C2X8"!:@7)R\K8)W-][J
M!\V #C->Y44 ><Z3>6!^(OCN>2:%5>RL@&DPIP(Y-XY],KD=N,URV@:D-(TK
MX:ZO?N1HUK;7%M<S8RMK.ZA4,G]WC*Y/3)]:]OH(R,&@#S_P=J%G>_$OQK+:
M2B6*=;%XY$4[) (2"0V,$<CGOD4>*-83PO\ $C2=;U;>FB2Z=+9?:=A9+><R
M*^6QG&X*!GV]C7H%! (P: /-M;UG1;&RT:[L],M[/3KS5S(FIRVQ"0N4.9PI
M ^9B2JEN/XN1C.+82:3<6?CJRU.^OHH)-6MY?M>PQRQ[O)$<V=H"X?#=!P"<
M8KV.B@#QW5-1U-O!'C;3]4OK/5%@L4CMM7MT"?:MP;$; <%U]%_O#UK9O+NS
M_P"$T^'!AG@V+;72Y1A@ P*%''3)&![BO20 !@#%% '/^.9HX? 6OF1U3=IU
MPB[CC<QC8 #U)/:N*\0WMJWPI\)%;B([;C3,X8<;"A;/I@=?2O5:* //[#48
MM#^*'B*36;F.WM=4MK673KJ9PL3I&C!T#'C(9BV,]#FLBR\+7UQ\,-86VC>*
M==5N-5T5&4AHE67?" .V[!X]'KU<@'J** /)9)M;?6]*\5V5O-%_PE$!T]H<
M#-J"NZ"4^N )&.>S8K7\4V5M9ZQ8KH_B!- U>QT\);&YVFVN( <>4X;T*CD<
M@'/../0\4$ ]10!B^$;VXU'PCI5W=V*V$\ENI:V4$+'Q@8!Y P 0.P->?Z5=
MP6OP_P#%/AK7"HUH2WJM;2?ZV[,I9HWC7J^[< ",\BO6J,#.<<T >6WH?1[G
MX86.JW48O+0[;DNX^4_9BF2?3<<9[FO2KU3+IURL8W%XF"@=\@U8HH \1&HV
M,_P<\(VC2J7M]0L8[B.12-I24;P<_P!T#GT&,]:W]=WZA\1?$%IID\?VNY\)
MM# 4<<S&23:,^N"#]#FO3Z* /+/"VH^%/$:Z%;FWU&37M-9";*:6X!LI%&UV
M8$[0HP<9X/ QDXK;^+SQ#X9ZI'(5S(T(5#U;]\A( [\ G\*[C SFB@#SWQ[=
MP:;>^&=>=9GT&WFE%Y-8LP,0>/;'+F,YVCD$CLV/:LO7+;POJ/@+Q7J>C->+
M;7BPR3:C^^E\^6-@5PKG)5<*&(XP3_=./5JQ_$>C7&MZ6EM::B]A/%/'/'*(
MQ(I*-N"NAQN7('&1T% ''^']?T+Q%X^@U;^WM,;4(].:SCL[:1B9,L'=B752
M<;>%P<<G-9.F'2+WPSXH@OM1DLXI/%,TD5Y;N UNQD5HI<]-NX#GIC/UKOK/
M1]7N+BWFU^_L;G[,_F11V=FT(WX(#,6=R>O08_&N@H \<UFXUJ^^'/C?3[^2
MVU1[2.(1:K91;1>+PQW!<C>@'...1Z5N:UJVEZC\0/ -W#<Q26^+UED;@?-$
M IY]2, ]STKT<  8 P** /+O$^IVHU_Q3I 3^SI_[(41F&#=-J(V/\JG!^1,
MX( SR3D 51TV_LKBX^$I,J$0VDBOO&-K"U"CK_M# /J.*]?HH \9U=EN]'^+
M$%H1,[NDB)'\Q8"% Q '7D'/N*]7T74+74]'MKJSE\V!XUVR $!N.V>M7Z*
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MGRB;AP2!N/L"/45%X'\0Z)X9^$&A:AJ4Z6\$42P2.D98I(S'((4$@YY->D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.&4.,_='.1CT.>*2?$:1O"GA?6+XQZ=;ZJK"ZO#"TD5NX& .ORAFS@G. /Q
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M]PI*KG&X^F:X*P\7ZNOB+PYIU^UE))JHG2[@@0D6<J1EP@D#%6(P5(Z]^.E
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M@^;)Y.2.@S795FZIKVGZ--8PWTKQO?7"VUOB)F#R-T7(&!WZD=#6E0!A>,-
MF\3>&;G2X+S[++(R.LC)O7*N&VLN1E3C!'O67!X7UQ/%<VOS:K8O+/IHLY(4
MM65 RLS J=Y('S<YR3[9X[&B@#@(_ 6I1>#?#V@KJ%H6T>]ANO/,38E$3[E7
M;GC.<$Y/2K2>$-7TW7-8N='U*TCL-9/FW-O<P,YBF*[6>,AA][N#_P#6KM:*
M ,/P?H=QX;\*:?HUS=1W3VD0C$L<10$#IP2?S_05N444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!Y$3QLJ/O<%L#:K,3SSBM2[\)W4^M^'=035 ?[',SL)H-[W#2J5<DA@%ZD@
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M(,E?P[CCD=QFL6V\)ZRGB>PUZZURVDN8+%[*2.*QV1LI96&T;R5Y49Z^VWL
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M W&11MZG!.>!0!TMIJD%YJ-]91QSK+9,BR-)$RHVY=PVL>&XZXZ5<8A5).<
M9X&:XJSU_7IM5\;60>RFFTD1?80Z^5'EX?,&\Y)QDC)SV[5'H?B6^E\;6NCO
M?&_M+K2FNS,T 0"5753Y;  /&0W!YZ?>- '3Z)KUAXAMKBXT]Y&C@N'MG\R)
MHR'3AAA@#P?45IUQ/PV_X\_$G_8PWW_HRI?%.JZ[:^+_  [I&EW=K!!J@N5=
MI;<NR&./<&^]SUZ<<CDXH [&BN$&K>(;F]O="BN99+[3+6'S[RTMX0)9Y%+
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MK0P7^5'DL&SEL;>@QSD5D^.O^0_X)_[#0_\ 1,E '4ZKJMEHFFSZCJ-PL%I
M 9)""<9.!P,D\D# JKH'B;2/%%K+=:/=-<PQ/Y;N87C ;&<?,HSP1TJKXLT#
M4=>MK1=,UM]*N+6;STD%NLP9@"!N5N"!D_C@]JXK6O&6O6OPS\41ZDD<&OZ7
M*EA)-;Y"/YI0)*GIE9,X[$=NE 'I U>Q-E<WIG5;.V#&2X;A %SN(/<#!R>G
M!]*SK/Q?I5YK8T=C<6U\\0FACN86C\Y#G!0G@]#QUX/'!KG_ (F6'V#X0ZG:
M64I@M[6R$6Q5!W(,*%]OPJUXTMKF'X8:I*UXTMW9VWVR"XV!&1XL2*1CT*T
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MK^<T:?O&D)YP22 %(P!G)S@/\/>,/#_AOP'X5@UC5(;2672+9T5PWS+Y:C/
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M",@CO2UD>%XIHO#&FK-<&=C;1D,4"X&P8'%:] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_BC19
M/$?AN^T>.Z6U%Y$8GE,7F84]<#<.:V** .5U;PI>:KINA6K:I#&^E7<%WY@M
M"1*T0^48\S@'OR?PJ>V\-WEKXKU;74U*$MJ$$4/DM:G$?E[MISOY^\<]/PKH
MZ* .!L/AU>:78^&HK/7U2YT(SK%*UGN26.7[P9-_##LP/X4DWPWN9?#VMZ/_
M ,) QAU34/MQ>2T4M&2ZN1PPR25'/ QVKL-:UBUT#1[G5+WS?LULA>0Q1EV
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M;E5.0=A;Y6&>#D\<>N>QHH Y;4_"$MX=#FMM7EAO=)N'G%Q-")3,9%99-RY
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M0N XP,,?4Y_*KD_@A[N]\52W&I*8?$-LEM)&EOM,(6-D4ABQSPQ)R/RKKZ*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KP_P 8ZUI]UX9\:6T$L6GRP:JOFV"#=-.RR1 W
M$F<D(0 1M"C@9)SBO<*88HR6)C4EAAN.OUH H0>(-*N=5CTR&\1[R2U^V)$
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MXATN_G^&36ETLZV[^7,T:EA&_P!E*[&('#9[=10!WL_COPM;QR22Z[9!(IC
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MQ('.,;0 <L>.V>#2VOCSPM>RQQV^LV[F2.653\P79$2')8C Q@]3TYZ4 =$
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M+J<4=C%*89'=64I(#@H5(W!@>V,T ;E5;ZPCU 1).S>5'(LAC&,.5(*Y[X!
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MC+!(T+%F[ X' SU)X%2KX@L%L+:ZFDD3[0=L<9@D\R1L9(6/;N/ )X'09Z4
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MT8D7=-J.H^2@/+[Q\FT=PW;'6O7Z* /,M1N6MKKX?:_N\S1K*-X;QT^80/)
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M@]"V.U87C34X[_P]XXL5@ELKF&]!^PV]J<W"AH_])D;:<A@.,$  #.37ME%
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M[ #KVK*U'4],T3Q_KB>)S?PZ?JR026%U!)/Y4BB((\1\H]<@D#'\7N,^I44
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MBR8L885R<.HVXW'H<$]!Q4=M\0/#%XU@+?4MZW\GE6\GD2"-G)("%]NU6..
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M,=MFX:"^5I6D1P5/EJ,D$EL $9/>@#U+6=:T_P /Z9+J.J7*V]I%]^0J3C\
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MD& ,DGU))/))/))ZDU-110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!G@>]+0 445F-K^GKXC30"\@U![=KD(8F"F,$ D,1@\D=": -.BBB@ HHHH
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M-.US1M7-IJ=K;&SF>ZA\]+J(MN(<!E.[=EL@CF@"G\,DGC_X2U+J599E\0W
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MB& WY"_-TR3G^+'%5(_A_=1>$_#^A)K,6-&O(;I)C9G,GE-N52/,XY/)S^5
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %4M6U*/1]+GOYH;F:.$
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MW*R[5 *G!!# XZY/2JFG>(=7B3Q1I.H7IDUFQN5CLF$2*'CF $#8Q@Y8D-U
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M2.8 0-C&#EB0QY QVJ_<:IJUC\0-!T9[U)K*ZLKB27,(5VDCV<DC_>Z #\:
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M^7&,L<CY%X/OS5Z;PM?W.NZ%J]QK2RW&E+,.;0 3>: &SAAM& ,8Z=\UU%%
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M6O;_ %#0;ZXU@//I,KS%FM1^^9E*G@,-HP3@<^Y-1)X.N$?Q,W]J1DZ]]_\
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M771>306;V;Q1V:Q)*C$$Y&6(S@9_3%0:#X$O=!=+*/Q-=S>'X9/,@TUX4W(
M=P0R_>* ]N/3ID'M:* ,#P_X<FT34]9NWOTN!J=S]I>,0;/+?:%P#N.1A16_
M110!@:GX=EU#Q7H^N+?+%_9BS*D!AW;Q* &RVX=E&./SJC%X-N8X/$T?]J1G
M^WF9I#]E/[DL@C.WY^?E'?O^5=;67XAUZT\,Z'<ZM?).UM;KN<01EVQ]/ZG
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M/+ "A &/R^I)Y)- &59>(_$,A\:V5F)[ZYTM89-/6YA1)F\R+=M*@ '!!(!
M/(!J&/XA6]MX;\0:[;:I<7_]GVJ9TV^@6&XMI\L,.%5?E)*>O0X-;<7@>:'4
M-8OT\0WPN-42#S'\N/Y)(N%<87T[=/7-3R^"K34KO4;O6GCNY[ZQ&GR^5#Y*
M^5DMTR26R>N>,# '< S=8U76?"\_AR]FU)]0M=0O(K&\A>*-0K2CY9(RJ@@!
MAT);(/KS6//J_BJ?2_&]S'X@$#:%<RFW\NSC.]4A638VX'Y>3[\]>U=79^$9
M%CTJWU/5'U"VTF19;1'A",752J-(P/SE03C 7GDY-0+X)D6Q\2VIU0E=?=WG
M/V<9B+H$.SYO[H&,YYH AFUC4KY]&==1^QP7NF?:/(LHUDNI)VV$85E8"-03
MECCDC)Q7*7.L:EXE\&_#O4YY8DU&XUJ,-+Y>5#!9EW;01Z9QD5V$'@>6UU33
M=0MM<N8)[73ETV4QPH1-"IRO#9VMGJ1^0JO:_#F.S\-:7I,6LW1?2KW[993O
M&AV,"V%9<?,OSMGG/N.E $.FZCKNG>,M2\,:OJ0U2"73#J%K=- D3Q@/L:-@
M@ /)!!Q61X3UNYL? 7@32;-9O/U.%P7A$9D5(U+';YA"Y)QUSQGC-=O!X>9;
MJ]U&>[$VJW5N+;[1Y6U(HQDA43)P,DDY))/?  &*WPX@;PEI6BIJMS#<Z/)Y
MFGZC"H66(\]1T8$$@CC(Q0!J>%SXC6YU.#6T=K1)5:PGF,0F="/F601?+E2.
M".H-<WXT\0ZUI%OXCN[750)=/2.6TM;6%9%1-H+&X++\I8[L ,#@ @5V.AZ1
M<Z9#(]_JL^J7TN!)<RHD?RC.U51  H&2?7).37/ZC\.UO_\ A(8$UN\@L=<)
MDGMEC0[92H7<&(SCY1\O'3KB@"MXG\67&D:M"NH7=YI.DW-DAM]1@MUEA2X)
M;<LQ*MM&-F.@.6R?1OB'Q5<Z+?6::GJ-S8Z5<6$9BU>T@2:#[22=WF$JV%QL
M*X !RW/IMR^%[U[>:V_MII;>XLUM)X[FU60-C<"Z@%0&(;'0C@<&D/A&2"S_
M +/L=1\O33I\>GFUN(!,NQ P# Y'S$-@YR.!Q0!3M]7U,>/=*TMM26>SN]%>
MZ?8J%3*K(N]&"YP=Q/IS7.WWBOQ'!X#\0:C#J2_;-.U][".1X$RT0G2( X&,
MX8\XKJ)? R0W&ASZ/JEQITNDVAL481K+YD!"_*=PQG*@@_H:I2_#=7\/:KHP
MUNZ\C4=1.H2,\2,R-Y@D 4_55R3G..V: +%\->TB6SCO/$R2V]U>N79+15N
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M+<)9QGS$CB1]C9!^7D].<GKVKK3X0<ZKX>OO[4D=M$BDBB$D*DRAU"L6(QV
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MZ(45L]<8/0$<C\*RX_A\8O"FC: FK,(-*NH[J&4P#>QC;>H;G&,DYQC/'3N
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M1FGDC9MQ0L<A">^U=J?110!#?ZS<W?CV'PO:W+V:KIS:A//&JEV'F"-47<"
M,[B3@GITKG;G5]3U#PYX\T'4+V3[7HD,@%W%&BFXA>!G0.-I4''!V@=L8KK-
M7\,B^UVQUZRNS9:K:1M")?+\Q)8FY,;KD9&>1@@@U$_A)&T;6K07A%WK._[;
M>&,%FW)LPJYP % "CG&.<G)H ?X%@D@\$:)YEW-<;["W9?-"#RQY:_*-JC@>
M^3[USOAFRNA\3/&N-6NB8S9YWI$1)F XW80<+GC:1[YKL]#TU]'T2STUKC[0
MMI"D$<FS:2JJ%&>3SQUX^E9VF^&[C3?$>LZRNHK))JOE^;$T'RH8T*IMPV>A
MYSG/M0!Q1\5^)#\,[;5UU*/^T/[8-I)(;=,.GVHQ 8Z#C\??O7066HZY8?$&
M\T*YU-;^&72/[0A,T*1"&02;"H*#.PY!YR1CK31\/"/"B^'_ .V'\A;[[:)?
MLXW[O,\W'7&-WMTXK1OO!_\ :7B&?5;J_/\ I&EOI<L,<6T&)CN8@Y)#9Z'I
MCMWH Y[3/$FL)XD\*6DNJ-?QZK'<)>.L""W\U(MX,#!59E!!&>01CG-4)]<\
M5OX9\8ZHFOB.30M1N$@5;./$J1JC;'R#\N">F#DGGH!T%I\/IK=_#TDOB.]E
M?0]R6Q\F)1Y13R]I&.NW W<GCC!YJ;_A!7.A^(M+;528]=N);B=_LXS&9  P
M7YNF ,9SCWH =#KEWKWB4:/;W;Z>D6F17LLD*HTC/*2%4;U8!5"DGC))'3!S
M0UG4?%6A:)X8%]J5JU_-K%O9WKV\(*S1/(1QN'RDJ!G ZDXQQ5R_\"337FFZ
MGIVNW&FZO96HLVNX8499X1R%>-L@\\Y]?PQ:U3P=_:.G:9:#4YE:QOH[]IY$
M#R3S(VX%N@P2>@ XP!@#% &+XRUW6=+3Q'/:ZKY;6%HMQ9VUI"LI4!2S-<;D
M.T$@@ ,,@''-/U6Y:\\=?#JZ<!6FBO)"!T!-N#_6KFH> /MUSX@*ZW=P6NNQ
M;;JW2-"-_E[-P8@D# 'R^W7%61X.E%_X<NVU>2230XY$C\R%?WV]-C;L8Q\H
M&,=.^: (_B#JNK:/I&GW&DW<=O+)J-O;OOB#AEDD"D<].O;GZ54GOM<TW6[/
MPY+J=UJ-Q=)<7K7-O;P12I$K(JQJ'.P\N26P3@=.XW/%/AUO$MC;6OVUK58+
MJ.Z#+&'):-@RCD],CFJWB;PC_P )#)IU[!J<^FZQIY8V]];*#C< '4HV0RG
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MGY"/Y!<Y8(YY"D]OUZY -_7O.'@._>WNIK69-/=TFA(#J1'G@D''3Z^F#S7
M74%S'\._AKMO7EEDU'3&C:=%(BS"< !0N5'N<^]>H-IB2Z&^E7$\LT;VYMWE
M;:'92NTG@ 9Q[5S(\!3?V)H6F/KLTB:-<PW%N[VZY/E+MC0@8^7!Y[GU% &;
M)XJU7PS>^,8-1O6U6/2["*_M6EB2-@7#@H=@ *[E'.,@$]:U+-_%B^(-,E N
M9]*F1A?B[^S*(SC*/#Y9+8SP0Q/&._-6Y?!L-WKFL7]]<BX@U:S6RN+7RMJ^
M6N[&#G.?F//\JB\.>#KS0V@BNO$M_J=A:#%G:SHBB+C W,!ND('3)P.N.!@
MA\7:EK=IXH\,:?I=_%;0ZE-/#,'@#_=B9@<GTQG''(YXXKG[CQ!XHT1?&6CW
M>K)=W6EZ;_:=CJ#6J*Q3:V4=  N0RX!QZ_AH>/9U'C;P1&E_%:SK>3OO?!VC
MR6 W D<$_+U'7@@UM7?@X7UEKBW%]F^UJ#[-<W*PX"0A2H2-<\ !F/)/))]
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M>QV4]]]OAB$49\F3S!(>2,L-PX!]><T -T^&\D^,.NK_ &K=^7'I]LZ1$1E
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M>/8C+NV@ D;B,@"@#KJ*XWQ->ZA'J]Q!!JDD4:Z<TL%K8HK3^;D_O)-RE5C
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M_58H+V-XX^5=7<ID*,;=H7(QGO2^'(+@_%;QB7U*[>.%++$3E"I5DD(7[N0
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MJ6@M)X=JA1& P&TXR#\QYR>M1:;X1N-)T_2[:UU^]9M.0Q1--'&RM%M"B-E
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M]-^<8Z<;< 8  Q@5U5% 'F7Q!T=])^%6NI=ZK=:GJ-U'&GGW&T.^)!A$10
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5DZCXFT?27D6]O1$(=OG/L9DAW?=\
MQ@"$SD?>(K6KRS2M<TS2-1\4>&?%5K(]Q>ZG/<V\#6S2B^@DQL"8!#$ !<=L
M#T. #U($,H(((/(([TM9=OK%BNK0Z"08=0^QBZ^SJA*I'G;PP&W@\8_2M2@
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M8[JX93"%,K+$[K%NZ;V4$*3Z$CJ*ST\9Z>_BZ]T$B5&LX$EEF>)PF6+<9QC
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MU-ITM9'+V[!)4DB>-D)&0"K $<$'\:R?'$.G7'AIX=3N9[2W>>$+=6[;7MY
MX*2 ]L, 2?2L_P "7NK37FL66IW5KJ:6C1+!J]M&$%TI4G:P'R[DXSC^\* .
MSKD_&OB2VT[PYK26VI2VU_:VCN)((C)Y+["4#MM94R<?>P>>*ZRO'H-8@TSP
MMX]\/ZTYAUF26_G2.1"3=1R(=CIQ\PQ@<= O.* .PTW4X+BU\&+>:_-!J-S:
MI*+56!-Z3!EMXP3@<MGCD5NR>(=+BNQ;/<-O,XM]PB<IYIX";P-N[GIG->>B
M\M_/^%19]ACC.\2 J4_T4IR#T&[CW-)-/-I?B"6Z\/:HEY;W.L^7?>'KM0SK
M+YV&FA/WEP1YG]W&3VH ] U'Q/HVE22)>WJQ"(J)GV,R0EL;?,< JF<C[Q'4
M5C3W]\GQ9L;!;Z5M/GTB:<VWR[ ZR( PP,G@GJ37.:1K>EZ3=^)O"_BFTDDN
MKO4Y[B"W>U:47\,A!39@$,0 %QVP/0XU+B:-/C!HZ$Q0.-#FBV!@1&YD0A/K
M@' [@4 =1/XHT6VN/)FOE3$WV<RE&\I9>FPR8V!L\8)SFI-1\0:9I32K>7#)
MY,7G3%(GD$2<_,Y4':.#R<=#Z5Y=82H?@QJ7A#44SXCB2XM6L6YEFG:1FC=1
MU8$LK;AQU.>*MZ]!<:5)<76G^($MO$%GIL,5]8W@$D&J*L?  /.XDLN5YY Q
MS0!Z2FMZ<^J2::MQF]C@^T-!Y;;C'G&X#'(SQQGFJ;>,O#J6$%\^K6Z6]Q<?
M9HG8D;I=VTK@C.0>#Z=ZY.35H],^)^F:GK$;6"7WAU8$5E+?O_.#M$,#E@#T
MZFN36[MF^'MG%."A'BWS'CF0CY/M19CSU 7KZ=Z /6K7Q;H=[8_;+2^%Q#YS
M6X$,;N[2+RRJ@&XD#G@=.>E7=+U:PUJR%YIUREQ 6*%ER"K X*D'D$=P>:X?
MQK?6^B^,-$UO4A=?V ]I/;27-H\BBWD=D978QD':P3%=#X.@T5;.]O-!M9H[
M.]N6G,\SR$W+D#=(!(<X/3/&<$],$@'25D2^*-&AO8[62^57DG^S(Y1O+,W_
M #S\S&S?P1MSG/%:KAC&P4X8@X/H:\K\$ZWI?_"-6'A'6M.>;Q#IT^UK":V9
MB95D)68,00%YW;_KUXR >@ZAXDTG2Y)4N[O88%#SE8W=85/0R%00@]VQ27OB
M?0].N+2"[U2VBENT,D"E\^8H7<6&.V!U[UQWA[4+;0]4\9:7XED2&6ZU&6\A
M\[I=6TB*JA,_?("[=HR1P*PM&L9]$;X5Z?K#!+NV%VTJ2GF$-&WEJWIC*J/<
M8H [V]\>:';^%-0\06UPUW;66Y)$BB;>) /N%2,KVY(  .>E3CQIH4-M8O>Z
MA';37:%HXI59&;:NYL C.  >>_:O/M1(O-/^+$%IB:24*\:1\EP+=0Q4#KR"
M#CO6EJFK:;?ZU\.KB.='@2>1BSJ0!_HY4-SVW8 /K[B@#MHO%>BW%A:WMO>_
M:(;M&D@$$3R.Z*<,P106P#P3C@US_CW7V;X:W.N>'M79 K1&.>V*D,#*J,I)
M!(ZGI@@BHI+H:!\6KJZU9UM]-U#3(H;.ZE.V)'C=BT18\*3NW<]:Y/6[1[/X
M:>-+CE+34];%Q81$8+IYT674=<,59A[#/0T >LZAKNG:8[I=3LK)'YT@2)Y/
M+3GYFV@[5X/)P.#Z&KT4J30I+&VY'4,I]0>17F_B^6-==NM5T/Q%%I^L0Z>C
M-!<[7M=1ARY5<'JV=PRO(W#UKO=%GFN=!T^>XM/L<TEM&\EM_P \6*@E/P/'
MX4 3WE[;:=9S7EY/'!;0J7DED;"J!W)JA!XETBX>Z07@B>TC$LZ7$;0M&AZ,
M0X!VG!YZ5G_$&]33_ ^I7,FFQZ@BA-T$J%TP74;V4<D+]X@?W>W6N2T[5;/_
M (6?=7;:C-=V]QX=7;=RPE(W(F<G:0H4*!CG\,DT =G;>./#5Y<64%OJ\$DE
M]Q;X#8<]AG& 3C@'!/:G^(-=LK"SO;<W\EO=1VYE+P1&1H!@X=OE8(.#RW'!
M]*\OM)[:'X2^ $,D:20ZQ9M(N0"FV4ER1VP#DGW]ZWM+UJWT77_&FF:[(8;R
M_N6NK)Y%)%U T2JBQD#YBNW&T<\_6@#J_A_?76I^ -#OKV=Y[J>U5Y97ZLQ[
MFNDKD/A=('^&>@ !P4M51@R%>1]>OUKKZ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***S=9U[3/#
M]O%/JEVMM%+*L2,RDY9C@#@>_7I0!I45S^F^-O#VKWEW9V=_NN+2/S98GA=&
MV?WU#*-R^ZYZCU%,TWQYX:U:6-++4U</!)<"1HG1!&APQ+, !CK@G."#T- '
M1T5CVOBC2;N_M[))Y(Y[I#);+/!)$)U R2A90&P.<#G'/2F7_B[1--DD%W=E
M(XIE@EG$+M%%(V,*\@&U3R.IXR,XS0!MT5DZIXDTS1O.^URRX@C$LYAMY)?)
M0Y^9]BG:.">>P)[4^?7],AALY!<^=]M7?;+;HTK2KC.Y0H)*X(YZ<CUH TZ*
M\X\'^+K:TTOQ+J6L:I>2V,.NRV\4]Q%(QB3;&%4@+E!N;&"!R?6NUEU[38=9
M_LB6=DOC UR(S$^#&N 6#8VG&1T.: -*BN;L/'OAK4[B&&TU(.9EE96,+J@$
M6=^6*@+C!/)''/0BKEKXITF[U2+34GECNIHC- D]O)%YR#J4+* V/;MSTH V
M**R;3Q)IE]<VT%O+,QN@S6[FWD$<JJ,DJY7:1CGKR.1D5=U#4+32M/GO[Z=(
M+6!"\DKGA10!9HK(MO$^E7-Q=6PFEBN+6)9Y89[>2)Q&<X8*R@D<$<9YXZU0
MM?B!X9O6T\6^HETU"3RK>7[/((V<D@(7*[58XX4D$\>HH Z:BL36]=L+2*[L
MWNKA+B.#S)#:PO(T"'.&;:I"]#C/H3VJA\-KVZU'X=:)>7MQ)<7,UONDEE8L
MS')Y)- '545SVI>./#VE7ES9W=^1=6R!Y88X))' .<8"J<]#TSC!SBAO'/AI
M=*T_4SJL1LM0E6*VF"L0[DXP>/EYSG.,8.>E '0T5AVOB[1KVQ2[M9YYEDDD
MC2-+64RLR'#_ +O;NP.,G&.1ZT^W\5:->:;!?VUV9HIYC!&L<3F1I!DLFS&X
M, I)!' !)XH V:*RX_$.F26#7HFD$(F-OAH'5S(#C8$(W%L]@*IMXW\/QZ?J
M%[->M#'IS!;Q)8)$DA)&1N0KNP1R#C![4 =!16%9^,-#O]573;>[9KIX3-$I
M@D594&,E&*[7QD9"DU4\/^-K+7(=6N'CGL[>PN982]Q \8"QX#%F(P&W9^7.
M0,9% '445DV/B32[_4Y-,BEECOHXA,8+B"2%VC)QO4.!D9XR.AZUR/C'Q5%/
M)X9.DZC>QK<:Y;0EXHW2&YC+X8!]N&''8X(SU% 'HE%(S!%+,<*!DFN2T_Q/
MX=TGPY=ZJ^NW=UIXO95>XN@[E)"^#&HV@A03M''XT ==16-I_BK1]4U>;2K2
MZ9KR*/SMC0N@>/.-Z,P =<\94D4[Q1K\7ACPW?:Q-!-,MM$7$<2%BQQQG'0>
MI/ H UZ*\\USQ%(-=\$WXOKNTLKJ:9;J!D>)'Q S#*L S?-C'4'C'-="/%.A
MZMX?U2ZBU&>WM[4/#=2>5)#-;';R=K+N4@'(.* .BHK"L-9TVTT/1Q'>W=ZE
MS:H]M(T;RSW$853YC +GH5)) Y8=R!6II]_;:I8QWEH[/!)G:S(4/!(.0P!'
M(/44 6:*YS5?'7AS1;RYM+[4#'<6T:RRQK!(Y52< _*ISSGITQS5C4?%NC:5
MYC7ERZ11,J33+!(\4);& [A2J=1U(QD9QF@#;HKGM0\<>'=+O)[2YU#_ $F"
M,2O%%"\C%3T("J=W0],\ D]*LVWBK1+S0X-9MK]);"X8)#(BL3(Y. @4#<6S
MQMQGVH V**QX?%.CSQW[?:FC:P :ZBFA>.2($9!*, V".A P>U8&I_%+P]:Z
M'>7]A+/?20V7VR..*VEPZGA26*X R0#D\=^>* .WHJKIUZFH6,5RBRJ''(EA
M>(Y_W7 .*JZAXBTW39I89Y)7EAC$TR6]O),8D.<,P0':#@XSUP<=#0!J45D'
MQ1HP.F8O5==4(6RDC1F28D$X#@;0< ]2.E-D\5Z+$^JI+>%&TI5>]#PR Q*P
M)4\K\P(!.1GI0!LT5BZ-XLT;Q!</!IEVT[I!'<']RZC8_P!T@D 'T('0@@\B
MKU_JEIIODK<2-YDS%8HHXVDDD(&3M502<#DG''>@"Y16/;^*M%NM(;5(KY3:
MI,;=B48.LN[;Y90C=OR0-N,G(XI;?Q-I-S)>1+</'/9()+B&:%XY$4]&VL 2
M#Z@$4 :]%<U:^/\ PU>R:>EOJ)==0;R[:3[/((W<YPA<KM#''"D@^W(J[JGB
MG2-'-Q]LN) +90]PT4#R+ IZ%RH(7UY[<]* -BBN*U'4)Q\3?#BV^H3OI]Y8
M74K0QOF)]H0JP Z_>/K[5L-XQT)=&O-7:\<6-E,T%S)]FES$ZG#!EV[AC/)Q
MB@#=HK+O/$.FV+,LLDK,D(N'$,$DICC.<,P4' .UL9ZX/H:HW.I:5/XIT./^
MU[N*[EAEDM[.,L(KE"@):0;<':.1DC!- '145B7WBW1=.:?[3=.L5O((KB=8
M':*%CCAW *KU&<GC(SBB_P#%NAZ;J,>GW5[B[DA,\<21.Y=!C[NT'<>1@#D^
ME &W16+9^*]&O]'75;:[+VK3?9P/*<2>;NV^7Y9&[=GMC/X5=T[5;75%N#;&
M7-O+Y,RRPO&R/M5L$, >C*<].: +M%9^H:W8Z9<6]M<2.;FX#&&"&)I)'"C+
M$*H)P,CGIR/6N/\ &/B2&XT/PUK>D:Q+%83:U:QRR1L8U>(R8=7R 0!M((..
MAS0!Z!16'HOB_0_$%Y=6>GWA>ZM0&EAEB>)U4]&VN 2ON.*6+Q=HDMQ:1+=L
M!>/Y=K,\+K%.WHDA&UB<<8//;- &W162GB72I)-3C2>4R:7M^V1_9Y-T6X;A
MQMRV0,\9XK(O_'VG6]WX=CM([FZ@UHL\<\5K*Z^4(V;( 7)8D#Y<9 ))Q0!(
M_A_Q!::U?WNE:_;);WT@ED@OK$SF,A0OR,LB$#"C@YQSZFMS3-.73;>1?,,L
MTTAEGE*A?,<@#.!P!@  >@'4\U:DE6.!IB'*JI8A4+-C&>% R3[8S7E_B/QK
M-KWPEU;6]+EU#3+B"5A&RQO$=HN/+'SD8)*CD*>"<4 >IT5C6'BG1]3UB72;
M6Z9KR.+SMC0N@DCSC>C, '7/&5)%-?Q;HL=[;6TETZ&YF-O!,T+B&27GY%DQ
ML+<$8SR00.: -NB@G R>E8D7BS1IM0M;);IUDO,_97>!TCN,#)\MR-K<<\'D
M<C- &W17F\VLGQ-XF\2:4U[K=A'81VZV<ME;W"-&Y1I'=E"\YX 5Q@@?*.<E
MGAG4V\1V+:Y>ZWJMC+87\SR,5DCMWMXW*"-E8",D@#.!N!)Z=* /2Z*R;+Q+
MI=]J4VG1S217L40G:"Y@>%S'G&\!P,KGC(Z'K44/B[1;B]M;1+I_,O$9[4M!
M(J7(49;RV*X?CG@G(Y&10!MT5Q5IXVTW7M U^:YDO]+M+62>W:Y%O)&\:* I
M<-M(#@[CCJ,#(X-:MKXDT:RCT/3FO[J:74+=/L4DT,CM<@(#N+!<;L?,<XZY
M.* .@HK/DUO3X;B\AEG,;648EN&>-E1%.<'<1M/0\ U4A\6:/+=W-HUQ+#<V
M\/VAX;BWDB<Q9QO564%AGCC//% &W17-6GC_ ,-7LNGI;Z@SC4&V6TGV>01N
MYSA-Y7:&..%)!]N15W5/%&DZ-YQO9Y52WP;AX[>218 >A=E4A>"#SV.>E &Q
M165=^)-+LMV^=Y L N7-O"\P2(YPYV X!VG'K@^AI+KQ'IEH/WDLSX@%RXAM
MY)2D1SAF"J< X.,]<'T- &M14<$R7%O'/$=T<BAU.,9!&165J'BK2-,:Y%S<
M2;;7'VF2."21(,C/SLJD+P0>>@()XYH V:*XSQOXH&FPZ'!:R7!34]0@B>:V
MAD?,#;F;8Z C<0N  =V#D>M;F@Z<=-MIV&HZA=V]Q)Y\"7I9I(%('R9?Y\9S
MPW(SB@#7HKSZ^\9?V]X1\9/I_P#:%A/I:720S>0\;9BB#9+,N%.\GY<AL <"
MM3PQXOTN[M-$TJ6^D?4[BQC=3)&^V9EC!?;(1M=AU(!)'.: .MHK$O?%NBZ=
M,$NKIXT\X6[3^2YA20G&UI -H.>.3P>#S6W0 45YU\3/%4,/@K4FTK4KV"Z@
MF2%;BUC<)YGF*&3S0NW.-P.".>.O%=/)>:<WCF"T_M6[744LG;^SU+>2T>Y<
MR,,8W X YZ$\4 ;U%9-OXDTRZN[>WAEF8W+.D$GV>01RE02=K[=IX4]^<<9J
M*?Q=HEM<QPS7;*)+C[(LWDOY)FSC9YF-N[((Z]1CKQ0!MT5QNCW5W_PM'Q)9
MS7UQ+:165K+%#(_R1%C)NVCH.@]ZUX_%VB2W%K$+M@+Q_+MIGA=89V_NI(1M
M8G'&#SVS0!MT5DW/B33+2XDADEF)CF2WD>.WD=$D?;M5F52 3N7J>,C.,TL?
MB32Y9]3@2>5IM+"F[C^SR;HPP)4XVY;(!/RYH U:*YZ7QQX<AM]-G?4AY>IH
M7LR(G/F@ G@;<YP#P>3T'-21>+]&N--M[ZWFN)XKB)IHTAM97DV*<%B@7<!D
M$<@4 ;M%5-,U.RUG38-0TZY2XM)UW1RH>&'^>,=JMT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P
MWQ8=(_!]N\BED74[,LH4L2/.7(P.OTKN:P/%OAV7Q-IL%E'?):+%<Q7)9H/,
M+&-@RC[PP,CF@##NDM]6^)>CZW82(UGIEA<"\NU^X=^T)'NZ$CYV([=\9%<Y
MI6DW^K_LZSZ/IT;QZD8908&4HY/GLY4@XY9>!Z[J]=0,$4.06QR0, GZ4M '
MG>L7$?C1O"!TI)%NK74X;VY4QE6M(T1MZ29'RDDA=IZ_09JAX;U:'2;+4?!^
MOZ/<W6I"_GD@A>S:6*^624R))OVE ,GDL1C'M7J=% 'EEW>6FA>-O$%KXGM-
M4:SU9XYK.XM1</%,/*6-HBL7\0*]".0?I3T=/"7CS2K^YTV>QT&?1?L-N%1I
M%LY?-W['QG;E=OMD8R<9KU"B@#Q6[BN+_P !?$*.VL;UGDUPW<:FUD4R1!X6
M)7(&3A&XZ\=*Z3^VK74OBGHNIVL=T^G_ -DW"?:C:R*F2Z'DD<# /)P.V>M>
MC44 >3Z'IUWJGP6US2K"-TU&62\VQ.I1FW2NRCG'WEP ?>M3P]JF@>);_3KF
M+1M4.K60=I1?"X_T E"'&Z0[23PN!DGKV->B44 >6>$EN--UO1+;0K^:^\/W
M2.\FFWL>Z;2/D)&'(W*,G9M;UXSUKK_'MW+9>"=2N(=,CU)U5<VTD/FJ074%
MBG\049;'^S7244 >9:1?0I\5&U RZC<6EQH*J+VYMG1799F8_P ("C&.P'ID
MGG!LP8O@UX.MGBD6Y@U6V>6'RSOC"W!9B5QD  Y)]"/6O:Z* /-M)U0:!XO\
M66>L1W ;4YUN["X2!Y$N8C&%"*5!Y7&,>]:_PJWK\,]#BDAFBDB@V,DT3(0<
MGLP&1[CBNRHH \^&HV6G?&C5'O9D@5M%MPLDG"_ZU^-W0$^G?'M7,2:6^E^'
M=+:2VEB@N_&:ZE#;&([H;4R'!9<94!0"<]-PSS7I%MX<N(/&UWXB:_C9;FU2
MU-L+<C:J,6!W;NN6.>/RKH* /._&-T-%\;:7KM_!?S:%+8O9RSV+29MI"ZN'
M81G)5@,=^@]J@O=-\.W>BVK6T6HZ'#=:D]U::G'YB2)-Y?,\@<956^93OQD8
M]17I=% 'C]W<>(?[#TS5]4MY=2ATC6I?/GTZ-HGO+8Q&,7*JA!R"Y^[P0/3F
MK>O/HFI^!/%6I:%I]X6O;$0&[G2;S+IP"%15D^9MH[XQS@9P<>JT4 >=7TT4
MGC3X>RQG='%;W0D=5.(]T*JH8_PY88 /<8K">VU&;PEXRTNSL;M]2AU^74!;
MB-T\Z(7"2 *^,$LH.,')Q7L5% 'F#/I/C'2]0F\-Z?J1UC^S;B!;J^\]#;,Z
M$"(-(<%BQZ+D#!.>F<R[UVWU#P=X,LXK*^2]TW5-/6\M/L4I>W,7#9 7V.,=
M1^->Q44 -WJ$WD[5QDEN,#WSTKQ6[S)\(/%5LL4K3S:W*\<(B;>ZM=*X(7&2
M"H)SZ ^E>V44 <+>SQ2_%W0YXFWP_P!E7$9E490,SH54MT!(!(%:OQ"M9[WX
M>>(+>VB>::2QD"1H,LQV] .YKI:* /--0U""_P!8^'MS$LWDQ32-(TD+IL'V
M<J&8$#:-QP"<9(XJ-94&I?$]OFV3PQ^2=IQ+BVV'9_>^;Y>,\X%>GT4 >5"T
ML[SPGX)1]4N]$U6VTO%MJ*#"0.L<2O%*&&W#''RMC.RNU\%76IWOA6UGUB".
M&]+2!S'&464!V D"GIO&&_X%7044 <-;NG_"Z[V3!VMHD4"R;3M+B9V9 W3.
M"#BN=MKC3M.U/Q!X=\4Z9JT\MWJ$\]HD*SR0WT,K;E4!#LR,X.< 8Y->MT4
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MDCH2.]4+LGQ+\,=%\.6L$L&NPR6<+V[1E7M'A9=\C<?*H56PW0Y &2:]8HH
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MO8K6]6TNK*T$,\EI)&CE ^>648^\.O7M0!U=]KEG870M&$T]V8C-Y%O$TCA
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M TI0R0[4R%!/)XSTH S=.\4P>'_%?C5=4O-0N+:UN+=HT"27!@C, =SA0=B
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M#J6GVU];%C!<1++&64J2K#(R#R.#5BJ6D:I;ZUI-MJ-J)%AG7<%E0HZG."K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]\Q+;W)<$%4PHP/4Y[8 .UHKS?2_%.OSZ)X5AOO/_M/75EG?R8HTDCC1 VU
MYVY.5.3G@GC.".E\+'Q&DVIP:XK/;),#83S&+SGC(Y601_+E2.HZ@T :UWJ0
MM+^QM#:7<QNW91+#%NCAVKNS(W\(/0>IJ[7)^(=5U*Q\;^$[.WN@ECJ$UQ'<
MP^6I+[(69?F/(Y Z8Z5S4^J^*;BP\<3Q^(3 =#GD:V\NTB.X)"L@1MP/R_KS
MU[4 >HU5OM0@T^RN;J7>ZVT9DD2)=[A?]T<]C46B7SZGH.G7\BA7NK6*9E7H
M"R@D#\ZX/18;HZK\0FFU2\G2&8H(Y?+*D&W!'101C.  0/7- '>Z-JMOKFBV
M6JVJR+;W<*S1B0 ,%89&0">:O5Y)X?OM9T/PO\/+M-4+V5^]M82V/D($"/$Q
M#!L;]P*^N#Z"MBXUGQ-K]OK,_AXW4=Q97TMI:HHM_(<Q,%82[SO^8[NF, KC
MN2 >AT5!;M<2V$33HL-R\0+H#N".1R,]P#7F^D:[XC'A[5?$VH:WYUMH]Q?J
M]DMHBBZ6+<$!8<J00.GXYS0!Z?17$6,WBV35-&NXOM$^GSK_ ,3!+K[.J*&7
M*O#Y9+#![$G(]^:P]1\6:^_AG5]4M;YH-7M-8^Q1:6(D8%?-5%3!&XLRMOSG
MZ<4 >C2ZD(M8MM.^R7;F>-Y/M"19ACVX^5F[$YX'?!J[7'SZEJUG\1=#TB34
M!+97.GSR2IY*KNDCV -GJ/O'@<5EZ!XINK_Q'!I.J:E=:;K*33>?IMS BQSQ
M8?:8'V?, =A^\20#G- 'H2NCE@K*2APP!Z' .#^!!_&G5Y'I=SK&E^!O'6JV
MVMW37=EJ-_Y;7$<4@)C/#'Y1SA0/[H'1170M)XCL]&M=1N?$\'EWTEH75[95
M:!"I\Q8<*QDD<E0 0>^* .[HKS%_%&NIX=\=^7>RK<:(3):3W-NGFA#") K*
M %Z],C.#SS5VWU37K+Q/X12ZU<W5MKEO*LUN;=$6)DA\Q60@;L\$')(.>@Z
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MD4L(.55DR#E3T((/;D54OO 4%WHHT^*_EA=]0&I7%SY:L\TX8,">@ R ,8Z
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M@OF8WE >=N1[YYSJZ'X;ET2^UBZ74/.;4[@W+JT.!')M"\8.=N .#Z=:WZ*
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M"RF.>,QR(RL5*LIZ$$&@#10,$4.0SX^8@8!/T[4ZBB@ HHHH **** "BBB@
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MH \]\1V=['?> KN[U6>[>75HC,C*@C+F)SN4  J!R ,]",Y(S5F/6]8.D?$
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M8C$C@!F & 3CC- '(V%R]_\ &75HY2=FF:5#% IZ RMO=A[G:H_X#5+P_;W
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MTV>26-HT&Z1"@#Y"@\[CQTK*T3Q+=7'B:VTC6;^^TO6A/,9+.>)?(O(MKA#
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M368_*N[>54\K_CW\P,H R"".22<YKJO'*._@/7S'/-"Z:?/('A;:V50GK^%
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MD=JTW&(F&<_+7B_AF?4]&^'7@35;;5KD)+?6]G)9A4\EHI)65LC&2W?.?PH
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MJK2-M0$\L<$X'X G\*XNWO;_ ,5:SXCTU-1DL'TR.&&#[*_262+?YK'JP!(
M'0A3D'/&9J=E?M\0? \5]JTTETUE>+<26S!(VD1(P65<$#)+9_+B@#TJFR,4
MC9U1I"H)"+C+>PR0*\Z^V>)_%6G:G>Z'<FVO+?4)K>UW7 6%!%)MVR1[3NW
M$G//S#&*TM/U*[\3>*]:TR6\EM(=)AMD*V<F-\TJ%R^[&2H& HZ'DD'C !O>
M&?$%OXHT&'5[6":"&5Y$$<P <;'9#G!(ZKZUKUQ'PC5E^&]@KOO<3W09L8W'
M[1)SBNLU2^73-)O;]D+K:P/,4'5@JDX_2@"W17E^H:YK-C\,;#QU%J4LMYY<
M%W<VIQY$L<C*&B"X^7:&X8<Y7DG-7MNMZS\0-?TF/Q)?V=G;6]I<0K%'%N0L
M7)7E?NG;SGGIS@8(!Z!(YCB=PC.54D*O5O856TR\DU#3+>[ELY[.25 S6\X
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MVU#(T<J[A&^5P2N"-W!/'-;JW.JZ5X_\.V\NL7-Y;ZQ:7!G@F5!'&\:HRF,
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MQA-Y'S$#.T@]>AH QU\"6L^AWVF:KJNIZK]L@-NUQ=2@R1IUPF  #D DX))
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M%M)"LTD)==OF1XW+],@C]*YD> =.'@@^$?MVH'2ROE\O'Y@3=NV[MG3/X^]
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MHVC>)U."C(1N#9(&,9.1CK0!M45DV?B/3KS4WTT/+!?+%YP@N86B9H\XWKN
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M<6L3N# [9;8Z@_,RC P=W.1ZUNZ!I8TZ*YDBO]1N+>ZD$T4-\[,UN"!E1O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME:V10K*!D$LI'(ID$MII>L^(-"\3:)JUT;Z_FN;,P1RRPW<4IR$^4[01T.[
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M/V!YC#)=FR<10,'*?O&Q\N2.G7D9 R* .VHK(U+Q%;:>TR);W5[);PB>=+1
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M4XY/(X'3OBLW6?B);V_@6_\ $&F6=U++;3&T>"6/8UO-N"XD!/&"PX&<Y'X
M';T5%;3FYMUE,,L);/[N4 ,.>^":\WDNSXI\3^*M.U"VU=(+%;=+5K5_+DM3
MY9D9P=V Y)X/.0 /:@#TVBN;B\9Z3_8FBZDK7,EEJLT=M;3&/DNYVKO'49.>
M<8J.Z\>:5;7VJV26VI7-UIBHUQ%!9NS88$Y&<9 "YSTY&,T =116,OB?39=/
MTV\M7>Z&IJ'LXH5^>8;=QP#C&!U)( [U@ZU\1+:V\,7.I:;:7$T\%\-/FA=
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MY(8HD##HQ"*"Q';)QGG&0"-VBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1:W'D@,OH[+&'8>Q//?-=+0!Y3*+VY\'_#^ :/JJ2Z;J%B;I'LWW1K%$5=B
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>elicio-q1exhibit312002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit312002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#.I!.Y<E@3C+'=@X/2LG7X[73Y/ 5M;V36,%MJ(D^S<L;:+RW WGG;RP!R<
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M<BN977;?PUX^\0C6X+B33M;6WFL+J*V>XCE"Q!&BP@/.>0.^??F?7#'%XD\
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MX;4(H//-O#:RR.R9P-H53NYSTSC!SC%9NK?$'3K7P_I6KZ<DU[!J5Y%;1-'
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MXC^ 6G>&[*-Y-2N=D<<?E,/+/G[C*3CA0 3NZ=NIQ7M4ZR/ ZPNJ2$85F7<
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MXAOK74;:ZNHY(60V8B!,F[(&#_"!WSQD9->DT4 >6Q[CIWQ.7[/<9NWE-N#
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M87AVEG 1"@&!R=SEW _Z: 5AXD7PG\,HOLUR);.[M3<I]G?,(6!D8N,?* Q
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MR(FK_$2Q\0V1D_L_3],FCGN/+8"1G8%8QD9;&&8XZ<=S7=44 >+VL4\7P?\
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M,RE6/#@@@Y7(_2@#3TV^ET/3-/TG4);K4=52U\R7RQYDA13@LQXR>0,]6(.
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M1%:K]QG"<(/;( ^E>86$MW<ZYX#U1]+UMGMQ/'>A[)XH[>1H-HC2/ 5$!X#
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MK]GQ$ZGDK@@$]1D8ZXKU2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2]9TO2KA+@W&I.T<#)&2@*J6.YN@X!XY- &M1110 45CZ_XEL/#NFB_O!-)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIH=2Y0,"Z@$KGD
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M"[5(5G]LCN*V;:/Q7_PD(A:6^_L:XMG66:Z^RB:VF'W6C\O((/3# X/-23>
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M%>$*H0+M P5*C!!Z^O:IM1\#W&K^%[K2=1U^YN;F\:,W%Z\"!BL;!E5$7"J
M1Z'J?7@ H^);CQ-X;L+2X/B!;DW6M6T1'V)$V0R.JM&.O'7D\\]>,T>,-9UC
M3CXAEMM5\HV6GBYLK:SB65@55V9KC<A"J2H Y&0&QDUO^(_#DOB/3K*UEOQ
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MGQ;X<;6WEN+*.WEL;U[>(.AE1CM90NTJ&7TS@GFK2^!'CTGPWIZZJ=F@S)-
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MK*ZIE 5SP<<\5I'PS?>+-"MGU'5YX]2L+LS:;J\%M]GE*[0-S1'C!RRD<!@
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M[KQ/JEEX4\):M>C4)--N=/675+NQB5Y8Y&C0J[+@_)DN3M'IVX-/5YI=4G\
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MQ38Y$E3?&ZNIR,J<CC@UP,5SK%OXH\1>'KC7+NYA_LI+Z"X9(TE@9F=6"E5
MQ\H(R,C]:P+"]UK2?A+X1N]/UF=)KJYLX7$T<;KLD< K]T''XY]Z /7ZI:QJ
MD.BZ1=ZG<1S20VL32R+"NYMJC)P/H*Y)KO5;'Q3IGA2;7+BY:\6XOI;QH8TE
M$2X"Q+A=O4DEL9P.,=L^]U?4!:>/_#6H3M=K8:6]Q:W3J [120O\C[0 2I!
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M+I-DL?LPR<&L4V.NV$VK,=;,MB]J'M/-C5IX)0#N.=H4J>#SGFL'2=<U6_\
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M?TUY$C +NJ@D*-QQDGH*\GU'Q9XCM_#6M0+J.S4M&UF&R^U>2F+F&1T"EAC
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M9D<LK':=O<HO7/MCFMJ7PTT_BFPU^34)3/9V[VZQ"-0CJY!8GOG*CH>*WJ*
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MV[(SC:2.,53U[P4NJZ[!KFG:O>Z/JD<7D//:[6$T6<[75@0<'H?_ *V.IHH
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M7RT\PL)/, )QC&[VKM** /*]:N$?QIJ+77B/5- N4$,$*FQ6:*Y55SYD99&
M^9V& <\9/7 ZK2K#6M1TRR>]UN\#6U[YRS+;K ]Y"!PLL>/E!)/0 X . >G5
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH'EY) 51DD]Z[;2;'7GFM+J7Q#=W%C<Z?F1)(8 T4Y*%60K&.,;Q@@]JXO\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48&<XYHHH ****
M# SG'-%%% !1110 4444 %%%% !1110 4444 %%%% !1@9SCFBB@ HHHH **
M**    8 Q1@>G2BB@"EJ.F1:HD45RSFW219&A&-LA4AEW=\ @' ZXYXX-VBB
M@ HHHH *,#.<<T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ#;W4,TML^R=(Y QB;&<,!T./6@"Q1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[*Z\??$4W$4$I2TM%^< [5,#[AST' S6) \3^ ?A5,[(91J=F@<XS@)(,9_
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M(KS4W^D2:UXRT#Q7KKZ8US=,_E3-$BW%JT:JA1G0DD $84\'ISFK-II.DO\
M%'1[&6U6: >%2JQWR!I& E11O!ZMMR#GWH ].1TEC62-E=& 964Y!!Z$&G4U
M$2*-8XT5$4!551@ #H *=0 4444 %%%% !1110 4444 %%%% !1110 4444
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MI(!![<5SFB7'B+6/!VD:LFNQI?7UO',L$ELGENQ7>4'<< \YXZ\T =?%IUE
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M K&\7P3W/@O78+4$W$FGSI&%ZEC&P %;-% '#6%S;CX&VTOF(D7_  CRC).
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ML5U%(CV]X58./F_<*./7)!^M>BM;PN[.T,9=EV,Q49*^A]O:D-M Q4F&,E0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (!&",TF
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M&#(^ !QV4* H'8#N<DZ%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N-^*__ "2WQ#_U[?\
MLPKLJY_QMH=WXF\)WVBVDL,+7B>6TLN<(,@Y  YZ>HH 2]T6P\0^!ETW48D>
MWFLE!+#[AV<,/0CJ#7'> O%&NW?PY\,W,S6ZI)YT-WJ=XV5B6,LL?R[E+,Q
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>elicio-q1exhibit321001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit321001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP]JFO:K\8?$?A>?Q%J(TZQMC)!L\H.K9C&2=G/WS4?Q1UGQ1X.\.^'?L^O7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5:UK.M>-OA[H6M>%+ZXT[5;YV011RX1F2.5G0@\?>B(!XZC/%0>&?B!+XP\
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MMO4;>N[//)Y]ZZ^PLWN?$45SI6O7\]KI]V]M?V\MP)8Y,P;ACC.Y6=._KZ4
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MVJ/[YXYR.<G&, 5[# TCP1M*FR0J"R@YVG'(H DHHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%%  2 ,DX KC/!.O7'C)=2UY)FCL5N9+73H>=NQ, RN 1N+'L>@&!
MR23UUU";BTF@#;3)&R;O3(Q7G7P11['X>2:?<H4N=/OKB"XCQDJX;)&/H10!
M!X$US6[[XK>+M+U35)+RWL%5($VA$0;NRCC/;/6N9UGQQ=V_BGQKI6O7^I:?
M?QQM_P (^EO(\:' ;9@+P[.=A^;(/(XZ5N>!+>\M_C%XPOKC3M0@L[XC[-/+
M9R(DF#SABN/SK"\0>&KC6X_'$?B?3[ZXUGSR^AS1V[R Q#=Y21,H( R<,/?)
MY&: /8_#3ZI)X9TQ];4+JC6R&Z P,28YZ<9]<<9KS3P_J6I3_M!:YH4NJ7\F
MEVEMYT-LUTY56Q$?7D?.W!XYKT'P38ZGIO@G1[+6'+ZA#;*DQ+;B#V!/<@8&
M?:O/9+&\\)_'R_\ $=]8WDFC:I:>4EU;6[S+&^V,8<("1S&>W<>^ #T&*!O^
M$\N#]JNS$MA'((#<.8PY=P6VYQT 'I6#\6O$=_X9\,V=Y:"X%J]_%'?RVQQ(
MEN<EMI_A)P%W=L]B:V[&XEN]6U+6X;.Y^RK9QPVZR1&.2=E,CMA6 ('S* 2!
MDY[8)PK;QCJ6L:'I=YJ/A"_AMKRYEMKZQ> S,D04XD*E02N0 1CGG /&0"?P
MMJ.F:_?6>I>&/$5Q=:<BN+RPGN7D9&*_*Q\PEUP<C&=ISD=,U?\ B)XO'@CP
M==:NL:RW.1#;1M]UI&Z9]@ 3^%<1IG@>QL/BSI.L>#8+JTTY8IFU,&-TA&5P
MJ+O R23DJ.%V@\5<U^TU7XM_#O5+.70KG1;^TO=UI%>''G%!UR0,9#,/3/<T
M ;7@[0+W4_#-EK&NZWJUQJE_"MR3%>R0QP!QN55C0A. 1U!YS72^'++4M/TG
M[-JM\]]=+/,?M#@!G0R,4R!@ [2HP!VKF/!7BG['X4T_2];TW5+/5;&!+:6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5GPZ/:VNL7&IVVZ&:Z4"Y1"-DQ PK,/[P'&1C(ZYP,
M:%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 9\6CVJ:S)JS[YKUH_)220@^5'G.Q!V!/)/4\9/ QH
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDA)6'E?M!^0_N_NG';YO>H3XSU;2]+\87%W/%=2Z?JL=E9[H@B()!&%W <D
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M&-HP%QC  XXK'N?"M]I.E06^@:G/:W<FI->S^3 OES,[996!X2,>F<X7')-
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MVECQNP0H!4AAP0<'VXK"\)V%RWA[QJPU>^7;JVH(<"+YB"/F/R=3C![<\ 4
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MMS@<=>M '5T5Y!9>(/$P\ :%XJGUZ66=M12":V^SQ+'-&UR8CN^7.['0@@#
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M[Z^N([>U@0O)+(<!0* ,VTT!H]475;Z]:\U&.W-O#*8@BQ(2"Q"CNQ"Y.>P
MQ5+3/"#:7INL646JSNNJ3S7,KO$FY'E^\5P,8] 0:EE\7PVU@-2NM)U2WTS
M=KR2)-J(?XV0,9%7N<IP.N*WXI8YX4FAD62*10R.AR&!Y!![B@#DY_ <=QX$
MA\)/JER+*)8T68(GF;8V#*,XQU4<XJ36?!1U'6[;7+'6;S2M6C@^S2W%JJ$3
MQYSAD8$<'H>WY5T.HWJZ;IMS>O#+,EO&9&CB +$ 9.,D#]:BT/58M=T*QU:"
M-XX;R!)T23&Y0PR <=^: ,/6? EIJEGIH@U&^LM1TUVDMM1B<&8,_P!_=D88
M-U(QC\.*;?\ @?\ M+0DTZZUJ^EF-S'=37CJADD=""@QC:J@@?*!^I)/6T4
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M.&,88YV+P,*.PK0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,FP/N*X9MN$R00-Q&>U7;/Q;H=_J4^GV]\#<PQ&=E:-T#1@X+JS !USW4D4
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M[V<,,99H(S(W.%X5>3R>?3FMI2&4,,X(SR,4M% !1110 4444 %>?_%^1?\
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M5S=1P/Y!$3.%?'!; ( '7G K(\%#5;37[W3FU1];T5+5'MM0GCQ-&VXCR'<
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M">2VZ%4B=7+C'R@$C)/K0!ZY7,?$'Q#-X9\$ZGJ-J'^UI"1 RPLZHYX#-@$
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M\EU),MI'.+>:\6%C#%(3C:SC@<D GH#P2#6U<O*EI,]N@DF"$QJ3@,V.!^=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEE:1-J,'SC:<Y/W3VH UZ*** "BBB@ HHHH **** "BFNZ11M)(RHB@LS,<
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M.5+ \_,<9R/8UOKX)2V;5H-/U.>TT[5I'ENK545MKN,.8F/W-W?@^V*L'PC
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MM+H1H75V+%@P(VL#O;M5F/P*L4GB%QK5ZYUR(1W'F+&=I\ORRXPHYQT'0>E
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MUVRAL;S[1HVT2QE5W2ED+J$^;G(QC..M<MI'BS4->C\&::]P8)]5T]KZ]GB
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MW-^^E. @4 * "1NPW!-8UQ=W_B"+X8ZC<ZA<Q3WK;IO(*JI?[.Y+[2",]?8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M((KK* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH IZAIL.IK#'<L[01R+*T(QMD
M92&7=W(! ..^.<CBKE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?7BI+C4;*TFCBN;RWADE#&-))0I<*"Q(!/. "3["@#'^Q^,?^@YHG_@HE_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6O/=!M=,N_BOXU2:"UGD6.P(5U5B"$8DX/N%/U KT*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.6"&< 311R =-Z@
MX_.I** &)%'''Y<<:HG]U1@?E38K:" DPPQQD]=B 9_*I:* (8[2VBN)+B.W
MB2:3[\BH S?4]338[&TBN#<1VL"3D8,BQ@,1Z9ZU8HH BCMH(7+Q01HQZLJ
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MW(K1@A3ZCTJ2.*.%=L:*BDDX48&3R35"/Q!I$NDQZK'J5L]A*0([A9 5<DX
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M$;3+L&\CTSUQ0+2V$OFBWB\S.=^P9SZYJDWB'1TU&.P;4;=;J1S$B%_O..J
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MZL$ /YU+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>elicio-q1exhibit322001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-q1exhibit322001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ<(Q';%1A=B_*,>W''M6C0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#"HHZ 5/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@KEASA0RG'0GKFLW1/C!+!\&O^$CU-%N=5AN#8*OW1/-@,I..GRG)QZ'&,T
M>QT5R'@C4;?5(7DF\1KJVL1J/MD44NV. G^%8A@;1T#')..M9OQ:\>7/@CP]
M;_V:B-JE_*8;<N,K& /F?'<C( 'J?;% 'H-%<#XDTK6-!\!76J6>OZ@^MZ?;
M&ZDGEEWQS%!N=3$?D"D XP 1QS7->(/'M[KGP+/BW3;B;3M3B=(Y/(D("OYB
MHXQT((.1G.,T >QT5YIHBW.M>&M"$'B;4DU^YTV/4'7[2&5P-FX.I' 8O@8Q
MW]*[76]+N]4:QCM]2N+&&*?S+@V[[7E38P"9P<#<5)^E &M17C/A&\U?7/B?
MXM\/W6OZJ+&P#"VV3X:/YP <XYX/?-,^)VI^(?"MOX,MX==NTN;E_L]]-')@
M3;?+&[!X!Y)XQUH ]IHKQWXPZ_?:$?#O]@ZW<VYN;DPSB*X+[E^7&<D\\GFI
M?C)J^J^&F\-_V/JE[:"ZN6AGVS%MZC;C.[//)Y]Z /7:*Y#3[1[GQ#'=:5KU
M_/:Z?=/;7UO+<"6.3,.X8.,Y5G3OZ^E6OB#K&HZ!X#U?5-)CWWMO#NC^7=MR
MP!?'?:"6_"@#I:*\S\*Z[I_BJQTZX\->)[UKZ*6%]0LKRXWO(FX>9E7SM[G,
M> >G?CI_'NN7.@>#M0N["-I=0:)TM409)?:6+ ?[*JS_ $6@#I:*Y7X=^*%\
M8>!]/U1F!N2GDW0!P1*O#?3/#?1A7#^&[_5=6^,/BGP_=:WJ0TVRB+VZ)<$&
M,[D[]3C<>N: /8J*\N^%/BC6/$5WXGTK4[M]0L].NC#:ZB $:1=SC&Y, G"J
M<CGGZ5R'A[Q-J5YIGCJ75/%U]:RZ3(RZ>YN%'(\S"[2/GR548ZT ?0%%<=\,
M-8U[7? UI?>(H&COF9E#O'Y9E0'Y7*\8S].<9[UA6/Q$GD^,\_AZY4QZ5=6V
MRP9A@22QLVYQ[,1(OOL7UH ].HKB?B5::]<Z/:+X:U*>RU62<QQ[)-JR 1N^
MT@\9.W /]*Y?PQ\0)_%O@'5[&^N9[#Q1I%M(TWEMY;L4!Q)CZ\,N, _44 >O
M45Y#\9=7U7PQ'X<.CZK>VOVBY,$Q$Q;>HV]=V>>3S[UU]A9O<^(HKG2M>OY[
M73[M[:_MY;@2QR9@W#'&=RLZ=_7TH Z^BO'].\=V-[XX\0Z-XHUF]T>^@O6A
MTX+.885B'"G^ZS'[W[S(.1CTKT[08;^WT:"+5+K[7>*7WW& /,^<X; X&1C@
M=.E &E17FGQ)\:ZEIOB'0?"&ARBVU'5Y4$EV5#&")GVY4'C)PW7IM]^'?$27
M5/ OA>/Q%HNJ7DCV4T:W4%[,9X[F-B%.0WW3DCE<=Z /2:*\L\<7>OZ_\.[+
MQ?X.U.]LY1;K<2VL;Y\R,C+#&/O*<].H!Z\58\*^(&^(^C:--IUY?6(M,-JC
MQS,"6 (\D$]=Q^;=U"X'5N #TNBO(?B'J^JZ5\3O!^EV&JWMO8ZE*D=U"DQP
MX\Q5/)Y&0<<5ZX(P(A'EMH7;DL<_GUS[T .HKP_1?$EW_P +!\:V>L^(-032
M-(222!!<["N'P%!ZDXX .:]$_P"$;UG_ (1[6-.3Q!?&ZDG:33KUY!YD0*+M
M5L#! ?<,8Z'UH ZRBO(_A=XZGN- UO3O$T]R^N:5*RSJ[DR2@G:JJ/[V[Y,#
MN5[FO1_#VGW>G:3&FH7<US>.3)*TLA<(2<[%)_A7H#WQDT :M%>??%OQCJ'A
M+PY%-I,9>[\Z.65@,B.%77<6]F8JG_ CZ5U4?B33Y/"0\2K(3I_V,WA8=0@7
M<1]>V/6@#7HKR[X?7FK_ !&M;OQ+J^I7EI8M<-#9:=8SF%$5<99V7#.<G')Q
MP>.<#HG\/>(7NKRU_P"$BO/L$DEN\$V4$T4:ES)&"%Y)^7YB,X/?% '7T5XW
M9WVK3_';4?"CZ[J?]DPV@E2,7!W!O+1L[NO5C7J6A6-YIVD1VE_?27T\<DG^
MD2D%W0R,4W8 Y"E0?I0!I45Y7X5\4:A\1O'6N1I>3VGA_1R(HX+9S&]PY9@'
M=Q\V/D8X!'4>^7OXLU#PC\7;3PI>W<M[H^K0K):-.=TMM(Q90N_JREEQSDC<
M.>#D ]1HKQJWU?49/CMK7AVZUV^AT2UM!.D?VDJ(SY<;$[CSC+-U->A^%;>9
M4FOTU:[U#3+^*&XL_M3AGB!!) ('0C:>?6@#HJ*\M^*EIXML]'O_ !+I_BJ3
M3X=/VM#801X5UR 2[?Q,2<X(QT'O46N^-=9&F_#[3I&:TO\ Q%+!]N>+Y76/
MY-X7^Z6W]1R.: /5Z*\?M_B+>Z"/B!87$K73:"WF:>\Y+-M<[51FZL%8KR>2
M">:BT[Q?JNCZM\/9+J_N+N+Q+;$7J3/N'FMM*,@Z)@N!A<#';/- 'LM%>-?$
M_P#X3;PS%%XJL_%$F3>+"FE11?N0K$[5']\\<Y'.3C& *]A@:1X(VE39(5!9
M0<[3CD4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M-XIU.YTC0VO+6QEOG6>%&MX8][O&TJJ^%[G:6/X5Y5X@\#Z-/XJT'5_ <4]G
MJWV]'N8H8GCCBBY+NZD#R\=-O&<D8KVZB@#P_P 2V4=W^T)IU_>Z5<7>BQVA
MAN)6L7FAW>7( #\I!Y9:[6R-EJFGS>!].MKU=+72I8)+N:TDB5=V$1$+@;B
MS$_0>^.[HH \A^%MQ<_#_3KWPMXHM;BT>*Z:6UNQ"[P3HP'W74$9R,X.#\WM
M7J&FZE_:8EDCM;B*V4@1RSQF,R^I"G# #CD@9[<<F]10!XQ;Q3C]I.YU4VEV
M-.>U$*W1MW\HOY2C&[&.H(J_\?[6ZU+P39V-A:7-W=?;TE\JWA:0A D@).T'
M R1^=>L44 >/?$;PIJ.OZ'X7\1Z';R75[HVQWM-I5Y$&QB #SN!7IUY/IBMC
MQ_KZ^)/ =SI.@6MW>:GJ:I"EL+=U:$%@6,N0 F "/FQS7I-% 'GNBZ1'X'\/
M^#=$G:266VNG>X>&)W56>&?<20.%WR 9..U8/Q/^'EP^L0>+_#8>.\W"/488
M>LT3?*S@=SM.&'<<]1S[!10 $X&3TKQKQ+\/;#Q'J*Z1X8LKJRT^ZNQ=:M>"
M61+7 S\L49.UW.>J@@8'(KV6B@#RF^T0^%_C$GB(P2#1[K2&MA)'&SB*5%4!
M#C.,J@QZGBN&?X;Z_8_!?3)%L)I-1@U3^TYK$+F3RRH3&WKN 53CKR>XKZ/H
MH \MT33)]4^.%]XIL(I4TDZ8D4D[1E!-*0ORC(&2 !GT(P>:F^-'@K4/%GAV
MSNM(3S=1TR8RI#GF1"!N ]_E4^^#7IE% 'GGBKQ6FL_#V]M--L;V;6-1M#;+
MIPMG$L3R+M;>"/E"Y/)XXZUR6O\ @Z\\,?L^/X<$,MUJUQ+'-)%;1M(2YE5F
M V@\*H S[5[A10!PGPY\.:=:Z%H6K0V*VFI1Z4MG=CR/*=V_=D[P0"2"AY/K
M7=,P52Q. !DTM% 'C/P^AN(/C3XPO9[.[AM+PN+>>6W=4E_>#HQ&*/CG9W&I
M:CX5CM;&ZO!;73R7 AMWE"(3'][ /7!_*O9J* /#?C-HMO*WAHZ#HI=DNC+.
M;&Q/"?+@MM7Z]:M?'.&;6!X9%A975ZL-RTLP@MGDVI\O)P/KQ7M%% '#Z?J.
MDZ'?KIWAW3KHG5=069TCT^6*"W7:@=B2H49"' _O-TK?\4ZE<Z1H,E[:64M[
M(DT*M;PQ[WD1I55P!W.TM6S10!XAXC\$:-<^)M#U?P)%/9ZS]OC:XAAB>..*
M+DN\BD#R\=-O&<D8-=^SR^(?%MR+>ZGM(]-B\F/S+0E9F?!D8;Q@@ *H(_V^
MQKL** /$OAK!>^!?B)KOAI[>]ET*Z?S+6\%L_E+( "!NQ@9!VD^J"LZS\*0^
M)_BQXT@U2QNXK#4;=H[2]:V=5$FZ/#(Q&,\'OR,CH:]^HH \F^$]_JWAI+WP
M9XBTZXA_L]V-I?+;MY,R9R1O P3W![@XZBN3\%6%E!%X['B'P]?3I>SE[.-M
M,E=Y03)_JSLX/*\\8X-?0M% 'CW@(^*/"OPQ>#7!>I?7=T(=/C>-YI+9'VKO
M8 $JJY9\'T]ZH_%/P=J%GHF@ZSH]W/>:AH\D:V<4-K\_EC!'W!DX(4\^IKV^
MB@#C9/$<.I67A?4)+6[@DENEDFA:VDW0$PR*=XV\ ,P&3QS7(_%3X>7$^H1^
M+_#8>._7]W?PP]9X6&UF [G:2".X]QS[!10!XU\>;2YU)?#L-G8W5XT%TTDR
MP6[R[4PO7:#76V&I:1H5\-/\.Z;=%M6U!)72/3Y8H+<%461B2H4?*A./[QZ5
MW%% 'E>NZ;X8\<:?>IXKTRXL-4MIIX8+L6SI)(BR,$:,@8E! 'R\\YXY!IOA
M+P1XIG^'^B6MYXEU31;FV67]U#@MY;-E%?/0@#IVSCM7JU% 'C?C?P/K.G:Q
MX4\56<EWKL^BNB7N5S/-$LA?<%'4C<PP.>GO6G\3K]_&/A%?#GAJ">^O-1FB
MWXA=4MXU8,6D9@ G( P>>>E>HT4 <3"P\'^']$\)633/>&);<W8MG>* !<O*
MQP0.<[5/4D9XR:\^_LR^^$WQ3271++4+[PYJ<:_:X(('E,'.,G /(/S#V)'O
M7N]% 'BOQ*$UY\4O!.HVMG>W%G9RQR7$T-K(ZQKYBGG"^@SCK7HDWBV*?6],
MTW3[>\D%Q([7,[6<J1PQ+&S<LR@9+!0![GVKIJ* /G[2-$LM0^)GC=M>TJZ_
MLW4%E6UN9-/D==V\89#MX(Z@CTKV70?$']NWFH>3:74-E;,D44MS;O"9FP2Q
M4, =HRH!QUS6Y10!XC=6 3]I*VU:/3K@:8T/[^Z6V?RC+Y3 $MC&<A.?4#O7
MMCNJ(SL<*HR3[4ZB@#S_ /LL^-K'7;F>]N+2UOE:T:WFL\,D$98*?G (R2T@
M_P!X>E<G\+;;4;OP9KW@#7+:]MU"S16EU);NJ/&X(.TD '#?,/4-[5[910!Y
M'\+;NX\!Z3=>%O%%K<64UO<O);7(A=X)T;'W74$9R"<'!Y'O7IVFZC_:2RRQ
MVMQ%;@@1R3H8S+ZD*?F ]R!GTQ@F]10!XQIT4X_:2U+53:78TZ6U$,=T;=Q$
MS^5&,;L8Z@C\*]GHHH \?\$Z/<?#3QYXBM=1AE&BZJRS6=^L9:-2K,0CD#Y3
MAR.< [?>GW&A77CGXT6'B&.WFBT'1845+F6,H+F52S#RP0"0&8<XQ\I]17KM
M% 'AT&D0:I^T-K5UJ>D27.C75J(DEN+-FA=Q%$O!*XSE6&:]ETG3HM(T>RTV
M DQ6D"0(3UVJH _E5RB@#R7XA>+FD\0PZ-+X7UO5-(M'6:X%M:,8[F8'*H21
M@HIY..I [ Y9XLL]2\0OX#\9MID]L+"_$EW:["TD$#2*0S+C/RA 6P.,^@KU
MVB@#Q"/P)?\ B4_$C48XG1-7/E:;Y@*>=Y;;]W/\)95 /?DTW3]!O?$.K_#2
M!;2XB'A^UWZB98F00.FS:AR/O%DZ>G/2O<:* /&_$GCIY_&:/-X/\0:EI^DR
M;K)8K1A')/R#,<CG'1?3)/<8];T^:>XTVUGN8A#<20H\L8_@8@$C\#Q5FB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ****  D 9)P!7&>"=>N/&2ZEKR3
M-'8K<26NG0\[=B8!E< C<6/8] ,#DDGKKJ$W%I- &VF2-DW>F1BO.O@BCV/P
M\DT^Y0I<Z??7$%Q'C)5PV2,?0B@"#P)KFMWWQ6\7:7JFJ27EO8*J0)M"(@W=
ME'&>V>M<SK/CB[M_%/C72M>O]2T^_CC;_A'TMY'C0X#;,!>'9SL/S9!Y''2M
MSP);WEO\8O&%]<:=J$%G?$?9IY;.1$DP><,5Q^=87B#PU<:W'XXC\3Z??7&L
M^>7T.:.W>0&(;O*2)E! &3AA[Y/(S0!['X:?5)/#.F/K:A=4:V0W0&!B3'/3
MC/KCC->:>']2U*?]H+7-"EU2_DTNTMO.AMFNG*JV(CZ\CYVX/'->@^";'4]-
M\$Z/9:PY?4(;94F);<0>P)[D# S[5Y[)8WGA/X^7_B.^L;R31M4M/*2ZMK=Y
MEC?;&,.$!(YC/;N/? !Z#% W_">7!^U79B6PCD$!N',8<NX+;<XZ #TK!^+7
MB._\,^&;.\M!<"U>_BCOY;8XD2W.2VT_PDX"[NV>Q-;=C<2W>K:EK<-G<_95
MLXX;=9(C').RF1VPK $#YE ) R<]L$X5MXQU+6-#TN\U'PA?PVUY<RVU]8O
M9F2(*<2%2H)7( (QSS@'C(!/X6U'3-?OK/4O#'B*XNM.17%Y83W+R,C%?E8^
M82ZX.1C.TYR.F:O_ !$\7CP1X.NM76-9;G(AMHV^ZTC=,^P )_"N(TSP/8V'
MQ9TG6/!L%U::<L4S:F#&Z0C*X5%W@9))R5'"[0>*N:_::K\6_AWJEI+H5SHM
M_:7NZTBO#CSB@ZY(&,AF'IGN: -KP=H%[J?AFRUC7=;U:XU2_A6Y)BO9(8X
MXW*JQH0G (Z@\YKI?#EEJ6GZ3]FU6^>^NEGF/VAP SH9&*9 P =I48 [5S'@
MKQ3]C\*:?I>MZ;JEGJMC EM+ ;"9_,V#:&1E4JP( /!K2UOQ7JNDC1/*\+7U
MV=1N?)F6)@3:)GAGV@C.#G&<#!&[O0!K^)+N]T_PQJEYIL/G7T%K))!'C.YP
MI(X[\]N]>8>#?%&G>+_#]M!IWB;4+7Q6J*UQ#=7;'[0P(,@5&)3:W.-@!7CI
M7J'B*\O=/\/7UYIUNUQ>0Q%X857)D8=% ]^E>3>/O!NC^)[:#4O#>DWVG^+'
MGC942VD@PVX;FEXVKM&3O!Y(&"<T 6OB/JVH:;\5?"FGP:O?6FGZ@RB[BCNW
M1&'F8)Z_+QZ8KM/#UO'/J0UW3=:O;C1S%<6[PW%VT\9D24*)$+$_W)._0C%<
M'\1]/O;OXH^#[K^R[^^L[#9]MFBL))8P/,R<X4@\<X&:[?2+VSM;RT\-Z-I.
MH+I\CW$UQ-+82P0PHY=]BEU7DLXP!Q@&@#E_!.M:A\4]<U?4[C4+VS\/V,H@
ML[*SG: RDY.Z1T(8\8. <<^W/6WGAG6?MEQ#8:_?QZ?/:&)!),7>VD\Q"65S
MEF)0-C<3@CK@UQ/P\TZ^^%FL:SHFL6=Y)I-U*)K+4;>W>:,XR,/L!*DC;U'4
M'VKU/3M5_M.:0P6=REHJC;/<1M%YC>BHP#8'J0!TQGG !Y1XAGU#3?C9X;\-
M6^LZL-+N[4//$U_*2[9EYW;LC[B],=*UOB-!JGA/X::W>6FN:D9XKR.6SG:Z
M<R11NT:E"<_, =^,YX([UF^*[2^F_: \.:M#INH2Z?9VPBGN8[.5HT;,O&0N
M#]Y>1QS72?&:WN=0^&E_86-G=7=W</%Y<5O \C';(K'[H.. >M '.Z[X^OO!
MWP8T'4H9I+G6=5MXMLURYDVNR;G?YCV[#IDCBNDU70=3TWX>W%]#KVJ?V_:V
M9NC=-=.RO*J[F4Q$^7M.",;>!7*^(? U_P",?@GX?L[.WEBUC2K>(BVN(VB9
MF$>UT^8#![@]./>NGU?Q5/J'P\N+:WTG4VUZ[LC;?8#92!DF9=I))7:%!).[
M."!0!CVOB34_B)\(H]2L+V;2]=6[BLS+;RLB"5I8T)(!Y4JX.#G&>*J^!?'-
M_J>F:MX-\4S7%KXET^*0)+YACDF"@G(8'EAP?]H8//-:7AOPQ+X"^&VGZ7=1
M7$]_-J5O=W*VD#S!&$\3-]P'A409/?!Q1\6/A[)XELH_$F@!X?$%DF]#&"K7
M$8YV^NX=OQ![8 /0M#C,>A6(:665C C-)-(79B0"22>>M>=^.-;U[3?BEX/T
MV'5G33;^XS);11A,[6 PS=6!STZ>U>D:4K)H]DK JPMXP01@@[17E_Q#M[RZ
M^*O@N\MM.U">UT^8FZFALY'2,%EQDA<=CTH [#QS82WFCS22^*;GP_901%S/
M;.(V+\XW,>=H_NK@G/7I7&>'?&>J:;\!I-?US4A-=D/%;7 822#<VQ"V#RRD
MDD'G YYS79ZWXBTY=770-7T+4+BQNH XNOL+3V[DY^0A02#]1WKE?"FDR_#G
MP=K-TVBW^H6=SJCS6VG01^9-';DA59E/?:,D=>F<<X ,_P"&%[#JFKM?K\2=
M2UE;6%WDTVZA:$XQC<07.X#/;/.*PSX^UR3X>S^/5O;@7:Z]Y26WFMY'V;:/
MW1CSM[_>QNSWKM+;PMH^N^.-&\4:'IL^G11P3B_WVCVOF[TV*NU@,MEF)(!'
M')Z5PI\$ZU'\.9_ 2V5P=2.O[TD\EO*-OM'[[?C;MX]<YXQF@#U#4_$[Z#XL
MT!GF>31_$/[D+(<FWGP#&5/]ULX*] 0",<Y[>O*_B;IC7.J?#_0[($RKJ:.N
M.JQ1!=S?@.:]4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/AT>UM=8N-3MMT,UT
MH%RB$;)B!A68?W@.,C&1US@8T** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SXM'M4UF35GWS7K1^
M2DDA!\J/.=B#L">2>IXR>!C0HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"/R<'! P2N,]LYQ6E6+_ &%<Q0Z;';:S=Q?9KCS[EV56:\SG<KG'&2<\8QC
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MQSX]T[VTRZS_ -_;?_ TWQCX?B\3:"=-:^>QN3,DMI<I]Z.9#N4@=^AX],T
M26_B:"35;73+FQO[*[N@S0I<0C#A1DG>I9>/3.>1Q6S++'#$\LKJD:*69V.
MH'4D]A7G6C^)M=T[Q+IGAWQSIL)NI7;^SM7M#^YG<(00R_PL5)_/H.M3?&N>
MY@^%VI?9V94=XHYV7J(S( WY\#\: .BMO%EM>VWVVRT_4KG3R,B\B@&QA_>5
M20[#W53GMFM/2]3M=9TNWU&R<O;7";XV92I*_0]*GMHX8;2&*V"B!$58PO0*
M!QCVQ1;V\-K"(H$"1@L0J] 223^I- $C,J*68A549)/0"LC3O$EAJ5[#:1>:
MDMQ:_;+?S% \Z'(&\<Y ^9>#@\CBIO$&HII'AW4=1DA\Y+:V>5H_[P"DX/MZ
MUR7AB#4/"VK:9I'VN/5O#]_"PTV[ _>6I"[_ "LY.Z(J"5.21@ YX- '?,P1
M2QS@#)P,UEZ'XAL/$,5Y)I[2E;.Z>TE\V)HR)% +##8/&X#D"M6N*^'?^L\7
M_P#8QW7_ *#'0!>E\=Z1;ZS:Z=/%?Q)=S?9[>]>U86TLIZ(LG<D]#T/8UHZ_
MXBLO#EI'<7B7,GFOL2*U@::1C@DX5>< #DUS'Q&N=0T[^R-2DTVUO-!T^^AG
MND$C"96SM1U&,85F!QGD@=!FM3Q3X3OM:O8-3TKQ%?:5J-K"T<'EA7A.X@G>
MA&6R57//8<4 7X_%.G'PX-<G6YM;1CM5+B!DE9BVT*$/S9+< 8YR*L:=K=OJ
M%W<67ES6U[;JKRVTX <*V=K#!(*G!&03R"#S7FVIZUJ&NZ=X"FU2!8)QXC%O
M>I']PSPM(@Q[%E)'_P!:M^\9U^.>F"'/SZ%,)\?W!*-N?^!?SH [RBBO-_&F
MNZQIEOXFN[35F,VGQ1RVEO9QJRP*%!;[067&6.?ESG;@@=Z /2**X#Q/XHNM
M(U"UFU*6_L-#N+%674;*%9$@N"3GS058A<;<<8ZYSV[32Y#-I-G(US'=%X$8
MSQG*RDJ/F&.QZ_C0!;J&[N5L[.:Y:.218D+E8URQQZ"O-[SQ%K-C<Z1.-5:[
MDN-?6QN?L\:FS$+R,HC4E02Z@#)4G#!@3VK6BU&]\4W7BE(-1FL;?2YFL8$A
M5"6D6,,SON!R,M@#@8![G@ Z?0=9M_$.A6>KVB2);W<8DC64 , ?4 G^=:->
M4>#-:N%\/> ?#=M,UM]OL)9YIT +A(QPJY! ))Y.. #CDY%C5_$FO:.OC/2%
MU%WFTO3AJ5A>M$A<(0V8W&-IPR\'&<=: /3Z:LB.SJCJS(=K@'.TX!P?3@@_
MC7FUSJ/B;0KWPIJD^MM?66L7$-E=6;6Z*L32IE7C(&[@@YR3GVZ"AH^JWGAO
MP[XUU?\ M"YNI8==FM8UN"A7<S11J[< Y&1QD+@8P* /6JR/$'B*U\.6]K-=
MPW$B7-S';*84!VL[!06R1@9-<\]WXDT/4I]3N3<S:##8RRW4=Y)"95D12P:/
MRQT(!!!X'45SGB-M1U3P%X9UV[U.5I+[4-/N9;953R562165%XR-N0,YR<'/
M7@ ];HJIJK3)I-V]O,89EA9DD"AMI SG!X->5G7?%MCX"T'QO)KK7*G[/]MT
M\VT:QRQR,$)! W!\L#G./;U /7Z*X:TU759=;\=V#ZE,8]-2!K-_+CW0[X/,
M/\.#SZ@\5CQZ]XBOM/\ AX\>L-#)K496\801G<?(9]P^7@YZ#IG&01Q0!ZC1
M7FVMZSJ?A2XAL]>U?4UTXV:K%KD%JA1;DN^3.H4X&#&!Q@\YYZ:MKJNH'XAV
M&E_VF9["YT)KLA%0J91(BAU;;G!!)ZXYH [2BO.-.U[6;GPQ?23ZU'#)!X@E
MLFN9HU\PVZ2[=D:JA#2D<#Y3DFHE\0ZVNG>/X4OKF)]&A6XLI;F*,RH&@,FU
MAC!&1QD9P>>: /3*:LB.SJCJS(=K@'.TX!P?3@@_C7G5KJ>NV>J>";BXUJ6Z
MAUN(QW5LT,:QJ?(\Q63"[@<CG).<]!TJU\.(+@7OBR2;4KNY":[<1;9BA#82
M+#$A0<X & 0,=J .[:1$9%=U4N=J G&XX)P/7@$_A3JX+QE!<3?$/P1'%J5W
M;)+-=C;"4PK+;N=P#*03@D<YX)QCK4^GW^I>++OQ(EIJL^GC3+QK"U$2(?WB
M(I,C[E.X%FQC@8'KS0!VU8^K>)=/T8W/VDR%+2%;BZ=%!$$;$@,W/?:W R?E
M/'2JG@3Q#/XI\%Z=J]U"L5S,K+,J_=WH[(Q'L2I/XUSFLQZAJ/B;6=4\.7,*
M:KI"QVESILXRFH0[!* _]W_6,$8#J&R2#P >B@A@"#D'D&L*^\7:=8_;)&CN
M9;6P?9>74,>Z.W; )#<Y. 03M!V]\5IZ5?IJND66HQQM&EW DZH_50RA@#[\
MUYK.=1\&>%O&EIJNF37-C/+=W=O?1R1^6Z3 _(X9@P8,<< YSQ0!Z%?Z[9V!
MLTR]S/?$BU@M\,TV!N)&2!M Y)) Z<\BI=+U:TUBT:XM7;$<C0RHXVO%(IPR
M,.Q!_P 1D$5YEX.M+ZR\>^%K'4@X>U\'KM1_X9#*H8?4*%!^E9'B._O[1_B/
M:Z?*T,=YJ=A:+*O2-I4593]2,#\: /7].UVUU:5_[/26XMD8H;M% A+#J%8D
M;^>,J",]ZTZX>&_U/PKXK\/^')C:7&D:C!)!;>1;F)K9X4W8^\V5*CZY[UI^
M-->GT2TTN&U81W&J:E!IZ3%0?*WD[GP>"0JG&>,D=: .EKGKOQ?:VUS)'#8W
M]Y#!=K9W%Q:Q!U@E8*<,-VX@;ER54@9]CC,EU#4M%\?Z=H4M_/=Z?K%K.T3R
MJGF6TT0!)#!0"I!'!!P?;BJGPTM)HYO%$CW]S*JZ_=QF-Q'M8_)\YPH.[Z$#
MVH [UY$0H'=5+G:H)QN.,X'X _E63I?B*UU76]6TJ&&XCN-+:)9S*@4-YBEE
MV\Y(P.^.M<UXU@N)O'G@E(M1N[9)+FX!6$I@$0.=V&4@G!(YSP3C'6LP6NH3
M^-?B$;'5Y]/>&*SD$D,:,[,+<D9W C;QR  3ZCN >H45YUIWB[4]:M/"MHHF
M%SJ6E-?W3VIC1V*[%PN_@ ER3CG@8[UTOA-?$$5G=P>(&61X[EOLDI9#(\!^
M[Y@3Y=XY!(ZT 6K_ ,06]EJ2:;%;7-[?M%YQM[55+)'G&YBQ"@$Y R<G!P#@
MU)HVN6FN0W,EHLZ?9IS;S)/$T;)(%5B,'GHPYZ>F:Y;Q5X>UY?$G_"3>$+^W
M&JQVZV]WI]US%=1@EE!/56Y.#Q]1SFM8>,)=8\*:]/;11>'->M)T34%OCN6%
MSL7>#@[LHN%XY('![@'HE97B37[;PQH-SK%Y#<2V]LNYUMT#-CZ$@?K7*Z9K
M.J2^)_$&D+>WJVT6FQ7=I)=PH)8V8N"0,=#M!PXR.>!7,Z@^N:K\$;W7]4UV
M2Z6[T;Y[3R$5 ^\$.& SG ((Z<]L"@#V.-Q)$D@R P!&?>G5Y[<W7B'PUXD\
M.2S:RVH:;J\XLY[1[=$$#E"R-&5&0!M.0Q/U]*=UXBUFRN=&G&JM>27.O+8W
M7V>-39B)W91&I*ABZ@+DJ3A@P)[4 >G45YVT_B#4O%'C/3(_$5Q:V^G16TEJ
M8H(MZ%XW;&2I!7(YXR<#D<Y9I7B_5-;LO"MIB476HZ6]]=26IC1V*E%PN_@
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MIMS>O#+,EO&9&CB +$ 9.,D#]:BT/58M=T*QU:"-XX;R!)T23&Y0PR <=^:
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M,D7BF7Q =2D:ZELELRAB79L5BP..N=Q)ZUF0_#JRA\.VFD_VA=&2QO&O;*\
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M/4GN3@8H2>%IKC2ELKC7M2DE2]-Y'=@H)8SN)5!\I&T9Q@@Y&1TKHZ* .?\
M^$:DNM6L=0U;47OFT]F>UB$*QHKD;=[8^\V"0.@&3Q5B/P^DMIJUGJ=W-J=I
MJ,KL8+G&V*-@!Y:X ^4=N];%% ',Z7X7U#1[5+"U\27ITZ(;8HYHHWEB3LHD
M(Y Z#()QWK1DT9A>:7+:ZA=6UO9&0O;(05N=PQ^\)R20<MG.22<UJT4 17.?
MLLV(1,=AQ$<?/Q]WGCGI7"^"=&_L[6Q/86]Q;:5<6(F:PN-Q&G7+,"T49.,
M\[E'0H.@(%=_10 C E2 <''!]*Q/#OAP>'I-39+Z6X&H7CWL@D11MD?&=N.W
MRC@UN44 <Y#X8N985MM7URZU2U2995BFBC3<5;<H<JHW $ XXSCG(XJS>Z-J
M-QK!O+;Q#>VEN\8C>U2.)TR,_,I925//O6U10!BWOA?3KS0HM)VO#%!(LT$L
M;?O(I5;<L@)SEMW))SG)SG)IL/A];>ZO]4GO)I=3N;86YNEC ,,:Y(6-0#CD
MENY)_ #<HH Q?"MEJ.G^'X+;5+R>\N$9\37!!E9-QV;R.-VW'_U^M8VH?#NW
MOVU^,:Q?P66M_/<VL>S:)-H7>&*[NPXSCCTXKLZ* .;/A>Y5&CCUNX:.2R6S
MG2>%) X&[Y\8 #?.1_=P!P<5L:5IMMHVDVFF6:LMM:0K#$&.3M48&3W-7**
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MR_Q$OM1TSP'J^H:7>&TNK:!I5D$:L>.W.10!U%%063M)8V[N<LT2DD]SBIZ
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M\NN7TS7NIQ(D<CQR2&:4]L@'D^AKKCJ=J-5&F;W^UF+SMGEMC9G&=V-O7WH
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M%-&Z-&\3C^%D8!E/U%5]4\4Z)HMY%9ZCJ$<%Q*C2)&026"CGH#[8'4D@#.:
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MJR L<#G  ZUZ!10!QWQ-ECN/AAK?D.)3/;%(1'\WF$D8"XZ_A6;J%Q!)\0/
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-2M;B]LS;V]Y)9ER
M\T0!D"]]I((!/K@XY[\U;K.UK6+'1;)9]1$OV>600DQP/* 2#]X*#A>.IXH
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M VWUY/)KFM8+2? [0[1()VNHTT]'@6%C(K1O&7!7&1@*<UOW\@?XNZ'.BR-
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M5F#Q=HTRZANN7ADT\*;J&>%XY(PWW3M(R0>V,YZ=:\RM[>_3X?V=Y!I][/\
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M"#9Q\WS<<9I]AJ3P3^%+*YL[NWMVT)$-Y;6;M.\PV!K8N%+1CY=QZ'('(QR
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MG@\N**)"[.Q(X '- #-(NM.T_7[+.KZSYNJP&*&RODG,;RH-S.ID7Y#M!XR
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M;G6-V ' P.!T Q0!VU%>43Z_?VWPJL_'\>HW$E^ICNKB+SF,$B-*$>$1YVJ
M#@$#=E>O)ST'CZV*Z%>ZLWB:^TMX82;%(+@0H9,94,#_ *PLV!@G&,<#DD [
M>L*V\/W*^()=3OM9N;V%9&DL[-XT6.U++M)! RQP2!D\!CW.:E74KC3?#-G<
MZD%GU P1(\<!'[ZX90-J=N6SST YZ"L+X?7FJW5QXHCU>\-S<6^KM$,$[(QY
M49V(#T4$G'YGDF@#M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4WA.#E<YQU_6N^HH \KUVT36/"U]JOAGPY<QLMS:7,BS0-%/?B&0,4VM\Q
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M'<020S1K)%(I1T<9#*1@@CN*AL+,:?9I:I+))%'\L?F'+*O9<]3CID\^N>M
M'&_#>.:S/B>WGLKZU#:U/<(UVC#=&RIM.]B=QX/<^_45)\*+:2'P5]I<%4OK
MVXNXE/:-Y"5/X@ _C76ZA9+J-H]K)(Z0R?+*$."Z=USV!]1SZ8JQ'&D,211(
MJ1HH5448"@= !Z4 <%H4TWA?Q/XJMM6M[IH;^]^WV=Q';O*LRL@4QC:#\R[0
M-IY.>*Y_3-#OO#UC\.[&[L[II+2]N+BX6*!Y5MED63:K%00,%P.OKVKU^B@
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MX5O]0O#>3O;2"W:2WO$DE:169_NK@MSNZ8]:]3N&DMM,E:%!YD4)**HR,A>
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MKT>B@#Q>_N+_ %+2M/FN='U:*^LO$44US9V]C(L%O$LY.Y0HQ*2,,6&XY)Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9F.  .I)IU !15+4]1_LR"&7['=W7F3I#MM8][+N.-[#(PHZD]A5V@ HHHH
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MD;E/8CH1D'L36G0 4444 %%-\Q/,$>]=Y&X+GG'KBG4 %%(3M4GG@9X&:RM
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!/)\3_$\"7CQ7!TFR47*(NX-F3Y@"".O;&*WU\-O_P )BGB1M0<SBR^Q&$1
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M<'&<5R4G@57\.Z%HPU298M&GAG@D\I=SF+[@;MCUQC-=80WEX##?CKCC/TH
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M% !1110 4444 %%%<A\2-0U+2O"RWFE7SVEPMW;QDA%8.KRJA!R,XP>Q!]Z
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M5XV_XF=YF-[,$GRSOS;\9^7MGC&.G.: .TT?4VU;3Q=O87EB6=E$-V@23 )
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MI3@(% "@ D;L-P36-<7=_P"((OACJ-SJ%S%/>MNF\@JJE_L[DOM((SU]@"<
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M% W$C@LV3CTR<])10!REEX%M;33[727U"[N-'M)EF@LIMI"[6W(C-C<R*V"
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MV )(XKJZ* ,"'PNMOX@U;68M2NEN-3BCBD0K&50("%V_+G(W'J3UJKI7@O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#R37M?UZ#XZ:3X7M]<NH-*O;8S21HD1*G;*?E9D) R@]>]=EH$&H3W<
M]XFO7>H:-=V_^CF98@\3AR"5**,AA@C(/2O,O&45A>_M"Z/-J$$=QI$=EY-T
M\D>^%6VS?*QQC.67Z9%>A^&M:T>PFMO#&DR^;9V-H\LER5811(& 1-YX)^;U
M/"^] '-_"'Q'KOB/5_$R:QJT]W'IURL,",D:C!,@).U1D_**ZKXF:C?Z/X U
M35-,O)+2\M8U>-T56YW*,$,"#P37G/P9U&UT?5O&#ZE+]D6YO%D@:=2@D7=)
MRN1SU'YUT/CGQ'%XD^&'BLVJ/Y(E%I9AHV5[@KY;,RJ>2,L1TZ+F@!MM\0;G
MP[\%++Q7JL[ZCJ5VNV-90JAY2S8&% P %)/TK?\ #&E>(-2\/VNJZQXDODU*
M\A6?R[9(EAMPPR$"%#NP",ELUP%QX3N_&'[/.CZ?IXW:GIQ$XMB=K%@7!0@]
M#M8D9ZX'K7=^$/'6D2>%]/M]1N#8ZK;VZ0W%C.C+.)% 4[8\;FSC(P#U]: .
M=^(NM>+?"?PSMM1.KM%K*7[0RRQ11[)4+R;3M8''RA,>E6?&?C^_\(>"=!6T
M?[9KNL1HL,EP!A257<Y  '5@ .G/MBJGQSG?4OAK;1Q6TZW4UY'(MJRYE" /
MR5&2.WTS@\U2^(?AB^\0^"O">O:'$;VYT:.-I+:+EW4JA.!UW*4''7D^E '5
M^+8O$/A?P3/K5EX@N;K4M/C$TZW,<9AN0"-X*!1M&,D;2#QUKHO!OB:'QAX4
ML-<@C\H7"'?%G.QU)5AGZ@X]L5RGCOQ9I^M_#V]L=$<W^IZG"+>&QA4M.I?
M.].J;1G.['2M[X<>&)O"'@33M(NF!ND5I)]IR [L6('TSC\* .)^)NH^*_!7
M@B/5H?$MV=0FU 1LGE0F..-@[!5&S/ "C))[UV^D:;K+RVEW+K][<65SI_[V
M*18@T<Q*%70J@[;Q@Y'2N._:##7/@2ULX%:6Y-_'((8P6?:$D!; YQDCFO1=
M&O;4>&;&Y-Q&($MH]TA8 +A1G/I0!YY\&?$.N^+]*UF?6M8N+B2"X$$15(TV
M#&<_*HY^M)\'?$&O>++;7GUG6;FX:UN!!"0D:;1@\_*HR?K7._!#1=%ETG6S
MX@TNQ:9;H.AU"W7<(]O4;QTS5[X!O'IMEXD2\Q:!KI9$68>7E,'D9QQ0 [X;
M>)]:\2Z9JTVN>*+^-H=0BLK=H([=26D;:O!C.3DC\,UT/CF]\2^%OA)<Z@=9
ME_MFRD"_:ECC_?*TX52R[2H^0C@=#7GOPIT[0Q!J=QKR)9WEMJD-Y9S3Q%7P
MC;CMXR00""/?Z5V?Q*UZ/Q-\'M9EM890MQ<I%9QM&RR3JDT>Y@AYZACTZ8S0
M!G>(_%GB3PW\,_#7BVWU^6>[NQ!]HM+J&(QS;XRQQM0,.1V/2O7X+Y6TF._N
M5^S*8!-*LA_U0VY(/T_I7S[J'AV[T;P[X-\=:);'4&TZW@CU#3I 9 C;0"P0
MYVGL<#(.T^M>J:GXFL?$NGZ3IUA>) VK$/+]HB)\J-1N:.1<C!8@)M)&06QT
MH I_#;X@3^*]8\1:9J,36]W9W;/!#(NUA;DX (]01S_O"L_XF>(-<T7QQX/L
M-,U>XM;75[H07,:)&WR[XURI920<.:Y[Q=!J'@;XO:/XK65+U;X>5J,=G;,I
M5 %4LR!F/0@CU*5:^+KV^I>.O 3Q$7%K#=>9<O'EECC:2(Y8CH" 3]!0!M^'
M/%.N-\6-<\$W=^^HV-O )8KWRT66$[4.UBBA3]\CIU K%^'?B?6O$,6NMKGB
MB_C6UU"&RMF@CMU.9'*+G,9R<[?UKU?3=*T30K:6?3K2RLX9?WDLL2JHD_VF
M;OUZDUX/\,=-T1[C7+C7D2UN(-5@O;*>>(J^$D+G8<9(.,$#UH ](\877B/P
MS\);^]?696UFQ9BMX(X\RH9\(67;M_U9'0=:T/!]YJ6K_"ZSU*[U.X?4+JT,
MS7(5 RMSC V[?TJAXJN)_'_PM\1II%K*V]C':*\91YUC9&)"GGDA@/7BJ'@+
MQ3IT7POLM(5W;6K>U:V.F[")S)R -N,X/'S=!W(P: .ET_3M;U*UT:Y;Q#>P
MVQL%DG,:0[YYF"G))0@ #/  ZCTK@?AOJWB_QQX:U^9_%%W%J-K.8K1EA@"9
MVY 8>7R":]=L8TTG0[6&YE1%M;=(WD9L*-J@9R:\E_9\5K;3==M[A'AFDO!(
MD<JE69=O4 ]10!?\3>(=>LOC=H'ARVUBXBTN_@$TT(2,\YDR Q7('R#O5S7/
M&&J:S\2X? GA^[^PK!'YVHZ@$5Y%7:&V1A@5!P5&2#RWMS@^,)%;]HGPQ>*<
MVMM;+'/.!E(VS-PS= ?F'7UJ34-,NO _QO;Q=-;S2^']5B,<UU%&9!;,54?.
M!R!N0'/3!]J /0;C1];L9]/?3=<O+BW6YC%W!=A'+Q9Y*MM!!]1G&,XQ7&Z'
MXZAUWQ9KVD:OX@N-%U.VOGM["V&Q(_+7A3\RD.Y()(;U&!7?VGB?2]2N88=*
MG&H%S\\EK\\<0QU=^@],9R<].I'F_B+2/!GC[2[JZUY1HVNP-+$MPRF*278Q
M5653_KE( Z9/8$4 >HZ&FHQZ-;IJTJRWZ@B:10 '.3R .@(P<5/J"N^GW CF
MDA?RR5DCQN4@=1D$?I7E_ASQAJ'@7P-X3L_%.GZE/=7S/&90F3;1[\)YA/?:
MR\=<#U&*]/U*>*VTVYEFD6.-8VRS' Z4 >7_  BU[7_&/@C5[_5M;NGNTN'@
MBD2.)?+ C1@0 F"<L>N:S_ GQ$U_3O$X\,>/+C=)J$:3:??;%0,''RKP "#V
M..&!!]F_ F>/2?A[K46H-]ED6[DE*3 HVPQ( 0#R1D$?6NBU[P38?$3X::7%
M#)&FHVUI&;2Y[QR!!E&[@'&".H.#VH OWWBA_!W@S6M=U*\N-0:"\FAMXY=B
MY(D*(@VJ./4G)P#3?!MIX@\1>';77]:\07L-U?QB>&WLEC2&WC;E  5.XXP<
MMGKBN57PGKWBWX$2:5>B3^WXKJ64K.<-)*DK#!/3)&<'H20<UT?@#QEIEMX-
MTW2M9F_LS5M/@6UFL[M3'(2@V@JI&6R #QGK0!UOAV'5X+":+6[E;FZ6XD"S
M*@0/'GY#M'3C&1ZYK7KD]>\<QZ#9Z5<RZ+J<PU&[^SHB0_.@)X9EZC(Y"G!]
M<$$5UE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 4]0TV'4UACN6=H(Y%E:$8V
MR,I#+N[D @''?'.1Q5RBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!1+_P#)-'V/QC_T'-$_\%$O_P DUT-% %/38]2BMBNJ75K<S[B0]M;M"H7
MP-K.YSUYS^%7*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]Z /38Y$FB26-U>-P&5E.0P/0@TZD1%C1410J*,*JC  ]!2T %%%% !1110
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M#*.L8/3?_LYS[4 7C:VYD\PP1%]GE[M@SM_NY]/:FFSM6" VT)V *N4'R@=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5C>+K>>[\%ZY;6H)N)=/G2,#J6,;
M ?C6S10!PMC=VR_ RVF:6..+_A'U7+, ,^1C'UR,57^'GA_0]4\#^%[^>,WD
M]I;1O&);EY4AE"\D1EBJL/ID5U^E:/'I"2VMN5^P,[210%?]26)+*I_NY)('
M;)'3 &DJJHPH ^@H \_\.?V==?%;QNC?99I<6.T':Q^6(YQ]"!]"!7/S7ED?
M#?Q947$!W3SX <<DVZ@8_P"! CZUZ^$4'(4 ^N*/+C_N+^5 'E\USI\6N?"P
MQ36R*(Y@-C*!AK4C]6P/K4'AC6M";P[=^%/$\2S:W#J$QET^5"9+N1IFDC=!
M_$#E>>@ R<"O5_+3CY%XZ<4GE1F42^6GF ;=^.<>F: .%M+BV;XUZO$)8C(=
M$@4H&&21*Y(QZX(KAK*UT_5OV>],TZQ^SOK,LL:VJ18\T7/G_>XY!"Y)/9>>
ME>XS(XB=H(XS-@[=YP,^Y )K \$>&Y?"_A>QTJZ-M-<6B&,7$0/SJ6+=QD=>
MF3TH \^\::O8SVGQ L$DBT^[2 "6 +NGOR(1B3!SB,#CY1QC)85M7FIV5QXT
M^&TL=W$R/;W95MXYS H!_$@X]>U>DF-"Q8HI)&TDCJ/2CRT)!V+QTXH QO&,
M\5OX*UMYI4C7[!.,NP R8VP*YGX;Z!HMQX/\+:M!%&;VVM48RQOGYS$48-S_
M +1X]17H!4,,, 1[T*JJ,* /H* /.8;RR3XD^. ]Q O_ !*[;=EP.BR9S],C
M/U%<W;7%A!\,OAH5FMXV76+(L0RC!^;>3^?/UYKVGRT))V+D]>*/*CQC8OY4
M >(^-=9L+OPUX[M+>6+3YXKT>99(-TUTRF+,[YR0A &-H ^4$GG%=:M]IEW\
M;+6X2XMI%/AUFC<L.\X((SZKD_0YZ5Z 8HR6)C4EAAN.H]#2^6A.2BY]<4 >
M'V6I1Z?X7T_4U/G:1IOBRXEO5A^<11%Y CD#^%2P;\C7;ZAJ7AK4O#_BO5M(
M-O*)].=+O4(_N2L(V")NZ,0#SCID"NY\M-I78N#P1CK2+%&D8C2-%C'10N /
MPH \JLM<TVTTOX=132VMK(^E8CU6=LK 1#&'C3G;YC<#YLXV]"3BL">_M1\%
M/%UN;K,L>L2AA*-C\W2D9&!@D G&!]!7NICC(4%%(4Y''0^M'EI@C8N"<GCO
M0 QA%=VK!7#Q2H0&0Y!!'4&O/_AA-'X6\./X3UF:*TO]+GE $S!!/"SEUE0G
M[RG<1QT(P<5Z*  , 8%1S6\-P )X8Y0#D!U#8/XT <#H=O\ VO\ %'5O&$;!
M=(@T]=.M[@\)<'=O=U/=01MW=#VSBL/1-0LS\ _$&+N#_5:FO^L'5GEVCZG(
MQZYKUW QC QZ4GEQXQL7'TH \N\37UDWPW\&2?:H"OV[3"&WC'RE2WY#KZ5/
M'X@TK1/'?BS3_%,T=O#J:PR6DMP/W=S;^5L,:GOAMWR]RQKTKRTQC8N/I2/#
M%(4+QHQ0Y4E0=I]1Z4 >7ZCJ.G>&_&&C37YNM&\/SZ.+6RD&46"19"VQ^#LW
M)LZ_W<'I5/7(?#ECHOA9--;&FS^*8;A6N9,B8$-OD7=_ 2?IW'!&?7)(HYD*
M2QJZ'JK#(I2B'&54XZ9% #88HH8]L,:(A);"  $DY)X]3S7B&H:]IEWHFG30
MW$&GQVWBB*2;3$^];8N3NDG9LE23EOX5&['.*]SIGE1_-^[7YCD\=3ZT >>:
M3<Z9)\4/&LLDMM_QX68W2$ A=DF\'/(_AR/IFN4\.:M'INC?#'4;Z=5T2".Y
MAGG)S'!<,I6,N?X>-P!/3)KV_P M,D[%R>O%(T,3QM&T:,C=5*@@_A0!P/A'
M4=/N_BCXT:SNH)5GCL71HF!$FV-@Q!'7' R*A^*UQ:"Z\&P7%RD6?$%N[#S=
MC!,."V000.1SVKT5(TCSL15SUP,>U#(C'+*I/N* ,'^P]$T>UU/4X(E6:Y@/
MGWD\S2NZA> 7<D[?;.*XC1/[.7]G62=/LP<:%<1-(-N0Q1LJ3ZEL<>M>K%01
M@@8]*38FW;L7'IB@#RI[FPEU#X3^9-;.!"Y&YE(S]EP#_P!] ?B/6LO6IW?_
M (6+_9H%T(=3L;F>V@(9I856,R@ =?NG/T(KVGRTX^1>.G% 15.0H!]A0!RV
MD:]X5\1:PFKZ3)!>74=F4EO4!'D0DAMCD]"3SM//!->:V\UB_P %/#1E>!K:
M+Q!'YV2"JK]K<G/MM/Y&O<DABB0I'&B*220J@ FN=\8>'[O7[*PM[%[:'[-?
MPWC&7/S>6VX* !W]>WH: .9UN*S/Q!?6-.MEN[>ST"Y&I):D$3*<&*(D?Q'#
M8'7 'M6)INM:=<>)?AQ=0ZC;-;BWN85M[89BM,P*%A!Y8OT!#')(!P,U[%!$
MD,05(HXNY6,<9[]A2K%&H 6-0%.1@=#0!P_@.Y@F\4>-UBGC=O[5#85@3CRD
M&?S!'X5W=-"*IRJ@'V%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&\6^,KK0?%.CPQQ
M@Z0LZ0ZI,?\ EF9@RP\]L%23[%?6NPO[^UTNPFO;V9(;:%2[R.<  5P1\-2>
M+/ VH2W&M+'#K:M>3+Y<;)$Q * OU^0*BYS_  4 >@W%S!:6TEQ<S)#!&I9Y
M)&"JH'<D]*IV.NZ9J5Q/;VUT#<0*&EAD5HW13T8JP!VGL>E>6MXIN?$7PETO
M4%5KN]TB^M9-6M8CN>1(9!N;'<'"OZ=?2MW6]0TKQKX;UZY\(QK>:E-I4D!O
MH8BK8ZB'<0,L<MQV[XR* .QM/$FCWU]'96]]&\\J&2%2"HF0=6C)&' ]5)HE
M\2Z-#=K;27\:NTWD!R#Y?F_\\]^-N_\ V<Y]JYC0/$WASQ8FDG3;=)-8LX&5
M5: A]-)3:^XD?+R N._;C)'*VTT-S\$+OPK=@?\ "11+):MI[G]^UR92R,%Z
MD$D/N''4YX- 'JZZSI[ZC<:>MP#>6\7G20!3O"9P&QC)&?2JO_"6^'_L5I>'
M5[06]Y-Y%NYDQYLF[;M7N2#P?2N06]B\/?%2 ZU=B-[CP[#;QRN#_I$R2MN5
M?[S<@X')S7)6MY9M\-/#$,[HNWQ4K2)*,87[5(Q)![!2"?3/- 'K5OXOT&\M
MK^>UU**X33QNN1$"S(",@X R0<'!&<]JQCXNTS7O!,&IG6WT-;EHRLW =26!
M"#<"&) P<9ZFL\W%O-\6M=B@FC>27P_&@5&!+N'DX]S@C\#7+W&IV,W[.UC;
MK<(9H!9PR(<@K(LZ%EY[@ DCL.: /5;WQ3H6G7LME=ZK;1744/G20E\NJ9 R
M0.>21@=3GBI8/$&D7.B+K,.H0/IK#*W ;Y3SMQ]<\8ZYXZUR4EY8-\;[>0W%
MN0/#KA7+C 8SJ1@^NW)^F>U<C%/8GX:7UQ]M6'[#XG:YB8*7C4_:LIY@7D1D
M'.?Q&>A /6;7Q)HUWJ)TZ+48!J ZV<A\N;IN_P!6V&QCG..E9?C/Q-/H2Z7I
M^GI&^JZO=+:VOF@E(_[TC <D*.<=\BL?PEJVAZ]XXU'6;77-.GO;BSCMULK2
M8MA$)8N2RJ6.6QP. />I/B+I5VVH>&O$MI!)<C0[TR7$,2EG,#@!V4#EBN <
M#WH N^(AKGASP_<ZW9ZO<:A+81&>>UNHXA'/&HRX!1 4;:"002..0:IZ[X\M
M?[,\-2V-P\4>MW$.Z0(2\<#*S,1P1N^7;ZC)^M6/%OB73M0\(:A9:-=0:EJ&
MHVSVUK;6L@D=V=2N2!]U1G))P!CFN=U>RM_"NF?#?1;F[A\ZRU&'S27 Z12!
MFYZ+N;&?<4 6(]8GB\6KX7F\2WLUE/;2WD=R(=D\>YHUCBW[?F R[;B.<@'H
M<])X1D\I=2BN/%O]O7%NZ+<.41$MR%Z87@9QD\GGTK*GU"S_ .%W68^U0Y.@
MR1CYQ]XSH0OU(!.*YK4DGU6+XJV>CNL]Y*\#1Q1-EI56% X '7.&7ZG% 'I]
MEXBTG4+T6=M>H]PT?G1H5*^9'TWID#>ONN12#Q+HYU&*P^WQBXF=HX@00LKK
M]Y5?&UF&#D DC%<WI_B3P_XS%O/H<2S:O%:RJDAA*OI^Y,%68C"G< N._)'
M-<QX4O/"^KZ/H6A:E%J+>(=+DA!TR2:<-#/%\OFXSM"CEL],''7B@#T%O&7A
MJ6Y6Q77+4W$UQ]C18Y,DRD#Y01WY'XG'6ET+69+C5-4T.]<-?Z:R$R 8\Z&0
M91\=CP5..,J2, @5SW@.6QN/%'C7RWMY)3JPD&""2HB0!A[!MPSZYJ73HGF^
M-FM7,6?(@T>W@F/;S&D9E_':/UH [JBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %! (((R#110!#:V=M8P""TMX;>%<D
M1PH$4?@.*FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>May 08, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Entity Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elicio Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3430072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">451 D Street, 5th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">209-0050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,086,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 14,948<span></span>
</td>
<td class="nump">$ 18,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,252<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">16,200<span></span>
</td>
<td class="nump">19,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">4,539<span></span>
</td>
<td class="nump">4,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">22,689<span></span>
</td>
<td class="nump">25,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,915<span></span>
</td>
<td class="nump">6,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">1,042<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,229<span></span>
</td>
<td class="nump">8,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="nump">3,599<span></span>
</td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">3,823<span></span>
</td>
<td class="nump">4,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">9,475<span></span>
</td>
<td class="nump">9,407<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">24,126<span></span>
</td>
<td class="nump">24,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 9</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Stockholders' (deficit) equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 18,654,350 shares and 17,814,762 shares issued at March&#160;31, 2026 and December&#160;31, 2025, respectively; 18,639,895 and 17,800,307 outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 14,455 shares outstanding</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">244,144<span></span>
</td>
<td class="nump">235,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(245,495)<span></span>
</td>
<td class="num">(233,672)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' (deficit) equity</a></td>
<td class="num">(1,437)<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 22,689<span></span>
</td>
<td class="nump">$ 25,862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">18,654,350<span></span>
</td>
<td class="nump">17,814,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">18,639,895<span></span>
</td>
<td class="nump">17,800,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares outstanding (in shares)</a></td>
<td class="nump">14,455<span></span>
</td>
<td class="nump">14,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 6,757<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,845<span></span>
</td>
<td class="nump">2,958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,736<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(10,602)<span></span>
</td>
<td class="num">(10,736)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(984)<span></span>
</td>
<td class="num">(507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction gain</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(176)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(1,221)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,823)<span></span>
</td>
<td class="num">(11,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (11,818)<span></span>
</td>
<td class="num">$ (11,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (0.87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (0.87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</a></td>
<td class="nump">18,211,745<span></span>
</td>
<td class="nump">12,950,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</a></td>
<td class="nump">18,211,745<span></span>
</td>
<td class="nump">12,950,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Conversion of Convertible Debt</div></th>
<th class="th"><div>At-the-Market Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At-the-Market Offering</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>At-the-Market Offering</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (11,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">$ 183,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
<td class="num">$ (194,101)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants', window );">Issuance of common stock and warrants from the January Offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of common stock and warrants from the January Offering</a></td>
<td class="nump">9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock and common warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock and common warrants</a></td>
<td class="nump">716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,209)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,983,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 8,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">214,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="num">(205,310)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2025</a></td>
<td class="nump">17,800,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,814,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="nump">$ 1,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">235,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(233,672)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">20,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,823)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2026</a></td>
<td class="nump">18,639,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,654,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="num">$ (1,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">$ 244,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (122)<span></span>
</td>
<td class="num">$ (245,495)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Conversion of senior note payable</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryOfferingMember', window );">January Offering</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,823)<span></span>
</td>
<td class="num">$ (11,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets, operating leases</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_InterestExpenseNoncash', window );">Non-cash interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">984<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(504)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term prepaid assets</a></td>
<td class="num">(225)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(460)<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_IncreaseDecreaseInAccruedExpenses', window );">Accrued expenses</a></td>
<td class="num">(602)<span></span>
</td>
<td class="num">(2,645)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred research obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(489)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(11,645)<span></span>
</td>
<td class="num">(10,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</a></td>
<td class="nump">7,988<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering', window );">Payment of offering costs for the issuance of common stock from at-the-market offering</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of common warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">8,027<span></span>
</td>
<td class="nump">10,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency on cash and cash equivalents</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(3,613)<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">19,267<span></span>
</td>
<td class="nump">19,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at the end of the period</a></td>
<td class="nump">15,654<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash and cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">14,948<span></span>
</td>
<td class="nump">18,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">1,381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">15,654<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid', window );">At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_FairValueOfCommonStockWarrantsUponSettlement', window );">Fair value of common stock warrants upon settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SettlementOfPromissoryNotesPayable', window );">Conversion of Convertible Note and interest into equity</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20,034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_FairValueOfCommonStockWarrantsUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants Upon Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_FairValueOfCommonStockWarrantsUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_IncreaseDecreaseInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_IncreaseDecreaseInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_InterestExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_InterestExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_SettlementOfPromissoryNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement Of Promissory Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_SettlementOfPromissoryNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business and Financial Condition</a></td>
<td class="text">Description of the Business and Financial Condition<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mutant Kirsten rat sarcoma viral oncogene homolog (&#8220;mKRAS&#8221;)-positive pancreatic cancer, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these unaudited interim condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2026, the Company had an accumulated deficit of $245.5 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. The Company&#8217;s sources of liquidity are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC (&#8220;Jones&#8221;), as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock at a weighted average price of $9.46 per share under the 2024 ATM Program for net proceeds of approximately $16.2&#160;million after deducting sales commissions. During the three months ended March 31, 2026, the Company issued and sold 699,678 shares of common stock at a weighted average price of $9.52 per share for net proceeds of approximately $6.7&#160;million after deducting sales commissions under the 2024 ATM Program. In March 2026, the Company terminated the 2024 ATM Program and was not subject to any penalties related to the termination.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In February 2026, the Company filed a registration statement on Form S-3 (the &#8220;2026 Registration Statement&#8221;) with the SEC, as subsequently amended in March 2026, that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $400&#160;million. In March 2026, the Company entered into the At Market Issuance Sales Agreement with B. Riley Securities, Inc. (&#8220;B. Riley Securities&#8221;), Jones, and Ladenburg Thalmann &amp; Co. Inc. (&#8220;Ladenburg Thalmann&#8221;), (each an &#8220;Agent&#8221; and collectively, the &#8220;Agents&#8221;), under which the Company may issue and sell, from time to time at its sole discretion,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">up to $100&#160;million of shares of common stock in &#8220;at-the-market&#8221; offerings through the Agents under the 2026 Registration Statement and related prospectus filed with the 2026 Registration Statement (the &#8220;2026 ATM Program&#8221; and, collectively with the 2024 ATM Program, the &#8220;ATM Programs&#8221;). During the three months ended March&#160;31, 2026, the Company issued and sold 119,479 shares of common stock at a weighted average price of $11.42 per share for net proceeds of approximately $1.3&#160;million after deducting sales commissions under the 2026 ATM Program. The Company incurred offering costs of $0.2&#160;million related to the initial setup of the 2026 ATM Program, of which $0.2&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $1.1&#160;million for the three months ended March&#160;31, 2026.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold 819,157 shares of common stock at a weighted average price of $9.80 per share for aggregate net proceeds of $8.0&#160;million after deducting sales commissions and $7.8&#160;million after deducting offering costs under the ATM Programs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">January 2025 Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $9.2&#160;million after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC, LLC (&#8220;GKCC&#8221;), an entity controlled by a member of Elicio&#8217;s board of directors, pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 8 and 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, the Company had $14.9 million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all. If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December&#160;31, 2025 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s most recent Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis on January 1, 2026. The Company&#8217;s adoption of ASU 2024-04 did not have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">_________________</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at March&#160;31, 2026 and December&#160;31, 2025 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;July 2024 Public Offering&#8221;), consisting of (i) 500,000 shares of common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock, (the &#8220;July 2024 Common Warrants&#8221;). The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable, and will expire five years from the issuance date. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of the Stockholder Approval, the July 2024 Common Warrants held by GKCC are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. Refer to Note 8 for further discussion.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2026 and 2025, the Company recognized a change in fair value of $1.0 million and $0.5 million, respectively, on the remeasurement of the liability-classified July 2024 Common Warrants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the three months ended March 31, 2026 was an immaterial amount. For the three months ended March 31, 2025, depreciation expense was $0.1 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $1.0 million and $0.8 million for March&#160;31, 2026 and December&#160;31, 2025, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued clinical trial and research and development costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Grants</a></td>
<td class="text">Research Grants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases, for $2.8 million. The development efforts as defined in the first grant agreement were completed in the second quarter of 2023. In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million. The development efforts as defined in the second agreement were completed in the third quarter of 2024. In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. The third grant agreement activities were completed in the second quarter of 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the three grant agreements was recorded as contra-expense to offset the research and development costs incurred. For the three months ended March&#160;31, 2025, the Company incurred $0.5 million in research and development expenses related to this project, of which $0.5 million was reimbursed from available grant funds. Following completion of the third grant agreement with GI Research Foundation during the second quarter of 2025, the remaining $0.4 million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock and Stockholders' Equity</a></td>
<td class="text">Common Stock and Stockholders' Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2025, the Company issued and sold 106,823 shares of common stock at a weighted average price of $7.82 per share under the 2024 ATM Program for net proceeds of approximately $0.8 million after deducting sales commissions. During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock at a weighted average price of $9.46 per share under the 2024 ATM Program for net proceeds of approximately $16.2&#160;million after deducting sales commissions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold 699,678 shares of common stock at a weighted average price of $9.52 per share under the 2024 ATM Program for net proceeds of approximately $6.7 million after deducting sales commissions. In March 2026, the 2024 ATM Program was terminated by the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March&#160;31, 2026, the Company issued and sold 119,479 shares of common stock at a weighted average price of $11.42 per share under the 2026 ATM Program for net proceeds of approximately $1.3 million after deducting sales commissions. The Company incurred offering costs of $0.2&#160;million related to the initial setup of the 2026 ATM Program, of which $0.2&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $1.1&#160;million for the three months ended March&#160;31, 2026.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">January 2025 Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors, the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of 1,261,830 shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925 per January 2025 Share and accompanying January 2025 Common Warrants. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $9.2&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of Elicio&#8217;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $20.0&#160;million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7&#160;million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for further detail.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, there was an aggregate of 1,280,971 shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including 645,103 shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, 178,953 shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and 456,915 shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to Note 7 &#8211; &#8220;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes information and activity related to the Company&#8217;s stock options for the three months ended March 31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,621,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">13.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">524,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(20,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(2,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,123,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">12.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">11,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,574,201&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">18.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. 524,793 stock options were granted during the three months ended March 31, 2026. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2026 was $6.73. As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested stock option awards granted was $8.1 million, which the Company expects to recognize over a weighted-average period of approximately 3.2 years. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.4%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.1</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">105.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">106.9%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Restricted Stock Units</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s restricted stock units (&#8220;RSUs&#8221;) for the three months ended March&#160;31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Restricted Stock Units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs vested</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of March&#160;31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested restricted stock units was $1.8 million, which the Company expects to recognize over a weighted-average period of approximately 3.8 years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense, which includes expense related to stock options and RSUs, as recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period were determined by Angion&#8217;s board of directors. In February 2026, Elicio amended and restated the ESPP, and filed the amended and restated ESPP as an exhibit to the Annual Form 10-K on March 12, 2026. No offering periods or purchasing periods were active as of March&#160;31, 2026. As of March&#160;31, 2026, 453,312 shares remained available for purchase under the ESPP and no offerings have been authorized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsAndRightsOutstandingTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;), certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 1 and 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of 1,261,830 shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrants were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7 million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 1 and 6, in June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March&#160;31, 2026, there was no warrant activity in the period. The following tables summarize information regarding the warrants outstanding at March&#160;31, 2026:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Underlying the Warrants Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">144,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">53.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,032,702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">441,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,261,830</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">June 2025 Common Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">103,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at March&#160;31, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,188,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of March&#160;31, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_WarrantsAndRightsOutstandingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_WarrantsAndRightsOutstandingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from the Massachusetts Institute of Technology (&#8220;MIT&#8221;), which agreement has been amended from time to time to add additional intellectual property rights to the Company&#8217;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from 0.25% - 2.00%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company would be required to pay a total of up to $26.2&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur. No such expenses were recorded in the three months ended March 31, 2026 and 2025. No commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2026 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;). The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#8220;ROU&#8221;) lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2026 and December&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for the three months ended March 31, 2026 and 2025 was $0.3 million and $0.3 million, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">As of March&#160;31, 2026, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2026 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,699&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,042)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 6, in August 2024, the Company closed the Convertible Note Financing with GKCC pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, and had an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Notes 1 and 8, in June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. As of March&#160;31, 2026, the interest rate was 12.5% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by 3%, 2%, or 1%, respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of March&#160;31, 2026, the Company was in compliance with all covenants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $9.9 million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of March&#160;31, 2026, the net carrying value of the June 2025 Promissory Note was $9.5 million and the debt discount for the June 2025 Promissory Note was $0.5 million. For the three months ended March 31, 2026, the Company recognized $0.1 million in accretion of the debt discount and $0.3 million in accrued interest recognized on the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company did not record a provision or benefit for income taxes during the three months ended March&#160;31, 2026 or 2025. As of March&#160;31, 2026 and December&#160;31, 2025, the Company continued to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December 31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2026 and 2025 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(11,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(11,209)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,211,745</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,950,574</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(0.65)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(0.87)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"> The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,123,218</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,265,453</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,642,099</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested shares under restricted stock grants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,913,771</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,907,552</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) to purchase up to 1,032,702 shares of common stock. As of March&#160;31, 2026, all 1,032,702 of the March 2024 Pre-Funded Warrants held by GKCC remained outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">July 2024 Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As part of the July 2024 Public Offering described in Note 3, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors, purchased 1,600,000 of the July 2024 Pre-Funded Warrants and 1,600,000 of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, all of the 1,600,000 July 2024 Pre-Funded Warrants and accompanying 1,600,000 July 2024 Common Warrants held by Yekaterina Chudnovsky remained outstanding. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Jay Venkatesan, a member of the Company&#8217;s board of directors, and certain independently managed family trusts  purchased 200,000 of the July 2024 Pre-Funded Warrants and 200,000 of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, 200,000 of the July Common Warrants held by Jay Venkatesan and the family trusts remained outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company closed the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0 million. The Company received net proceeds of approximately $9.9 million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. As of March&#160;31, 2026, the June 2025 Common Warrant held by GKCC remained outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,689&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other segment items include interest income, interest expense, and change in the fair value of liability-classified warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of March&#160;31, 2026 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of March&#160;31, 2026, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2026 ATM Program</span></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the period ended March 31, 2026 through </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">May&#160;8, 2026</span>, the Company issued and sold 445,456 shares of common stock for net proceeds of $5.0 million under the 2026 ATM Program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December&#160;31, 2025 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#8217;s most recent Annual Report on Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis on January 1, 2026. The Company&#8217;s adoption of ASU 2024-04 did not have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">_________________</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">249&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued clinical trial and research and development costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes information and activity related to the Company&#8217;s stock options for the three months ended March 31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2,621,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">13.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">524,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(20,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(2,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,123,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">12.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">11,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,574,201&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">18.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.4%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.1</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">105.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">106.9%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Components of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense, which includes expense related to stock options and RSUs, as recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Unit, Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s restricted stock units (&#8220;RSUs&#8221;) for the three months ended March&#160;31, 2026:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Restricted Stock Units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs vested</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">RSUs forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested as of March&#160;31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding Warrants</a></td>
<td class="text">The following tables summarize information regarding the warrants outstanding at March&#160;31, 2026:<div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares Underlying the Warrants Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">144,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">53.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,032,702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">441,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,261,830</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">June 2025 Common Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">103,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at March&#160;31, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,188,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of March&#160;31, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock', window );">Schedule of Quantitative Information Regarding Operating Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%">As of March&#160;31, 2026, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2026 (remaining nine months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,699&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">4,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(1,042)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">3,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Quantitative Information On Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Loss Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2026 and 2025 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(11,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(11,209)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,211,745</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,950,574</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(0.65)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">(0.87)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</a></td>
<td class="text">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,123,218</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,265,453</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,642,099</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Unvested shares under restricted stock grants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">235,234</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">6,913,771</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">5,907,552</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,689&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other segment items include interest income, interest expense, and change in the fair value of liability-classified warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (245,495,000)<span></span>
</td>
<td class="num">$ (245,495,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (233,672,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid', window );">At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,948,000<span></span>
</td>
<td class="nump">$ 14,948,000<span></span>
</td>
<td class="nump">$ 18,351,000<span></span>
</td>
<td class="nump">$ 18,563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember', window );">January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_A2024RegistrationStatementMember', window );">2024 Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member', window );">At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member', window );">At-The-Market Equity Offering Sales Agreement 2024 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="nump">699,678<span></span>
</td>
<td class="nump">1,717,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.52<span></span>
</td>
<td class="nump">$ 9.52<span></span>
</td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="nump">$ 9.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_A2026RegistrationStatementMember', window );">2026 Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member', window );">At-The-Market Equity Offering Sales Agreement 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid', window );">At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member', window );">At-The-Market Equity Offering Sales Agreement 2026 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember', window );">At-the-Market Offering | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.80<span></span>
</td>
<td class="nump">$ 9.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions', window );">Consideration received net of sales commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819,157<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_SaleOfStockAggregateInitialOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Initial Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_SaleOfStockAggregateInitialOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_A2024RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_A2024RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_A2026RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_A2026RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eltx_AngionCommonStockMember', window );">Angion Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eltx_AngionCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eltx_AngionCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 6,296<span></span>
</td>
<td class="nump">$ 6,245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">6,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">3,599<span></span>
</td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">3,599<span></span>
</td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">6,245<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">6,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">3,596<span></span>
</td>
<td class="nump">2,614<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">3,596<span></span>
</td>
<td class="nump">2,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_WarrantsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_WarrantsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Warrant Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of the period</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=eltx_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=eltx_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Weighted average strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">76.00<span></span>
</td>
<td class="nump">76.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Volatility (annual)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.768<span></span>
</td>
<td class="nump">0.676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.040<span></span>
</td>
<td class="nump">0.038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=eltx_MeasurementInputStrikePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=eltx_MeasurementInputStrikePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage', window );">Sale of stock, beneficial ownership limitation, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (984)<span></span>
</td>
<td class="num">$ (507)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember', window );">July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsMember', window );">July Pre-Funded Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_SaleOfStockBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Beneficial Ownership Limitation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_SaleOfStockBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eltx_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eltx_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_PrepaidResearchAndDevelopmentExpenses', window );">Prepaid research and development contract services</a></td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AdvancedProfessionalFees', window );">Advanced professional fees</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent', window );">Other prepaid expenses and other current assets</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 1,252<span></span>
</td>
<td class="nump">$ 748<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AdvancedProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advanced Professional Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AdvancedProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_OtherPrepaidExpensesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expenses And Other Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_OtherPrepaidExpensesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_PrepaidResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Research And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_PrepaidResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,051<span></span>
</td>
<td class="nump">$ 2,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,802)<span></span>
</td>
<td class="num">(1,756)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">$ 995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 623<span></span>
</td>
<td class="nump">$ 818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent', window );">Accrued clinical trial and research and development costs</a></td>
<td class="nump">3,345<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedInterest', window );">Accrued interest</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedOtherOperatingLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 5,915<span></span>
</td>
<td class="nump">$ 6,427<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Trial And Research And Development Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedOtherOperatingLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Other Operating Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedOtherOperatingLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grants (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 6,757<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member', window );">Research Grant Agreement with GIRF Sept. 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_NumberOfResearchGrantAgreements', window );">Number of research grant agreements | agreement</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds', window );">Reimbursement from grant funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_GrantRevenueNonoperating', window );">Grant income</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member', window );">Research Grant Agreement with GIRF Sept. 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member', window );">Research Grant Agreement with GIRF Aug. 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_GrantRevenueNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue, Nonoperating</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_GrantRevenueNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_NumberOfResearchGrantAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Research Grant Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_NumberOfResearchGrantAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ResearchAndDevelopmentArrangementGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ResearchAndDevelopmentArrangementGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Reimbursement from Grant Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Feb. 28, 2026</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember', window );">January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member', window );">At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member', window );">At-The-Market Equity Offering Sales Agreement 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryPublicOfferingMember', window );">January 2025 Public Offering | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="nump">699,678<span></span>
</td>
<td class="nump">1,717,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.52<span></span>
</td>
<td class="nump">$ 9.52<span></span>
</td>
<td class="nump">$ 7.82<span></span>
</td>
<td class="nump">$ 9.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">819,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.80<span></span>
</td>
<td class="nump">$ 9.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January 2025 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_SaleOfStockAggregateInitialOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Initial Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_SaleOfStockAggregateInitialOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketEquityOfferingSalesAgreement2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_JanuaryPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">1,280,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">524,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 6.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation related to unvested stock option awards | $</a></td>
<td class="nump">$ 8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">453,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation related to unvested stock option awards | $</a></td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eltx_The2021PlanMember', window );">The 2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">645,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eltx_The2022PlanMember', window );">The 2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">178,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eltx_Inducement2024PlanMember', window );">Inducement 2024 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Shares available for future grants (in shares)</a></td>
<td class="nump">456,915<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eltx_The2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eltx_The2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eltx_The2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eltx_The2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eltx_Inducement2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eltx_Inducement2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">2,621,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">524,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(20,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (unvested) (in shares)</a></td>
<td class="num">(2,347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">3,123,218<span></span>
</td>
<td class="nump">2,621,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested and exercisable (in shares)</a></td>
<td class="nump">1,574,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 13.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">4.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (unvested) (in dollars per share)</a></td>
<td class="nump">4.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">12.66<span></span>
</td>
<td class="nump">$ 13.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 18.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Option Activity, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life (in years)</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life (in years)</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, total intrinsic value</a></td>
<td class="nump">$ 11,552<span></span>
</td>
<td class="nump">$ 5,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options vested and exercisable, total intrinsic value</a></td>
<td class="nump">$ 6,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details) - Stock Option<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">105.40%<span></span>
</td>
<td class="nump">106.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">RSUs exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs granted (in shares)</a></td>
<td class="nump">235,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">RSUs forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">235,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 8.10<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">RSUs granted (in dollars per share)</a></td>
<td class="nump">8.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">RSUs forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">$ 8.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 868<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 518<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,188,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">6,188,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_ElicioWarrantsMember', window );">Elicio Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">144,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_ElicioWarrantsMember', window );">Elicio Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 53.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_AngionWarrantsMember', window );">Angion Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">3,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_AngionWarrantsMember', window );">Angion Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember', window );">July 2024 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">441,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember', window );">July 2024 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember', window );">July 2024 Common Warrants One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember', window );">July 2024 Common Warrants One | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember', window );">January 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember', window );">June 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember', window );">June 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_ElicioWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_ElicioWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_AngionWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_AngionWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2026</div></th>
<th class="th"><div>Jan. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 6,757<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Aggregate sales milestone payments per product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | University | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments', window );">Future minimum annual maintenance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_CollaborativeArrangementFutureMinimumMaintenancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Future Minimum Maintenance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_CollaborativeArrangementFutureMinimumMaintenancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_RoyaltyRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_RoyaltyRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eltx_UniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eltx_UniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Proceeds from secured lines of credit</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=eltx_BostonMassachusettsMember', window );">Boston, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=eltx_BostonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=eltx_BostonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Quantitative Information about Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 341<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term&#8212;operating leases (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2026 (remaining nine months)</a></td>
<td class="nump">$ 1,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2027</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2028</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2029</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2030</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">5,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(834)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">4,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liability, current portion</a></td>
<td class="num">(1,042)<span></span>
</td>
<td class="num">$ (1,011)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">$ 3,823<span></span>
</td>
<td class="nump">$ 4,094<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember', window );">Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | GKCC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum', window );">Ownership maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025WarrantsMember', window );">June 2025 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ClassOfWarrantOrRightOwnershipPercentMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Ownership Percent Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ClassOfWarrantOrRightOwnershipPercentMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=eltx_GKCCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=eltx_GKCCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (11,823)<span></span>
</td>
<td class="num">$ (11,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)</a></td>
<td class="nump">18,211,745<span></span>
</td>
<td class="nump">12,950,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)</a></td>
<td class="nump">18,211,745<span></span>
</td>
<td class="nump">12,950,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (0.87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (0.87)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">6,913,771<span></span>
</td>
<td class="nump">5,907,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">3,123,218<span></span>
</td>
<td class="nump">2,265,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">3,555,319<span></span>
</td>
<td class="nump">3,642,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested shares under restricted stock grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">235,234<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,188,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember', window );">July 2024 Common Warrants One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember', window );">June 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | Jay Venkatesan and Trusts Affiliated With Jay Venkatesan | Purchase of Warrants | July 2024 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eltx_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eltx_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eltx_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eltx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eltx_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyCommonWarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_June2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=eltx_PurchaseOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=eltx_PurchaseOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>entity</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | entity</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 6,757<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">3,845<span></span>
</td>
<td class="nump">2,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,823)<span></span>
</td>
<td class="num">(11,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">22,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=eltx_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecoveryOfDirectCosts', window );">Contract and grant reimbursements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Professional fees and other general and administrative expenses</a></td>
<td class="nump">2,020<span></span>
</td>
<td class="nump">1,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items(1)</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">11,823<span></span>
</td>
<td class="nump">11,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">22,689<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eltx_ClinicalTrailMember', window );">Clinical trial expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">4,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eltx_EmployeeRelatedReasearchAndDevelopmentMember', window );">Employee related research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,684<span></span>
</td>
<td class="nump">2,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eltx_TranslationalMedicineAndCMCMember', window );">Chemistry, manufacturing and controls expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eltx_OtherMember', window );">Other research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecoveryOfDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecoveryOfDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=eltx_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=eltx_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eltx_ClinicalTrailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eltx_ClinicalTrailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eltx_EmployeeRelatedReasearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eltx_EmployeeRelatedReasearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eltx_TranslationalMedicineAndCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eltx_TranslationalMedicineAndCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eltx_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eltx_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Common Stock - 2026 ATM Program - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>May 08, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued of common stock (in shares) | shares</a></td>
<td class="nump">445,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds | $</a></td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eltx_A2026ATMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eltx_A2026ATMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>191</ContextCount>
  <ElementCount>254</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>76</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition</Role>
      <ShortName>Description of the Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Research Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/ResearchGrants</Role>
      <ShortName>Research Grants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Common Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CommonStockandStockholdersEquity</Role>
      <ShortName>Common Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.eltx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/BalanceSheetComponents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/StockBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/Warrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/NetLossPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eltx.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of the Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Research Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/ResearchGrantsDetails</Role>
      <ShortName>Research Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/ResearchGrants</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CommonStockandStockholdersEquityDetails</Role>
      <ShortName>Common Stock and Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/CommonStockandStockholdersEquity</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/CommitmentsandContingencies</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Quantitative Information about Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/Debt</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/IncomeTaxes</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/RelatedPartyTransactions</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails</Role>
      <ShortName>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="eltx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eltx.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.eltx.com/role/SubsequentEvents</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="eltx-20260331.htm">eltx-20260331.htm</File>
    <File>eltx-20260331.xsd</File>
    <File>eltx-20260331_cal.xml</File>
    <File>eltx-20260331_def.xml</File>
    <File>eltx-20260331_lab.xml</File>
    <File>eltx-20260331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="560">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eltx-20260331.htm": {
   "nsprefix": "eltx",
   "nsuri": "http://www.eltx.com/20260331",
   "dts": {
    "inline": {
     "local": [
      "eltx-20260331.htm"
     ]
    },
    "schema": {
     "local": [
      "eltx-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "eltx-20260331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "eltx-20260331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "eltx-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eltx-20260331_pre.xml"
     ]
    }
   },
   "keyStandard": 222,
   "keyCustom": 32,
   "axisStandard": 27,
   "axisCustom": 0,
   "memberStandard": 31,
   "memberCustom": 44,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 6,
    "http://fasb.org/us-gaap/2025": 1
   },
   "contextCount": 191,
   "entityCount": 1,
   "segmentCount": 76,
   "elementCount": 564,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 560,
    "http://xbrl.sec.gov/dei/2025": 30,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://www.eltx.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-24",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition",
     "longName": "9952157 - Disclosure - Description of the Business and Financial Condition",
     "shortName": "Description of the Business and Financial Condition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.eltx.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.eltx.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.eltx.com/role/BalanceSheetComponents",
     "longName": "9952160 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.eltx.com/role/ResearchGrants",
     "longName": "9952161 - Disclosure - Research Grants",
     "shortName": "Research Grants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.eltx.com/role/CommonStockandStockholdersEquity",
     "longName": "9952162 - Disclosure - Common Stock and Stockholders' Equity",
     "shortName": "Common Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.eltx.com/role/StockBasedCompensation",
     "longName": "9952163 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.eltx.com/role/Warrants",
     "longName": "9952164 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eltx:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eltx:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.eltx.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.eltx.com/role/Leases",
     "longName": "9952166 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.eltx.com/role/Debt",
     "longName": "9952167 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.eltx.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.eltx.com/role/NetLossPerShare",
     "longName": "9952169 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.eltx.com/role/RelatedPartyTransactions",
     "longName": "9952170 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.eltx.com/role/SegmentReporting",
     "longName": "9952171 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.eltx.com/role/SubsequentEvents",
     "longName": "9952172 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.eltx.com/role/FairValueMeasurementsTables",
     "longName": "9955512 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.eltx.com/role/BalanceSheetComponentsTables",
     "longName": "9955513 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.eltx.com/role/StockBasedCompensationTables",
     "longName": "9955514 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.eltx.com/role/WarrantsTables",
     "longName": "9955515 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.eltx.com/role/LeasesTables",
     "longName": "9955516 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.eltx.com/role/NetLossPerShareTables",
     "longName": "9955517 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.eltx.com/role/SegmentReportingTables",
     "longName": "9955518 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
     "longName": "9955519 - Disclosure - Description of the Business and Financial Condition (Details)",
     "shortName": "Description of the Business and Financial Condition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-60",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "9955520 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R35": {
     "role": "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails",
     "longName": "9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-75",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
     "longName": "9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955524 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "eltx:SaleOfStockBeneficialOwnershipLimitationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "eltx:SaleOfStockBeneficialOwnershipLimitationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
     "longName": "9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "eltx:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "eltx:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails",
     "longName": "9955527 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R42": {
     "role": "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
     "longName": "9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.eltx.com/role/ResearchGrantsDetails",
     "longName": "9955529 - Disclosure - Research Grants (Details)",
     "shortName": "Research Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-100",
      "name": "eltx:ResearchAndDevelopmentArrangementGrant",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
     "longName": "9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)",
     "shortName": "Common Stock and Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-110",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails",
     "longName": "9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
     "longName": "9955533 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-120",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-120",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails",
     "longName": "9955534 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Unit, Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails",
     "longName": "9955535 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.eltx.com/role/WarrantsNarrativeDetails",
     "longName": "9955536 - Disclosure - Warrants - Narrative (Details)",
     "shortName": "Warrants - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
     "longName": "9955537 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)",
     "shortName": "Warrants - Schedule of Outstanding Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955538 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-159",
      "name": "us-gaap:RoyaltyExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.eltx.com/role/LeasesNarrativeDetails",
     "longName": "9955539 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails",
     "longName": "9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "shortName": "Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.eltx.com/role/DebtDetails",
     "longName": "9955542 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.eltx.com/role/IncomeTaxesDetails",
     "longName": "9955543 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
     "longName": "9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "shortName": "Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R59": {
     "role": "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
     "longName": "9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955546 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-178",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails",
     "longName": "9955547 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "shortName": "Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.eltx.com/role/SubsequentEventsDetails",
     "longName": "9955548 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-191",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-191",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eltx-20260331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "eltx_A2024RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "A2024RegistrationStatementMember",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Registration Statement",
        "label": "2024 Registration Statement [Member]",
        "documentation": "2024 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_A2026ATMProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "A2026ATMProgramMember",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 ATM Program",
        "label": "2026 ATM Program [Member]",
        "documentation": "2026 ATM Program"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_A2026RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "A2026RegistrationStatementMember",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 Registration Statement",
        "label": "2026 Registration Statement [Member]",
        "documentation": "2026 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r775"
     ]
    },
    "eltx_AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued clinical trial and research and development costs",
        "label": "Accrued Clinical Trial And Research And Development Costs, Current",
        "documentation": "Accrued Clinical Trial And Research And Development Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AccruedInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest",
        "documentation": "Accrued Interest"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AccruedInterestPremiumForConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AccruedInterestPremiumForConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest Premium For Convertible Preferred Stock",
        "documentation": "Accrued Interest Premium For Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "eltx_AccruedOtherOperatingLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AccruedOtherOperatingLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Accrued Other Operating Liabilities, Current",
        "documentation": "Accrued Other Operating Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r114",
      "r550"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r57",
      "r120",
      "r547",
      "r584",
      "r585",
      "r1030"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7",
      "r16",
      "r407",
      "r410",
      "r476",
      "r580",
      "r581",
      "r908",
      "r909",
      "r910",
      "r966",
      "r967",
      "r968",
      "r969"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r775",
      "r1090"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r966",
      "r967",
      "r968",
      "r969",
      "r1031",
      "r1093"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r76"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AdvancedProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AdvancedProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced professional fees",
        "label": "Advanced Professional Fees",
        "documentation": "Advanced Professional Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r812",
      "r822",
      "r832",
      "r864"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r825",
      "r835",
      "r867"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r860",
      "r868",
      "r872",
      "r880"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r367",
      "r368"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of debt discount",
        "terseLabel": "Other expense related to accretion of discount",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r63",
      "r282",
      "r1042"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r282",
      "r956",
      "r1042"
     ]
    },
    "eltx_AngionCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AngionCommonStockMember",
     "presentation": [
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Common Stock",
        "label": "Angion Common Stock [Member]",
        "documentation": "Angion Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AngionWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AngionWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Warrants",
        "label": "Angion Warrants [Member]",
        "documentation": "Angion Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total segment assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r115",
      "r137",
      "r139",
      "r140",
      "r177",
      "r187",
      "r205",
      "r209",
      "r218",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r397",
      "r399",
      "r445",
      "r535",
      "r536",
      "r543",
      "r638",
      "r733",
      "r734",
      "r746",
      "r775",
      "r790",
      "r791",
      "r803",
      "r989",
      "r990",
      "r1047"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r121",
      "r137",
      "r139",
      "r140",
      "r218",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r397",
      "r399",
      "r445",
      "r775",
      "r989",
      "r990",
      "r1047"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r766"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AtTheMarketEquityOfferingSalesAgreement2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2024Member",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2024",
        "label": "At-The-Market Equity Offering Sales Agreement 2024 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2024"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AtTheMarketEquityOfferingSalesAgreement2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2026Member",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2026",
        "label": "At-The-Market Equity Offering Sales Agreement 2026 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2026"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-the-Market Offering",
        "label": "At-the-Market Offering [Member]",
        "documentation": "At-the-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "eltx_BostonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "BostonMassachusettsMember",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Boston, Massachusetts",
        "label": "Boston, Massachusetts [Member]",
        "documentation": "Boston, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Axis]",
        "label": "Project [Axis]",
        "documentation": "Information by project."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r531",
      "r1056"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r112",
      "r713"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at the end of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r65",
      "r134"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of cash and cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r65"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r117",
      "r118",
      "r119",
      "r137",
      "r140",
      "r167",
      "r168",
      "r170",
      "r172",
      "r179",
      "r180",
      "r218",
      "r251",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r289",
      "r290",
      "r292",
      "r293",
      "r295",
      "r297",
      "r300",
      "r301",
      "r304",
      "r307",
      "r314",
      "r445",
      "r591",
      "r592",
      "r593",
      "r594",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r626",
      "r646",
      "r669",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r891",
      "r961",
      "r963",
      "r970"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r179",
      "r292",
      "r300",
      "r301",
      "r302",
      "r304",
      "r307",
      "r312",
      "r314",
      "r405",
      "r591",
      "r592",
      "r593",
      "r594",
      "r747",
      "r891",
      "r959",
      "r961"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "netLabel": "Weighted average exercise price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r142",
      "r315"
     ]
    },
    "eltx_ClassOfWarrantOrRightIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ClassOfWarrantOrRightIssuedInPeriod",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in shares)",
        "label": "Class Of Warrant Or Right, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares of common stock to purchase (up to) (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants outstanding (in shares)",
        "verboseLabel": "Number of warrants outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "eltx_ClassOfWarrantOrRightOwnershipPercentMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ClassOfWarrantOrRightOwnershipPercentMaximum",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership maximum (as a percent)",
        "label": "Class of Warrant or Right, Ownership Percent Maximum",
        "documentation": "Class of Warrant or Right, Ownership Percent Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "eltx_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms",
        "documentation": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_ClinicalTrailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ClinicalTrailMember",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Clinical Trail [Member]",
        "documentation": "Clinical Trail"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "eltx_CollaborativeArrangementFutureMinimumMaintenancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "CollaborativeArrangementFutureMinimumMaintenancePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum annual maintenance payments",
        "label": "Collaborative Arrangement, Future Minimum Maintenance Payments",
        "documentation": "Collaborative Arrangement, Future Minimum Maintenance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate sales milestone payments per product",
        "label": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies - Note 9",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r88",
      "r544",
      "r625"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_CommitmentsAndContingenciesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Line Items]",
        "label": "Commitments and Contingencies Disclosure [Line Items]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_CommitmentsAndContingenciesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Table]",
        "label": "Commitments and Contingencies Disclosure [Table]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r243",
      "r244",
      "r696",
      "r981",
      "r986"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r794",
      "r795",
      "r797",
      "r798",
      "r799",
      "r800",
      "r966",
      "r967",
      "r969",
      "r1031",
      "r1089",
      "r1093"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r626"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r626",
      "r644",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value per share; 300,000,000 shares authorized; 18,654,350 shares and 17,814,762 shares issued at March\u00a031, 2026 and December\u00a031, 2025, respectively; 18,639,895 and 17,800,307 outstanding as of March\u00a031, 2026 and December\u00a031, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r290",
      "r296",
      "r546",
      "r775"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r123",
      "r125",
      "r129",
      "r533",
      "r554",
      "r555"
     ]
    },
    "eltx_ConversionOfConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ConversionOfConvertibleDebtMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Debt",
        "label": "Conversion Of Convertible Debt [Member]",
        "documentation": "Conversion Of Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes Payable",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r261",
      "r262",
      "r272",
      "r273",
      "r274",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r145",
      "r146",
      "r264",
      "r302",
      "r482",
      "r492",
      "r542",
      "r715",
      "r716",
      "r717",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r1026",
      "r1027",
      "r1028",
      "r1029"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r137",
      "r138",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r249",
      "r250",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r276",
      "r283",
      "r284",
      "r286",
      "r405",
      "r461"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r42",
      "r43",
      "r85",
      "r87",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r773",
      "r959",
      "r960",
      "r962",
      "r965",
      "r982",
      "r983",
      "r984",
      "r1041",
      "r1043",
      "r1057"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r461",
      "r462",
      "r742",
      "r743",
      "r773"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r262"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r285",
      "r405",
      "r539",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r773",
      "r959",
      "r960",
      "r962",
      "r965",
      "r1041",
      "r1043"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r773",
      "r959",
      "r960",
      "r962",
      "r965",
      "r982",
      "r983",
      "r984",
      "r1041",
      "r1043",
      "r1057"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information by period of debt redemption feature under terms of debt agreement."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period One",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period Three",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period Two",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, prepayment fee prepaid (as a percent)",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r32",
      "r35",
      "r40",
      "r74",
      "r75",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r285",
      "r405",
      "r539",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r773",
      "r959",
      "r960",
      "r962",
      "r965",
      "r1041",
      "r1043"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "documentation": "Amount, after accumulated amortization, of debt discount (premium)."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r1040",
      "r1041",
      "r1043"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r132",
      "r718",
      "r719",
      "r721",
      "r723"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r333",
      "r362",
      "r363",
      "r365",
      "r757"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, basic (in dollars per share)",
        "verboseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r130",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r165",
      "r167",
      "r170",
      "r171",
      "r172",
      "r176",
      "r288",
      "r366",
      "r390",
      "r395",
      "r418",
      "r419",
      "r534",
      "r556",
      "r725"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, diluted (in dollars per share)",
        "verboseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r130",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r167",
      "r170",
      "r171",
      "r172",
      "r176",
      "r288",
      "r366",
      "r390",
      "r395",
      "r418",
      "r419",
      "r534",
      "r556",
      "r725"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r173",
      "r174",
      "r175"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign currency on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "eltx_ElicioWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ElicioWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elicio Warrants",
        "label": "Elicio Warrants [Member]",
        "documentation": "Elicio Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "eltx_EmployeeRelatedReasearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "EmployeeRelatedReasearchAndDevelopmentMember",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related research and development expenses",
        "label": "Employee Related Reasearch and Development [Member]",
        "documentation": "Employee Related Reasearch and Development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards, period for recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option",
        "verboseLabel": "Shares issuable upon exercise of stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r100",
      "r101",
      "r102",
      "r126",
      "r127",
      "r128",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r178",
      "r219",
      "r220",
      "r231",
      "r287",
      "r316",
      "r366",
      "r380",
      "r381",
      "r387",
      "r388",
      "r389",
      "r391",
      "r394",
      "r395",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r463",
      "r465",
      "r476",
      "r553",
      "r580",
      "r581",
      "r582",
      "r600",
      "r669"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r812",
      "r822",
      "r832",
      "r864"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r809",
      "r819",
      "r829",
      "r861"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Change in fair value of warrant liabilities",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r760",
      "r762",
      "r768"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r760",
      "r762",
      "r768"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r768"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r710",
      "r772",
      "r1038"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r444",
      "r710",
      "r772",
      "r1037",
      "r1038"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r434",
      "r435",
      "r437",
      "r442",
      "r487",
      "r488",
      "r489",
      "r710",
      "r742",
      "r743",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r766",
      "r768",
      "r772"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r436"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r430",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r532",
      "r766",
      "r769"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r318",
      "r323",
      "r324",
      "r422",
      "r435",
      "r442",
      "r487",
      "r710",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r766",
      "r772"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r318",
      "r323",
      "r324",
      "r326",
      "r422",
      "r423",
      "r435",
      "r442",
      "r488",
      "r710",
      "r742",
      "r743",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r766",
      "r772"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r422",
      "r423",
      "r424",
      "r425",
      "r435",
      "r442",
      "r489",
      "r710",
      "r742",
      "r743",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r766",
      "r768",
      "r772"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r436"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r436"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r431",
      "r436"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r436"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of the period",
        "periodEndLabel": "Balance, end of the period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r436"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r434",
      "r435",
      "r437",
      "r442",
      "r487",
      "r488",
      "r489",
      "r710",
      "r742",
      "r743",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r766",
      "r768",
      "r772"
     ]
    },
    "eltx_FairValueOfCommonStockWarrantsUponSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "FairValueOfCommonStockWarrantsUponSettlement",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common stock warrants upon settlement",
        "label": "Fair Value Of Common Stock Warrants Upon Settlement",
        "documentation": "Fair Value Of Common Stock Warrants Upon Settlement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange transaction gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r449",
      "r450",
      "r451",
      "r452",
      "r666"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "eltx_GKCCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "GKCCMember",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GKCC",
        "label": "GKCC [Member]",
        "documentation": "GKCC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "Employee related general and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r648"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "eltx_GrantRevenueNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "GrantRevenueNonoperating",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant income",
        "label": "Grant Revenue, Nonoperating",
        "documentation": "Grant Revenue, Nonoperating"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r239",
      "r240",
      "r401",
      "r402",
      "r403",
      "r404",
      "r427",
      "r431",
      "r436",
      "r446",
      "r447",
      "r448",
      "r577",
      "r579",
      "r653",
      "r709",
      "r710",
      "r760",
      "r761",
      "r764",
      "r765",
      "r767",
      "r772",
      "r1023",
      "r1024",
      "r1060"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r401",
      "r402",
      "r403",
      "r404",
      "r427",
      "r431",
      "r436",
      "r446",
      "r447",
      "r448",
      "r577",
      "r579",
      "r653",
      "r709",
      "r710",
      "r760",
      "r761",
      "r764",
      "r765",
      "r767",
      "r772",
      "r1023",
      "r1024",
      "r1060"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r141",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r382",
      "r384",
      "r385",
      "r386",
      "r541",
      "r587",
      "r596",
      "r759"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax provision (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r98",
      "r137",
      "r161",
      "r162",
      "r177",
      "r195",
      "r209",
      "r373",
      "r374",
      "r383",
      "r557",
      "r720",
      "r722",
      "r724",
      "r759"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "eltx_IncreaseDecreaseInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "IncreaseDecreaseInAccruedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) In Accrued Expenses",
        "documentation": "Increase (Decrease) In Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r955"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r955"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long-term prepaid assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r860",
      "r868",
      "r872",
      "r880"
     ]
    },
    "eltx_Inducement2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "Inducement2024PlanMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement 2024 Plan",
        "label": "Inducement 2024 Plan [Member]",
        "documentation": "Inducement 2024 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r884"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r884"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r884"
     ]
    },
    "eltx_InterestExpenseNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "InterestExpenseNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Interest Expense, Noncash",
        "documentation": "Interest Expense, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r720",
      "r724",
      "r912"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Interest Payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r1058"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r190",
      "r209",
      "r733",
      "r911"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and warrants from the January Offering",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "eltx_January2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "January2025CommonWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2025 Common Warrants",
        "label": "January 2025 Common Warrants [Member]",
        "documentation": "January 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JanuaryCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JanuaryCommonWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Common Warrants",
        "label": "January Common Warrants [Member]",
        "documentation": "January Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JanuaryOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JanuaryOfferingMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Offering",
        "label": "January Offering [Member]",
        "documentation": "January Offering"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JanuaryPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JanuaryPublicOfferingMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2025 Public Offering",
        "label": "January Public Offering [Member]",
        "documentation": "January Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan",
        "label": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]",
        "documentation": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_July2024PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "July2024PublicOfferingMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July 2024 Public Offering",
        "label": "July 2024 Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulyCommonWarrantOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulyCommonWarrantOneMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July 2024 Common Warrants One",
        "label": "July Common Warrant One [Member]",
        "documentation": "July Common Warrant One"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulyCommonWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Common Warrants",
        "verboseLabel": "July 2024 Common Warrants",
        "label": "July Common Warrants [Member]",
        "documentation": "July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulyPreFundedWarrantsAndJulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulyPreFundedWarrantsAndJulyCommonWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants and July Common Warrants",
        "label": "July Pre-Funded Warrants and July Common Warrants [Member]",
        "documentation": "July Pre-Funded Warrants and July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulyPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulyPreFundedWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants",
        "label": "July Pre-Funded Warrants [Member]",
        "documentation": "July Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulyPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulyPublicOfferingMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Public Offering",
        "label": "July Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_JulySharesAndJulyCommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "JulySharesAndJulyCommonWarrantMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Share And July Common Warrant",
        "label": "July Shares And July Common Warrant [Member]",
        "documentation": "July Shares And July Common Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_June2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "June2025CommonWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Common Warrants",
        "label": "June 2025 Common Warrants [Member]",
        "documentation": "June 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_June2025WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "June2025WarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Warrants",
        "label": "June 2025 Warrants [Member]",
        "documentation": "June 2025 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r474"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r475"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r475"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r960",
      "r965",
      "r1057"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r960",
      "r965",
      "r1057"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r960",
      "r965",
      "r1057"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r960",
      "r965",
      "r1057"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r960",
      "r965",
      "r1057"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 (remaining nine months)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less present value discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.eltx.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r42",
      "r43",
      "r44",
      "r46",
      "r47",
      "r48",
      "r49",
      "r137",
      "r139",
      "r140",
      "r218",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r398",
      "r399",
      "r400",
      "r445",
      "r624",
      "r727",
      "r746",
      "r803",
      "r989",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r89",
      "r549",
      "r775",
      "r790",
      "r791",
      "r959",
      "r964",
      "r979",
      "r1039"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r111",
      "r137",
      "r139",
      "r140",
      "r218",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r398",
      "r399",
      "r400",
      "r445",
      "r775",
      "r989",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r1032"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r982",
      "r983",
      "r984"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r29",
      "r982",
      "r983",
      "r984"
     ]
    },
    "eltx_March2024PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "March2024PreFundedWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2024 Pre-Funded Warrants",
        "label": "March 2024 Pre-Funded Warrants [Member]",
        "documentation": "March 2024 Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r245",
      "r246",
      "r247",
      "r248",
      "r327",
      "r357",
      "r358",
      "r359",
      "r369",
      "r425",
      "r493",
      "r576",
      "r578",
      "r586",
      "r616",
      "r617",
      "r676",
      "r678",
      "r680",
      "r681",
      "r683",
      "r691",
      "r692",
      "r694",
      "r695",
      "r706",
      "r707",
      "r738",
      "r747",
      "r756",
      "r760",
      "r762",
      "r763",
      "r768",
      "r769",
      "r770",
      "r771",
      "r785",
      "r991",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (per share)",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility (annual)",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r768",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "eltx_MeasurementInputStrikePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "MeasurementInputStrikePriceMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average strike price",
        "label": "Measurement Input, Strike Price [Member]",
        "documentation": "Measurement Input, Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r423",
      "r424",
      "r425",
      "r760",
      "r762",
      "r763",
      "r768"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r760",
      "r762",
      "r763",
      "r768"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r245",
      "r246",
      "r247",
      "r248",
      "r327",
      "r357",
      "r358",
      "r359",
      "r369",
      "r425",
      "r493",
      "r576",
      "r578",
      "r586",
      "r616",
      "r617",
      "r676",
      "r678",
      "r680",
      "r681",
      "r683",
      "r691",
      "r692",
      "r694",
      "r695",
      "r706",
      "r707",
      "r738",
      "r747",
      "r756",
      "r760",
      "r762",
      "r763",
      "r768",
      "r769",
      "r770",
      "r785",
      "r991",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r67",
      "r90",
      "r102",
      "r109",
      "r122",
      "r124",
      "r128",
      "r137",
      "r139",
      "r140",
      "r144",
      "r150",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r169",
      "r218",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r288",
      "r291",
      "r294",
      "r298",
      "r366",
      "r390",
      "r395",
      "r419",
      "r445",
      "r552",
      "r645",
      "r667",
      "r668",
      "r720",
      "r722",
      "r724",
      "r801",
      "r989"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r860",
      "r868"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "eltx_NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-the-market offering costs incurred but not paid included in accrued expenses and accounts payable",
        "label": "Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid",
        "documentation": "Noncash Or Part Noncash Acquisition, At-the-market Offering Costs Incurred But Not Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r737",
      "r974"
     ]
    },
    "eltx_NumberOfResearchGrantAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "NumberOfResearchGrantAgreements",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of research grant agreements",
        "label": "Number Of Research Grant Agreements",
        "documentation": "Number Of Research Grant Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r720",
      "r724",
      "r728",
      "r973",
      "r975",
      "r976",
      "r977",
      "r978"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/LeasesNarrativeDetails",
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, current",
        "negatedLabel": "Less: operating lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash outflows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets, operating leases",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate\u2014operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r774"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.eltx.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term\u2014operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r774"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialCondition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business and Financial Condition",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r103",
      "r104",
      "r106",
      "r588",
      "r589"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r7",
      "r82"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income:",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other general and administrative expenses",
        "label": "Other General and Administrative Expense",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r1092"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "OtherMember",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other research and development expenses",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "eltx_OtherPrepaidExpensesAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "OtherPrepaidExpensesAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other prepaid expenses and other current assets",
        "label": "Other Prepaid Expenses And Other Assets, Current",
        "documentation": "Other Prepaid Expenses And Other Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r824",
      "r834",
      "r866"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r827",
      "r837",
      "r869"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r827",
      "r837",
      "r869"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "eltx_PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of offering costs for the issuance of common stock from at-the-market offering",
        "label": "Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering",
        "documentation": "Payment Of Offering Costs For The Issuance Of Common Stock From At-The-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "eltx_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrant",
        "verboseLabel": "July 2024 Pre-Funded Warrants",
        "label": "Pre-Funded Warrant [Member]",
        "documentation": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r300"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r626"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term prepaid assets",
        "label": "Prepaid Expense Other, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r739",
      "r980"
     ]
    },
    "eltx_PrepaidResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "PrepaidResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid research and development contract services",
        "label": "Prepaid Research And Development Expenses",
        "documentation": "Prepaid Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and common warrants from the January 2025 Offering",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "eltx_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs",
        "label": "Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs",
        "documentation": "Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r591"
     ]
    },
    "us-gaap_ProceedsFromSecuredLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSecuredLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from secured lines of credit",
        "label": "Proceeds from Secured Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of common warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r495",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r711",
      "r719",
      "r722",
      "r724",
      "r748",
      "r749",
      "r784",
      "r785",
      "r786",
      "r789",
      "r792",
      "r894",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r987",
      "r988",
      "r1059",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r495",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r711",
      "r719",
      "r722",
      "r724",
      "r748",
      "r749",
      "r784",
      "r785",
      "r786",
      "r789",
      "r792",
      "r894",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r987",
      "r988",
      "r1059",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_ProjectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProjectMember",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Domain]",
        "label": "Project [Domain]",
        "documentation": "Planned program of work."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r531",
      "r1056"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r474"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r113",
      "r551"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r474",
      "r540",
      "r551",
      "r775"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r474"
     ]
    },
    "eltx_PurchaseOfWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "PurchaseOfWarrantsMember",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of Warrants",
        "label": "Purchase Of Warrants [Member]",
        "documentation": "Purchase Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r245",
      "r246",
      "r247",
      "r248",
      "r317",
      "r327",
      "r357",
      "r358",
      "r359",
      "r365",
      "r369",
      "r425",
      "r490",
      "r491",
      "r493",
      "r576",
      "r578",
      "r586",
      "r616",
      "r617",
      "r676",
      "r678",
      "r680",
      "r681",
      "r683",
      "r691",
      "r692",
      "r694",
      "r695",
      "r706",
      "r707",
      "r738",
      "r747",
      "r756",
      "r760",
      "r762",
      "r763",
      "r768",
      "r769",
      "r770",
      "r771",
      "r785",
      "r795",
      "r985",
      "r991",
      "r1035",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r245",
      "r246",
      "r247",
      "r248",
      "r317",
      "r327",
      "r357",
      "r358",
      "r359",
      "r365",
      "r369",
      "r425",
      "r490",
      "r491",
      "r493",
      "r576",
      "r578",
      "r586",
      "r616",
      "r617",
      "r676",
      "r678",
      "r680",
      "r681",
      "r683",
      "r691",
      "r692",
      "r694",
      "r695",
      "r706",
      "r707",
      "r738",
      "r747",
      "r756",
      "r760",
      "r762",
      "r763",
      "r768",
      "r769",
      "r770",
      "r771",
      "r785",
      "r795",
      "r985",
      "r991",
      "r1035",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ]
    },
    "us-gaap_RecoveryOfDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RecoveryOfDirectCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and grant reimbursements",
        "label": "Recovery of Direct Costs",
        "documentation": "Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r809",
      "r819",
      "r829",
      "r861"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r480",
      "r481",
      "r1046"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r1046"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r217",
      "r480",
      "r481",
      "r482",
      "r649",
      "r650",
      "r653"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r478",
      "r479",
      "r481",
      "r483",
      "r597",
      "r598",
      "r599",
      "r651",
      "r652",
      "r653",
      "r673",
      "r675"
     ]
    },
    "eltx_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r145",
      "r146",
      "r264",
      "r302",
      "r482",
      "r492",
      "r542",
      "r715",
      "r716",
      "r717",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r1026",
      "r1027",
      "r1028",
      "r1029"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r1022"
     ]
    },
    "eltx_ResearchAndDevelopmentArrangementGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ResearchAndDevelopmentArrangementGrant",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award",
        "label": "Research And Development Arrangement, Grant",
        "documentation": "Research And Development Arrangement, Grant"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ResearchAndDevelopmentArrangementReimbursementFromGrantFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursement from grant funds",
        "label": "Research And Development Arrangement, Reimbursement from Grant Funds",
        "documentation": "Research And Development Arrangement, Reimbursement from Grant Funds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/ResearchGrantsDetails",
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r709",
      "r720",
      "r721",
      "r733",
      "r1055"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grants",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r708"
     ]
    },
    "eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Aug. 2024",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2023",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2022",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r820",
      "r830",
      "r862"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r821",
      "r831",
      "r863"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r83",
      "r112",
      "r134",
      "r545"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, noncurrent",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r897",
      "r957"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested shares under restricted stock grants",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r76",
      "r548",
      "r583",
      "r585",
      "r595",
      "r627",
      "r775"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r219",
      "r220",
      "r231",
      "r287",
      "r366",
      "r380",
      "r381",
      "r387",
      "r388",
      "r389",
      "r391",
      "r394",
      "r395",
      "r406",
      "r408",
      "r409",
      "r411",
      "r417",
      "r463",
      "r465",
      "r580",
      "r582",
      "r600",
      "r1093"
     ]
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty expense",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "eltx_RoyaltyRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "RoyaltyRatePercent",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty rates (as a percent)",
        "label": "Royalty Rate, Percent",
        "documentation": "Royalty Rate, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "eltx_SaleOfStockAggregateInitialOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "SaleOfStockAggregateInitialOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate initial offering price",
        "label": "Sale of Stock, Aggregate Initial Offering Price",
        "documentation": "Sale of Stock, Aggregate Initial Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_SaleOfStockBeneficialOwnershipLimitationPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "SaleOfStockBeneficialOwnershipLimitationPercentage",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, beneficial ownership limitation, percentage",
        "label": "Sale Of Stock, Beneficial Ownership Limitation, Percentage",
        "documentation": "Sale Of Stock, Beneficial Ownership Limitation, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "eltx_SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration received net of sales commissions",
        "label": "Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions",
        "documentation": "Sale of Stock, Consideration Received on Transaction, Net Of Sales Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares sold in offering (in shares)",
        "verboseLabel": "Shares issued of common stock (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r163",
      "r328",
      "r892"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r474"
     ]
    },
    "eltx_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quantitative Information Regarding Operating Leases",
        "label": "Schedule Of Quantitative Information On Operating Leases [Table Text Block]",
        "documentation": "Schedule Of Quantitative Information On Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r480",
      "r481",
      "r482",
      "r649",
      "r650",
      "r653"
     ]
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.eltx.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "label": "Research and Development, Contract to Perform for Others [Table]",
        "documentation": "Disclosure of information about research and development arrangement accounted for as contract to perform research and development for others. Includes, but is not limited to, royalty arrangement, purchase provision, license agreement, and commitment to provide additional funding."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r1022"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r365"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Unit, Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r78"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Black-Scholes Option-Pricing Model Following Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r74",
      "r75",
      "r76",
      "r117",
      "r118",
      "r119",
      "r179",
      "r300",
      "r301",
      "r302",
      "r304",
      "r307",
      "r312",
      "r314",
      "r405",
      "r591",
      "r592",
      "r593",
      "r594",
      "r747",
      "r891",
      "r959",
      "r961"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.eltx.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Outstanding Warrants",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r95",
      "r177",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r211",
      "r216",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r241",
      "r242",
      "r392",
      "r393",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r730",
      "r733",
      "r734",
      "r740",
      "r788",
      "r1059",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r214",
      "r215",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r613",
      "r614",
      "r615",
      "r677",
      "r679",
      "r682",
      "r684",
      "r691",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r712",
      "r726",
      "r748",
      "r750",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r787",
      "r795",
      "r1059",
      "r1061",
      "r1062",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r177",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r199",
      "r201",
      "r202",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r729",
      "r731",
      "r732",
      "r733",
      "r735",
      "r736",
      "r737"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items(1)",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r201",
      "r202",
      "r209",
      "r733"
     ]
    },
    "eltx_SeniorSecuredConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "SeniorSecuredConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Promissory Note",
        "label": "Senior Secured Convertible Promissory Note [Member]",
        "documentation": "Senior Secured Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_SettlementOfPromissoryNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "SettlementOfPromissoryNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Note and interest into equity",
        "label": "Settlement Of Promissory Notes Payable",
        "documentation": "Settlement Of Promissory Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "RSUs forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r346"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r346"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Restricted Stock Units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Activity, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (unvested) (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofRestrictedStockUnitActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (unvested) (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share of shares issued (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r95",
      "r108",
      "r177",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r211",
      "r216",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r241",
      "r242",
      "r392",
      "r393",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r730",
      "r733",
      "r734",
      "r740",
      "r788",
      "r1059",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r117",
      "r118",
      "r119",
      "r137",
      "r140",
      "r167",
      "r168",
      "r170",
      "r172",
      "r179",
      "r180",
      "r218",
      "r251",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r289",
      "r290",
      "r292",
      "r293",
      "r295",
      "r297",
      "r300",
      "r301",
      "r304",
      "r307",
      "r314",
      "r445",
      "r591",
      "r592",
      "r593",
      "r594",
      "r600",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r626",
      "r646",
      "r669",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r891",
      "r961",
      "r963",
      "r970"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r100",
      "r101",
      "r102",
      "r126",
      "r127",
      "r128",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r178",
      "r219",
      "r220",
      "r231",
      "r287",
      "r316",
      "r366",
      "r380",
      "r381",
      "r387",
      "r388",
      "r389",
      "r391",
      "r394",
      "r395",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r463",
      "r465",
      "r476",
      "r553",
      "r580",
      "r581",
      "r582",
      "r600",
      "r669"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.eltx.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r214",
      "r215",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r613",
      "r614",
      "r615",
      "r677",
      "r679",
      "r682",
      "r684",
      "r691",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r712",
      "r726",
      "r748",
      "r750",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r787",
      "r795",
      "r1059",
      "r1061",
      "r1062",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r178",
      "r289",
      "r290",
      "r292",
      "r295",
      "r465",
      "r495",
      "r590",
      "r601",
      "r612",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r647",
      "r648",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r669",
      "r722",
      "r724",
      "r796",
      "r1091"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' (deficit) equity:",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r163",
      "r328",
      "r892",
      "r893"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r178",
      "r217",
      "r289",
      "r290",
      "r292",
      "r295",
      "r465",
      "r495",
      "r590",
      "r601",
      "r612",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r647",
      "r648",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r669",
      "r722",
      "r724",
      "r796",
      "r1091"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r813",
      "r823",
      "r833",
      "r865"
     ]
    },
    "eltx_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and warrants from the January Offering (in shares)",
        "label": "Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants",
        "documentation": "Stock and Warrants Issued During Period, Shares, Preferred Stock and Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32",
      "r51",
      "r54",
      "r76",
      "r277"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r76",
      "r591",
      "r669",
      "r686"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon settlement of restricted stock and common warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r76"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r76",
      "r342"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r76"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r76",
      "r600",
      "r669",
      "r686",
      "r802"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon settlement of restricted stock and common warrants",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r76"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r76"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' (deficit) equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r55",
      "r68",
      "r628",
      "r644",
      "r670",
      "r671",
      "r775",
      "r803",
      "r959",
      "r963",
      "r964",
      "r979",
      "r1039",
      "r1093"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r299",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r316",
      "r405",
      "r416",
      "r672",
      "r674",
      "r690"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.eltx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split, conversion ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r485"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r485"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r485"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r485"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r485"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.eltx.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r486"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/RelatedPartyTransactionsDetails",
      "http://www.eltx.com/role/SubsequentEventsDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.eltx.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "eltx_The2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "The2021PlanMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2021 Plan",
        "label": "The 2021 Plan [Member]",
        "documentation": "The 2021 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_The2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "The2022PlanMember",
     "presentation": [
      "http://www.eltx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2022 Plan",
        "label": "The 2022 Plan [Member]",
        "documentation": "The 2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.eltx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "eltx_TranslationalMedicineAndCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "TranslationalMedicineAndCMCMember",
     "presentation": [
      "http://www.eltx.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chemistry, manufacturing and controls expenses",
        "label": "Translational Medicine and CMC [Member]",
        "documentation": "Translational Medicine and CMC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares outstanding (in shares)",
        "negatedPeriodStartLabel": "Treasury stock, beginning balance (in shares)",
        "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 14,455 shares outstanding",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r54"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "eltx_UniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "UniversityMember",
     "presentation": [
      "http://www.eltx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "University",
        "label": "University [Member]",
        "documentation": "University"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "eltx_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrant Liability",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon the exercise of warrants (excluding pre-funded warrants)",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r794",
      "r797",
      "r798",
      "r799",
      "r800"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "eltx_WarrantsAndRightsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "WarrantsAndRightsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants And Rights Outstanding [Abstract]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.eltx.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.eltx.com/role/DebtDetails",
      "http://www.eltx.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.eltx.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
      "http://www.eltx.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, contractual term (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "eltx_WarrantsAndRightsOutstandingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "WarrantsAndRightsOutstandingTextBlock",
     "presentation": [
      "http://www.eltx.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants And Rights Outstanding [Text Block]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "eltx_WarrantsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eltx.com/20260331",
     "localname": "WarrantsFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eltx.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrants, Fair Value Disclosure",
        "documentation": "Warrants, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.eltx.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r425",
      "r491",
      "r706",
      "r707",
      "r768",
      "r1049",
      "r1051",
      "r1054"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)",
        "verboseLabel": "Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r172"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.eltx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, basic (in shares)",
        "verboseLabel": "Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r172"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.eltx.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii)(B)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-1B"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0001601485-26-000042-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601485-26-000042-xbrl.zip
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M[+V%L^_+OR=_Y)<!]T.!_ CQ+U!+ P04    " "%@:M</_?G7*@&  #9$
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MH[4BV0',6'^A ) X9E[A-=(5=:Q.^8I%1+%*);S<9DV*0-\$3]"W*?P9%AW
M,K(X9O$;-GZ6P-^K<=&4WM,#DR?FN(:/V1,J:<2EL-R9[<-/"_02Z^H^6T>'
M3S,)* ,4#,P2<,5Z[A W[JMB3%*M5N"5V*'8HZD[KNM/4E>?J&G0E]1E5CIT
M F21?@_>,BP_X[IOZLL7]?0X"HB99+PWH);EJ\\V,9>O&2CO4Y^:D-GRI9@>
MEV\@O:>N.50WTA.8VJA<C/0L(BZ@J9FXE/Y,71MG@<?#IA^I3[X:9NIKKPN/
M(W<%<L$U@%:)@[R&3:H9J[%N3LA4X9*BICW @7&MZ) - ?56Q-_!%<\!V *5
MALW$+/H<I, 'X@_+10,]NG@[F "K'^PP79R@U*;TR :O(>U 6M$ZB*1@MEB2
MVH3E>*S?5#TYECS9OG>65PPLEJ#((1@:<K]<N:#DD@L,F_/6"7N52HM DM4F
M@P 3T+&<UR*EFE0M.(0\&28F+G@VB'Q49HQ41GY0LMBB&E B<=A]HK^P$E)!
M#ZD7:MI31"G+?OAVW6BU%*EWQ^B/-:,*2"KH!H8T%A+EU+%U'W2JAL6(\4 D
M$NCB1"*QA.*12,]VT+R!Z;Z 76"XAB>C'=\"&SY7YS!!3-L0$Z(\0A!*'T0
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MO)Z/E!6EMG'M^U]IU,)W7E1W777BG"OM9*TTA=8%7:NF5_]$M)_@Y@$E-D)
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M*9W/Y,$>6Y^UL;],O][MM.MJ1K>,"A9CW8J6]A!:+M9N\V ,Q)%0?&^AYNV
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M&=2&2GMK/LFFUYV)SCQ&R2G3S0;1N3W=**T6T(V2[@=[&+HY+6/RQK8:S%O
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M_D=G/*PK0WD3"+5;YXXX7OC'N0:V@6O@>S,J!;("@]<AW?WJPT/>'1!=EIV
M":>=LA*\.0@3";8X)K985U:S1+;(7;:JT^*M;-6QF'K9M')%#$=ZP4V>5+6W
MN,2;/\5KU/,"FU!LHQ_SAN$Z/8G$PC8$%XKIAL4=W1] )@\QE13A>?D(2X0*
MKC@FKEBG)HMQ19KZE=I0[56D\"GW?B[W$ZRX(QY4E'217\!>2-27E,#6H\RO
M-H!Q<!\-?]ALA\V;"=_ZF)V(=3;#7/;=CNX<>V*XKNW,D%C<NR#N4L124'GS
M#H1#+7@AMZ50E!<V[T)UVK6ATJJWU*VW@/?C+7.OGL4$\TWPDX?D"O_5C9?A
M%_@G&CTASK-AL5VTP:*8TB@:!KM@7O:N,\.#[V@;V+F+64!CRH+_$Y@'YKCB
MG@'N"3AHOS#SY=DAIC0ECA>>$78I\#SQ=8,E!ME8%LD-?K%M6H*7PSTP>-#U
MX )RN=N,V6\93.&$< E3.XBGG3G4))[Q0C^_&KHW/I-;+90]B8<"-CMKS1\A
M3S !WUO]2 (=W1VC0VYM%*8(_?XB3)+_XKQ1L!DCN=/N4T76-86VB:P032;R
M@%"UK:JCI[;^?YAX'SXTCC>VI^29-IX<2GXVR C6=D;,5S)SD6:3$ %PA!/J
M*3#C?)!;#:?1J'PX=?X28 H$OXVMJ0'3(*JI@Z-@)H2':4AC!S7>GS8C2P9D
M/:*X"%T&+SB,0X8KN2,!>S;-362[TATNE9[3F^5(SY??KB^N;Z7'OUW>G]]=
M_GB\OGBH2]<W%ZMY_Y \F;T&9H)(X*W]B*7<-<[$F""^0FEWD91V5[&T>XBE
MW;8+'GYY<CX-L\3#)K;,>K* ,.G6"DWZW[[K&:/9?M&DA&B2Y,@!"NR]&W\"
M+]/2'MEB;M2M\TPLXS^,B>>(Q%T<2[\#;QUS/?#/VU&,V3EBO\8I((_PB5]-
M6_LYMT [@05L6#[5S[WP&DZ @K4ZA2EXC@]"ZRO\Z1BL<'I4>.-7WX4ENL%N
M_)R@D.*8=HM,VG")2_B%>^%WV<3G\\%O9\Q(R:L80_0NE$!4E&9GG1+8A;)$
MC%^"16/8$E@L#L#2!YO;!>%B:4WI Y*!TOH<C&!_R)^EL'ME>.\B,''"FQ\E
M T M:? 59KJ#F?),I2<#B$H;6["6YYD4&D42T5_"A![+?J&F9$PF/EA);!H&
MG;?)]$#;>E$K30V;!CGU,/,"'Y[X'H%[_S <%X2^!#I$<HD#'R'2BX$VEFUI
M]C.UJ#2V)SB#>%F3?]R?/T03;P3VS@L%FXQ56_.0X,.O,2Q0+4CL#BZ9/N:&
ML#\8;;&)2^R54ORJX+[;E$(8L]"5YTJO8]LT9PW[U0(QY_I/KJ$;Q(%%UZ.1
M#U3S'9;C!+3J3$/5.,?(PT4T\7I@4&*J% -2"-[X3;=3B@_#;"^B.PO(O0)G
M$&:^@../P?GD\ WG0*P 2(-(=]Y,^N;IRY2!UQ>F$S]AS5<W V9%@]YPQVC)
MALB=^K XS)8!W/[APR,C9BWC;908@,BQ!-C0C;!OJNL!UF$X&L@^RZ$W$I^K
M,P,;L&52S!&CY@S>,J(L<0<T#W&E3(KVQJ#7G\>V[Z4,<2-44:48Y(<1]RL]
MEVP%\,WXPP>$ ::1!'ZS \I!.K;>OS N!!WZ9"$/2&.@!<S4 J:#I>FL>SJH
MGRAORZ+/).1@=RR-3/LU[)!CQ]PTST*40,5H6!]6HTSW-*5S1L_?D7J#$(DJ
MU[%I6;?.B'X^"1VY!?Q$?^*;C*!T.@+*9*+NS^\_,]!965#UGGH$ *-?$@<K
M"[KG\V]_#3X=1X"Z<_W;Q0*2G6:Z<+8$&#+9DI/ 1<!JP+#>&(0Q<NX<:EDP
MGM]-0/L57ARKV%A<8'UVEU)FZ(]\#Q-&B;L T^@19FKJ%&2 /65SF#HV2@R4
MR3KC7G=ATLSBZ7T&9-J^HP4"R9RS GQ(9];%$^8 PDM?MV#S?7%#@9B%$B1
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M06A/OV-'4!P"O+LW%"&K[5[-=%M:R]Z)_;0!$D41TR# QD4R^]>_F5E5N!
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M=YGNMQ#RAK7H*FGI LO V@SS&=?RPN!?'LX*\UI4!%ZJ2EWM=++KU"G(R4Z
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M0K?^$L6[.V54/"\0.MA#K(Z2DJMV$H ^G933H.-H$F)GF<?BXGM/[[VWOT$
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MO\W=2=R*,]@KO)7FK?K!4EZ*KC/$KE?F_>&&RUP<9ZI[\P?W47=]\</M],_
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MWFT'T13>WKS0=:'MQ?-DI1-76^M.ZT+AWM7-H-=O02B12]\D/6<!W0H\\]*
M?*("RZK8"2U(2HM7'H&PK?+4W-JJ5A=J8D70<-0:]P] 34UVA49$Y>1,])>7
M[V-6U='!R.O8#TO\+%]YE$KPB+SENZ![@ZN;7G^0.7"Y"($+* /J6;BWC4 4
M#&2Q\'H,-N3S2-6?PYOC'/MVM5:L\#=>ZA4Z,K/0D?$B1R8,!7&*IJ)VKO\9
MIH\-L-L!55M'R4KYX&RM=DZEH'RV!N<@+^4*E!@",ITS(Z""JTQ.IO>(U]SR
MP8 KBA$R')SANBMS7AY&7PRVF(7CRVB L.(%"U@\S:6():]%)1FGR'J1^[K@
M<./K<#)N+5!6I%OSH3A#BJ7*! 0-5@9Z6?K28Q_D/WX&F0!.7WTP;=HZ?>GG
M9!H:4QWK> EX,/S/413>[O!(7, UB#>+/[?A3W]/_[XW:&N#4>:?.FTU\_=Y
MCU+5]D =EWI4_N^[HUZSJ*,O2NMN?-06,)"-$#'ICV7,QN=A[,''P8\*92>X
MMT7Q"L;3V>I]'2_I8JGQ+]GJ=BM:W8@H,A6N4"Z\H0JGRM=P\"4F==#CP]*@
MW\R9^/L[T^9Y]/=OCV(<5H?(< ^T,6T//"*:O1/1QI\[@0?&?(T^1X)E.Q7Z
M1.Q:1C23R?D:TOOH[P/3M@=DR7F =.0,$#E4M"@L0>S4OHCZOI)!(H%Q#S2U
MI65D-7:#_#H]\LX&U+@#,FJ=Q+DXMDZY?9^?8&ZX?M]\^UZA;$I#+>QTX@H_
M2RBQ7J';[N^-3GL. EGF^X4W4G<VS>N+&F<RX60[$TY*,V'H)L:\1"S(T#(K
M,M!A#/FSW\$)*./<"ZA\=[)1U8VJKA+HK$(='<8#% Z4!$KK]57$-NST]P9*
M.[C*/A*F:LA<E*D\'H=1$E*<+K_)8$8V;.KA,=-K)V YEUH'#E(XK-N]#6Z8
MZ1B_NHY7NH*SKX%X:;W6<+QWD+(71'NE(*!OD $W#5G=SQGW2C%A28>\W[VZ
M&;752^2]<_S^I:?BA/6*NMWVR;R=E^9X5[7MBJ:7\0&#7/YY#4O\+ENJ@-)E
M%OT>]H&U>MUTT54JP5Z204\:CE\<:]70*$FFV]DN]:]N>NW]?:(:LM\Y?O_8
MH=61!>BSX\X8E9B_"VC<6;Q:_.*#JLHMTYY1E3B-P(VT1VG3A2W,K6XOG;0H
M;KEJZ-)>'.O5T')E<%]9VS5$V]7/&]YYS@QXCM^_])@J5=Z0K*QL:AM*IPT/
MUAA356U#?X032%2MV]+4--A"W?+R1[@PN^QKL?.__"J$*E>C.H4^UBEH[4$:
MSN=-Q9]GHM>+-H#4L>)@0!,LM%-7'#0*]/3;*E,]T#V3ZH$!XH>HK7X&A-)I
M-.F%9[+D#0M/8HGQ-N&\FWUR6L(_%+U372"]X038B44^8LQ[7/]3$RKL(8B?
MHL/;+508:-@\WQ_V6EH&QNYN&8E*6.%$J8R]\V=UDO;BAC!K=^<G@R>+)&)B
M6#*2&.#PBE&[TWO;V< S4?M'BB3RV2DODE +1!*]JYM^NU=))-$HT(M5H+M$
M$M6P>C*24$N'$OVKFT%+[>W=.U*1)J5(XN\T6" ^83$N>F<U%$(30R&BD5)F
MV$CZ0HVD8N*L/G%>F)@887H*T&8:\)D0B.M*\T@0/X7AA)4)\U\9X]^#D(0&
MUAO*3#==\<S4P)),F*ST5%+\;6+61+OTQ)OZ%P</!OG%P<G=<T0K416N&-L1
M9\/[(3X/-H6X2H_B8T=CIQ5!G,K)'O%5R/DZ95Y/@\QV&C&[YSWP/E6U],=?
M@#:?@30B+Y(^O"&A*:=/KJULGNZF^-3+'=@NFSK/-H@O6NUH$Q*5*#Z*19:M
M),]#QPV%S0+;2;W9-J1FRG]:+"UGQ=@3<U] ++-)_L412R/J>M2G'O\[3A7\
MXOC_R^"E<KOQ\L6,*=.#$14MYX+2MC)&:B/-IAPX+R2K GK,C<$-7X=PPW3H
M:9R-<E[BP<C#>?*SXXI?X>>*.(CCJYMN.M7,1R:</:X&S3-*V!6&2(%"$L!.
M1>9'0,W(F<I<U04>W: K'RUP&*Z?IG,'@8S%U]'LX)\7CL&L:%ZY[GG!0BA@
MVQ'P.R3!9!PGS')>N7Y-KDP7HLF?Y-C6BA"IB$V0JSB$ "Y:7SC@?OS%;6NF
M$D Q!S*[.M+B&NFB@"\&7R7FQL404HAGPF;E*R+^IEW@4J3,P!>?F0UB8%D<
M%Q2YDX 0Z3OMQ" S@F2A#7%%X\]UGZ1")]!1^ KQI)W8%5J/F&9[G8-[X 73
M*>(9F0+TTJ#9^B!Z$R)DS*#$GRF7%$?,P3'FS )1YWI18 SS(7!198_P5%:*
M,YT&;DMQ=1J;#>NW)9_(%]KAN)KX)G$37*7P]R"5^$)<T_OC>H96+P3\<<F9
MBG,@9S8_R_"Z@BM=!BNU\7B_MY_@T2[3/1!HXC-/@ LI%LX^X0N*%)4G7":Q
M.OJ,.&K.SGRAT?(AOL0/.,G>,MP6$RK,(]L1\_2B#7@F?,:<F?#+!?/G3LA)
M+EO"[FEV'7&9V)]8R30VP44N(%IAZ/BER)-DQZQ]24X(/$&)U I!,*<Z_%DQ
M,3W)2'8YO*47S&8@Z3CQ;VXBZBUZ_G)-H1,*BD,G5 '7>0%6)7A=W7-L+O0D
M?,$2<0VX%7+"@T_2G"\W3HCT41'= ^R4D Y7ZEPSC@VT^W5X=&WED_S*BX/S
MW"T:".@I%+))99@BM%A&C RQ;Z,TP!& 7&!H1>#FRV!BF5-4&JYN"(]%MTWF
MM6+,8NB@\PGK.,163;B+J*E 2R+]DP<<8[T4WY++<\UWPV4TR0B$WBD' PO<
M;U)N0 /"U/)PYB;L#!5IQ  1G$:,!O&Q>!@EN89<>I(Z6:/Q$I$-#V2 $9U%
M?%IE2X%CYHN9FNXT6. U'!*)(P:U4%/.N<03WB>:7,[:!#F(((6HFFQ'L1SX
MO,N/P27.#$^$DX>,%^%!(Q.#O*U,9AD18Q +KPV3)-+SW<,F46R6.F'+RH=X
MT@("F4#X&9_ 2=,WUV9.[CV[,>ZTQQU&],>YLQ]9YYPYCL/.><]QW.#W2/$G
M31K7!QD1&RF90NY1TCE**)!HEF1*E<3<I,)NYKD,>AQJ[=%P<.'C"[>^/".I
M+,\%>(^=YE,%QRJ>*D4]WC;7+=[PGYO%'Y_?I+H-*:$"EQ4'X85ZS?6IU7%M
MK"&OA )OFK;YLP?/2)56536U, W#8@?4L=G795^S0_8*JJ4JZYPX$67*8BYK
MG7C&N+JRQ##/'O/I\=0^PZ'%H9NSH)J'B$D>S?2JIO:ILC:)$QWL3U67!93Y
M_DZ*>Z.^B(41ZP2OO\RH-909#5L8TS5+/R6CM\NR6;OU_9U(@,.<7C)]<_QY
M*B#%-2IPJ8%=DB?SBSB87!GK(E1U59-0=[,^)SF\W6S/22>[-.[7[FS>.SV;
MU]C).D,[N6=L5^G8S)+&DJZ,)$I$85^FLNKF4]K*G)L65!D557QNTA(%:YB'
M6.,95?8<JH;Y2&Q>MY DCP6JJV^O@@4&FUF@"3QJ$GA$%]Y-T%$;;^Q_PD/)
M]<>&5S=JIY\1W#>!QR%O@B[(CM0RM55" D8H 8.,E/#9I;<VMY_\?0TJ/<%,
MXF![6!RQ=#RJS?Q %>7F"XMJ(GY*LJ"HJ.A$7]$GGF,%?OY7\LMH^%W<<?7
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M0:9 'Q C:BR+^LV<,>4=Y2#>)W9_[ F91ZZ\%85G)93@+CL^TMB$HGLF/_%
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M&,'-PO\FD4L6^DJ9X+CD%\=ZX8@I%I%@&9&@A5"SXH->,/DWFQ*8R8ONFDZ
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MOSY\EX<GF /OU^C))8FEE2$6+RB>???8+;XNBVB#JYM1.Z^!4]*,6$B'M;A
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MPS)>H9WA%+8G9IN.JXBY/C@DD'@469X.2 P*M)_/?/;-K4?IE,#S^$@TVMP
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ME#S8JE8RP*;)K4O)F!6 U5+7W79&+PFV@O%^\7?J6C=N$W:4LD/K75'$#_?
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MC 76TBA:&XPNCI-']^UOGH+8"@$5;Y/-N+5U:^69I$4C$ M$N2#=0)_YRKS
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M+?X*\>/,J<G?BO!4*,4$R;4"00,M9HBV:=U@?P8<WYK9S[B(D*NG"!H\E1+
M0CDA-B#P>%1[<!B+0"#CZ8:^)/:C;\!2N)RO\1AL1TH?<0O73?S>*USJ4E]9
MCFYXZVL&7\Z(@? )7I7W>CDLR[DTQOFPA'!WZ*I*CD><9AM_'9T#"Y]R!E=(
MF\L'X"B0?*BF,-F+9@M"$[0%E /(TO#P440'QS\:%!2'$&Z@M9\A^ !["8<J
M3O)%EY'S_]_>ES<G;J7]?A55)C.WNTI@@]?NGC=5CML]<::WL3LU=_ZZ)>
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M)DAMBA+/8%RB;ZU0?-T=<K<JEFR&4>&>0]58.9::Y_*]-<5DL!=]52JZ@J?
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MA$>F,^]SDJL&2;D.27E_,9+R&O!XG0,#C]?@+S?XRP^)O_SX*(L?PS^+<(!
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MGAK,JB%$*YYC+%DV,6LZCJV.[X!_Z:YOO3NXM3+A ]1[-&M[)W2V-90B[SW
M69=!OU],"C8U!@I>/\R9(O8/V@=EJXBV'Z>:F1\0;!EL(/(_R0/>KYC\O&ZF
MPAD/:QS*9#1"TT82JFE TK/;:P'.;T8$!Y8O4HT*#D\(R.$FXQ,5@K\4#UQN
MT :)"*])DUH7OR@N(P2+E"9$ HO1@9DQ1-=CX,5K]-%G,I'% 2U'X.UAQ+,E
M]2P48UT2YK=C0@J0-<YAGI&*$USU%,'']4VW?=0CD@JS2[7('.O#1GQ&]@R(
MC'B\GNQ&E9!]'NP813JTXB":]T7?V=%_[A%KD-H &!;<A-S+X397A@T=T-N*
ME.11*+B/C.8>4_2:7LI.48%CS35$>1J$Y4F5% K/O:!'H1S8$F>:DIE02;#O
MHX0AU'%H7^S"WK-7C>+/N:U+W&;HT?PH3"UV5AO9B!M/Z/)ZAL[\U!C<).?-
M:9BC<W-VQXJ8L-EYRU;=/)SM!9* ^#'*%'!;*F.%X!'_*H(4C',0&1>* ?MC
M'!,T\3J[K7\YJA+T%#N4-&N6!LOR3"/PU(J),^"(EGG# 3@R"]YO&LET))RS
M ZSVOV:<,-Q7B;^'PQ>R86#FLCN8WOJ$8IPCC,\M4A:>/9PP#!+M+OLV2&C@
M@AX%@#&78("2@#]F%Y'/C1?0QZ$(F@YY&!([LGVS++PH14ZB]7G!A.654)/^
MM?Z[[KIINR<4R:'!G'HB:3:FN477>&RX;"39%3@"QYZ3&A@,>'[SF(:7QDRE
MQIRB.8Q!9%#676/'3I&RU@0%EQCGWQ@2N+B=))TW1G#:@ *6-@R1R2A1?C;?
M6\LCL;[=V1KP%#A94@-H](ST3?4XLW$XU;:1,^U,AG[)W2FT%O(0!5D,:CTU
MPLG5%IL>R.JWY!IG7I!AA?R$PSF(&7@P0HD=>J4IKSBM Z09O>B\H*45PW=I
M>)<K)D#L9N9VP5401NS$Q7HF'!TU3OGCD:LYCE$&6ZR>(%B>TC$ST;'%(>]@
MC6D,B0-MV"='H+:=>,O\E_7*^VPU$0_^FP>?!5&6L+$RH)U5TXP'BX&\5)6G
M&FV-#)SR[9#2G4W.ENQR8(:\D00GJM_,R.8"?XTPXF?>I19)Y+&C.O^ ZGS+
MS9A:5'S%$^J!(0.!R#<##<VP8+1E]%B8V2WL_S)X_FI ^8?;@Y-_U&T?'QT^
M:TCZP^[-#V_0WQ>COS<(ZPW"^MH[=7"W(F]0RFK](F\#(?[H(>G/6M7@3.1P
MP#&+5Q3C"./7E7CU.EC7LA$/@-M<V>+;?G\#<)M7 I(7VZ7S))UY%OG<#J>K
M)XH[=[0LWI%'7O,#@Y\^R9JP-/EP_^"1VJ9PB1N,JMM0U3V"(W0Z:Q2\WP=5
M/<@ BR<=AG%'FV%SM,4'$]]=IBU6JIFNV9?5:Z:?A"&._=WNNM"5]:?_,))V
M%=/I>9T(2*B][KK=J?=Q)"_79CP;#FG2\M#,/.T7::KB_@PCN.AL/!6NPY-0
MX+I-%!MB>3W3T]CK/,%QO(@HPBO=^?"Z5'"]F-]7=- ?IW=PPWV"^]R2S63,
M5WO^X3JC(.YQ1Y["W&J(OR%^)^Z\ORZV^E.2_[;U2-H@YLD"MW3K,LH?5F_D
M,LED">H[A0?62S?UIX>E8LU*U2761 V]P%:M4H5GI]HQR<U7IA%2BA>=*B>W
MNH<J2RMMDES($@81E7<.L7JHAP7!<8L6TA_#&9FOFOI8KG^:NXJZX)S6F?FF
M3*SH,'665$)A.WFP9I,+B]VW]FM:V71M<JL7<,W5!*LZ JX*ALN[E4V:)+!$
M6P2&S[WX\@=O$]>JPI<ZIOAWH*:IPIXB7.D+H=Z#]:@7MNLVU%L]F'6I=[>]
M=UOJ[;3W*\71BTG85CR[Q.PVO-V2CDLWN)F$O16IMT2Y\+%9D>EE,S"/FM#G
MF.DV!+\)VL8&05^TMG'SR<.:N##S['%5%E/1)C?Y:KIRBZE_/JH1NW/EF=0K
M1G\^^?8)NR-':3#)^.7@^FD 9I"Y*S4,+Z)#T_NQL 6E[2T\W)?<;7E0U^K6
M]$TV?9,/WS>Y[5+T8&TIVJDQ08RUL$RB[E;-]YLE*KS@OBM60=F_62@U?P_B
M NM:J1;UBY3%&UF[OX*LK6N*+\O?C30-ZJN</W!##=4U?Z;>0ES.AX([NBZX
M86;"S+;5!L.O9#\F;#IS]B>OE-E3)Y8N60=S%/Z,_2G\IV7=.CX7^4>ANN)B
M^L5-B+9>?H@=8/@BIK,+.YC@56)5ZO)RT' *+,_^D]\$WPQM'*<?0O=ZLKDL
M#5'_5=PW07SDM*9QRT#J'#(U-&!/T51W\F*C2S CKJ?6A1ZUEB:P?_V<.ZNX
MNP#;)L&_8,_$]$?89TC+B)<E2:RHRX*Z#KD9C'H4@M1MD0"+',1%KH3]@G[N
M=#N4FQ7J%L)NBWR#NBQ-PR-^6?>1"9V7MH".!TQ]%1.]3+"1 ?N?DM1M>/&]
M7I%3AY+MR5BUF%W'NEH8^7R[MP+7M#K'3\$T?_O+F\/][KLGT+'=OY8WJ;/?
MWB>124U0?3A\ZLP>8;^4+[I$]Q=EW.BK6W!)/=DN7.+VN29!7[X;X]_Y$F7P
MKQ#D*E2Z,<P%Q<K>-4?^*$>>%#GH79+%Q(_,OY7#\+D=%CY7/\*,CC$QO#Y_
MYLW9/?S978\5-?)=LWS7TCT/OF,;[A484.!PZ5/]\/Z$% (WB[K-O10!FZ(2
M@L.>BO=L3GMAZV]SPH_*G;X#=6;U;:;4=U*822\/@%]%'$_@9_T['CP=<3PS
M%3JI&F&C/.)NZ)-OSO.1SE-#/98AP_!T!BH*9IDV^E1,B \JK;ITZBJ)KMBR
M,J=8MC-39'^%_>):>=,S!!R$NJ$;SGYZ2HB+20^/%RV?<9 BADB*JK5/)E8-
MV (BB11I5BBW.;SF.@(^M":6(^R;HWV<H]50"8N!,X )M8UM@ #J3LSI_(YF
MS?$]_/%Q1S;GV\!@"B1RL!!TR$;G7*YD9 HZ=!<*H7%P'OLX!>U+D"0D"EK/
MDR6I.IYE(2CH&(XO$:POYU89@9>%?6UP@5DUZ2%"2R-D']N20O^FC]8/V<$6
M*@6LH#"^4IE&#]:X.8([AV=O?ZI"&N6J/XYA::.P,8<>2^@Z,%?:?_&U!&:A
M.U2"D4M!*LW(6&00(8Y:P?[K5*5P%PPB#Y,H3$I2>5'<$NWA:3!C^WF:8 :,
M*SK$L![P6WU7OH&Q$3,=["P57I%%AA(_YG"PQ0$V!.E+W)MH#H&$6*C0J@28
M7<7@H%G\0GZI7-OTC-I3OUJJWVLH]3'- R)+2[+C"OB9@2AWZ0_>)F#T)K_6
MV ,=HP;T1XUTB:DQ]V[-$3^.;E&FJXG*HA@-32N%F;$%G+-CQ3%"H+28.'@*
MTJ??F.Q/&E;I*;+0-%0;HZ#-7)9TS?UP,HU8^CJ,3#5L^$,VRW(UR62$QC -
MLCP%TZ%(2^ZXQ=MCNQ#U$/Y=OMV0PU.2 ^/WB<T.IF$ 5)&-&3)0RUI=YLAQ
MU+C ]"1_J1],G5+*$K)HDLU/ 9@&_>_!B#3^=9 JA.4RZ3*$G U[9 (T%/%(
M$AVLLV0"0H \>K*E!%/0-0,'.MZBK4N3[:H'832A]1+T8L4/X:>5OD95!URO
M;.*].9EW7(O >34]$T+>D)YE$O7&7B6<1BK9>8>7-/3T*/3$9^*S S#-*X>#
M6*)B$0C<M&/-.23F)%PY$T.8[=H[#>F"9L!'7<GI87E7FI+3IW^-IN3T:>OP
M_HCS,&)\79!.BDT4PI=E(92KTHR"%)P71$ZF2DP66+5Y)Y)#I@3.0HS+D FW
M8LR=4-% *AM(Y9.!^K/ ]]=%<:CPL;ZM!'@,6UID];#'C$1/L,??$BG;0Y[!
M V' XQK Y;J#P' 6YJ72TC@.VDIW5 85'ES+1M@V'CU4 X]PG$3 ][;BDFZ)
M@,SP\R!$;3+PK0&#RY#Z3T2[MX>..Z%QR",:V2)=1GI/>8Z(LJC(DMO&6F=V
MT@FBG )@=:0F[]GVWI?HA5T W@WS1]:X^D!\>3G,M\,&CU*EM,$56/!TA$:/
MJ5B9BA7%Y,/M2D,N=ZL$-ZD^!S/QR(>>T(@OL-@9 _>SDV*/% \(7^>[6Y-9
M O2'9X),CA@-'R17"))H *L^'UH:8:1M318NQ92(W'<(&I8$]RS;KA+;#-,!
MM[[1N XV8JD^EH"O03K!YF9C:D@C4I8C@D]Q0]P(NZ]-("V18.\4M?"8K)NI
M2TIJLZGPUY%TN_5Y+@=BNQ/1F3);X;=A< 4+%7X3\<*!7,+J1F(R/7156M+;
M62ZGG6/ \CY;EJM(+!X/PO,GS [V5"GF3#4A/I.6;_#$V76!&^6JE,LJS6Q(
M:YQ:-40,:F>_[*'(=\7OY1$Y]:EK/"1D%(0G)XXG6KG&36!F77 [HO"ZP\/$
M&;!877'_JG/:CG]ZFI: &QL 3E'&833WA*>W(&M^Q:B@+GB]=+3Q[\5@9%W*
M,RG1WO;6 !SI8J/>?_O+<;=S]"[# $B_H+F<XD 'T0P';^@2<A-$LY,:.)S&
MY4RVUIXJ^#-=DB\=".N,7V$?O&8<2$AZ.$D'9..0S/NC?=GV_G%R\I4KX/E2
MMRDV6VOVBV;T#-6^Y)=,;;Y$%JK] J[*H]BB&MA1&\-%?<M:#>.V1TF&HI8B
MVT22%.]<\#U^DNW46'.V367ZCGEC.SV)E!T6I'*(S5Y%27B@N60@L[.<C4E5
M^<#'(4CGE#@-[YR&:"UPG"<&80XW0;N*%)HT&Y@4GNXJ"4C[!%G"4IT;H&B]
M8=HO)AF5#HAAY% A4\\0&U7P$YX>,R2-0JKZOY:I:9P/W1&4Z0P_-&IFP>[S
M@:<T+0U?;D#]75,D3S@RGI#$6IKMVS:V(!?<$4(OB/ID$*(M;;JM,I?">)5\
MA5"!H3:V$)GWGL5@J;X6QH$5QE,CC%,T@C.XI@=D94\?)Q'CA2BXNKOO/LU+
MLO=E27;B2+(/AB=.2U+LPM+/%R/%Z(;==_>A,NAE.^]T+%&W4?U3#QRQPBY&
MH8-5ARAI"4L@TP@(-V\7A\^%C.0Y%7&XIB1V)<#RB1?N%&".OHMHL[/4G&7?
MVJSH=I:8%9WN9K0:GH&=AZD&[Q]I<@V:2D_2)HJ9@-\(]'QAY*K^%,>O%-MN
M84AW6^!ELDZK/_K.+L [*;U)(]XDDPT,,AH8%Y=8_W<0A4">:4[:YU>I'L(]
M2_-BZKT2D?#[EU\OA>%>H_QM>W_86\!G^#=_P:.1E3 Z0T:^S*?C8C-"T8"M
M(4_R*D2R=OB0I@(&Z2"CUEZ<L%GT,K EI-N1P@,Q*#I=2.*^BU?,!XF8@^Q=
M0<=$,ZY0Y;"+>5U0Q3+(6TV<F9SLE[CISE)!>C&W(Z0C%V^*]JVGZ/_%N94I
M,;[7=>+-P"MD@T>FG]6*%#3AL$I>!CR2%Z<'#G%_"UP2TG"\2N#))WK1B[2]
MRLZRI((7'6T:HXDODJ3_)Y--0-/#I([1TDJ3"-[X2KG6K6/J8%UWP'>]#-)>
M ,36^O(C4C/:+FI&W>T2J083%HF: LN7:UJL6P'R0FD%VC7N">79&99?>3^T
MI'"TT1>,OB#_>;\F0"VXO_ _J6X92%,);@:L$R1PFN22$B/S!EF(0E<9SG)T
M[%$[[A!>&HNCKE0)D:84@K@!A6-KA!9I827S/RGTI_MQ<SY?"B&RU<"&,-$L
M[DE$YB.Y)*L("3IF>IPU];B^A<Z =#C>6GB I^%6&%_$!KU@D(+-G&K!,N!&
M8GC$J_"U#HZ 81$E\8BZ&Q;)77SO5Z%\9XC$$O#@6JZP +?@*NF#-3[#WG^/
MJ&.X;(<,@((8 5K>T"Q<W43CKVV;..$CMCSL]$&]/[0#?#BKGPSWQ)>+4ZI'
ML^VV][^5'A"*59TWT4.5Q#C@C%3U7O45]<I8Y"&B'"JPQ.FL@V!F8P=IAK(G
M0^,5]032@LFT2X RI_J<&)TE>(DL,Y%'ANGJ[AUX/8V/ <Y<@C4^\$1Y)/O#
MSEW9?8!U#:2-/] >0X207A30CR@!@P0&/_G:1G=,#WC-BP+(JM/MM;J.SKRT
MP?*S'X+X)3JA\V9OOZP3\ OR:/=BJQ7XG2<JB-DGE]B<\44E6NE$Z#G:G8$O
M% TTM!GR:Q1R-/ 'S\W^&2Q3"QAFP![H>'3MM7M.DR3+*7D>Y]&,.4?A_F18
MJ#'0!ZC1&% DO JO%NP_G:K80GA8#(& T'_F&,.88<D69SU<#P3D'V>3E&H1
M#;%\V79>/,/(+27"<=>LD(9=CN =B9)NL),E1 WKB:+2=S3)+33!#;ESO%TN
M)TJJLH:^5 B5AFOB7$2.D<TW-T^<89@9\(%KFY+5XQ@9):O4)@-9M#MFZT#+
M]HC', 9:O^!ST&@VY=UB]GE!GF,]&>FB<C/F$!F8_KZ_NT^_ENPUOV1 NP$Z
M4 HCB7!:&VN!<21..[\EZ!(^@$Q/MO\Q<[39[:/LW?VG<H=O='[/86'>7ALQ
M9$"#Y#PF'%?^+R11^?V]V=G,.R%;\Q-+OHLP^]X4V-04V!PU!39-@4U38+-N
MK,D:=& K.0:=J*B2"4>!*1/@MZI'QQ4(O0V;@B8ES6+#5&"6A2#][B#2CS8Q
M<4H2?;]-A$MQ$]RHKVD"*A(%^#(K3.0O$M)3K^0]TH(-_7_$/'Y@ ,.L4C)+
MW7(+$V.ECA'3=P]P:@[0>S7O]V1>9R]H=0Y>J==T=>=@(+]95\AEGM?$.:4'
MZ((A\QB301LH+'R3INZ87DV*>&J8BUVX4D*!.\#9ID(K=;#@I6P9SRJH=B%:
M=IABQOH/>NTLPQ]Y/CCL^L!I(I&V @ELD!4J^5%=3&3#'I=GIR9!E1:Z$AF7
MBG50RX^'A!R.M%^T;[1*=_-@*6#)%Y."L:IU^UJ!+6X2X$I*I0#5'ASPN.)^
M.*44KC9Q$\3P$^?/?FXC-/(Y>\!8/0T7430J$9\!=RE"8)5^F%4,:7/:EEHY
MSVQ?T5-4NT1H#3JW7[M=Q-SPWU&"=Z8D<-NSN4(ZY%$,YZDIDOH%:N_E2TX.
M7;0QK(#2Y^84B,BG["WYE#K0FH(BXTX"&U.YJ6YW#_KC4%V);QNFX%K\ER-,
M LWF+#E62(0")3J=1A2-!Z+7B6RD,-D6[2MCJTVKIV)@YYS!RG&KL6X08UM)
MEI&SO6"]3XKG>7-*35;)F8<:2;VF4MH"P>URI_%PJ<0/.<]-['Z%!6.%(9LP
MIT!>0Y"#FF^_:+Y<PMA,?7@1W^&2RV<Y &RSYPMNYT142;K-BP4.L0L3<P6,
M":[&3H_/HRDL>B*ELAD+5X<SMSZ?81!@:8]+G+/:!ONKD]5:1(//HUSB@$7O
MBL=-(QAL('[QP6VL^#JUY1SG.@TIDHM2>,Y6F<* +2="KFZAHP,E6JEGJ>9B
M%Z=B;V+U88G5AZ\7\SI36W^^O$U'M)VZEC)-^3IAEYGB'%/KCFH?@4TRJ^MG
M7A1^5Y'@9E2N]]=;>]-I5A<(.UX<"%O#T][;_:D)GS7ALP</GV&3[N.RS;P"
M0K;YBJ53Y^?>EV^_G5UXYY\_?+GX=/+M_,OG6\>J]O8V-E;5:7L?P;6,V!]0
MZ&%NNT/P@6J>,,R :;<0$6AMBTI6D N)'^GZZHC6/[7K1XB;(!3 C&  0DSJ
ML*Z4>YD.TH29&625H(N.@R3ZU!JBK4B3178&8NA.)>P^:7LG43XV+6].F38#
M,>623Q.L<7HW\*&EL&.:(O2.06\ VQ$1J/*9.[F@-+* M2;MRB"1'"(7DTM%
M 'I.,XVV2L_SG87CJSOO5 'BINPGM:,-%/?ZH/MO.M^H7LB7]AL@%.SW*G@$
MF<$0"$8C#'?DBGN*C+G #9P<DR$/*;!%P!HW5L/?Q*6-Y[:'>KAP9RDA5@O)
M_K6]2PP5V4]I31SOSK"O#N,8M H!N(67QVK&/" $+L'QD.7:B!%'4.H@/CAD
M/E 3KI+67L@@Q*$*6/E/W@,[!S=$'UZRO?/F?NR=P_NP=^@ &GNGL7?65*%/
M90><M*F@P/O ?49;;@.<NP":<SW\TAF-]3]C^!)H*FR1IO$@L 5M[S])X65C
M$NY]T(>$8,S3.;7+C-?9^2^V 4<T6":%,WF88\I%JH;<_5W4ZE+M/-/8B4["
M(EXI1=-3B)E/&012/'KF J*%T>:0PAH'J:IM/E^KY<;=#5UR3JTMU7VQK2VW
MMZ7?;*PMW<46"J[:5Q@[N=3(%&=<FNC40Z(N_X,-1#&\U^.X)V:OSTFL;G^$
M^]V-/<(]1%L8!F1^_S$%9KA4,194VJ/;NF.Z?1/9_L'&GM-^V_L$GP"+#15P
MEE,C]Y+.9R.Q ^A\#G2_U;G57%MN4KRWD?!*B?<- ?$83MCFDK0GEZ3S*<7,
M^WOXXRU<_[F8P OV*>0-R[Y 0[C?ZOSDQ<$$5JKZ@[= -QC<[^SV#CHG:7K"
M'5 ?HF#TD\?;#?3S(W\[#'^H 6Q$E(%)C40U;!T>8F?HRD^Z_6- QDMGUM]W
M2H_[I?J[[TV2 5>!P,;<[MV^I9,X7_75]M;9@<I>K_6@_9]^,7 G2[?!%E<$
M?2HR8916Z>2X!NV3(\I#!$0_E FMTP)(#H>_P^\N8%6U!^*:T'ET[U'B8>UU
M-I3&3=O 9""];?\\WI%+ 6']K<ZK_FM/QFLYE?#.!=C9-*B 4[7%UFU"%O,A
MB[W=>PE9''3N(V1!4)J+]JX%1-6"#4/J?,MU7K.5BQ2?,HY1>G'U8QSVPOQ=
M$]QXB.#&,AK!QSQ^/H<,DL.V!_^<\?%GJU:MP,LRFIV1.2F<8HM0QZ:9>JM_
M>#<(,Y#,L[=A3,^G+^F5BZ!"Z48=7& ZB-0A&N&/+=^U=YGW\A3^'>@GR\=M
M^&AG_N]'[<.#^D]VVYTU_[YW<+#6-Q:]T\%1>_?-_H:]U%[[Z'#=9S_T.[UI
M[Z]YIX=_I\/VP=[QQKU3IWNT[$[ D<C9__/3WD_Z&LV;:(OC53O$649-:EG!
M'6"56Z3)-?_<-;<3&2!<W9GF'O5@>RC#-.KRV^[TA]>I,S&J(H!O<X]"\7BI
M3$1)+H+0^WLOW?GE,XWS,R(Q'RS:2;VZ75Q;S8:_B-UZ3T'-:<FCO>66=0[F
MKMOTK3C',>_3A-M>L4](8YPVY+-PSSY0W\5OL$^8Z%UAH^XBL5;<Z_4NN_$8
MY$,R\+;T@,"17^%8EB_T96_C>Q *S3;>>1OO31W?+$UN?SPU&XA3)N:\FV1:
M#B$\;;R%O*H.F(H5)_;.^_LH&[:T.N !PABP8QL;8KGYW23$,L[S:?9V9^?Z
M^KH-K]@>)5<[)VE_C UD.VHP"M*=09 '.YW#W<[^\<$.O*K\V#W$]][K[J@H
M_Q'DDQ9-&3!(ZNUQ#G+AQ$ QG&>(@=97DO(]T=?Y'F,S.6T87N=0)P=ZW/K1
M4_DU)MC/$*,RH;Q[,%4%CM/V/;"WVG35KUB?@:AJEP[:/7[J>[\#8V??)/!Z
M'@.AY(4 >E^J]"I$ /J/'T^YCS<8J+A7I"-X3A#!YL?>WX+)])UWFK3I=FYX
M::LXY*E$RG'KGQNQ7_4ZC'?LD;=D#SAJ!VG\_I38MF])2?$\PF[<KTVP'7N\
MU[G//6Z4]],J;T7JL/5G1]YIK]-AM7N*&^^62'\UG;7S+9=?'7A2IR%N_U7@
M-,31;^OAUDDRO'1_#9>UMVM 4Q8CHCZ(HGUYEZTLD2;A8!"IQ\WPHC?W?V\?
M[]EZ:=QMI/'SE<;=I=)XKJ>=1-[V+E5P,VAY6[Z4(-KR!92 O9\'=36FRO.^
MK#%5-M94Z;8[?_O+CX.S=XW!\FP-ENY=W<?.,<U1.VT;Z=G9.]A=*F+?[!XV
M(K81L8V([38B]KF+V%OXA-Z6FNUZK=OO$W:WW2?LUOB$6[Z49\(<C?FT59<U
MYM.FFD^=W4[[_//E$]M.CWW:OUY\I'H6*JUYG_0+JKVY_TUX.9<U'+[)''YY
M^ML+Y/!OP8\D3B8S[XS':R+J1G^L)D'#\@W+/W>6/SWYV+ \LOQI$/4+'L'@
M?0SC[SW$-6@$0", GKD >'_VH1$ R/3.P*F&_QO^?RG\__'DUX;_B>F#GHH:
MUF]8_\6P_M>+LX;UD?5Q>A(<36/\-Q+@)4F _9?%_:<TO.EK,%(\V"O@$67O
M@SSP$"+#>\6 BM(PRU!:'LD,GLH9XUP&!I/6B"P@1E\W\J&1#S7R88= V!X.
MO*$>T/'_+?UG51A<.:$6\N_;[E$%LKB%?WE :(IZ#%RNX/+,/SA5I5\J]N&9
M.'T>*LX I,NPZA'&=)4J 8&3+5V^5I4 S2W&"2X#[,XWL/PT%EGC\?<8%?6"
M4-Q3? J"K<(CITG&8.[FO8[-$U<HP@\FA+ZZZMC%-4[_%T*E>O3[NIBA#PK:
MN@+PZ$8@N59Q16Z)Y+K?#)]YXM=XOOBL+A1KMRH,:/R>_DO*=ZV=R%>2&'N/
MCC&/S'9Y_H_/)]_^N#B[7%7N/36"/ T6=!07SWFC2>[HXV8KZQ+^HM%..&QU
M4.!XFJ#(:%:P&?"&C\&)=SR!'2?'P&-Z:AQ$0ZWFB.CE H3K5T4,7Z+[!44^
M3E)8W>HZ:^$>KZ>B'((C,MP6$-Z#]M'1>MBH"U%JW[0/]O?N"?#VX.C>@%R/
MUX/S7?1.^XCD>O.M5O3P[^(+O=E0YWD!!.G'\]/S+QZ.)#WY>O;'M_/32]\[
M_WQ:=G[K@2(/'@TG\H$O>P2JV*Z0RJ^SMX\20]J,L!DM>2?;\2Z^_'IV\<T[
M_?+Y\]G'C_^I8X%;+%(/FWEH%,@5%XIHFF^]-8YW14(UZR$U_,B+^A3,>$1.
M1T;D/%'1_G-%I*--ODAZ\)+HD,0JBF8/YXS0S=Z&.2RWO[Y[\NB;MN;K8E8J
M1&.6PL^GXU -:SJ$MVM-KVYH=GY=PXNE2.I2?W+1DE>W_VEA);?TJ%OC$BQR
M0==\4-W[-J[&RW0U*C9S9_^!C>9Y]Z-JYC96?&/%/VE3_%/9+VCB?[TX._MV
M\LF[_.WD-]_[^EO[?7N1>FJ,_<;8?[G&/EBI*@\FWN4X& .CC.<89=--4C:L
M+W,<*3-B1/0:X,!M6M&KF^ N'+P(^.L\BMWZ5OA+'I_979QTW>DE@QG\;YQ/
MHE_^/U!+ P04    " "%@:M<;VLT/)T1   )P0  $0   &5L='@M,C R-C S
M,S$N>'-D[5U9<]LX$G[/K\!JJW:S59$MR4=B;YPIQ8E3GK4CK^Q,YBT%D9"$
M"D4J .A8_W[1X"E> &5IACO4/&0LL@]T?TV@T0#!M[\\+1ST2!BGGGO1Z1_T
M.HBXEF=3=W;1^?)PU7W3^>7=BQ=O_];M_OY^?(,^>):_(*Y EXQ@06STDXHY
M$G."OGKL.WW$Z,[!8NJQ1;?[3K%=>LL5H[.Y0(/>X#0BB^ZR\U[_S")'O9/N
MFS?]7O?UT0!W<:_?[UI]&[^>#@;3U[TWKV;G@XDUF1Q;_>YQ_^RX>]SKG7;Q
MT>GK[M%D:MO6Z6F_=W*LA#[Q<V[-R0(C:9K+SY_X16<NQ/+\\/#GSY\'/X\.
M/#8['/1Z_</?;V_N%6DGI'6H^WV-^FG"G(C^Z!!N3S G$3EQQ-,:.5PXL+S%
M(9C:.SKJ1Y0@AU9(IBX7V+5BR;9@7;%:$E[,(V\?PFW0<]SM];OKFFP1LZ75
MG!P&-SL("\'HQ!?D2@+U@4RQ[T@6W_WA8X=.*;%E%#@$<%XC2-T6F,V(^(P7
MA"^Q131>>/<"(0"&+I8>$\C-L4TQGZAF<B: [:2# A!O/ L+%9M R2.+<O2'
M4BF'7UWX=?#$[<ZAN5:?=V<8+VMI3O,$VL,K=5I0%0E%S2AD@5_=B*\+E[K]
M@0R)C=N0Q'F]-D1\SVQ#8727@:+C5+^Y83.*GQ9#)T0,8+TI_HJ?$^M@YCT>
MVH2:1&"6'/ZH$W-K0HAEU]$9D<,?!3JQZWI"\<.5\-IR2=VI%UR0ER!(SJ-(
M&9-IU&_E^MZPI^Z?G9T=JKNRBU/,F%G,<T@U\>&2>4O"!"4\W6\K 7-&IA<=
MZ*:Z41?U;<G(@6Q)1))3L![N<%MJ(%QVD<K>F\2@2 0$WD6'2QP<$KBHR?;;
M9%K7?LE"7?J7L-[!D[K62Q;B_-\;;F&GKN&2Q?*=3:(>V!_D?43MB\ZE)]/.
M#H)K7\;7Q0F$TA<01I(B64GPO>NI__JHFV2G7:2XWAYF:3-2?$[LD?M._9U]
MG$/FD*2",>,08[[UYZ>0+;P8.:[2G:Y-7,DL_^">0VW(SM]C!W*"^SDA@IOY
M6BNE HBSLY-!_P2 N)=N)#$2H4R4%HI"J2@0NT<JY>,[S*1Y<R*H;/!V8%L7
MJ<5PL F&Z.6:EG^U'=/8@=R;CF2GK-K(L2N)%M+<N62@C^3&XYL_FC54:#$_
M,L,\48F\*4J4(JD5K:E%H'<?! E"]\*SOL\]QR:,?_SA4[&24VMJ4;$5_,NE
M:Z$_W@3ZM+Y__/W-H/_ZWRC0BUZ&FO==@ D^V^GN-U"EC8N37<7%?J@H!^\2
M\_F5X_W<SJB02-.B?;H)VB ?*04MPO #X1:C2Y#F3640O_<Y=0F'@?>*NC(E
MHM@![RE])C#6$ZA%\C7,A2BW'(_[C,"/1#Z !O7Z2(4:MV,E*-;2(CCO_<4"
MLY7L-^G,I;*'PJX86I;GNX*ZLSL9^9:<3YO@:"A)"^";+("A8-6_)J)1(AM%
MPEN$VQ6F[#?L^.268/"3ZI1,8"IFU*)RED4%Y" E"*4EM0B"]"03DG_/-<6@
MA%,'PFDO"\+:)!0EHEJ$PE@V'C-K_HEA0^]G.+1>[V>]'@E @806.5M&V,)S
M598KA\Y\JFV6MFED: $99 $)1 ;9MQK3TU+_&6;@+8))F?\>J]1XL91Y+#9-
MQDHXM9 <Y09M$-15DE!:5(M0^(J9<9\4TVH]?9SU=,3:(L_"\TZ%RC=4O4]E
M@<0US52KV+7^/RGJ?$)I81TP):]%H-S(+-#,_R&EUM6G65<'C"WRZ0<R,2J0
M*CJM/PNFQA/1(F]>N])AY $_F85IFESKV]RL->!&BKU%/OY,!"Q]W!%V/\>,
MF/@YRZ+U=6XN*B6H!1<D92 EI$4>'Q,':I-WF(G5@\P$.+;4HI395*B$5X?!
MZ]Q4-!2%E"R4%M8B+.[)#!*!,8']9S(),$JYLSQ:W^<FI*$(%,MHD\O]"2<_
M?&G QT?3^DN.1^ORW)0S$8$"&:URN4FE=_NU8\,:\LE)/_^$&->0T<OHKS:M
MS!56A1_PQ#'#KXI="U;NV2HI+:.7@<0VX5)<*38'II)?BTRNJE-6;VXC-,6E
M,G-H*OFUT.3*0&4%MS9"$Y7$S,'(<&C=GZL"10+:Z.Z@+&/N[#5ZK:M+JD!M
M='1FIFSN\6)&K>MS!:/\1+N-,&1G;#7Z_&).+1#Y/1'9&5\;<:BU<^@#$9@Z
M1BAM)%>+8:YJM<'&)-A%J-2U"6:SR6$-?.L)U $[R)7"ZDPV6XAGX6017D:W
M?8=XT_CVD'.B5NAN*)Y0A\*+72&+[;EC8OF,26?*E)?607^7ZK6QDBM,E,UU
M912%38(P2JA>H:!=JH=(M2SBMI'L)>+&(=6Z?915P&R [A?7FW#"'F& O7:7
MOAR_+4_VS [%-4>6/[Y1VH@TKKZ41V2JM:^JXO 52C<:J5:C]6;O0[4B*E*W
ME>^@<X(;0>& 6'.7_O!KC80[TJP-NEQAJ6[0I:F"0 IZQ+A1*&G5/J8B=WZ&
M(H6@C^2Y(9(3I$4\5Z\J1SP6WDK@BBNVR3-YQ\@24UL&^TC.&-BE[& E09 4
MU(!U&VJTH.>J9*7UX_7G/%2NGFBE'H7ZH^1G'QA%B*G3#U;2:;#A=0F/TV<B
MMAH3E1JTX9"KY!F'0Z!7Q4.L^96J1NTC(7+:)IV[H20MLKE"806R^^Z]ZAD;
M6A;SB?WQ"19P:N5R&TK68INK/1H^M:$^%"EL)=SK[YK40+.840M6KLB8>5>E
ME2#HWCBI 8NI*!U01[FBH=$[+*V$KWBA?)/ASE"2%KS\]J*RQ?>V#W?%'D\&
M);6&.%)K($-+>JG>T_@,Z5J,\SO^RC%.#WO!JFB@%$5:]]@7H"/G<OY"^8E_
MD43"^\@%76!!XI)#>)I'B.!/S.Q:RSR[U*^-'^,WXK)I4](J!,U"PD-1P])%
MD^BTD3C45//V@58 M,R!!*.6.AU$4GZ1BG?0V1AHT0:-^:ZN]:!)=(=! =I?
M[;N?*KR2B4OXF.=HPYG+%F.DMDYMQ.1*;(81DYJV13U)$5/8G%8&4+2E;Y-,
MLY17"VBN2!;O+&Q[+ADY(GF<1KZ D[_AQ/[HY@88&<G3XI8K@:5P2S]X*1VI
M3:,MA+/B+>R:$W*-%"UTN0I7Y2O=K00KV'.[24]8PJD%)5?)"K?]MKT7#-R0
M]%G_]64/0H5RR+4+7Q]1#<03SQ?A":7N+&"JC=JSM.@0/LZ5P&*$T_UE6C-*
MJ49*-XJ5Q]O"]S$QO<7"9VH_CC=5]U([=)X1!"9BM:CG:F>%J">JX)<B6=OM
MMD?9"(YO_1WA_*V_1WIW2,.Y'+7VJT^,%^&/<W5-X&ZEEU/G>]1P=@&7UN>Y
M6F#Z<)!6^C[S0E+2]V1NP+Y12Z;@'ZCC"V+7P.F9&K28YDIU!>]&K?=T>8)7
M:E^LI>88H?Y]-*2Q&LK4SP;'R.3O'C83JS'AXY/E^#:QKYBW@&J5']@=0[L,
MY6PC6K;3 FTTY<IXVFA*-PPE+4-1TQ"T#:4:MQ:"R^3]O1;&6]FQ-[7V9U2+
MT"*>J_.5'Z#32HRRKTJF5G4S=U*3PLDJO%FG9K\515J\<_7!_"N<F87DW/V4
M_E=HLHHI6AD>F2-\:KW^5\RJA;#@9/+,(4!_=2C>'JY_U3#XO?;E0_CN8?@!
M5044^/Y;6.B.YG6K#L(3+ICLWRXZ4^S =]K@8XUQC3]%Z%+'@=>%+CJ"^? ]
M-_B<[+D<OZAG/Z@/K@6?_Q31K4FP/?&B8S%BP_=EN$1)4.%#"S\QSU]>= )*
M*LBB@X*OM@57%IXK\6.K:WD'A">?=\R9-!0/<W*+V7<B1M,I@;><;LEB M]U
M2VP+FAR85L&@M]'V@T\-&5H3?T/WW/86F+H&]OR*75]:;F9+"7$3[+CTW/";
MSJ-I\+>@LDDPRZVVR8"Q"?:II=JA:T=K1]><^W+:X@,.=ZHE*J_C=XQ(<%BX
M&R'%4/KL;4'RUAT47.%*KX%SKEU!)*4(EZT_>ZZ%^;S4XC+R.F9D.AV;3';7
MYUR[LD_#L#L@^/^UF]G476&IEK.I1M\QSR+$YC"?@9 $E?"$QAMQX49!Y\H_
MP]\1QZ7'*T)_JSH:ZTB\@@NC:=1ZU=XKCTFSZAA=[L6M*7B&"W<[ZH==Q(C!
M+"W\,;1^^)2K;*K &.4#^?C!"VSV>U\RB3M,[5(G;E%#4P,QWE^Y%@S1*/)E
M*2\0(0*N4C_5$])45R1M','K=0O*N<=6$D$YS.(5M+A\N#9@;:K9$4PR>1C3
MV5SPU*Z886AN69YFQKNK3$3 $_=,"Q_(DWCOR&C538-TW#O,1T6DQ22(PZK%
MJ&R;P,C-[!%09U7IW?!\P0WQT'#0&QR/R8R"F6I+:/0A0<V<4<O7A"E):DP*
M7E.*1J9[[! ^G#&B&, 6XRFRJ:!&V ^?E-\0W6J^1EAG#,KIMM ];9+]8:TC
M2#*BCMFH/%+,T@2;[HE+/:96C=3G4Z-BQWH>46UD/1F-L!K#4!)4+68RW&;R
M:;N&,BAVHE"\8]2J2+F,!6Q>M=QMNID8 -^UI7;X!?,QL8@<6>V1FUIW4G-;
M]6RJ_; <2F,5U:,MB&YJNCIT9U)>:IJAZ>C*R)OP$$3=43Q_2E8TM.EH(4]3
M"_39I81JS,JHFP!9]O2M>SD)^4Y43U-ME %C$^S[U7?J#:^E]$VQYHZ1*]^U
MB6UN4"E+8VSR)PZU#->'2NF;8DVPE"'GU[E@TENFYVV"E:D!^3UQR93"4<*C
MGRYA?$Z7-W1!@T7;.\(L6'R>&>4]QJ)J# LU^O^E[,Z,U@S4 6+1X2<2J@_D
MD3B>.CA*NUABR-W0'&]H/X(66^;A4Z(R*^Q<D0ISRQD::J$Z$BX$*8)C&!Y4
M%QP0%QX75VIR#0D-]4&X?'?I4)=:V'E@\HF$:F%AS*H5 IU/GB&QJ2E@:%*T
MS*LS/:%KN$$J3I/*9_*VA"'&>OZF.F#M6*RX9/25BOG#G'S"TF@/4)2:92<6
M$5]Y,K%2 ]2GZ_'5/5E"C6E0/<[O0%$3DH(MF74@[3KZ0QRXINDOXL&A/_.Y
M03E\)ZJ:Y,/U,64(*?1,D2J+2WLQ4_:&#MV??4!B-"V&MSQ/T_+M)N6F,L1F
MA&T#UC&ABXG/N/H!FS^4"3#M+;?Z>4(;NY%$-7(L#7)]V'?F18-QJ1_*&1IK
M8[@,4JMP4,72A*XK6Z:I-J>,N@F69))>V=0%]1=7'EM;RTEO]33-GXU$-39J
MY=@JQ\O^G516#6X!81-P#9HU,&W_H&GMOW9MWXK7^?5FE-,WP9JP0Y--.]E@
M!;F<K0FV?82/6'EF!A73-L&*8+7.S(IBVB98<0LYDGH ZBT]Z/F:8%VNT#YR
M-4M?51S-L,@EM3N%2IXF6'7I8,Y'T\CE3&U>_$K@7V(/92J 9V1,0)C:M^PJ
M(WWL/!"V*)\"/%/JCK:"1DQ&[R3%YXD-LX>4Q2OI#]G=ONLO)YE+V(*]MCB?
M2TIF^1.UW++A)M@O+E6O5.D6W_-TC0AF$Y_?4%=YB#\+N924/WOC\MA;84>L
MQEB0<#FO?&I>0+I#X):!#B/DH!%><$I<NE2@]E+#0H^<7LY4*_@M?J(+?Q'O
MY[JECIS"R.E"^#8+G EQQSR98Y8[8F?ZFEJ&+S/XRA<RFF]E1RQ-O,50.H)O
MV,:VU?:@7F!37?3> U1OY<B%K;G/B="-[A4,3>@-H^2C7JK2Q"3ETW\N+ZM;
MGZ9H0HL+$Z!X_T78]X8=2[TLJE3(MFO)FW3CA=NBBK;=;+*]JE).$T#_%:]^
M(^YW.41P[,K6/C"?RV9/I^I;J=(0*N9K-+J*PH;BFN"+.U_.4C$G<?AJ$"^G
M;X(U$'=JREUS1UTY3Q.L*NQ?@C,$KMW@_(!Z?5.6]\\^7"#9&8.IHSE+HHBT
M"2!]7"P=;T5(>-C4&%Z:RZ^N:4IYM60TP6KUYD%P3 Z6<-C4DO,MF(W=:A(!
M \8FV*?V\U1;LD;2A#8'QUI!*\)CK'1[(4K(FV"+>I%O^' KYVTSAA<&;_WE
MB?]0.]2Y3=R:DP5^]^)_4$L#!!0    ( (6!JUQK A,F+Q,  (/0   5
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M@^KS2+K ;+]P;BE,/?VH)^[=[+7^.IGK:3LX9# PEFI@H8BKFQ2>ZMSK_DY
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MNK#\,)FJ DHKX(EKP]4^?5J1%;*(NE$=Q_S)H[T>E!@@^@);47^$4&*@N;7
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M #XLDM3BQ$FQ'\OPD-=Z.O7NU>V#O^S^BUOP TZ]Y.(YR5@9#%4..92[1?I
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MZU#5-V^K^G)^[>OU:C3.DGB6,<:;%,Y @2)$ 6ZM5MBS..USSZL<N/-=+@Q
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M&L%2><9 0+!:8R0,\SW+RV2'=I13[7/U7)V,DG*7L,DTFK_&X9"NX5B@K-/
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M8 X\Q1HY+3"VN9>/_NC.@2V%=-%"F\'^X76H;[7U%S?5XK&Z^5,@OL- .\A
M0!QQQ@CG/O?=01>6\Z/$,^7<0H#!3M[5E6TC3F(3&X4FVM<H 71$*DB8Q+D7
MBAUPSH$&N:3=PH1GNWOOTN*MK9?W#W=KU<?:WTP6J1;Q6ACMZHW7ELO'"" 9
M5T!I[5#03F+3KUKSX>]^R5080]PM]."9:S;?1>CJ)@5:WZ3R]4M'](=D0L\G
MW_R DLT]GSRP8O-S\&<JV+R\W-EZ]4I-\%>W3U_YJ&^7:1%_Z-J][^IO+; !
MAJ5J[DA#%1<-;5SV8G6#46<L!;T/2],%IC687!$&%-04(!XBEYA&")=K5#P0
M_%AEID=FZ8Z:U",J^U0J6*?>\RDCYB'F>74 DA,@M3& (.$8#-1 FCL,?/7]
M)Y -,B8#-BVVYVJB1"#@/9:GD.B]:$KU\UU#<IP<D>=KID/% \0ZNK*112!^
M0"!XYJFRT?J#V3U[(RAY3P[(2#K>*<W<N:!?KGT4-4J(GC(1U@:&(QK*"%#6
M$L,9E\RX7B>IK4<?H;/C $%7V:24NS3''1K<C0:*:-ND,QF-E@U$W&F^Z43=
MJ3-\/CI[KI1RS[-W,[>PC\4^NT$1+($TA@'HJ)?<4&8#[:6ZKC>\7 UFD5F!
M@/<[8VXE"7 5#"8P+@)Q.8!<>JE@D-KG/KZM ?B^+>+GZZ)$ ?=G"^)I&#.W
M>_JTCJE4R?<"XSF.>3Z )INN@%/1<8E2\B.,C4@+I(<.T  --M0S(G*7D7@Y
MO-USXGA9M-VIVA*]DFZ^3JM;[S<ZNJS9>.E.PF(.-%$<>1$DY+E/IBTPCE#!
M^.CZW>RM-% Y!7*;/_EF7D_L_/X2Z_>HD^;3Y]_7,O"M 5IA=F]4QH^ !08%
MU- *G=NQN1/0#PYE5-@Q-LLN8:VGVEU\TY-I,H/?5O6R0^[618470!L4!^<M
MMB98;N3H&^8SQW*"'"Y\470*I"C1J>S9XZIFEU_3=^_Z6CQ%'37+<=UEKZ^.
MC-L0/R$-")=&4AD(YB=S>[QW-#\(?QQBG-+Z?C>LNV$T[V8??3VIW*]UU;1(
MV@-)'0=*8!ZHCG:\R&UC%!C&#Y*/3(5CN*H.&M+??4I1\.[BFZ_UE5_^\HV>
M^[=Z4B\K4"R-M>"D <QZ#X2V!&AH-,#8^#C>P*P^&:/F>4/\,2M.B$(EBI<\
M^W349[QK>6";:J$* 0,% RX$9CB- Y;9&S:.-[P?,^5$J%.@3,NCV\?7WR*<
M]I%_2''%31I!&F/SI9KKZ>KO4Q;_AVK^__GY)V^KJUFJ<K7T -R+8SOX(IZ&
M%!- 09*Z-$#L-[N0Y?/RE1S8=S<S3H\N!4K7%!ODW7+PMJKO?Y2^AS9':](G
M00(PWFI)*?4TN_]HW!'^F"6G0Z "I7IR^=#6"B2N79PQ!20A%ABL;$!$. %/
MQ\74,8COCO3'I4%G6:#".4L/4355N&B:Q<W=!O9[_-*\^J693VY63T156-GE
M[F9]]DRG3'B*Y$>5D-5)956Y@$R(5@J$*9W/ @F-!3P@ 4F(B[!4I[)HO3_)
MK*I5\=%4EI\2!9"S@5FG!639'4[?9U95;Y86S:KJK>Q3R:K:BNU9'8$P&F@I
M$+ &,R>\XH'E]OB<7Q1I?P[LBR+MK8L7%(6W=TP_HD@/C2+M3Y.1PO$.UO$+
MY:\4-(Z-"*"1U5I(B1G*7:CNY?#VT"C2DZ;M3M66CB*].Q^L!)BM &,4 PVY
M 4QQ28R(6PKE)6-)5\&<X/&_N*YW190^6U&G%!SU>#I=.;]^FC3_?%M[OUJH
MZWZ %@*ML03"I,COP Q0T@<)&1(4Y>[*6GQ0)\CHPL>=DZ+)J<^#7_[\ZE/D
M[YO)MXGS,[<RP$?Q.QF7#^<]L#35')+0B>S1_<4']6,>')4FI0Q@LW^ YI !
MIIJO:'-D1"&@&?' !!0(9<Q[6\0I6&0TWR?SCT^,4PHGW#6R_ZRF\3'3R?QV
M=7=#@"KA@< B2IY9"BQ!D'-,7)SG+V'Q7Q_6]SD)3H@JG:&"H]WTM:0Y7=AY
MW-#FMP7O\WJ\M?"MW:'C/JV[.4LL 1Q! @25!!@8)P%43!ELI(8_*A[N<=6O
MB ^Y:)]Y'@!C2&,DB284_KB;&Y6E9>_F^BK[=._F5D;@C8NV%3= &\DUPPXI
MECMKYPSOYGIS8._=7%]=O*2[C7UC^G$W=_#=7&^:C'7)<:B.7RA_G=)Q6!P#
MBA&U&#&-Z.C>Z9/A[<%W<Z=,VYVJ+4#77@4@'J5%&9"(B73>4T)8##W+W>3U
M.ZG8T5_GSZG8T4MAIW0_T9VKOM*4ZU,UG;ZMZO3]IX%:CW"T=U"<Q]:0U(52
M\P"UM^YD8C</'=P)LKSP4>@D:7-*\V-[?/-K7W^YUO?C;QYS4^YB\S?5H8,&
MRL75P)@@6&I:HEWV]MQC#>X%S8^R!,TUC8JRZY0*A^P=Z'H:\.8XL4$@KF0$
M8&>%<R(H(?&+F47K8_LQB<:>1 .X=4KWB=W:>$B3WQJ;@@$HH@SP!!D! PXA
M?\.=@N/Y,5=&L]N>QZ%C%"-Y]CH0)1_\9)[:P;4O!40JH* )0!C*F2/*N],I
MW7/X\'[,GK%WFF$,*U"S9'3+E /IL0:",0L,AQY(3B4RRIF 3L8O,.S<<Y):
MV%MCJF7R,( MHU%7@D8+*.J*,:DUY\PJ.'K&R;@B>$%+XY$]/2= P1=UD.TO
MCJV]P=&X-\3=C :)D4JU2%SV6)$3&/<+FGNG0/X3G,@',?=%S=[G%&Y<$43@
M"$@AHB:5ED@@Z;@^F?-V[L'_F,>G.8]+<OB4_&%]3V.+VC<'2X%I#+0Q'#AA
M-0XH:C3[C?MIC/S'-#[-:5R,O2_*9W>X4:( )-)'&1 .=+ :(!.H())X?3H5
MZ+.;TZ-E=*2?5K,$^;[NV-9W4^+*K/$%\SL.QE XVV.83#+E?O2JI'DQ73XH
M?KH,F[4R4Q7-YGU7@4.M"9 PA35!XSP++"5>ERH1D6<(^;)"\@!K;0D:G ?*
M!@J@Y-! XBD6V:^V2PQDK&R18_*Z.W7D6(PXE322=[.X.OK/\[@3I<>]OQ]G
M6S-'H3B0*4<=QQ_'71D[[G)OQ#O@'#_%Y&A<J<KHK(!'IP-:>Z.]5G"%LDAV
M CM..D@V-?:CQP =')LHVJ:F0T@"[)UEC!HH5.[DU2,09$_>Q4GP8Z?HRZ13
M^/C ZXN9>^._^6GU-6&\-[O;>[0*BX *V -DO5<R:"%8;G;T@#6^_R6C(K=S
M)+)JH4 D^*]^%@_2TXCPPMU$4<<3>!S]-[\3)/0&1& !0&R)<4%2BG(7Y.@%
M[)S(DE\3!=:5>[/,NW:K[1[K5FNB>)Y0B'% N3<,6JB-S<V7?LC&)\PIG=<*
M:*]S2<KF@?N[KI<W.!_2?].$&.!)ZWS60(]8/XR9/%NOI[II+L/].R_K3\DC
M^GZC8H\U\2"D)8@+C@#:"@D(%]J@X./_YPZCV(UHZ)K3^O36XY]C%)A@": $
M:DVU49R8,<8ZJ@<HH_XW%XA,HCX5KTSK<%9*(S\*22 ,C.$!4"&,4QJ'N-2-
M09QC>F1R*;L/APX6>@';I1786K7BW= *N51VP#J.0R63 OO08H#TCTP0C(!Q
MVD6(#G+*F"8BMT4[.C'V.%*.SXM=0L_(AV3;_>,_]&RAZ]NDE6@CWU2S!QMO
MK1+YTS8K!%#>!:!HP%Q#Z>-Q;Y\YVN=%XY]8LFFD*B3.C&Z0);:/M7^[2(;Y
M/:9V2)B*N!V:5&T56D7CSR2#O33<_OPS46P&X94(B7UPT-Q%ECQ%)+2M5RCR
M3$IN (HG:8<=BR3-7E]V%Z SLP#S";] ?.4&IG;ZMX(J9/^U CJ.Y9=1<9L=
M/;))O41?F%[@E .26P\41T3&9=$$9U\N%?;8>L=FPBYAE[#\ER;),E:M8_\*
M'A@<4DH'#4QI;0W.K?TM$$=P5@]7SJ9Y/TBR)4H?+4PS<9-HBW[6RX*G"5H;
MJXVF0#*O */<*PBY(2QW$ZA.,.=F$601>HE([2<XJ2[>9?@2Q]UHNWZGMQ=A
MJ9JM>]$=R4[(H\Y-DI3118G3Q<%(L3- VY2+(!VQ)IX/#<W=Y?58;-EG2IP(
M67:J(+OW:#&]_;@PTXF]#,'7D]E5^^XG"0$RGJV!5\%)&P2!JI]3H>L-1\A?
MRJR**K<<"U@1;[R9/Z6KM+'9IHH?+E(Z[HT<!HYX_B[NVRC.S&X8*.8"%636
M$6WUN]R-JY"9T(7I.,;!4)WMI,! @1>P!?KBHXP!+:4 "G)'"2.*^MP=#,<E
MPIY]_T@\V"GGW-O\9S^;5/5G;Q=U"J6:??/U?!(7O8]1&I.FJ>K;#]7<=UQQ
M>!X70JT!-EQ;"A'U$/7:^@]YZ_CF0!Y%56-(N8!AT+H1KA1MV\1'1 !*" U\
M*M+&C Y4Y<XCW(?I1&ZBWI<+87JN DKXGYZLY8_UQ/J/OEY&8VXMC@H"(U,M
MXW1=1CUR@F=W/W5@.2M"9!'X6-$F#V5'ET@??]G<_[9!FZ!A:ME O0<Z0(2%
M<,BBW"4ZGP7TK"A47E4%+CH? %W,W!VBE44P=9+=Q!?7/:"X5X $IJCP1 J>
MNYG//DQGQ9JL"BC@^]Z%;\MC@TTTU5,.@!/6&Z*1\+G7F5UXOAMB'"3XXOZ-
MM]KZBYMJ,9MOXN(F[I9:&R"MD5[+^+^0FQ!=6,Z*#%D$ODT$5L0\N:O_&ZVI
M=!:+,O?-:SV=>O?J=G/[V[*N/ 0:!@T,1/&X;Z4@V0L@#X1\5K0:4WW;[.-#
MV1>/]M9[U[R-,GO7- L]2S;6^^INYTQS9FM^"!(7R@!!G!Q>.(()P;D)MA_5
M67$HLQ*V:2(*I0H^E:):V5D??IDA?;#7\S.E%!X^EM'2#!^O=1 0R%.@B-:1
M U I)YW3;I2$B/<CIQFFL4H6%T-# ()Q%13!IOCT,<9Z8FF&O?7_S#3#?:)^
M$6F&JZ,1*:N!6@:0,IASC;!6N>^ 7FJ:X5YE'Y)FV%OHXV>1[87V(\WP( 4>
MEDYVL/2/2Q L%(CG/ XPL] K!XD4V<..7U*:X1B\V"GTW#?(OTPG=E)M)\.M
M K(T-0>/1KMW @EDB#'$[;-5.Y]^(D>4Y\B^RBFXW%F$%[.K25M:X]H.A^,.
MYQ@#E#AIM1:4<]I+DVU//Q--#A9<[CGY6WS4=50!W<QM[ "'DW.$(0ND@8$&
M3Z0RMI=6][WI3#2<5: 9K\KV)+"N0M(T;C:.:V""4PQK9I4CO73\0K)_GZ?9
M#,++>+/U&#+<E6*^!HHH$($10 /""$&NF5&]--KUAC/1:18!9KR::@=U.5N-
M^!+Q_<!#F&[,K 6*2P&HI2(>(9W41#]/KX_O.%?-/D^(&6^;^M:&6+,%+ 4Z
M! 2PB7: Y(H8U<\<?FFE-IZIY8SBS'BU<\_ F>\+##($)/<,P#A2[G50P82>
M$[G[+>>BY%R"[+R5.5S#33W_QZ?4ZJ7UM$ZB38<] M#CX&APOJ?O,SYUQ8T1
M__;DPEA[X9GX-Y\OQ(R&\2.(=D*UPCC$;]E'I_FGZW[?Y #A;ZIO@.0RGF?W
MP(F+/=#:0I!^ZJQ!#(9>;=V.K< .'V)Q_>T46&:];;2Z:@=$- ;2$@Z\=E1I
M1!E'O5IL[M%@Z\O'VSL'J:'**<,CY8BLC=;'D[.-FSC26H3X/"YY[N3QEY@C
MDO?^^;D*&(L@?>+-UY8['6W)$%GM&*)8$,;DYJW!C]2 ,E3*JJK<WNU6Q!OK
MY">?Y!IGPNMJ-J^UG2_T-,5\;>^IR4] 7%R(&1066XL-WVC7UG%&&P3C+"@T
MLC8ZCP?9PN_2670R7_;OC.MH ALQ^YF=^"%!=SV>.C#4[E#< P/L[O3^],Z+
MS7=.FA2]M*A])[^$,D![I0!DE#+'HB6+^[G #GOOL(6FSZM:#\HF%1 F,,0Q
M!A>,( ;W=,WW?V?I,+K26EY?1<J(^M@!=CN/<Y *H*5FP#C#& W6P'XI2:?J
M4"JJR3[>I9T2'<\IT0KC[+U+NX7?SSO12W+C*5($&2V1P !S"$KH:#1*LLW0
M4_,NY=#?3H%EUMMO45(WBYMV("9E=+CX5^P%=YX+&V%ET-S:2T_&F[1;[%4.
MF65T$BR!Z#^[@:!XFM0$8Q!TP#90!07LU4)[G_)67_H"E?=LF16( ?X2OW<9
M+M*A[\JOUD=:6U(< ='BBY\4M]YJ3R3/G=+6"N0<+9]\DB]0JV$%3AK\AVJF
MGWZR4DZQZX*W#6ZA/((#H1XGMR"#DC=;)XZ@H1+].H?!YD0!B9 %0FH9#1H$
M(>YUN_32"+4G)^'D^+13,44*Y$_C3ZN[YI87K4C_/IE??]3U_/9+U?7M#L,I
MU9/'3 &',&'"0Z%$]M( &?&/[WPN2I:M@OU'TG1F$_EU*J+AZZ\)9RI"V#9C
M68I+5D0#*J5*C9H=<SG"']K>?8XV518Y9XS_7AX5_-=%;:]UXR^N:K\DXR;$
M]MB[5I YW4Y]@8WOE!JNPVHL!>3V7CT;K"5 6TD!APPK2K4WOE?=SM-FR0[/
MUXF09)?<<U^5_SZ+NUK=3.:W'1NKH4!#IP&7/L3!0Q@V"T%TW%-M/GED=TH9
MZ5>Y1)?9%'AL9O79^F@Y3:K'8M3*4@JH-S@-+>YU*?2:*299')T0.H?+L_7E
MYVH,#)=TQKRA):!['+_/FJ_>3L+$NY5JU/M 9=S].X&,O]MG4%)52L*9M_?>
MX +C0%EA4P7@>%P*4%N<(SMA9+7OV+Z/I/6=@BVD[;=5[:UN5EO1+A%QH2(B
M3QPPSC+@:6!26^T\Z558NZ>JU]\^[L:>22TMBAX@T]R%%CY5MWHZO_T4^?PQ
M;GW^KE;FZGXEN0**" XHXQ!;R:S7LI==MOWL\10X:L300"'FUFF7'^DN8#9*
MXM),)U?ZSLEU=Y%W<15MU_@C_]MDZIMY-?,?]>U2<'% '^O*+>S6F 330'-L
MX_IFI;/&!RM8+V(4 GBF[#H%=1;P@G_RC8\/O(X#>.._^6GU==DB]\^O<?_=
M-II57%VM=P!*HKG'D"&4NY[Z3D#GQZW\>BAPEWN_LG:@L<$ I5-=(B0%PD@J
M[F%N5JPA.&,:/%_2N8N.="UX;Q?S.-R'N*$HO'DTIV;V<6W;<HNX98ZB!M)(
M:*7DPI%^3:&>B^#\Z#&>0CJ=%=E2*MY[W?CF0[KN2P,9D$;1\:2!J1-]\&6J
M1_S>-XWWRQ>^\8VM)U_OH;93A2H/)*08,.2@ID(&37*73MP#:>A.TO[X5@^=
M$CA:0DK'0UVP&D&IHKD^RFA'K4F<DP.;NTDN:9]"TL2CL^=77UW5^NOUQ.II
MVX6-TB%E'B)@?8AKG<;2D!RQHIT CE6E(YMVV[S=@Z2<VPEVQYY52.UW.:V@
M<GJ\NX <T>,]3%%5*2D?BP*84J"H"<!:2>/!2$.H<\2_C*SZ/E[O\36_4[BY
M;ZI?5<EE\IMN&FVO%XV?=]6""C0 8UPJ\2:Q]1;&HQ'O=<#H?,7(+NX\\J^R
M"Z] '8C+N,'I=$!:[EL=YUPAXSD76P*PP@I:Y[G<K#X[V/1K!3)^'&1)\V^X
MK(L3X*Y,2?B]\1=1#ML.>^6 4<''@4N#(8=>L-QG@)V SID00V1?P!.]#N[]
M1)O)=#*_?;VHZY:K'"HXD%HX !T.0@M+!,T=QK\;T3E38Y#T"SB@5]MVW3=-
M3\-N+L/K^'&RA0\2"R1U% 3,9##:.81SNZ3W83HO?F350*>K.IN3,75R&^!9
M7/WG ]V)G4@R^1#7FVVN*=LI2R207BW#6%/Y'FH!Q%)PQ!CR-O?570>4O/U;
M6_T;<:1 (HNC=4R,#$$+!G/O!BTPQO(1YM#Q[B:MATOUV#[!]G&L1( ]BD5!
M"93"*9.-:>*Y"YSFW@RV41S+*SA8KSMY<K!\"QB*ZXC6([OWXBJ40MR%Z3BY
MPD-UMI," P5^1$)@&X AJ95K-'6P)]0QF[M\Y+A$V)/C>R0>[)1S;C?A9S^;
M5/6]2?JZFGWS]7P2%[UHL-Y,FJ:J;S]4<[\6X_D(U&,*)-$6N&"DT%(;J?LE
MNQSRUO$/ GD458TAY0(>IM3->7[?S3EEN;?QGL+D&U<:<"1Q()X2:7M=$QQR
MN=R"XURL@L$R+N DV,34SOE65(6L@G9$Q[$)AFML#P4&B+N 3= /G7<!:",8
MB B)=HHRE]TB&),$>^R!(W%@IY2+5/9XW)\2L/9=B5($I,,"."VT1L1RJ4QF
MU;<".8)?,(.6MDIJ#!7Q6#7FVSB.! 7*$ 9XJGM/"25ZG#KRYV0"Y)%VQJCE
MG<#:.=\*[4>W\H,4>%A7ZH.E7V)_Z \QM?G4ADM@/78"02P8'66E.-5NY6/P
M8J?0<_L/NMN]KD)R2@+EC $L".FL1U3+?N7;7TBOW/[R[]<KM[?P<J==/G01
MW.X?F" 9X(4@T=A!-.YYJ;2+9!))!VTP_7H?MS__3/2907@%UNO'B,=?_GN1
M8A*JFZ_5;)ENT^;1E 1(%DB*=Q88(^&8SQT[MA/0N=AW^:2>L0#* [@-3!WW
M$6V@"EEWK8".8]=E5%Q52NH%5HE>X%@JK4VY 9QS1;BV!,->]?M/DPI[++DC
M,V&GL(OX?5+CX,_SROZSW1#1J:8']!8H9.( (<)&]:IP=Y#/9P/$^*9!!N5L
MN7N&2#9S[;.U?A4)A 8*(Y?"XR.#->= 2D^=<X)RG:-QZ-'[,>?:VI\OO6T5
MLHP=5O;".,M6.?V%W]UJY6#)E6V5LPH'Q0.?U#8>%;A2CCF+O,M1E.ID6N7D
MUM].@>5NE;/9.60-2#SD*04-"$X[9%0<D>SE]'HQW5;ZBWU7MY7>,BMPU[&^
M)7SRSM\LH[T_^GI2N3:*"AHW:V@8",&@0)4P4.4V??>C>NE;:"'Y;S.$EV7(
MNE&X$^,H(9/M^$XA?'*X;@^BS@#%% ^M[(?5,04TM! $(N(<,D8ZUJOPZ(L@
MST$AER?!G9WZ&)TSE[..?5B2N ]+AN)?.=:II)GI5\0T&VT>H1T[8C.'7@\B
MSO.4,KI9\^6/JATFYP)( WF41T#,$,&%+QO9W0GMN^/.\Y0R^KKS)=*@@^0Z
M+KZ2(P.()=BE/O/>]:H8E(\]3^"^/_X\4S$9(XB=G_SCO;_2TU]F\\G\=G67
M?KCSA#*"2LT=M$*$:4RQUKM.3XVW?[VJOOT<'WU'C_CAB14M+WSI!Z.A,MQ6
MIQBBSCL4Z^3=B:/'*6>_3E??.N[99;#XJXRRR[BX[\6C3;K&P  3XG20002Q
MZ[K_%'38<808386[1)8[O.K7__?UZ_8HDGC:2=Y2#P*VVLO G%0;:;D=(3A/
MSQQOLQPFU&JX1(H;V^]2LR3?S%/]_.7%L;NOHJ^O_.9UGR41J> IA<Q@PS&R
M<6<H:C'M0G=LD^E]@83\;-HHSINWVOJ+F]1K:PN7@!$7E, 'B@@)WG%$B[+D
M"<LY<N*9DBYPU%JM!K.1"K()C<-X4N > 8VUI8PP*VANM\X...?!@USR+I!U
MV1J'^F&19'09E@G#4=Z^>:VG4^]>W3Y$EMY_<3O]C$"@ PG >L2911ZI[)5<
M!D(^#TJ-J;?<K0DNK*T7WCWLD1]K?S-9W+RMZK7,=!]\77NWC%K:@LM\--=T
ME!<2+MK0AM'-#+ .X_/P=[]LOHPA\ (!PNLB>*6;2?/Y:^VUNYS]IZXGR<V1
M3"NT[7(20!FA 38*"A$0=;#L+40WMI=-G**:R!B/MM=+64^LWS:^'V J:U/]
M5 X(4C1HKJU5N4N4]H1VCGS)HX<"X16M^^<O?T9\D\8OL3[^\G'31)LG?F((
M4-Q@( ,46EIOG,Q=FNQ90,^#2N5UE-%K_0#Z =#%S-TANES,F[F>N<GLZHNO
M;S;Q29KJ]'(-)'<B19X9JE1F#NW#=!YTR2KY;6;(8>VXVKA\^<?,U\WUY.O]
MNG@?HK@)5#L7I0 QX H1Q)"0&/5LP77 6U\V"<H*>9L-JN0ZL8D-NVA]$Z8
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M(W%@IY2+M%=>*SS;OF_9N-P9(P30*/[0>&@MS[U'M (9WV#(H:6M/LM#15S
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M#Q8@6U-\D= D&JB%Z9)S0E6TR13% 'VB@7(UC0+8:IA.6:!H5JM,O;N>7EG
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MF?F)$JN8^P1[X&@WW'X'7OC5. XTXPU'T.\<%R20T12. Y"M%)B367^U$!V
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M$,30+(TQ.\U='%M^DE [LH(45%A[.2=UA!Y692'0C7<I8U0=>>@ F#-E!]J
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M;(@*K!!#"PWP&B8H7*$1)@ODT+LUF0P96;T2LQ6'6YMD.G 6M@9&S4_-O@3
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MD_=4:I]OV8:V['3G<B[.]@]3 W*2D(FD36)L^33/,M>RPAB4$+$,TG3R7X_
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MMGV N\81MB_"<ET3<M=%?MT!O"^R,6?S?5\&"\6FK5QOOF^:+<W>;&N>:RV
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MS?T;H(8^TW9;2W9C5>#A@J?#*/N AHH:YPQT"5#CB%)[ ""HU?H"J+%@V!!
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M//DC?;OUSFW <477+68/X0[=_1(OL1V I)F7V!:U1)N5MP>6KZ.;C;,Y/MJ
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M9*!DGDEHNNVB%I14[O8TFP1M&E7$ ZT70;HEYL<)T*-L5-P4K)6GP@F0?3D
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M]3P2V)AD=B+4WVH<A&8Q9@"-(T2I<-\ 7P0=^8NHA0DJD%"X%WZ4%E6.]4L
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M8[T&72/P)7M0LQ%35\7PU"=Z;'B6B6('$V3;MN6GD9EZ'KU*[FJ\%3LVS@&
MU/L!C+ >N6>O&+M#(B5LWM,H5\34\!):8>J20^+ER.J&$\U1H:IE]/GRZ_:)
M'B'NHCGTV'/OS>K[W'5,[1M^_>ZSK"E(G!$;N5D2IYBUCK<#"8?RBB2LXY0>
M:#C[SFS!R[U]:W-0;JO>N45X(.K/912.[L6[MPLO,?\_8AJ.;LGJ[5L'4)!(
M!AQ)VF6%4</ETVF:H3",$D2RT(W].$OCV!1."9P%I]DW,)Z]SE  ),C-\VW&
M3ZF<&U#S\L"(VTM&R*0,SG,$D#BHE#-RZ8/3'%*412A,YV0NX?PJZV44"E-T
MDE<H_I9L*R]>1'Z'R_KUGJK@"B?L8_B2%^2F)D\7EV++8OE1IHG<Q(Z\P+.M
MP :UHIX#J-L'VH W.'RCAX#Q&T/!X#@ 9[O,\E#,=%7)&9C.6\@4B59?8I0J
MZ_8U V[EAE]BQ%_V_!)\3T6GAV\D)4_<JFHLJ?L_=D>K)XT2!Z/(ME(4V-3@
MP=BCID^4$<N,S-@-%TQS&H6K62U<="\X(K)I[T4&Q65)GX=QEHJI!PV,@FD)
M01YIZ!X#)%U+=X=QJ&_8VF&6%=-]'>9?E[@X?4\>2;K?DMOL_]MCEEM*K4O6
MDR;;E4U0^;8X+2*O[EFM\NCP"];>-\J2%)F6&1,;6X18D?"]:BDVNM-$6O38
MI:N/H-'#D&4[T^LO<^F?=4F U&TMWA:!:]N:S 9ZU#H^WT[P^;:X8+#Q&\?0
M$,E*T<!SP,5P3=[+W1ME]T#1C5(5@R8OG(N!K'<?5<6/D^NJLD7A-3T?VX^2
M BYK-D3Z&WG>E1?]@R)ZG(1Q[*&(F*P?2.AEJ9#!.@%#MW':0C4.8(T&KGAQ
MSQASII6Z(I*!9B:86E"5SPP]4H4^8VNN5NLS0U2_W&?N4<FFH^D_]E7-O?+W
MNZLTS9FLX^T=SMD8$_Q,%<&VUR.#_1=3JGBH^:(/:9JB.,Y\E-KT4AG9) @M
M4+K>$F1620O.6XA&PD "6Y$NX;3837,M_L'T0@\KUJKTB)?!$./#CQK46*_!
M8[N>C='A9UQ/<AO>TU0!FU2U.5V"RKJ=3Q4P[:(9JHHU)?4>KV\:F"1WKM0"
MQT0X\F.$W2 (,C-+4PM#DLE&(:V25293K3C.&T$UI()BH([A(#?&X,Q&A9IC
MCC)5:F$4SKHR/T?NA4#/OK!PZ&H#X*I(NP:&.:G:X:3I;?&-->9B3;SH U]W
M1=G]\P.N\HJ]SV\R]R1Y+/)_[B?]5S&BLIZV/0A-@H,PB=+("J2&M^K$>D4_
MU_! 6..F>-ZWB9T';(TCNI+S8K7NM)@>>W?[!].)<ML%<9S)3[E=@Z.JI^5J
MQ?EMINZNL0VCTWM7 0ZO9[U^9/ELZ1TAY<_E;O_\N0"7L4XLH3L;K(%L,- &
MA\U217<U:RXK7K4ZQ8*9:((ZZF'*;HIP#;6I C1*E:1.K;M:):H <?T"5)''
M86)8E?7OW\@SW>I'7)'#I)WKW9[ULW]FB12LV<W'W1/.B_,+6TP\A%.3(-].
MHR3V"<OH%)%<$%3M69U'H+Q3DO%; U<PB@7CX+1,:^,+4,+A+!$6:2D2I^P+
MNF#/MJ#_.HHY#-8J0B]%?J<"Y%Y>N22)6A!-KOE%+GH[COUB'**/46SBA/XS
MQ0YQW<2,XU5*SV=1U7WCX_5$!G[!^9;?!+)=:63[FIIE30UZ]09E1_/[)W:E
M>Q^[ E-\"HJ**/:H07^@OJ@M+R?OH8!(F,UO72\TC^B?HSQ(F.'*JH'$(<J=
M$5\(O5>2D7$G+2+5QSWY.\'E_1^[BZRUQ$+8\@CRK)BX5IIF8>1!%#\0OF9M
M3K_X$*:CH?P34[P:N0+3I@TBF_-DI9.Y1?7.B F/3FX,AM!D!C%8.4JR0I'&
M@T)?58U)LN9<-\DNLV#RT>-N2]^H&IWV=<?&K='??G^F$(^50-^8CK0N.Q_Z
M"&<8HS B<9C1:ZN5@#H?0A%8)56B8I W1G*L.6.; 4S$![-6T K4R#"@;=?#
MY#\ZVXPAT^5"?&_8V"O=^S;)1KEY1!*\4#F!" )^_9E#$LP9G#(DLX[$Y('T
M'_>[.[)C5IF$ZWKD=<TJXY@(8MSOC+M/MR<7'1D7]A@;YMW7"C@ S%T0)%Z#
M&WN&5KD!!2-KKC>@8)JHDP$%,X\N\%+%\U>C^/QJU+9#N-W758T+5CCR-Y(_
M/-([T155#_B!?"/,B49_3Q5&7>*DWN/M/2F?[/,9"%EDH2B('63%EAM$9APX
MEM#TD3>D0;..:1$S=D?,-L8?+6X&;I SR@X[9KETZ!G;/"/<Z_5*+48II]?*
MGP/ &_9^-WEU-]FAN\YM_QOI2#-:VHP#<4:/.H.1I]B#]C9;H]*UMC(%Z_O<
MWF:+!IUQ;X3*\M$ ?)XF2;_D!:ENLVOZ8WXY/3P)441(AK!OV3@.$Q=CT$#@
M.8":3Y_3=OA5@P ]5R@&?$8 QT%^-, @"\4. 96,@6GL4YZTL(TO'4^NIWFR
M:%# %*$:A@4,@GNS@0%3Q$\-#9A\3V9LYW[[>K>/MWERFV6$)7<--^C"5H3B
M.(A0EB21ZP5VYH1"L=A)*)H%GH$U&KA&!Q@RKG*,-S,76%44PR1YB%BI(9UC
M5$,F="J@7JY.6G2W@6,Y9^B9GLDY]O** SEG\#^=QCGW\'MK97O:V/K,>!H8
M@WG>Z!9;*#93$T4V\1+?MQ/+M]_CA(-9RC2KTXL1".ENNZ5W<>.9E$TNRKOI
M@ O]) !W]?> [[N^P4O.4QBXY&L:"_MNM_.M$VJ4T_7GR+_1M9UO-=I!'$%X
M:.N^3"G"-T5ZG]=;X5G:IV]I/J8X#/$HU1E%\\$I>6)@JOB^Q+QO5>\#V5"M
MFN8O><J=G9-T@F)0PR1)A9[.EEHMXC1,0C_0-/($7 8.51:\O)N+;!-7_E87
M5T^UJ%#,+*/;&78HTC&:*O4> L8W4N]+>N8_L01R<5&:8\R\;"GD"= /MIP=
M((D3)%1*!.?67DTF!8GL"ZGH*W)WT'OZVFW64ZA7/_*+%CJ.GZ X\BSDI:83
MI::)HPP4MQV$HEF<K]E5+-Z535.XOK'.BHS[_^[9XJ<O_<;0!'9O'F:HV&UJ
M,9M@$JZ?0^ +R"0'%%T&AF&L:IA/DGEN)$\_##^LOY&JIK8O6XG9P/S[%#R@
M!U[5[6$Y0C0^$C;R/B^:ZS=#X+_$3^(AJN=/WX4$P^1QFE9ELC9#E]0!.[3>
M:H?J!#']@W3J,;@4?65=CG=?2==U6U""SE[3+#VLPHJE[GW]="LN*>>4S4O)
M J)@$M*C1V%?\ D2I(3A?*W5!&&$B+X0C#VR<@3C,L/CIJC+O*CRY!"1Z'<]
M2ET;1:$?H #C+(TBAR097B4B,8?I6^0'\KYK1M[A8;Q,>H%7WCG-@0.5^[%Z
M(& XE>] P+MQYXLR^:W=\[-X_CG<[:+L5N8^%P8H._PE(V7)L*KJJNV8F?^+
MHE"29YRG5T7*+Y1-JZ5C.[[1F0UFF*'0CCR4I(F7AG;BQFD"FPJS#"'-2K[?
MSJY%B5_!FVOW]9ZBSG2(1-/,Q3LAILW7Y"],:7>8-=UZ-T8/N4W'ZTV/V0V*
MO3:=6CO/J>*;LA$U"]%9>7:-&N9=#K51M*[,M!O,AAWP$KP/I"!9GN1X>_M'
M077*8_[\)7_*F^RO.T(_]Z+&#Q>=@4,S0:'O$)2Z&7$R+[$M(M1H2A*^;M6(
M&[58,90V1GQ RMAU6!G; UH;EGC3(@89K +G^LRE6#\O@;8K;@:E?&_8>,3'
M."!D?.FQ\6XE-D(FTFAEI^0,&O5L!4ZAD6;*]-P9^+(K3IJ1IOETMHS\,I+.
MDGU<Y6F.R]<>Z*%P6QS:*(QM!^$0VUD490D.8,Z.,4@K*>NF28!,]&R<1X)N
M!1642ZA64:+A5_@Y@E1=P4?AK'N%GB/WX@H\^\*"C"[6(1"<T,5>TNW6IR D
MTKDX.?/>?&E*8'(SE\PU2:1<+E>?H&6I7'RE]3.Y^@0,)G*=/*#)IU^->97X
M?UBTFEZ1[NA>#W?#97TL;=M%&&,?>4GH>Z;GIH$3*G7G2R"I66@Y8(-!!G;-
MU;HQBKSUFMD-TRP03JOWJ2]@Q5KN=!D4WY<G?0&3P4[T);#T-HO\2G[4]W^0
M[0OY95?4CQ<7"3^@%PG6=)PX81 Z7A:8+J@\7181S:J4?O&!GO:1%QP5TX]K
M\ FF Z4:2MX6"H./2WFR<F?)"S3>98O),6;)]IH<70]^:_KTS_KUZH\RK:[2
M?U2PI*B!5S5KD+8BCVOPRNA-_!._5@W1.W^Y6D@J3 F,4JDX>6J"**EKUM!Z
MJUVV)HCI7[FF'I,]]:F0LM3^FZ?G<O?2V!X#O2=B%. X1CA.0A1G(4[]-+12
M"]@.>A269LD[0#;R'FCH:3[.*=$#6PG]T#.Y([T/5:$L JA3=KJ.0UKY )TE
M^?*,G']%HA2NJ(H/158SO2#1Z73D=<U">4>O/2R3K0F$U"=GA4R?TS$FS)^/
M"NB'":48Z1JZG,Y0*E?G-K+F>O5MTT2=U+7-/"IWB/X-E[SRFU[)O[&:[WZ.
M6V_>)!\W>=G-S4&1'03(Q)@DB>^[H0L:K0H!KEFB.U0VQE-ORF;.(,/.6A!#
MQ0Y?76R""7Z'!4_^:O X3<N]&$^J[H"6X8"B$QL$>M4C7(8IYV>ZU!KP0[ZW
MZC>24-NA?&7.0T"I^_@*FA7#:>8ZL)Q]@N[YHUT-R3 A[\$T.J &A 6@(WV>
M0JE3?6+9U0[V>=+Z9[O T[*9Y7%][/KR&2>DV;^+YHQ.@"+?)R@-+&P[-B8A
M;'K)&"#-TLG TE.Z@[LQ,@K9P  QG>64V!FM@GZ8J'+2;WJD,Z#*Q%.4+F69
MU"-@5LZ0GB;V,O-YYGD50CL^(S=U$A0&04S_&05F;&+B1J!PU1B@-82V_^5*
MC,:=Y96,V*X1;)<D?J'@:HN=CX)Y0\&=CV'//K]R>>^AK]I55>V?FF*S3S^>
M25*3]"-+\"+4/L?U1?%"2DR$O2!%IHOM+,[BR,'P 2$Z,=:L2A34F![[0AH]
M6C9&1XW1D<-F=JU5-2S\08BIN7>US3!]^7YV>+UR8BC7W[JL6!C?]Y44I8K]
MRLJ,P8 E*N;ZHP!N*!A,>7F;442?=@5/!F=_N*KO'\DON/Q?4G<=O*NO[.?N
M#5[K=WX:621 V#=C%&<^3AT_L=U,O,._0L1T1W].)E[D+60^ (1CVQ3?-7_%
M-:H?"7KB*--'6IPW1L'_>7P[88@#BL=4[N.,+^H-=P<8F^HVAB%C=$!9P5F#
M:%MSPO]Z52.*+&JP/73[IQOSE?_S^/;U&VX,H-SOC39(<L;"^AL%JQ/4P,W)
M D*5\-:K+-3 I9.20QWKR_3_:SRRM]FGLF0G^K&&_4M>D)N:/(FUQIM?1I]J
M/#CSZ9E#X>\*LMM7VS;7[=RT[G=S8+@9'#EEK?3$^2#96T\ P(K-]L3)/>V^
M!W@/_E'_4CSG;,7[_(FDGW<< C4]/V_Q@VA(;F()S0;8+U_O;OH?*<? R';E
MZ6<\W1T*Q))Y\5;$#9A40QAA_,9P423$ M1*R>[4NJN)K !Q?4D5>1PNH$T2
M\C7=6'*_ZT  :VRGUM LHK"2VTEBYV5/%9TPX6O3Q#E8-H2&[3^K$3D3RDI3
ME:X(T7*COZ<67F_^MP!Y)T/ 19Y_;W/'ONZ*%U+5!#YR+$HPBJTX0';B!7Z0
M^IX3@'+OW@-1FG50/YD%UT9,'O*"#WRF-O SGW/SSF>0P3^/")E.2%#@!"&*
M7"=!?NJGL9U:ED,Q;HC^5*3_-S^14_)D/Q,6!_@_^(%H#A2]T9:O'DL2'$UW
MH/;_TDPZ^!:^=6!*)4E_CMB5ADU<;PB=!&YR%AT;;5#F+*QVC:M'"C9I>L9>
M5#AX$8IP8*,L(788>[9)7!]B98T!TFSY',$:"86[,8H#9-C1-<HHL>-$!?E0
M/^>!\FM.^==YRL$J=HXL16IO%,RJJFB.V'/U,/N\9*'2J4KXNF=UA[<9US3]
MJH6/^7;/P^7=_9M[2J]BBA1.+@3<]3,4Q4F DL@VW2#TO"@")5"I04M[PF6Q
MX[-Q=J7@!"#%7!?3%NOS$J9;+BRY!D/>S)#C:)R73Q1)OLT;$_.W#C^%.9YJ
M&::J8$H-4NN64BEEY$61E=K5)7S)#P]U&T7ZNJO_3NIN6A9)P077(FMI5F<4
MA9(\L/O3(9)Y>IVCB!D4,^.(&L 5+<(K 9>T8C8!7=-P#FFHV(;P0,Y3+0)@
M/8\U@-P3SS7D/3GCZ=/3\W;W2@A/FKAHD1*%%@I,RT*AXS@HQL3R'<=.<0BZ
MZ@S T*P'.HA-MA#,L!GBB)B5LI!.F""?DJBA]<D$-8KL@2$(JQ[N$R2>G]13
MCTK&CMA*+!.)GNM[EIMTQ_W*W(EQS=P=)>NFP9*:V,]U'F_)=T)O3'F=DXL$
M6^)$*"8I1E'J8-?W<&0GL'*/)=AHEN8C?#Z_@A3YKC1X+Y%G_,I'RN1%O3M)
ML06ZX1=MA:#_?"T& QW?7'LT>!D-8D:#V:9Q/V^,4_;W\#..""IT4JO@DRKO
M\B)<UG4+JV#;A3]7R:(2I0A725)2H#<%U1:DJN]*\I3OGW@&S0$2_64S78AC
M>=[7C5@!B@/BH<#*PCAT(@P9W@.'K_MBTR#$%!W'")!U+L'+F4N,?@X![S0M
M<SIDC!8;XS-/=SOJJP-"$+M0EHF #'V]S)1+Q%?.5%B:O3Q+)K/I)99=+VE>
MGN:3W/@%R\A9LKT^;_>[JS3-V8>&MZP=\DW1CGWC+JWX/#3XC?QSGU=Y38^-
M\B5/2'.^,/_H0\%7.1]AS"^DGF6CT')\Y/J1'22)$[N>4#796@AK/@SXGB&.
M&S-Z#\C!C%[MNR9F%[^GO0 >.W<WUYOAC)#302Q)R?ICMLG75)/V4%1G-Z_%
M1T6FM79T5[6^UV+^N8&^&ER9<F(J-H\4[&W6M9(;Z,#,1BO$&=5E&4:^;?D6
M=C#)Q!I,34+1K(([L.Q&W &&5(*.\4; \E9!,4S1'8B]/1([[W $4 TI9E5
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ML7C&Q-#).&EE<][C]1!J9+@8W[7S#!"%U,4[N<BD2A[" I<R?)@,9H(67"_
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MI4KX_)V/).$;=?(G;V/0MY])PK9T^]K <Z)-&'D'0!0YQPR857^<[<P3<)=
M J8\GW\=8M;%DCV'Z:-^#=%A#D0S"$!ACO$(.:J2AL^77S<+>(2XB[3>L>?D
M]4[>%.W3V_[UKF"7"%(D5*_-!)=9-F[J$A1E9H32-+&S, YL)P9K)7'P*^BL
M%ADNQR?HP 46P%9Q<=;#++BPC_))?TQ;C@T*E00 ^.HJ!,Z8(04CL8K24;SM
M^,J+L987D3LK0F&0T?\DEAF[GI<X=JA@YNX8?,T*Z# 5%K=38;LBJJ/E0^^
M*-L7*7WH4"+>LTPV1MJ@+E]>M7!+,A*BT/8#E/B^'4<)CDPO^9VN%>_>P:;T
M\9#?EEYYVWO>&;%312.W8<<*:";RQF@1U#X">8X1>F<=CT)_#T.-YU@C.+UX
M=AGEINUYI7M,3!2Q7IR!A],DB'S;(:!FNA.P5C9:DQ-C#+'QO,2(E%FORTW5
M-[)+5[$_US,VWXUE*6%&+O!6?]T5/]/5VRSJCZ1*ROR9><3!P\?G5](LN!0!
M]//5U=TAT;Z'@[CW6H A\SYLM;R ">T4&S0,$A<G5<JO+;#\:MYM<5+[/F[
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M+RK%;"M".,$8A6YD8\M/$M,75OMC0-;1_4>H1@-67/V/<F?^#%!!,TQ@.X@
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M@59HHC!*$Q2[9I9&4>;9MI#C5 O[9!0P2W.DUP%V7C+#?XN9D5?O#)S0;_7
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M7 Y!6%4>)T@\E\.I1^7D[QNI,;T<IY]P6=!UJZLDV3_M>3OVCR2C%^>+(SG
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MCA/849I8D6_9(/M@!)!N;T<#UCC %?ER89P2%%H%] .%5H9TN-#.T*5*:,?
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MH@:I:5!W8,RSQ,*)Y[J8,BYMFG*GWY5RKT\1T!X2W9'L2M^F>]K)267:'*K
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MXL&3S(.HJ #+L\;72[&HCQ&D)1# X)3107I*<SL][=2,FSP<1OOM$.NCB@)
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M]!9[ 1C:X.'=[$97TZWX)2XGG08\4F^AUXH+DGV0[DY""L%,?T5OQHV]I5X
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MQB1O<<L#4)K1*%NHB5&68)X[]]*/XM%[-XP-W2$T6RZ.FX5Z,+/226"4UB#
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M]--CRP7V/2Y+3-:)UDR.T]K[+C;>][1Q[ 0: B)X&3US20%BEC"N!)<H=ZW
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MX[&7IESGSKJ>IJ$K#R]IW5DLC"#A%KCH  ;IC=396Z.WT=*["?+&<]N=7:.
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M7A.$(;$\MW?9D^1N:6AXA@@]I2Y+A>[[G[ZVU=PW.8?''S[RB#:9E#0)6%E
M@],>"Q:]Z=RM,XXBM!M,S_&X9'B]%0#.?7W.O_GZ9O/D6RL"#,840"D-XMXJ
MS'+C\"6:ND'NG,Y7!M%& >BZJF?6>S=/+0@?$@7-_(^'ZOA-AI0C0#)#@ ]8
M(<X,\SYW(O)%HKKAZQQ/4?+JHP" /2\+^J"MO[B9+:>+33XXML PKH#C6 9)
M>& N]ZV6-EJZP>D<STZR2+\ %.U>%I]F*Z.;N-SDR*.4T]0$,.F=UMS(_#TS
M7Z:J&[+.\9@DLT8*P-C;E*N<NO2?5#;V(THL;?2+MW'+OXO;>QI5Z+?V=XJ
M$G%_9\HKJC5U(?MVV(FP;D@[Q^.._'HIL?7HU^7-393>+'RMOD^K4-DT^]W:
M9*Q3AF@VJ6R,N'OT'#WL!?W;*!_/3Z8NH]MO:VNYB&$ "I$ #"<ZI,:XFN0>
ML=5.3>9)8V_NFK#XL=9UG5&7;IL1)X"G,>1%B!+ELA=#M9,S;MUF)CR\,";L
M:/$7L ,^WLR_3ZP\Z]*WSD@:KR!C+ LXPHP&I(@DV3MJMA$S<O5O+G6WM;_H
M)?L"0+1._],-D&>#S)4&!A,#J)0.6Q)_X@9*[:]144C3BW[JW9T /5;68Y^;
M7TR_-YV3=[1B>+:.@@4J* ZD#1!*QA'1ZB5W9]\+BKC_>[329IDE6)C->!8T
MK#.AN .*> HH\R;2R9 CN:<Q[21DY,L" VTX_65> '!V3V9MOOOU=E(M5K<&
M4_G&EZ0PM,D?@A#(8#R@! 4=E# .#E+M< "-Y5BG(V&QJ]QA*!V5&,I_T%7=
M)"7^XG6:I]Y4:CXLXUEX_/'%?.X7:?K&P_#%&)+<_XEK"I.6=:H.2=//^@3^
M0Y+3.TUP,EEE2BH\$O2NFMO)++V_-8SDC@+MM8W U809IAVDN=,*^^CI:UP?
MG_WF[HV>I 3OUVOO%[_5L^7MPV"L39Y-9%=JAD"T"UZY@ *CN2^(=J%K7".:
M#26;MC2[2@K8P]=X>OSX/RI?1Z*N[S[Y'WZR*TZ"(NX*U$M J*(*666"SQU$
M=J.L$*AE0T0[Y'*IIR30K>\[V_SMCL\<P4!IKH'SA,4(#;GH=0^%O2X$%@/!
M; AI V%V=96$Q8_3V^5BWD@,M03R6@(E5#/TTUM!);79KP'N(:<0G.4'01O<
M>FJD4'#AW:S U&O7*0(P4@0+I3#4N;O,["%GW#3+N. Z1B.%@HOL9L5#GLIL
M%8B,>,T59![E'DJ]AYQQVRZ,"ZYC-%(2N';YM=L#%=_J9K+IO#UI12#0S!%@
M/(-<"!6@'&SO/)+F0FS@\+'$"51: (176:L=V8"V9  )!$@,*3!,&L89XM+D
MKH)]D:A"O+R38&3S:GU6A16 P-W%<SL8W,JZ1XEIR0-@3ANK0["296\;WY6X
MD0N'\H*B4WEC7PT5 +U6L6V+*TK*&0I\FN$0(E_4YG8-6XD9=\<=%EIY-' \
ME&8+/<D"I;5#GP-DI86-CC/S0!L##<98DLWA7[UQU8VR4MRZ$7;4 50W=MG2
MPQW #@L+<PRTA0;HH! .Q$IING6RW/.2<7?#(10Z&T"Z!>R ^T6U5?F'*=!$
M4A"8800BP[7.[7'MIVA<,S4@L 902+9=<83"DPXU%+]/9V;NZQ\IY&]22?''
ML[A/3*J&PA.4H^0C\F1%*@/)=832%>H9,!@)$#BCC$.$Y&:#M/,H7=FADLO#
M5+(SZZ72]3+D,;#1_CCJ,90L]T6:W#P4DM;IB[[6G.(8JB[ R5A+VCY(8%4B
MO/-V 95 D>  $T8Y&2BW;+!3F%T$%0+"4;#27EC34W$EH;"_9#?%L?M4#$$"
M)&0<.&:(,<@29P8KKAR*J4)60W\ #F>3,Z"AD'S!(Q^[CV.#$$!C9X%SRE#$
MH2&8O.1,[WE^(=@J P$[$@Q]U/&Z#&YKHH_@* /G& @DAA].>LJ?FG:59V-+
M.T4ORLD8"R:O:ZF\U1.;YC&ERTJSR>3#K/Y#UVY3()9I8*3CJ?,E#U@C9LQ@
MT?-03+V:_>-(W ZWD#* J*15M984^VNUN-YB?OZ<^_ES63UNPX]M?)Y=CH$4
M2"WC+FRQX!9+[7SN1A.#,/)J5D\.L'8HYC\M<HY>/K>K3MT+72]&740MDO@M
M.L:?9O,T3V&R=&GHUL,DP2W;QQTP'"G@J<%>,(F<&"R!.31SK\;?*VBQ#8NP
M_RK[%U46:.L-0$I*P9"P=KAS@I/O7\/7R[^J)94/.3WWK_=3-^X!]-J/5X+2
M4Y=^L IZO;V>5G]?]NIV.! E)SM*[B.A$<Z+ V- (Z^ ,\I+ZKU"F_.*SN.\
M>%4R>;&SS\2:Y8F_\'DVK9^MYQWJV9F_L4S&E6VBK4%,D^ 0)"AWG<^0_!02
MVO1%9:M5'QL")?E&!]WHQM:#&&5AP# DU%+L@QSL6OPYM&08'4E96CGL56M)
M8#WF<J5/XQ,XTH K8@U1%&(]6$'$:VWEL!\A.5LY[%5725A\^?HMLA0H3SU
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MN$S**1!V[W_>>KOP[EWUHW)^ZMHY4UH#98R(CB@GQGG#!<M=&=.=NDZP&VR
MXHE@ETDY!<!NH#CI4UNE';,Q5M+. <HE#M!*3,A@Q^ #\53(B7AID6U14"I@
M:>T;$+UI4+9X$P8H00Q@PBGB)-$P>[W](?05DB,L ED'S 'OI>;"(?PPX_Q9
M/E93('GZ1UGI@O.(V-R9["P3Y\\M[S@\5 ]6Y]G,6_F<N%Y4/WSN(J*M!P]3
M$[2?_C%:0@06(WCN &8ANLY*IJK.,RKQN1]L=+\:+NMF+>SV?R "*B #J-?<
M!X8YR=[\HIV:0C;=OHAH&3?65_P%;(\[.7E([SN!H **0PV$# )H@72Z::0B
M1Y@'DCLSU$I,$5/$>FN["X@.%GVI&'I*6:RSXBT%6FH,*(.(&@F-R5XNN(><
M G%TN,*[P.@(Z8]]EO:OR\G=:O;G@X_WE(Y:9T)8 :15%D""-67:\KCV.AVA
MM;VA0%0<H[]9;F&6@(BKVG]8)N=P!Q^6\!AV8DG3D%D&3/ 6>(LIQ)1:'7!G
M4+2\9-PP;#!<Y!!I ;O.UZ695Z[2]=U7_3A0=I<U;:9"",J!)<)23(3*[P&W
M$E,@AOI[+GE$7P*&GLC_K&_BQV]13O,8':3NA3N7&G$0:,\P<(A9 BED.OO<
MYI>I&GG\>Q[U;X(JKRZ*V+R69E+9RQ#?WF12=^W /$W;,M@ "(72 AHNH.V^
M<^UXP\C@R*S&K=VKKTQ+,#N/W<G7YE,_+J"X!UN M)) .$F U!0!S&C 4F ?
M!97;VK01,^X9X5!;5Q;1%X"A=?K7UM4:!Y098-)T!>D4#($QB5'N$5';5(QL
M??*H=W>(?:RL2]B*OE[KE/R<NJW(\+GW_\ 0$E$^!DK 0@A*<6GH9J^:/=O2
M2V\K(N(^6IV;6U)6V99C6IZ;WF?'=\^"3QJ $=0#$L-0JSW!..2^=+:?HG'K
MM4Z9'3Y."05 JEEK'^?SI7?OELEQNUKU'FI6SF?_1_.C^68*P@01^?,8^+A.
M&,%:!XVRNS]=*"O"8&7!PI8_E%TQ!<!MI\ ^+Y,QCG8_52HTQ0QO]63BW9N[
MAT38_2]NL1MP&EH:XUAC93!4.>00/(6)ZTYR@7FF/  ]I2H+0.YJX:T69',7
M(:['YGN;3D3P,6HV.OHIDB.KE'3.Y?;N6XDI,#3,9 ZSB+\ ''6IDW(!:0PX
M%CC&0S"N"TSBER((;(UF#A99]G9:/RX/JK(J8^QH<BW!]\9/?:C2O+W+/Z;Q
MZ=?5[:?JIEKI+*X<F_3WW6_*SDD'-(O> Q:>((L]DV@CA]X26Q[^[DZ88F>$
MJ5/HH #[]52$ZOYC.5^DE,ZC'+<$9S$$DCH:;3-A&@J%*!FLL>XN@CJAC)\1
MRO*KX7!,J16FIOZ[7GCW;;B2V_5)HF]G-[>SZ?,^=E>UO]65B_;Z<G'MZ[?+
M.FEE51W=HR WQVM[E^MFYSU3,>]E_5U/J_]<=;V<3>>S222B65#3Z)@]<7H9
MMF>^MM9X,NR!9"B&K<9Y(B)XA<Q]>)N%\%X;]+W*OL1WI;XS\;WO4I^8V6UZ
M1;KV-YW[K2)\"&4:/ J!QTH)*SS:ZDW>LB=W>MVX^9/3@^G9;IU?(6/[@!?N
M1[(:47BSX.?S*#H]^>!W,&$$,)XX8)#QT%$AB7"=4-7VAG'S'",#*8O8"W#N
M[A?$Q^E\62>&-ND7.+7P@!PX;HQ31//@<^=]-VD8-Z4Q'K"RZ&1L>]3X)O<<
M/!C4BWN79>6KW#LNV^.'7'19C0)0>,&1CZ9V,^W18J ZOW+<K,;(%FL8Q91C
MPNYYZL229@%(H3A0@7+&M#0J^PV:#F2-FQ$IQM!ETUR)L]-?CNIFM[Y>W,6P
M[OW?EU7CB'[VBT&#V;UO/$$<VYWCDD-8#'6Z;H]3?:/#TB$$<>ZCR%%#V,>3
MF'O573ZJ[BIJ>'&QIK^=119>V^BG* FH$H$XG2Y#9#\7ZTC;*XQZ]^)OZS1M
M"!T6L?FW<//FKJT[)DQM:#02@$K+.+4.6I6[BU\'LD:NSAP$#UO[>U[EE(RW
M]MY@GC"0SA3C.A64*\@,MKF;5'4@:UR\98="5Z@=J9<"H/;(0DL+0IZFC$H,
MB!9$02R]D;EAM4%"H1 Z5L6S?/(N "X?EO6T6BSK%$=]J'ZF3_.6+H(QH%=4
M4N!#Y$<X83"7F9'33LVX:>.A091)"P7@Z9/7<W\]F[B/-[?U[,?*%]W-B@X:
M:.8XX$%X007$2.9.I^PA9]Q\\="(RJ6' B#5*JI/;0W)H&Q&:<=/#CNFK)&>
MY.Y<^#)5XYJL<5WUXU13,MA^JV?S;6Z(!C(-;L?0>"73;-GL@P;W4U2H<W6D
M_KO"ZW!E% "M"VN7-VGXJW?O?"3"KN:PQL\3?Y_5N;B9U8O[C$\K\YM\&QN
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M'+Z:7/I9K,OAP/<:EN:.E.M!ILN&52<I1[4,W$ADL_>*/36/KR:M?Q;+<T@
MGL,"'<;5#SK9+8J!=U(P(3FT,/=DH9(BRW,X-"AB.8X M]=WS'"(:" 10/.
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MP_,"( JIEHHAC$.?VW=+$CMV'XWV\65PE*$36/[VM>AKN[7YI6^X==CR32+
M"2) &>6B1R0(S.<-M$[+&#NBGXEB@<%)G7S^E-K?L3E2*:BR' CE5G^AG#&E
MY0P-:T<4BGP=,L:.^]^&?%/!>0^AV:]BM7UQO+9[6YUIO?G&?"9X\'6V;F\3
M;2D%A,TQ()@5!>,FIV;038[(=0(].^+GF.#)4VO_BOUG-V_$XN]&'!PT$"&!
MBQ.(;PPDG=[&H. 9B_'2)AVU'6--=YY^=L 26%P':?IQ;;ZYJ7WSAUD\F%_K
M:O7S(((5TCH7;AE0D!,&#;/8ADYXC)4UZ4@O."VG@O6.2.DGW,T?]<%S#90#
M3@4$)F-6"R(YS$*W8#E3Q*3CO3DH. ::]\8\1Z6#4S<#,R"8DD 2J)7$'.4R
M?'!RII"Q,\%QV'<V/.^,?Y_K]>%+-18"@64&K-O+2RJ$%$Q&I)^7,>[+I)'8
M=S8X[XA\AZUMB(MQE0:LX()*AG AHVQ*G&QQGSN-0+:SP!A/LGHE%O.3[+=*
M;U-&1G_Z4[E_>G'G_W;0)A42(#53($>,D4SEE@SK+QR*<7V"QGU+]:WH%P2F
M"2^]^+NT^F;NHI&#2C]< "$Q Q@AA3-.I96#NLQ,KQ:)^P)K0%J%,'4"3NS,
MXA9,G4N&%.",:,NEBSQ-Z'>J I09\??+GS&&G^I_YB32M[I2W2KQ3  N. 74
M&O_.&]1Y^U&IN;CT*M2P/&_V?ODTTOXIGE=]-'(UX1QJ][\^^7RI5Y9 YT:;
M\4^^VZ,Q!&[GKX%!&&I"&93!:XF[)9GJ+?RH7RHWUGK3M[CK.H+F"C"H_(D^
MELQ:4= L]%ZL0XRX)S\!<&\[AJFF3F [OZ_"3I] %U<QPS?.C '.D6\,3P4V
MN;8Y"7UH<RA%?*Y, O8H4<ZV<G(\V>]2NZL'4M;-'YL!QJQ !A--5>@PMD^6
ME#AS/L9'*3/2X+$OF?XP55DWV^KKR[IZ,,VJ=)/IVEFO7"[KQ@51*[/7*_)%
M,8,(8%@HH*UDA6!",C&LV?,Y7TV),V-!KM_"X@GXH*]U=>M&N_-6\\^9=,TQ
MDOE;W%R '#)DL7'QO1ITL_V<I%^''''+!T*O5Y,MG2!;NF>6T18(65#@-,%"
M<T)U\/6J6Y+(=5"3$3Y!F1'F3H T.Q[3*]+M)PF!@&E4 "T*(2!6.>.AST\[
M!4F+,F,0/GAM9ZJY4^!,UZOC7?,)%@1PB2G(I<D9P00+'-K7] H3M[@H] (5
MQN:IDJ=[9@G_6*S,&5 &Z0)FJ*#D3>B3PGH5"/ A-!IA_=C[K.O&?%[[W.A6
MDVY'JKG;?VHI ;4%T\I (MBPI]J[QT^0$6.PJ\,:,C87_K:NC)_76PV6^RI(
M8(H"^QHWM]?C_KDI1AED.E-6XD%<Z!X_[OYG%BX$,&0""\Q+_[-/_UK[0]#Z
M[KZN?%E09X:*8<"HQ;Y948$0+#0UH=OP'!4H;A%JZ"@EG.T3(%)+A^[91?T#
MUR27(,]SCG.A,,I"7Z/L%"3N6A00Z#JTU1.@CF\@75<_5K7Z9_>"*OR[0)E1
M@$/I#))!)/F@9R'/VE&WA(A+F0# 'FRFIU@Y]HNBOMGW[FP1@".H?2-&-UM$
MG@/&#-%:%R07@\ZJ3[T8^OS!N)7GH9:<\39, ?A]OCZ+#5V$S81R\57.N:9:
M0:-#O,:V\\F([X". ZL-]PC+109\^]Y-C^ NI.8\D\!JH:'DS@)L4([C!.1[
M'XT,^AC(ZA#V2R 2V'=WWXTV=YN67]>F*6O=-1T*XI:O3%)@K826\$)F/'1$
M>5JJN#=&YBU'F8Q"\KS:#ZZ>==*4 Y&I#%A<.'-)R30-7:H_1*Z42A"F<^$L
MJHT )GFR754]'IYAY^$9A>ZO.1+^*2TY[''98'Q[$2UERHWAQ%FD&P=0\KR[
M^:/N5BO/"\"D;Z&464@E+O(B^,V2@:*E5"7SYKP;!U#ZO/-7Z+L5$VZ18#F4
M "N,-,T*973H>RB#A4OI /SMN3<2I(CLTZ;\QU=S*Q:??&_7Q]U(Y/GL)6-.
MB4P+(#C$5"""A#BV-U@:]6^W]<._NZ&?J.7^\,JHC@_&O:D;*NR?:LG()'B2
M>G^*O,CM.V>1' &$L1:6V<(6QPZL3C-@]VMQPJ3)<-4!;!?[%/N7_W-YV7W@
MZC8=/C5F@$5*&&:I9KQU'Z7GY/IUS'C C@>DGFZ=Y&*)K[N=WO<./GR#"DP4
MR! K<D@I-"IT[X8>4>)>HY\WU3/.WLG1YDOE1C;+3<O8S=&KWC:.%;>FK9G"
M;D(XE4"!))(Y@LI9;58F'9,NI8WW2#(<)5@P9)+CW&>AS&L#DST]BLSID3%@
M+($86Z/SX(W]^V1):4,]!Y]&6CT!]NP^/](J<V^KDF=NGY<;" 02BE!,54%"
M)P:/B)/2QC@,AT+9/@$:=58V?EO[T._*;J[Y;1IM7XK%PN@/C\^UBMM_>'BE
M!V= 6&R!,C"G"AK(@]_\GRAR2B6 8>CXEAC&WK==*-6LC7Z. ZX;<U>N[S[7
MS=Y=U*U@FUJE _6H<9&M</:%A7;;6DE)^Y9,S_[N_&^G5/LSC6MO8?P$W.&^
MR3Z(9;G\X601^JKZ732EWR[YT!,>)CD+P&4A )(\*PH+B<[F/7OKERVE6H(Y
M8K9 J"3'MIV<>E,J<[BQ>5:+*^4?5<T!AIQ8D0NE^!R]@P:(EE(">PZNA<$D
M :IUQ@B?_G3ZE$NST>WEER^! 6PG_[#$@.<2 6:S0C!EI&:A6_6,$C2EG-J,
M,5U0O!(@Y;,"%Y5^TN!JO5JN1*7+ZM:_$M;6AQ'_\&\N ,MUX:L/)>&AWU0X
M)5/<+I9S4"TH"K'W!YWSYNJ/RHW^L[S?^N]MB6M;,:&ULUJ&0,XAAA06#$$X
M:&=PSE<C]ZT,OBF8S>*).ZBV+DB[K8U_6@191!A6DB+QELYI&*_>5>X_F/D3
MH-)NSO#+<KD6E5_"?<^3FVW/DV>-%,AA07T=K'0+-\. 9@CZ)\FID:$ORYZ6
M:ABMWM410& H$B#7KNS[;8-WM3"2NNVPR-W";9#)B12BP($)U2W),!*]JS.
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M\AUEJ')V*B '(LNS7%B$K$WO/8"W(M$(O,]N]S_4^ DPJ;\_^8X27"+ "+3
M6DH,R75!]: &RF<PZ%VV^Q\,].!V_T.MG@!UNAO1[YJ$2B"+/ >60YS;HM!9
MNR7R_YQV_X.!'=3N?ZB5$Z#)\29T.XH4"KE@'14@$SG5I.#&MA^UCMP9<K[3
MB>!K5!"CI\">8=WI=C3"3 )!: XP=\-QX^_'!@]WWG7CQ\'PCVO\.!2+V*5
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M2P$"% ,4    " "%@:M<2% ';(P&  "+$   %P              @ $
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M,BYH=&U02P$"% ,4    " "%@:M<P!!)YX43 0!N(@T $0
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M+3(P,C8P,S,Q7VQA8BYX;6Q02P$"% ,4    " "%@:M<P<+=*IZ)  "?> <
M%0              @ 'R@0( 96QT>"TR,#(V,#,S,5]P<F4N>&UL4$L%!@
0   *  H G@(  ,,+ P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>eltx-20260331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:eltx="http://www.eltx.com/20260331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="eltx-20260331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2026-05-08</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">eltx:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2024RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2026RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-28</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eltx:AngionCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">eltx:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">eltx:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">eltx:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eltx:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">eltx:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:The2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eltx:Inducement2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">eltx:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">eltx:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">eltx:GKCCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eltx:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">eltx:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eltx:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eltx:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">eltx:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eltx:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">eltx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eltx:A2026ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-05-08</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>eltx:agreement</measure>
    </unit>
    <unit id="entity">
        <measure>eltx:entity</measure>
    </unit>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-25">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-28">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001601485</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-67"
      decimals="INF"
      id="f-292"
      unitRef="number">0.1</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-3">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-4">001-39990</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-5">Elicio Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">11-3430072</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">451 D Street, 5th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">02210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">209-0050</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-14">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-15">ELTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-16">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-17">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-18">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-19">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-20">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-22">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">19086081</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">14948000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">18563000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">1252000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">748000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">16200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">19311000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">249000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">295000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">4539000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">4782000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">706000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">704000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">995000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">770000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">22689000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">25862000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">272000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">672000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">5915000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">6427000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">1042000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">1011000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">7229000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">8110000</us-gaap:LiabilitiesCurrent>
    <eltx:WarrantLiability contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">3599000</eltx:WarrantLiability>
    <eltx:WarrantLiability contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">2615000</eltx:WarrantLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">3823000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">4094000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">9475000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">9407000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">24126000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">24226000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-63" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-64" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-65"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-66"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-67" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-68" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-69" unitRef="shares">18654350</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-70" unitRef="shares">17814762</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-71" unitRef="shares">18639895</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-72" unitRef="shares">17800307</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-73" unitRef="usd">186000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">178000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-75" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-76" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-79" unitRef="usd">244144000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">235407000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-81" unitRef="usd">-122000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">-127000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">-245495000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">-233672000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-85" unitRef="usd">-1437000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">1636000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-87" unitRef="usd">22689000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">25862000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-89" unitRef="usd">6757000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">7778000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-91" unitRef="usd">3845000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">2958000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-93" unitRef="usd">10602000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">10736000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-95" unitRef="usd">-10602000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-96" unitRef="usd">-10736000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-97" unitRef="usd">984000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">507000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-99" unitRef="usd">13000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-101" unitRef="usd">157000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">210000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-103" unitRef="usd">407000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">176000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-105" unitRef="usd">-1221000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">-473000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-107" unitRef="usd">-11823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-109" unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-111" unitRef="usd">-11818000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">-11178000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-113"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-114"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-115"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-116"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-117" unitRef="shares">18211745</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-118" unitRef="shares">18211745</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-119" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-120" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-121" unitRef="shares">17814762</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">178000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-7" decimals="INF" id="f-123" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-125" unitRef="usd">235407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-126" unitRef="usd">-127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-127" unitRef="usd">-233672000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-128" unitRef="usd">1636000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-11" decimals="-5" id="f-129" unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-12"
      decimals="INF"
      id="f-130"
      unitRef="shares">819157</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-12" decimals="-3" id="f-131" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-13" decimals="-3" id="f-132" unitRef="usd">7769000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-14" decimals="-3" id="f-133" unitRef="usd">7777000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-15"
      decimals="INF"
      id="f-134"
      unitRef="shares">20431</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-16" decimals="-3" id="f-135" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-3" id="f-137" unitRef="usd">868000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">868000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-17" decimals="-3" id="f-139" unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-3" id="f-141" unitRef="usd">-11823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">-11823000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-19"
      decimals="INF"
      id="f-143"
      unitRef="shares">18654350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-144" unitRef="usd">186000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-20"
      decimals="INF"
      id="f-145"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-146" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-147" unitRef="usd">244144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-148" unitRef="usd">-122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-149" unitRef="usd">-245495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-150" unitRef="usd">-1437000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-24"
      decimals="INF"
      id="f-151"
      unitRef="shares">11043837</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-152" unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-25"
      decimals="INF"
      id="f-153"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-154" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-155" unitRef="usd">183004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-156" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-157" unitRef="usd">-194101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-158" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-30" decimals="-5" id="f-159" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-31"
      decimals="INF"
      id="f-160"
      unitRef="shares">106823</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-31" decimals="-3" id="f-161" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-32" decimals="-3" id="f-162" unitRef="usd">834000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-30" decimals="-3" id="f-163" unitRef="usd">835000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-33"
      decimals="INF"
      id="f-164"
      unitRef="shares">1628</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-34" decimals="-3" id="f-165" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-166" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-5" id="f-167" unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-35"
      decimals="INF"
      id="f-168"
      unitRef="shares">3500573</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-35" decimals="-3" id="f-169" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-36" decimals="-3" id="f-170" unitRef="usd">20141000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-37" decimals="-3" id="f-171" unitRef="usd">20176000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-38" decimals="-5" id="f-172" unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <eltx:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants
      contextRef="c-33"
      decimals="INF"
      id="f-173"
      unitRef="shares">1261830</eltx:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-33" decimals="-3" id="f-174" unitRef="usd">13000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-34" decimals="-3" id="f-175" unitRef="usd">9130000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-5" decimals="-3" id="f-176" unitRef="usd">9143000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-33"
      decimals="INF"
      id="f-177"
      unitRef="shares">68500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-33" decimals="-3" id="f-178" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-34" decimals="-3" id="f-179" unitRef="usd">715000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-5" decimals="-3" id="f-180" unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-34" decimals="-3" id="f-181" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-182" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-39" decimals="-3" id="f-183" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-184" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-40" decimals="-3" id="f-185" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-186" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-41"
      decimals="INF"
      id="f-187"
      unitRef="shares">15983191</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-188" unitRef="usd">160000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-42"
      decimals="INF"
      id="f-189"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-190" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-191" unitRef="usd">214348000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-192" unitRef="usd">-144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-193" unitRef="usd">-205310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-194" unitRef="usd">8904000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">-11823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-196" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-197" unitRef="usd">46000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-3" id="f-198" unitRef="usd">53000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">243000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-3" id="f-200" unitRef="usd">225000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <eltx:InterestExpenseNoncash contextRef="c-1" decimals="-3" id="f-201" unitRef="usd">0</eltx:InterestExpenseNoncash>
    <eltx:InterestExpenseNoncash contextRef="c-5" decimals="-3" id="f-202" unitRef="usd">107000</eltx:InterestExpenseNoncash>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">68000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-5" decimals="-3" id="f-204" unitRef="usd">35000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">984000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-5" decimals="-3" id="f-206" unitRef="usd">507000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-207" unitRef="usd">868000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-208" unitRef="usd">517000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">504000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-3" id="f-210" unitRef="usd">4000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">225000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-5" decimals="-3" id="f-212" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">-460000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-5" decimals="-3" id="f-214" unitRef="usd">2999000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <eltx:IncreaseDecreaseInAccruedExpenses contextRef="c-1" decimals="-3" id="f-215" unitRef="usd">-602000</eltx:IncreaseDecreaseInAccruedExpenses>
    <eltx:IncreaseDecreaseInAccruedExpenses contextRef="c-5" decimals="-3" id="f-216" unitRef="usd">-2645000</eltx:IncreaseDecreaseInAccruedExpenses>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-5" decimals="-3" id="f-218" unitRef="usd">-489000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">-240000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-220" unitRef="usd">-215000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">-11645000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-222" unitRef="usd">-10119000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">7988000</eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts>
    <eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts contextRef="c-5" decimals="-3" id="f-224" unitRef="usd">835000</eltx:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts>
    <eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">61000</eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering>
    <eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering contextRef="c-5" decimals="-3" id="f-226" unitRef="usd">0</eltx:PaymentOfOfferingCostsForTheIssuanceOfCommonStockFromAtTheMarketOffering>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-5" decimals="-3" id="f-228" unitRef="usd">343000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-5" decimals="-3" id="f-230" unitRef="usd">9143000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-232" unitRef="usd">7000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">8027000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-234" unitRef="usd">10328000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-236" unitRef="usd">31000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-3613000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-238" unitRef="usd">240000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-239" unitRef="usd">19267000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-29" decimals="-3" id="f-240" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-241" unitRef="usd">15654000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-46" decimals="-3" id="f-242" unitRef="usd">19732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-243" unitRef="usd">14948000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-46" decimals="-3" id="f-244" unitRef="usd">18351000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-245" unitRef="usd">706000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-46" decimals="-3" id="f-246" unitRef="usd">1381000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-247" unitRef="usd">15654000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-46" decimals="-3" id="f-248" unitRef="usd">19732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">150000</eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid>
    <eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid contextRef="c-5" decimals="-3" id="f-250" unitRef="usd">0</eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid>
    <eltx:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">0</eltx:FairValueOfCommonStockWarrantsUponSettlement>
    <eltx:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-5" decimals="-3" id="f-252" unitRef="usd">373000</eltx:FairValueOfCommonStockWarrantsUponSettlement>
    <eltx:SettlementOfPromissoryNotesPayable contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">0</eltx:SettlementOfPromissoryNotesPayable>
    <eltx:SettlementOfPromissoryNotesPayable contextRef="c-5" decimals="-3" id="f-254" unitRef="usd">20034000</eltx:SettlementOfPromissoryNotesPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-255">Description of the Business and Financial Condition&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Elicio Therapeutics, Inc. (&#x201c;Elicio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mutant Kirsten rat sarcoma viral oncogene homolog (&#x201c;mKRAS&#x201d;)-positive pancreatic cancer, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#x201c;ESC&#x201d;), an investment company, Elicio Operating Company, Inc. (&#x201c;Former Elicio&#x201d;), and Elicio Australia Pty Ltd. (&#x201c;Elicio Pty&#x201d;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#x201c;Elicio&#x201d; throughout these unaudited interim condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has experienced net losses and negative cash flows from operating activities since inception. As of March&#160;31, 2026, the Company had an accumulated deficit of $245.5 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. The Company&#x2019;s sources of liquidity are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2024, the Company filed a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Sales Agreement with JonesTrading Institutional Services LLC (&#x201c;Jones&#x201d;), as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#x201c;2024 ATM Program&#x201d;). During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock at a weighted average price of $9.46 per share under the 2024 ATM Program for net proceeds of approximately $16.2&#160;million after deducting sales commissions. During the three months ended March 31, 2026, the Company issued and sold 699,678 shares of common stock at a weighted average price of $9.52 per share for net proceeds of approximately $6.7&#160;million after deducting sales commissions under the 2024 ATM Program. In March 2026, the Company terminated the 2024 ATM Program and was not subject to any penalties related to the termination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In February 2026, the Company filed a registration statement on Form S-3 (the &#x201c;2026 Registration Statement&#x201d;) with the SEC, as subsequently amended in March 2026, that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $400&#160;million. In March 2026, the Company entered into the At Market Issuance Sales Agreement with B. Riley Securities, Inc. (&#x201c;B. Riley Securities&#x201d;), Jones, and Ladenburg Thalmann &amp;amp; Co. Inc. (&#x201c;Ladenburg Thalmann&#x201d;), (each an &#x201c;Agent&#x201d; and collectively, the &#x201c;Agents&#x201d;), under which the Company may issue and sell, from time to time at its sole discretion,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;up to $100&#160;million of shares of common stock in &#x201c;at-the-market&#x201d; offerings through the Agents under the 2026 Registration Statement and related prospectus filed with the 2026 Registration Statement (the &#x201c;2026 ATM Program&#x201d; and, collectively with the 2024 ATM Program, the &#x201c;ATM Programs&#x201d;). During the three months ended March&#160;31, 2026, the Company issued and sold 119,479 shares of common stock at a weighted average price of $11.42 per share for net proceeds of approximately $1.3&#160;million after deducting sales commissions under the 2026 ATM Program. The Company incurred offering costs of $0.2&#160;million related to the initial setup of the 2026 ATM Program, of which $0.2&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $1.1&#160;million for the three months ended March&#160;31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the three months ended March&#160;31, 2026, the Company issued and sold 819,157 shares of common stock at a weighted average price of $9.80 per share for aggregate net proceeds of $8.0&#160;million after deducting sales commissions and $7.8&#160;million after deducting offering costs under the ATM Programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;January 2025 Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#x201c;Investor&#x201d; and, collectively, the &#x201c;Investors&#x201d;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#x201c;January 2025 Offering&#x201d;): (i) an aggregate of 1,261,830 shares of common stock (the &#x201c;January 2025 Shares&#x201d;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#x201c;January 2025 Common Warrants&#x201d;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $9.2&#160;million after deducting the placement agent&#x2019;s fees and related offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into a note purchase agreement (the &#x201c;June 2025 Promissory Note Financing&#x201d;) with GKCC, LLC (&#x201c;GKCC&#x201d;), an entity controlled by a member of Elicio&#x2019;s board of directors, pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#x201c;June 2025 Promissory Note&#x201d;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of common stock (the &#x201c;June 2025 Warrant&#x201d;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 8 and 11 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March&#160;31, 2026, the Company had $14.9 million in cash and cash equivalents. The Company&#x2019;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all. If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-256" unitRef="usd">-245500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <eltx:SaleOfStockAggregateInitialOfferingPrice contextRef="c-47" decimals="-6" id="f-257" unitRef="usd">200000000</eltx:SaleOfStockAggregateInitialOfferingPrice>
    <eltx:SaleOfStockAggregateInitialOfferingPrice contextRef="c-48" decimals="-6" id="f-258" unitRef="usd">40000000</eltx:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-49" decimals="0" id="f-259" unitRef="shares">1717507</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-50"
      decimals="INF"
      id="f-260"
      unitRef="usdPerShare">9.46</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-49" decimals="-5" id="f-261" unitRef="usd">16200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-51" decimals="0" id="f-262" unitRef="shares">699678</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-52"
      decimals="INF"
      id="f-263"
      unitRef="usdPerShare">9.52</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-51" decimals="-5" id="f-264" unitRef="usd">6700000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <eltx:SaleOfStockAggregateInitialOfferingPrice contextRef="c-53" decimals="-6" id="f-265" unitRef="usd">400000000</eltx:SaleOfStockAggregateInitialOfferingPrice>
    <eltx:SaleOfStockAggregateInitialOfferingPrice contextRef="c-54" decimals="-6" id="f-266" unitRef="usd">100000000</eltx:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-55" decimals="0" id="f-267" unitRef="shares">119479</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-56"
      decimals="INF"
      id="f-268"
      unitRef="usdPerShare">11.42</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-55" decimals="-5" id="f-269" unitRef="usd">1300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-11" decimals="-5" id="f-270" unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid contextRef="c-57" decimals="-5" id="f-271" unitRef="usd">200000</eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-58" decimals="-5" id="f-272" unitRef="usd">1100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-12" decimals="0" id="f-273" unitRef="shares">819157</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-59"
      decimals="INF"
      id="f-274"
      unitRef="usdPerShare">9.80</us-gaap:SaleOfStockPricePerShare>
    <eltx:SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions contextRef="c-12" decimals="-5" id="f-275" unitRef="usd">8000000.0</eltx:SaleOfStockConsiderationReceivedOnTransactionNetOfSalesCommissions>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-12" decimals="-5" id="f-276" unitRef="usd">7800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-60" decimals="0" id="f-277" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-61"
      decimals="INF"
      id="f-278"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-62"
      decimals="3"
      id="f-279"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-62"
      decimals="1"
      id="f-280"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-61" id="f-281">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-63" decimals="-5" id="f-282" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-64" decimals="-5" id="f-283" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-65"
      decimals="INF"
      id="f-284"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="2"
      id="f-285"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-64" id="f-286">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-66" decimals="-5" id="f-287" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-288" unitRef="usd">14900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-289">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December&#160;31, 2025 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s most recent Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Adopted Accounting Standards During the Period&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2024-04&#x201d;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis on January 1, 2026. The Company&#x2019;s adoption of ASU 2024-04 did not have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-290">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December&#160;31, 2025 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s most recent Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-291">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Adopted Accounting Standards During the Period&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2024-04&#x201d;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis on January 1, 2026. The Company&#x2019;s adoption of ASU 2024-04 did not have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-293">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash equivalents at March&#160;31, 2026 and December&#160;31, 2025 were held in U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There were no transfers made among the three levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the warrants assumed in the merger (the &#x201c;Merger&#x201d;) with Angion Biomedica Corp. (&#x201c;Angion&#x201d; and the warrants, the &#x201c;Angion Warrants&#x201d;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion Warrant liabilities was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed an underwritten public offering (the &#x201c;July 2024 Public Offering&#x201d;), consisting of (i) 500,000 shares of common stock (the &#x201c;July 2024 Shares&#x201d;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#x201c;July 2024 Pre-Funded Warrants&#x201d;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock, (the &#x201c;July 2024 Common Warrants&#x201d;). The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable, and will expire five years from the issuance date. At the Company&#x2019;s annual stockholder&#x2019;s meeting in November 2024, the Company obtained stockholder approval for GKCC, together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) (&#x201c;Stockholder Approval&#x201d;). As a result of the Stockholder Approval, the July 2024 Common Warrants held by GKCC are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. Refer to Note 8 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the three months ended March 31, 2026 and 2025, the Company recognized a change in fair value of $1.0 million and $0.5 million, respectively, on the remeasurement of the liability-classified July 2024 Common Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-294">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:116%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-68" decimals="-3" id="f-295" unitRef="usd">6296000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-69" decimals="-3" id="f-296" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-70" decimals="-3" id="f-297" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-298" unitRef="usd">6296000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-68" decimals="-3" id="f-299" unitRef="usd">6296000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-69" decimals="-3" id="f-300" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-70" decimals="-3" id="f-301" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-302" unitRef="usd">6296000</us-gaap:AssetsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-68" decimals="-3" id="f-303" unitRef="usd">0</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-69" decimals="-3" id="f-304" unitRef="usd">3596000</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-70" decimals="-3" id="f-305" unitRef="usd">3000</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-306" unitRef="usd">3599000</eltx:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-68" decimals="-3" id="f-307" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-69" decimals="-3" id="f-308" unitRef="usd">3596000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-70" decimals="-3" id="f-309" unitRef="usd">3000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-3" decimals="-3" id="f-310" unitRef="usd">3599000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-71" decimals="-3" id="f-311" unitRef="usd">6245000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-72" decimals="-3" id="f-312" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-73" decimals="-3" id="f-313" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-314" unitRef="usd">6245000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-71" decimals="-3" id="f-315" unitRef="usd">6245000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-72" decimals="-3" id="f-316" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-73" decimals="-3" id="f-317" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-318" unitRef="usd">6245000</us-gaap:AssetsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-71" decimals="-3" id="f-319" unitRef="usd">0</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-72" decimals="-3" id="f-320" unitRef="usd">2614000</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-73" decimals="-3" id="f-321" unitRef="usd">1000</eltx:WarrantsFairValueDisclosure>
    <eltx:WarrantsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-322" unitRef="usd">2615000</eltx:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-71" decimals="-3" id="f-323" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-72" decimals="-3" id="f-324" unitRef="usd">2614000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-73" decimals="-3" id="f-325" unitRef="usd">1000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-326" unitRef="usd">2615000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-327">The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-74" decimals="-3" id="f-328" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-75" decimals="-3" id="f-329" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-76" decimals="-3" id="f-330" unitRef="usd">2000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-77" decimals="-3" id="f-331" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-78" decimals="-3" id="f-332" unitRef="usd">3000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-74" decimals="-3" id="f-333" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-334">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion Warrant liabilities was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-79"
      decimals="2"
      id="f-335"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-80"
      decimals="2"
      id="f-336"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-70" id="f-337">P2Y4M24D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-73" id="f-338">P2Y8M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-81" decimals="3" id="f-339" unitRef="number">0.768</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-81" decimals="3" id="f-340" unitRef="number">0.768</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-82" decimals="3" id="f-341" unitRef="number">0.676</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-83" decimals="3" id="f-342" unitRef="number">0.040</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-83" decimals="3" id="f-343" unitRef="number">0.040</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-84" decimals="3" id="f-344" unitRef="number">0.038</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-85" decimals="3" id="f-345" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-86" decimals="3" id="f-346" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-87" decimals="0" id="f-347" unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-88" decimals="0" id="f-348" unitRef="shares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-89" decimals="0" id="f-349" unitRef="shares">2300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-90"
      decimals="2"
      id="f-350"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-91" id="f-351">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <eltx:SaleOfStockBeneficialOwnershipLimitationPercentage contextRef="c-3" decimals="INF" id="f-352" unitRef="number">0.1999</eltx:SaleOfStockBeneficialOwnershipLimitationPercentage>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-92" decimals="-5" id="f-353" unitRef="usd">-1000000.0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-93" decimals="-5" id="f-354" unitRef="usd">-500000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-355">Balance Sheet Components&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation expense for the three months ended March 31, 2026 was an immaterial amount. For the three months ended March 31, 2025, depreciation expense was $0.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other long-term prepaid assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $1.0 million and $0.8 million for March&#160;31, 2026 and December&#160;31, 2025, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued clinical trial and research and development costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c-1" id="f-356">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <eltx:PrepaidResearchAndDevelopmentExpenses contextRef="c-3" decimals="-3" id="f-357" unitRef="usd">563000</eltx:PrepaidResearchAndDevelopmentExpenses>
    <eltx:PrepaidResearchAndDevelopmentExpenses contextRef="c-4" decimals="-3" id="f-358" unitRef="usd">115000</eltx:PrepaidResearchAndDevelopmentExpenses>
    <eltx:AdvancedProfessionalFees contextRef="c-3" decimals="-3" id="f-359" unitRef="usd">319000</eltx:AdvancedProfessionalFees>
    <eltx:AdvancedProfessionalFees contextRef="c-4" decimals="-3" id="f-360" unitRef="usd">193000</eltx:AdvancedProfessionalFees>
    <us-gaap:PrepaidInsurance contextRef="c-3" decimals="-3" id="f-361" unitRef="usd">208000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-362" unitRef="usd">367000</us-gaap:PrepaidInsurance>
    <eltx:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-363" unitRef="usd">162000</eltx:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <eltx:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-364" unitRef="usd">73000</eltx:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-365" unitRef="usd">1252000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-366" unitRef="usd">748000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-367">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-94" decimals="-3" id="f-368" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-95" decimals="-3" id="f-369" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-96" decimals="-3" id="f-370" unitRef="usd">258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-97" decimals="-3" id="f-371" unitRef="usd">258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-98" decimals="-3" id="f-372" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-99" decimals="-3" id="f-373" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-374" unitRef="usd">2051000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-375" unitRef="usd">2051000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-376" unitRef="usd">1802000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-377" unitRef="usd">1756000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-378" unitRef="usd">249000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-379" unitRef="usd">295000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-380" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-381" unitRef="usd">100000</us-gaap:Depreciation>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-5" id="f-382" unitRef="usd">1000000.0</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-5" id="f-383" unitRef="usd">800000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-384">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued clinical trial and research and development costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-385" unitRef="usd">623000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-386" unitRef="usd">818000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-387" unitRef="usd">833000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-388" unitRef="usd">2528000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent contextRef="c-3" decimals="-3" id="f-389" unitRef="usd">3345000</eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent>
    <eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-390" unitRef="usd">2298000</eltx:AccruedClinicalTrialAndResearchAndDevelopmentCostsCurrent>
    <eltx:AccruedInterest contextRef="c-3" decimals="-3" id="f-391" unitRef="usd">1080000</eltx:AccruedInterest>
    <eltx:AccruedInterest contextRef="c-4" decimals="-3" id="f-392" unitRef="usd">741000</eltx:AccruedInterest>
    <eltx:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-393" unitRef="usd">34000</eltx:AccruedOtherOperatingLiabilitiesCurrent>
    <eltx:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-394" unitRef="usd">42000</eltx:AccruedOtherOperatingLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-395" unitRef="usd">5915000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-396" unitRef="usd">6427000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-397">Research Grants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#x201c;GI&#x201d;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases, for $2.8 million. The development efforts as defined in the first grant agreement were completed in the second quarter of 2023. In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million. The development efforts as defined in the second agreement were completed in the third quarter of 2024. In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. The third grant agreement activities were completed in the second quarter of 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The award money for the three grant agreements was recorded as contra-expense to offset the research and development costs incurred. For the three months ended March&#160;31, 2025, the Company incurred $0.5 million in research and development expenses related to this project, of which $0.5 million was reimbursed from available grant funds. Following completion of the third grant agreement with GI Research Foundation during the second quarter of 2025, the remaining $0.4 million of the grant funds were recognized as grant income, as there were no further conditions to be met.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <eltx:ResearchAndDevelopmentArrangementGrant contextRef="c-100" decimals="-5" id="f-398" unitRef="usd">2800000</eltx:ResearchAndDevelopmentArrangementGrant>
    <eltx:ResearchAndDevelopmentArrangementGrant contextRef="c-101" decimals="-5" id="f-399" unitRef="usd">3100000</eltx:ResearchAndDevelopmentArrangementGrant>
    <eltx:ResearchAndDevelopmentArrangementGrant contextRef="c-102" decimals="-5" id="f-400" unitRef="usd">1500000</eltx:ResearchAndDevelopmentArrangementGrant>
    <eltx:NumberOfResearchGrantAgreements
      contextRef="c-103"
      decimals="INF"
      id="f-401"
      unitRef="agreement">3</eltx:NumberOfResearchGrantAgreements>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-104" decimals="-5" id="f-402" unitRef="usd">500000</us-gaap:ResearchAndDevelopmentExpense>
    <eltx:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-104" decimals="-5" id="f-403" unitRef="usd">500000</eltx:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <eltx:GrantRevenueNonoperating contextRef="c-105" decimals="-5" id="f-404" unitRef="usd">400000</eltx:GrantRevenueNonoperating>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-405">Common Stock and Stockholders' Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Authorized Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the three months ended March&#160;31, 2025, the Company issued and sold 106,823 shares of common stock at a weighted average price of $7.82 per share under the 2024 ATM Program for net proceeds of approximately $0.8 million after deducting sales commissions. During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock at a weighted average price of $9.46 per share under the 2024 ATM Program for net proceeds of approximately $16.2&#160;million after deducting sales commissions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the three months ended March&#160;31, 2026, the Company issued and sold 699,678 shares of common stock at a weighted average price of $9.52 per share under the 2024 ATM Program for net proceeds of approximately $6.7 million after deducting sales commissions. In March 2026, the 2024 ATM Program was terminated by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the three months ended March&#160;31, 2026, the Company issued and sold 119,479 shares of common stock at a weighted average price of $11.42 per share under the 2026 ATM Program for net proceeds of approximately $1.3 million after deducting sales commissions. The Company incurred offering costs of $0.2&#160;million related to the initial setup of the 2026 ATM Program, of which $0.2&#160;million remained unpaid and was included in accounts payable and accrued expenses as of March&#160;31, 2026, bringing the aggregate net proceeds for the 2026 ATM Program to approximately $1.1&#160;million for the three months ended March&#160;31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;January 2025 Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors, the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of 1,261,830 shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925 per January 2025 Share and accompanying January 2025 Common Warrants. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of approximately $9.2&#160;million to the Company after deducting the placement agent&#x2019;s fees and related offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with GKCC, an entity controlled by a member of Elicio&#x2019;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#x201c;Convertible Note&#x201d;) in the principal amount of $20.0&#160;million (the &#x201c;Convertible Note Financing&#x201d;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7&#160;million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for further detail.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-406" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-407"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-408" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-409"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-106" decimals="0" id="f-410" unitRef="shares">106823</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-107"
      decimals="INF"
      id="f-411"
      unitRef="usdPerShare">7.82</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-106" decimals="-5" id="f-412" unitRef="usd">800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-49" decimals="0" id="f-413" unitRef="shares">1717507</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-50"
      decimals="INF"
      id="f-414"
      unitRef="usdPerShare">9.46</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-49" decimals="-5" id="f-415" unitRef="usd">16200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-51" decimals="0" id="f-416" unitRef="shares">699678</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-52"
      decimals="INF"
      id="f-417"
      unitRef="usdPerShare">9.52</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-51" decimals="-5" id="f-418" unitRef="usd">6700000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-55" decimals="0" id="f-419" unitRef="shares">119479</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-56"
      decimals="INF"
      id="f-420"
      unitRef="usdPerShare">11.42</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-55" decimals="-5" id="f-421" unitRef="usd">1300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-11" decimals="-5" id="f-422" unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid contextRef="c-57" decimals="-5" id="f-423" unitRef="usd">200000</eltx:NoncashOrPartNoncashAcquisitionAtTheMarketOfferingCostsIncurredButNotPaid>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-58" decimals="-5" id="f-424" unitRef="usd">1100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-108" decimals="0" id="f-425" unitRef="shares">1261830</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-109"
      decimals="INF"
      id="f-426"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-62"
      decimals="3"
      id="f-427"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-62"
      decimals="1"
      id="f-428"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-110" id="f-429">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-111" decimals="-5" id="f-430" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-112" decimals="2" id="f-431" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-432" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-112" decimals="2" id="f-433" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-113" decimals="-5" id="f-434" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-114"
      decimals="INF"
      id="f-435"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-436" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <eltx:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-115" decimals="-5" id="f-437" unitRef="usd">300000</eltx:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-64" decimals="INF" id="f-438" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-65"
      decimals="INF"
      id="f-439"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="2"
      id="f-440"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-64" id="f-441">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-442">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March&#160;31, 2026, there was an aggregate of 1,280,971 shares of common stock available for issuance under the Company&#x2019;s equity incentive plans, including 645,103 shares available for future grants under the Company&#x2019;s 2021 Incentive Award Plan, 178,953 shares available for future grants under the Company&#x2019;s 2022 Equity Incentive Plan, as amended, and 456,915 shares available for future grants issuance under the Company&#x2019;s 2024 Inducement Incentive Award Plan. Refer to Note 7 &#x2013; &#x201c;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options for the three months ended March 31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,621,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;524,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(20,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,123,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,574,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;18.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. 524,793 stock options were granted during the three months ended March 31, 2026. The weighted average grant date fair value per share for the stock option grants during the three months ended March 31, 2026 was $6.73. As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested stock option awards granted was $8.1 million, which the Company expects to recognize over a weighted-average period of approximately 3.2 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#x2019;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;105.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;106.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s restricted stock units (&#x201c;RSUs&#x201d;) for the three months ended March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Grant Date Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested as of December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested as of March&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March&#160;31, 2026, the total unrecognized compensation expense related to unvested restricted stock units was $1.8 million, which the Company expects to recognize over a weighted-average period of approximately 3.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense, which includes expense related to stock options and RSUs, as recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#x2019;s initial public offering. The offering period and purchase period were determined by Angion&#x2019;s board of directors. In February 2026, Elicio amended and restated the ESPP, and filed the amended and restated ESPP as an exhibit to the Annual Form 10-K on March 12, 2026. No offering periods or purchasing periods were active as of March&#160;31, 2026. As of March&#160;31, 2026, 453,312 shares remained available for purchase under the ESPP and no offerings have been authorized.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-3" decimals="INF" id="f-443" unitRef="shares">1280971</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-116"
      decimals="INF"
      id="f-444"
      unitRef="shares">645103</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-117"
      decimals="INF"
      id="f-445"
      unitRef="shares">178953</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-118"
      decimals="INF"
      id="f-446"
      unitRef="shares">456915</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-447">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options for the three months ended March 31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,621,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;524,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(20,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,123,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,574,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;18.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-448" unitRef="shares">2621203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-449"
      unitRef="usdPerShare">13.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-119" id="f-450">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-451" unitRef="usd">5057000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-452" unitRef="shares">524793</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-453"
      unitRef="usdPerShare">8.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-454" unitRef="shares">20431</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-455"
      unitRef="usdPerShare">4.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-456" unitRef="shares">2347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-457"
      unitRef="usdPerShare">4.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="INF" id="f-458" unitRef="shares">3123218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-459"
      unitRef="usdPerShare">12.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-460">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="-3" id="f-461" unitRef="usd">11552000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-3" decimals="INF" id="f-462" unitRef="shares">1574201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-463"
      unitRef="usdPerShare">18.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-464">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="-3" id="f-465" unitRef="usd">6140000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-466" unitRef="shares">524793</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-467"
      unitRef="usdPerShare">6.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-3" decimals="-5" id="f-468" unitRef="usd">8100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-469">P3Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-470">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;105.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;106.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-120" decimals="3" id="f-471" unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-121" decimals="3" id="f-472" unitRef="number">0.044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-120" decimals="3" id="f-473" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-120" decimals="3" id="f-474" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-120" id="f-475">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-121" id="f-476">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-120" decimals="3" id="f-477" unitRef="number">1.054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-121" decimals="3" id="f-478" unitRef="number">1.069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-479">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s restricted stock units (&#x201c;RSUs&#x201d;) for the three months ended March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Grant Date Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested as of December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;RSUs forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested as of March&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-122"
      decimals="INF"
      id="f-480"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-122"
      decimals="2"
      id="f-481"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-123"
      decimals="INF"
      id="f-482"
      unitRef="shares">235234</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-123"
      decimals="2"
      id="f-483"
      unitRef="usdPerShare">8.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="c-1" decimals="INF" id="f-484" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-123"
      decimals="INF"
      id="f-485"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-123"
      decimals="2"
      id="f-486"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-124"
      decimals="INF"
      id="f-487"
      unitRef="shares">235234</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-124"
      decimals="2"
      id="f-488"
      unitRef="usdPerShare">8.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-124" decimals="-5" id="f-489" unitRef="usd">1800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-123" id="f-490">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-491">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense, which includes expense related to stock options and RSUs, as recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-125" decimals="-3" id="f-492" unitRef="usd">350000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-126" decimals="-3" id="f-493" unitRef="usd">288000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-127" decimals="-3" id="f-494" unitRef="usd">518000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-128" decimals="-3" id="f-495" unitRef="usd">229000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-496" unitRef="usd">868000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-497" unitRef="usd">517000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-129"
      decimals="INF"
      id="f-498"
      unitRef="shares">453312</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-129"
      decimals="INF"
      id="f-499"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <eltx:WarrantsAndRightsOutstandingTextBlock contextRef="c-1" id="f-500">Warrants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with FASB ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 815&#x201d;), certain of the Company&#x2019;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Notes 1 and 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of 1,261,830 shares of common stock and the January 2025 Common Warrants consist of common warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrants were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7 million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Notes 1 and 6, in June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the three months ended March&#160;31, 2026, there was no warrant activity in the period. The following tables summarize information regarding the warrants outstanding at March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.905%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.548%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Underlying the Warrants Outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;144,814&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,032,702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;441,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,261,830&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;June 2025 Common Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;103,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Warrants Outstanding at March&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of March&#160;31, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.&lt;/span&gt;&lt;/div&gt;</eltx:WarrantsAndRightsOutstandingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-108" decimals="0" id="f-501" unitRef="shares">1261830</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-109"
      decimals="INF"
      id="f-502"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-130"
      decimals="3"
      id="f-503"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-130"
      decimals="1"
      id="f-504"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-131" id="f-505">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-109" decimals="-5" id="f-506" unitRef="usd">9700000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-65"
      decimals="INF"
      id="f-507"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="2"
      id="f-508"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-64" id="f-509">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-132" decimals="-5" id="f-510" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-511">The following tables summarize information regarding the warrants outstanding at March&#160;31, 2026:&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.905%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.548%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares Underlying the Warrants Outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;144,814&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,032,702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;441,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,261,830&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;June 2025 Common Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;103,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Warrants Outstanding at March&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of March&#160;31, 2026 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-133"
      decimals="INF"
      id="f-512"
      unitRef="shares">144814</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-134"
      decimals="2"
      id="f-513"
      unitRef="usdPerShare">53.59</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-135" id="f-514">P3Y3M18D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-136"
      decimals="INF"
      id="f-515"
      unitRef="shares">3950</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-137"
      decimals="2"
      id="f-516"
      unitRef="usdPerShare">76.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-138" id="f-517">P2Y4M24D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-139"
      decimals="INF"
      id="f-518"
      unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-140"
      decimals="2"
      id="f-519"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-141"
      decimals="INF"
      id="f-520"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-142"
      decimals="2"
      id="f-521"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-143"
      decimals="INF"
      id="f-522"
      unitRef="shares">441500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-144"
      decimals="2"
      id="f-523"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-145" id="f-524">P3Y3M18D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-146"
      decimals="INF"
      id="f-525"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-147"
      decimals="2"
      id="f-526"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-148" id="f-527">P3Y3M18D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-109"
      decimals="INF"
      id="f-528"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-149"
      decimals="2"
      id="f-529"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-150" id="f-530">P3Y9M18D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-151"
      decimals="INF"
      id="f-531"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-152"
      decimals="2"
      id="f-532"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-153" id="f-533">P4Y2M12D</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="INF" id="f-534" unitRef="shares">6188021</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-154"
      decimals="2"
      id="f-535"
      unitRef="usdPerShare">4.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-1" id="f-536">P3Y6M</eltx:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-537">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Legal Proceedings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company may be exposed to litigation in connection with its products under development and operations. The Company&#x2019;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from the Massachusetts Institute of Technology (&#x201c;MIT&#x201d;), which agreement has been amended from time to time to add additional intellectual property rights to the Company&#x2019;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from 0.25% - 2.00%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company would be required to pay a total of up to $26.2&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur. No such expenses were recorded in the three months ended March 31, 2026 and 2025. No commercialization royalties have been achieved to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2026 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <eltx:RoyaltyRatePercent contextRef="c-155" decimals="4" id="f-538" unitRef="number">0.0025</eltx:RoyaltyRatePercent>
    <eltx:RoyaltyRatePercent contextRef="c-156" decimals="4" id="f-539" unitRef="number">0.0200</eltx:RoyaltyRatePercent>
    <eltx:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-157" decimals="-5" id="f-540" unitRef="usd">26200000</eltx:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-158" decimals="-5" id="f-541" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RoyaltyExpense contextRef="c-159" decimals="-3" id="f-542" unitRef="usd">0</us-gaap:RoyaltyExpense>
    <eltx:CollaborativeArrangementFutureMinimumMaintenancePayments contextRef="c-160" decimals="-5" id="f-543" unitRef="usd">100000</eltx:CollaborativeArrangementFutureMinimumMaintenancePayments>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-544">Leases&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#x201c;Boston Lease&#x201d;). The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#x201c;ROU&#x201d;) lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of March&#160;31, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease expense for the three months ended March 31, 2026 and 2025 was $0.3 million and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"&gt;As of March&#160;31, 2026, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026 (remaining nine months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense contextRef="c-161" decimals="-5" id="f-545" unitRef="usd">11100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-162" decimals="-5" id="f-546" unitRef="usd">8000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-162" decimals="-5" id="f-547" unitRef="usd">8000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ProceedsFromSecuredLinesOfCredit contextRef="c-163" decimals="-5" id="f-548" unitRef="usd">700000</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-5" id="f-549" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-5" decimals="-5" id="f-550" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock contextRef="c-1" id="f-551">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</eltx:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-552" unitRef="usd">341000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-3" id="f-553" unitRef="usd">334000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-554">P3Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-46" id="f-555">P4Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-556" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-46" decimals="3" id="f-557" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-558">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"&gt;As of March&#160;31, 2026, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026 (remaining nine months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-559" unitRef="usd">1042000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-560" unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-561" unitRef="usd">1467000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-562" unitRef="usd">1512000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-563" unitRef="usd">253000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-564" unitRef="usd">5699000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-565" unitRef="usd">834000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-566" unitRef="usd">4865000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-567" unitRef="usd">1042000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-568" unitRef="usd">3823000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-569">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As discussed in Note 6, in August 2024, the Company closed the Convertible Note Financing with GKCC pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, and had an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was de minimis. In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As discussed in Notes 1 and 8, in June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. As of March&#160;31, 2026, the interest rate was 12.5% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by 3%, 2%, or 1%, respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of March&#160;31, 2026, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#x2019;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company received net proceeds of approximately $9.9 million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of March&#160;31, 2026, the net carrying value of the June 2025 Promissory Note was $9.5 million and the debt discount for the June 2025 Promissory Note was $0.5 million. For the three months ended March 31, 2026, the Company recognized $0.1 million in accretion of the debt discount and $0.3 million in accrued interest recognized on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-570" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-112" decimals="2" id="f-571" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-113" decimals="-5" id="f-572" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-114"
      decimals="INF"
      id="f-573"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-574" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <eltx:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-115" decimals="-5" id="f-575" unitRef="usd">300000</eltx:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-64" decimals="-5" id="f-576" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-66" decimals="4" id="f-577" unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-164" decimals="3" id="f-578" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-165" decimals="3" id="f-579" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-166" decimals="2" id="f-580" unitRef="number">0.03</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-167" decimals="2" id="f-581" unitRef="number">0.02</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-168" decimals="2" id="f-582" unitRef="number">0.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-64"
      decimals="INF"
      id="f-583"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="2"
      id="f-584"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-64" id="f-585">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <eltx:ClassOfWarrantOrRightOwnershipPercentMaximum contextRef="c-169" decimals="4" id="f-586" unitRef="number">0.4999</eltx:ClassOfWarrantOrRightOwnershipPercentMaximum>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-132" decimals="-5" id="f-587" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-66" decimals="-5" id="f-588" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-165" decimals="-5" id="f-589" unitRef="usd">9500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-165" decimals="-5" id="f-590" unitRef="usd">500000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-170" decimals="-5" id="f-591" unitRef="usd">100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="c-165" decimals="-5" id="f-592" unitRef="usd">300000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-593">Income Taxes&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company did not record a provision or benefit for income taxes during the three months ended March&#160;31, 2026 or 2025. As of March&#160;31, 2026 and December&#160;31, 2025, the Company continued to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 4, 2025, H.R. 1 (the &#x201c;Act&#x201d;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December 31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="INF" id="f-594" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="INF" id="f-595" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-596">Net Loss Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2026 and 2025 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average of common shares and pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,211,745&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,950,574&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:116%"&gt; The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123,218&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642,099&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested shares under restricted stock grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,913,771&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,907,552&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-597">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three months ended March&#160;31, 2026 and 2025 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(11,209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average of common shares and pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,211,745&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,950,574&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-598" unitRef="usd">-11823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-599" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-600" unitRef="shares">18211745</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-601" unitRef="shares">18211745</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-602" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-603" unitRef="shares">12950574</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-604"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-606"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-607"
      unitRef="usdPerShare">-0.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-608">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123,218&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642,099&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Unvested shares under restricted stock grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;235,234&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,913,771&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,907,552&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-171" decimals="0" id="f-609" unitRef="shares">3123218</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-172" decimals="0" id="f-610" unitRef="shares">2265453</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-173" decimals="0" id="f-611" unitRef="shares">3555319</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-174" decimals="0" id="f-612" unitRef="shares">3642099</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-175" decimals="0" id="f-613" unitRef="shares">235234</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-176" decimals="0" id="f-614" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-615" unitRef="shares">6913771</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="0" id="f-616" unitRef="shares">5907552</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-617">Related Party Transactions&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement and Subscription Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into a subscription agreement (the &#x201c;March Subscription Agreement&#x201d;) with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#x201c;March 2024 Pre-Funded Warrants&#x201d;) to purchase up to 1,032,702 shares of common stock. As of March&#160;31, 2026, all 1,032,702 of the March 2024 Pre-Funded Warrants held by GKCC remained outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;July 2024 Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the July 2024 Public Offering described in Note 3, Yekaterina Chudnovsky, a member of the Company&#x2019;s board of directors, purchased 1,600,000 of the July 2024 Pre-Funded Warrants and 1,600,000 of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, all of the 1,600,000 July 2024 Pre-Funded Warrants and accompanying 1,600,000 July 2024 Common Warrants held by Yekaterina Chudnovsky remained outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Jay Venkatesan, a member of the Company&#x2019;s board of directors, and certain independently managed family trusts  purchased 200,000 of the July 2024 Pre-Funded Warrants and 200,000 of the accompanying July 2024 Common Warrants. As of March&#160;31, 2026, 200,000 of the July Common Warrants held by Jay Venkatesan and the family trusts remained outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company closed the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0 million. The Company received net proceeds of approximately $9.9 million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. As of March&#160;31, 2026, the June 2025 Common Warrant held by GKCC remained outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-139"
      decimals="INF"
      id="f-618"
      unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-139"
      decimals="INF"
      id="f-619"
      unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-141"
      decimals="INF"
      id="f-620"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-146"
      decimals="INF"
      id="f-621"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-141"
      decimals="INF"
      id="f-622"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-146"
      decimals="INF"
      id="f-623"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eltx:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-177" decimals="0" id="f-624" unitRef="shares">200000</eltx:ClassOfWarrantOrRightIssuedInPeriod>
    <eltx:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-177" decimals="0" id="f-625" unitRef="shares">200000</eltx:ClassOfWarrantOrRightIssuedInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-178" decimals="0" id="f-626" unitRef="shares">200000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-627" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-113" decimals="-5" id="f-628" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-114"
      decimals="INF"
      id="f-629"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-112" decimals="-5" id="f-630" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <eltx:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-115" decimals="-5" id="f-631" unitRef="usd">300000</eltx:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-64" decimals="INF" id="f-632" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-66" decimals="-5" id="f-633" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-64"
      decimals="INF"
      id="f-634"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-635">Segment Reporting&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;), its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other segment items include interest income, interest expense, and change in the fair value of liability-classified warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c-1" decimals="INF" id="f-636" unitRef="entity">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-637">The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other segment items include interest income, interest expense, and change in the fair value of liability-classified warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-179" decimals="-3" id="f-638" unitRef="usd">1181000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-180" decimals="-3" id="f-639" unitRef="usd">4192000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-181" decimals="-3" id="f-640" unitRef="usd">2684000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-182" decimals="-3" id="f-641" unitRef="usd">2298000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-183" decimals="-3" id="f-642" unitRef="usd">1736000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-184" decimals="-3" id="f-643" unitRef="usd">646000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-185" decimals="-3" id="f-644" unitRef="usd">1171000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-186" decimals="-3" id="f-645" unitRef="usd">1136000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-187" decimals="-3" id="f-646" unitRef="usd">0</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-188" decimals="-3" id="f-647" unitRef="usd">-489000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-187" decimals="-3" id="f-648" unitRef="usd">1810000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-188" decimals="-3" id="f-649" unitRef="usd">1087000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-187" decimals="-3" id="f-650" unitRef="usd">2020000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-188" decimals="-3" id="f-651" unitRef="usd">1866000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-187" decimals="-3" id="f-652" unitRef="usd">1221000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-188" decimals="-3" id="f-653" unitRef="usd">473000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:NetIncomeLoss contextRef="c-187" decimals="-3" id="f-654" unitRef="usd">11823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-188" decimals="-3" id="f-655" unitRef="usd">11209000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-189" decimals="-3" id="f-656" unitRef="usd">22689000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-190" decimals="-3" id="f-657" unitRef="usd">28178000</us-gaap:Assets>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-658">Subsequent Events&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of March&#160;31, 2026 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of March&#160;31, 2026, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2026 ATM Program&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Subsequent to the period ended March 31, 2026 through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;May&#160;8, 2026&lt;/span&gt;, the Company issued and sold 445,456 shares of common stock for net proceeds of $5.0 million under the 2026 ATM Program.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-191"
      decimals="INF"
      id="f-659"
      unitRef="shares">445456</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-191" decimals="-5" id="f-660" unitRef="usd">5000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-661">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-662">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-663">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-664">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
